BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1492315 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C27H24FN5O2/c1-33-14-12-21-24(27(33)35)26(30-20-5-3-2-4-6-20)25(31-21)18-11-13-29-22(16-18)32-23(34)15-17-7-9-19(28)10-8-17/h2-11,13,16,30-31H,12,14-15H2,1H3,(H,29,32,34) AFSLPDXBYRNVPE-UHFFFAOYSA-N 721030 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 1 Casein kinase I isoform alpha Homo sapiens 2.54 US Patent 10.7270/Q21C22F4 aid2061065 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721030 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721030&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674350 513841082 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492316 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C27H24FN5O2/c1-33-14-12-21-24(27(33)35)26(30-20-5-3-2-4-6-20)25(31-21)18-11-13-29-22(16-18)32-23(34)15-17-7-9-19(28)10-8-17/h2-11,13,16,30-31H,12,14-15H2,1H3,(H,29,32,34) AFSLPDXBYRNVPE-UHFFFAOYSA-N 721030 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 1 Casein kinase I isoform alpha Homo sapiens 1.97 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721030 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721030&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674350 513841082 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492317 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C27H24FN5O2/c1-33-14-12-21-24(27(33)35)26(30-20-5-3-2-4-6-20)25(31-21)18-11-13-29-22(16-18)32-23(34)15-17-7-9-19(28)10-8-17/h2-11,13,16,30-31H,12,14-15H2,1H3,(H,29,32,34) AFSLPDXBYRNVPE-UHFFFAOYSA-N 721030 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 1 Casein kinase I isoform delta Homo sapiens 5.64 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721030 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721030&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674350 513841082 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492318 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C27H24FN5O2/c1-33-14-12-21-24(27(33)35)26(30-20-5-3-2-4-6-20)25(31-21)18-11-13-29-22(16-18)32-23(34)15-17-7-9-19(28)10-8-17/h2-11,13,16,30-31H,12,14-15H2,1H3,(H,29,32,34) AFSLPDXBYRNVPE-UHFFFAOYSA-N 721030 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 1 Casein kinase I isoform alpha Homo sapiens 28.4 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721030 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721030&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674350 513841082 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492319 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccccc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C27H25N5O2/c1-32-15-13-21-24(27(32)34)26(29-20-10-6-3-7-11-20)25(30-21)19-12-14-28-22(17-19)31-23(33)16-18-8-4-2-5-9-18/h2-12,14,17,29-30H,13,15-16H2,1H3,(H,28,31,33) NCIGMDJBHNIAJD-UHFFFAOYSA-N 721045 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-phenylacetamide::US12227501, Example 2 Casein kinase I isoform alpha Homo sapiens 3.95 US Patent 10.7270/Q21C22F4 aid2061065 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721045 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721045&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674295 513841097 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492320 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccccc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C27H25N5O2/c1-32-15-13-21-24(27(32)34)26(29-20-10-6-3-7-11-20)25(30-21)19-12-14-28-22(17-19)31-23(33)16-18-8-4-2-5-9-18/h2-12,14,17,29-30H,13,15-16H2,1H3,(H,28,31,33) NCIGMDJBHNIAJD-UHFFFAOYSA-N 721045 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-phenylacetamide::US12227501, Example 2 Casein kinase I isoform delta Homo sapiens 5.41 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721045 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721045&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674295 513841097 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492321 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccccc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C27H25N5O2/c1-32-15-13-21-24(27(32)34)26(29-20-10-6-3-7-11-20)25(30-21)19-12-14-28-22(17-19)31-23(33)16-18-8-4-2-5-9-18/h2-12,14,17,29-30H,13,15-16H2,1H3,(H,28,31,33) NCIGMDJBHNIAJD-UHFFFAOYSA-N 721045 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-phenylacetamide::US12227501, Example 2 Casein kinase I isoform alpha Homo sapiens 114 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721045 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721045&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674295 513841097 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492322 Cc1cc(CC(=O)Nc2cc(-c3[nH]c4c(c3Nc3ccccc3)C(=O)N(C)CC4)ccn2)ccc1F InChI=1S/C28H26FN5O2/c1-17-14-18(8-9-21(17)29)15-24(35)33-23-16-19(10-12-30-23)26-27(31-20-6-4-3-5-7-20)25-22(32-26)11-13-34(2)28(25)36/h3-10,12,14,16,31-32H,11,13,15H2,1-2H3,(H,30,33,35) PUKUDMLAYTVLDN-UHFFFAOYSA-N 721046 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluoro-3-methylphenyl)acetamide::US12227501, Example 3 Casein kinase I isoform alpha Homo sapiens 4.28 US Patent 10.7270/Q21C22F4 aid2061065 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721046 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721046&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674271 513841098 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492323 Cc1cc(CC(=O)Nc2cc(-c3[nH]c4c(c3Nc3ccccc3)C(=O)N(C)CC4)ccn2)ccc1F InChI=1S/C28H26FN5O2/c1-17-14-18(8-9-21(17)29)15-24(35)33-23-16-19(10-12-30-23)26-27(31-20-6-4-3-5-7-20)25-22(32-26)11-13-34(2)28(25)36/h3-10,12,14,16,31-32H,11,13,15H2,1-2H3,(H,30,33,35) PUKUDMLAYTVLDN-UHFFFAOYSA-N 721046 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluoro-3-methylphenyl)acetamide::US12227501, Example 3 Casein kinase I isoform delta Homo sapiens 5.66 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721046 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721046&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674271 513841098 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492324 Cc1cc(CC(=O)Nc2cc(-c3[nH]c4c(c3Nc3ccccc3)C(=O)N(C)CC4)ccn2)ccc1F InChI=1S/C28H26FN5O2/c1-17-14-18(8-9-21(17)29)15-24(35)33-23-16-19(10-12-30-23)26-27(31-20-6-4-3-5-7-20)25-22(32-26)11-13-34(2)28(25)36/h3-10,12,14,16,31-32H,11,13,15H2,1-2H3,(H,30,33,35) PUKUDMLAYTVLDN-UHFFFAOYSA-N 721046 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluoro-3-methylphenyl)acetamide::US12227501, Example 3 Casein kinase I isoform alpha Homo sapiens 78.4 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721046 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721046&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674271 513841098 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492325 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C28H26FN5O2/c1-17(18-8-10-20(29)11-9-18)27(35)33-23-16-19(12-14-30-23)25-26(31-21-6-4-3-5-7-21)24-22(32-25)13-15-34(2)28(24)36/h3-12,14,16-17,31-32H,13,15H2,1-2H3,(H,30,33,35) UYAQWCZWVIFRCN-UHFFFAOYSA-N 721047 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide::US12227501, Example 4 Casein kinase I isoform alpha Homo sapiens 11.2 US Patent 10.7270/Q21C22F4 aid2061065 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721047 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721047&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674286 513841099 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492326 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C28H26FN5O2/c1-17(18-8-10-20(29)11-9-18)27(35)33-23-16-19(12-14-30-23)25-26(31-21-6-4-3-5-7-21)24-22(32-25)13-15-34(2)28(24)36/h3-12,14,16-17,31-32H,13,15H2,1-2H3,(H,30,33,35) UYAQWCZWVIFRCN-UHFFFAOYSA-N 721047 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide::US12227501, Example 4 Casein kinase I isoform alpha Homo sapiens 5.49 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721047 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721047&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674286 513841099 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492327 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C28H26FN5O2/c1-17(18-8-10-20(29)11-9-18)27(35)33-23-16-19(12-14-30-23)25-26(31-21-6-4-3-5-7-21)24-22(32-25)13-15-34(2)28(24)36/h3-12,14,16-17,31-32H,13,15H2,1-2H3,(H,30,33,35) UYAQWCZWVIFRCN-UHFFFAOYSA-N 721047 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide::US12227501, Example 4 Casein kinase I isoform delta Homo sapiens 15.1 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721047 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721047&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674286 513841099 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492328 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C28H26FN5O2/c1-17(18-8-10-20(29)11-9-18)27(35)33-23-16-19(12-14-30-23)25-26(31-21-6-4-3-5-7-21)24-22(32-25)13-15-34(2)28(24)36/h3-12,14,16-17,31-32H,13,15H2,1-2H3,(H,30,33,35) UYAQWCZWVIFRCN-UHFFFAOYSA-N 721047 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide::US12227501, Example 4 Casein kinase I isoform alpha Homo sapiens 115 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721047 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721047&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674286 513841099 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492329 C[C@H](C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C28H26FN5O2/c1-17(18-8-10-20(29)11-9-18)27(35)33-23-16-19(12-14-30-23)25-26(31-21-6-4-3-5-7-21)24-22(32-25)13-15-34(2)28(24)36/h3-12,14,16-17,31-32H,13,15H2,1-2H3,(H,30,33,35) UYAQWCZWVIFRCN-UHFFFAOYSA-N 721048 (2S)—N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Stereoisomer 1)::US12227501, Example 5 Casein kinase I isoform alpha Homo sapiens 3.62 US Patent 10.7270/Q21C22F4 aid2061065 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721048 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721048&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674384 513841100 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492330 C[C@H](C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C28H26FN5O2/c1-17(18-8-10-20(29)11-9-18)27(35)33-23-16-19(12-14-30-23)25-26(31-21-6-4-3-5-7-21)24-22(32-25)13-15-34(2)28(24)36/h3-12,14,16-17,31-32H,13,15H2,1-2H3,(H,30,33,35) UYAQWCZWVIFRCN-UHFFFAOYSA-N 721048 (2S)—N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Stereoisomer 1)::US12227501, Example 5 Casein kinase I isoform alpha Homo sapiens 4.45 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721048 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721048&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674384 513841100 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492331 C[C@H](C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C28H26FN5O2/c1-17(18-8-10-20(29)11-9-18)27(35)33-23-16-19(12-14-30-23)25-26(31-21-6-4-3-5-7-21)24-22(32-25)13-15-34(2)28(24)36/h3-12,14,16-17,31-32H,13,15H2,1-2H3,(H,30,33,35) UYAQWCZWVIFRCN-UHFFFAOYSA-N 721048 (2S)—N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Stereoisomer 1)::US12227501, Example 5 Casein kinase I isoform delta Homo sapiens 12.1 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721048 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721048&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674384 513841100 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492332 C[C@H](C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C28H26FN5O2/c1-17(18-8-10-20(29)11-9-18)27(35)33-23-16-19(12-14-30-23)25-26(31-21-6-4-3-5-7-21)24-22(32-25)13-15-34(2)28(24)36/h3-12,14,16-17,31-32H,13,15H2,1-2H3,(H,30,33,35) UYAQWCZWVIFRCN-UHFFFAOYSA-N 721048 (2S)—N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Stereoisomer 1)::US12227501, Example 5 Casein kinase I isoform alpha Homo sapiens 63.4 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721048 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721048&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674384 513841100 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492333 C[C@@H](C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C28H26FN5O2/c1-17(18-8-10-20(29)11-9-18)27(35)33-23-16-19(12-14-30-23)25-26(31-21-6-4-3-5-7-21)24-22(32-25)13-15-34(2)28(24)36/h3-12,14,16-17,31-32H,13,15H2,1-2H3,(H,30,33,35) UYAQWCZWVIFRCN-UHFFFAOYSA-N 721049 (2R)—N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Stereoisomer 2)::US12227501, Example 6 Casein kinase I isoform alpha Homo sapiens 33.3 US Patent 10.7270/Q21C22F4 aid2061065 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721049 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721049&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674407 513841101 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492334 C[C@@H](C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C28H26FN5O2/c1-17(18-8-10-20(29)11-9-18)27(35)33-23-16-19(12-14-30-23)25-26(31-21-6-4-3-5-7-21)24-22(32-25)13-15-34(2)28(24)36/h3-12,14,16-17,31-32H,13,15H2,1-2H3,(H,30,33,35) UYAQWCZWVIFRCN-UHFFFAOYSA-N 721049 (2R)—N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Stereoisomer 2)::US12227501, Example 6 Casein kinase I isoform alpha Homo sapiens 44.0 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721049 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721049&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674407 513841101 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492335 C[C@@H](C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C28H26FN5O2/c1-17(18-8-10-20(29)11-9-18)27(35)33-23-16-19(12-14-30-23)25-26(31-21-6-4-3-5-7-21)24-22(32-25)13-15-34(2)28(24)36/h3-12,14,16-17,31-32H,13,15H2,1-2H3,(H,30,33,35) UYAQWCZWVIFRCN-UHFFFAOYSA-N 721049 (2R)—N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Stereoisomer 2)::US12227501, Example 6 Casein kinase I isoform delta Homo sapiens 49.6 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721049 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721049&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674407 513841101 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492336 C[C@@H](C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C28H26FN5O2/c1-17(18-8-10-20(29)11-9-18)27(35)33-23-16-19(12-14-30-23)25-26(31-21-6-4-3-5-7-21)24-22(32-25)13-15-34(2)28(24)36/h3-12,14,16-17,31-32H,13,15H2,1-2H3,(H,30,33,35) UYAQWCZWVIFRCN-UHFFFAOYSA-N 721049 (2R)—N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Stereoisomer 2)::US12227501, Example 6 Casein kinase I isoform alpha Homo sapiens 1600 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721049 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721049&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674407 513841101 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492337 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C2CC2)CC3)ccn1 InChI=1S/C29H26FN5O2/c30-20-8-6-18(7-9-20)16-25(36)34-24-17-19(12-14-31-24)27-28(32-21-4-2-1-3-5-21)26-23(33-27)13-15-35(29(26)37)22-10-11-22/h1-9,12,14,17,22,32-33H,10-11,13,15-16H2,(H,31,34,36) HUWCGRYLNBSQLN-UHFFFAOYSA-N 721050 N-[4-(3-anilino-5-cyclopropyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 7 Casein kinase I isoform alpha Homo sapiens 2.52 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721050 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721050&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674329 513841102 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492338 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C2CC2)CC3)ccn1 InChI=1S/C29H26FN5O2/c30-20-8-6-18(7-9-20)16-25(36)34-24-17-19(12-14-31-24)27-28(32-21-4-2-1-3-5-21)26-23(33-27)13-15-35(29(26)37)22-10-11-22/h1-9,12,14,17,22,32-33H,10-11,13,15-16H2,(H,31,34,36) HUWCGRYLNBSQLN-UHFFFAOYSA-N 721050 N-[4-(3-anilino-5-cyclopropyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 7 Casein kinase I isoform delta Homo sapiens 8.48 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721050 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721050&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674329 513841102 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492339 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C2CC2)CC3)ccn1 InChI=1S/C29H26FN5O2/c30-20-8-6-18(7-9-20)16-25(36)34-24-17-19(12-14-31-24)27-28(32-21-4-2-1-3-5-21)26-23(33-27)13-15-35(29(26)37)22-10-11-22/h1-9,12,14,17,22,32-33H,10-11,13,15-16H2,(H,31,34,36) HUWCGRYLNBSQLN-UHFFFAOYSA-N 721050 N-[4-(3-anilino-5-cyclopropyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 7 Casein kinase I isoform alpha Homo sapiens 107 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721050 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721050&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674329 513841102 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492340 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C2CC2)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C30H28FN5O2/c1-18(19-7-9-21(31)10-8-19)29(37)35-25-17-20(13-15-32-25)27-28(33-22-5-3-2-4-6-22)26-24(34-27)14-16-36(30(26)38)23-11-12-23/h2-10,13,15,17-18,23,33-34H,11-12,14,16H2,1H3,(H,32,35,37) KAPROIFCQLMDFT-UHFFFAOYSA-N 721051 N-[4-(3-anilino-5-cyclopropyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide::US12227501, Example 8 Casein kinase I isoform alpha Homo sapiens 15.4 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721051 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721051&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674409 513841103 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492341 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C2CC2)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C30H28FN5O2/c1-18(19-7-9-21(31)10-8-19)29(37)35-25-17-20(13-15-32-25)27-28(33-22-5-3-2-4-6-22)26-24(34-27)14-16-36(30(26)38)23-11-12-23/h2-10,13,15,17-18,23,33-34H,11-12,14,16H2,1H3,(H,32,35,37) KAPROIFCQLMDFT-UHFFFAOYSA-N 721051 N-[4-(3-anilino-5-cyclopropyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide::US12227501, Example 8 Casein kinase I isoform delta Homo sapiens 37.9 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721051 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721051&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674409 513841103 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492342 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C2CC2)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C30H28FN5O2/c1-18(19-7-9-21(31)10-8-19)29(37)35-25-17-20(13-15-32-25)27-28(33-22-5-3-2-4-6-22)26-24(34-27)14-16-36(30(26)38)23-11-12-23/h2-10,13,15,17-18,23,33-34H,11-12,14,16H2,1H3,(H,32,35,37) KAPROIFCQLMDFT-UHFFFAOYSA-N 721051 N-[4-(3-anilino-5-cyclopropyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide::US12227501, Example 8 Casein kinase I isoform alpha Homo sapiens 1930 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721051 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721051&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674409 513841103 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492343 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NCC3)ccn1)c1ccc(F)cc1 InChI=1S/C27H24FN5O2/c1-16(17-7-9-19(28)10-8-17)26(34)33-22-15-18(11-13-29-22)24-25(31-20-5-3-2-4-6-20)23-21(32-24)12-14-30-27(23)35/h2-11,13,15-16,31-32H,12,14H2,1H3,(H,30,35)(H,29,33,34) UMQXUQDUPKDQIR-UHFFFAOYSA-N 721052 N-[4-(3-anilino-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Stereoisomer 1)::US12227501, Example 10 Casein kinase I isoform alpha Homo sapiens 4.61 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721052 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721052&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674250 513841104 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492344 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NCC3)ccn1)c1ccc(F)cc1 InChI=1S/C27H24FN5O2/c1-16(17-7-9-19(28)10-8-17)26(34)33-22-15-18(11-13-29-22)24-25(31-20-5-3-2-4-6-20)23-21(32-24)12-14-30-27(23)35/h2-11,13,15-16,31-32H,12,14H2,1H3,(H,30,35)(H,29,33,34) UMQXUQDUPKDQIR-UHFFFAOYSA-N 721052 N-[4-(3-anilino-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Stereoisomer 1)::US12227501, Example 10 Casein kinase I isoform delta Homo sapiens 14.0 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721052 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721052&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674250 513841104 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492345 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NCC3)ccn1)c1ccc(F)cc1 InChI=1S/C27H24FN5O2/c1-16(17-7-9-19(28)10-8-17)26(34)33-22-15-18(11-13-29-22)24-25(31-20-5-3-2-4-6-20)23-21(32-24)12-14-30-27(23)35/h2-11,13,15-16,31-32H,12,14H2,1H3,(H,30,35)(H,29,33,34) UMQXUQDUPKDQIR-UHFFFAOYSA-N 721052 N-[4-(3-anilino-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Stereoisomer 1)::US12227501, Example 10 Casein kinase I isoform alpha Homo sapiens 25.5 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721052 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721052&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674250 513841104 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492346 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NCC3)ccn1)c1ccc(F)cc1 InChI=1S/C27H24FN5O2/c1-16(17-7-9-19(28)10-8-17)26(34)33-22-15-18(11-13-29-22)24-25(31-20-5-3-2-4-6-20)23-21(32-24)12-14-30-27(23)35/h2-11,13,15-16,31-32H,12,14H2,1H3,(H,30,35)(H,29,33,34) UMQXUQDUPKDQIR-UHFFFAOYSA-N 721053 N-[4-(3-anilino-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Stereoisomer 2)::US12227501, Example 11 Casein kinase I isoform alpha Homo sapiens 30.4 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721053&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674250 513841105 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492347 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NCC3)ccn1)c1ccc(F)cc1 InChI=1S/C27H24FN5O2/c1-16(17-7-9-19(28)10-8-17)26(34)33-22-15-18(11-13-29-22)24-25(31-20-5-3-2-4-6-20)23-21(32-24)12-14-30-27(23)35/h2-11,13,15-16,31-32H,12,14H2,1H3,(H,30,35)(H,29,33,34) UMQXUQDUPKDQIR-UHFFFAOYSA-N 721053 N-[4-(3-anilino-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Stereoisomer 2)::US12227501, Example 11 Casein kinase I isoform delta Homo sapiens 30.8 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721053&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674250 513841105 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492348 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NCC3)ccn1)c1ccc(F)cc1 InChI=1S/C27H24FN5O2/c1-16(17-7-9-19(28)10-8-17)26(34)33-22-15-18(11-13-29-22)24-25(31-20-5-3-2-4-6-20)23-21(32-24)12-14-30-27(23)35/h2-11,13,15-16,31-32H,12,14H2,1H3,(H,30,35)(H,29,33,34) UMQXUQDUPKDQIR-UHFFFAOYSA-N 721053 N-[4-(3-anilino-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Stereoisomer 2)::US12227501, Example 11 Casein kinase I isoform alpha Homo sapiens 3970 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721053&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674250 513841105 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492349 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccn3)c2C1=O InChI=1S/C26H23FN6O2/c1-33-13-10-19-23(26(33)35)25(32-20-4-2-3-11-28-20)24(30-19)17-9-12-29-21(15-17)31-22(34)14-16-5-7-18(27)8-6-16/h2-9,11-12,15,30H,10,13-14H2,1H3,(H,28,32)(H,29,31,34) GUNUORYXEAKXIM-UHFFFAOYSA-N 721054 2-(4-fluorophenyl)-N-(4-{5-methyl-4-oxo-3-[(pyridin-2-yl)amino]-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl}pyridin-2-yl)acetamide::US12227501, Example 12 Casein kinase I isoform alpha Homo sapiens 2.32 US Patent 10.7270/Q21C22F4 aid2061065 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721054 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721054&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674326 513841106 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492350 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccn3)c2C1=O InChI=1S/C26H23FN6O2/c1-33-13-10-19-23(26(33)35)25(32-20-4-2-3-11-28-20)24(30-19)17-9-12-29-21(15-17)31-22(34)14-16-5-7-18(27)8-6-16/h2-9,11-12,15,30H,10,13-14H2,1H3,(H,28,32)(H,29,31,34) GUNUORYXEAKXIM-UHFFFAOYSA-N 721054 2-(4-fluorophenyl)-N-(4-{5-methyl-4-oxo-3-[(pyridin-2-yl)amino]-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl}pyridin-2-yl)acetamide::US12227501, Example 12 Casein kinase I isoform delta Homo sapiens 10.2 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721054 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721054&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674326 513841106 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492351 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccn3)c2C1=O InChI=1S/C26H23FN6O2/c1-33-13-10-19-23(26(33)35)25(32-20-4-2-3-11-28-20)24(30-19)17-9-12-29-21(15-17)31-22(34)14-16-5-7-18(27)8-6-16/h2-9,11-12,15,30H,10,13-14H2,1H3,(H,28,32)(H,29,31,34) GUNUORYXEAKXIM-UHFFFAOYSA-N 721054 2-(4-fluorophenyl)-N-(4-{5-methyl-4-oxo-3-[(pyridin-2-yl)amino]-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl}pyridin-2-yl)acetamide::US12227501, Example 12 Casein kinase I isoform alpha Homo sapiens 5.20 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721054 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721054&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674326 513841106 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492352 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2Cl)C(=O)NCC3)ccn1 InChI=1S/C26H21ClFN5O2/c27-18-3-1-2-4-19(18)31-25-23-20(10-12-30-26(23)35)32-24(25)16-9-11-29-21(14-16)33-22(34)13-15-5-7-17(28)8-6-15/h1-9,11,14,31-32H,10,12-13H2,(H,30,35)(H,29,33,34) CNNUFNBSGQUOFZ-UHFFFAOYSA-N 721055 N-{4-[3-(2-chloroanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 13 Casein kinase I isoform alpha Homo sapiens 1.90 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721055 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721055&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674269 513841107 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492353 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2Cl)C(=O)NCC3)ccn1 InChI=1S/C26H21ClFN5O2/c27-18-3-1-2-4-19(18)31-25-23-20(10-12-30-26(23)35)32-24(25)16-9-11-29-21(14-16)33-22(34)13-15-5-7-17(28)8-6-15/h1-9,11,14,31-32H,10,12-13H2,(H,30,35)(H,29,33,34) CNNUFNBSGQUOFZ-UHFFFAOYSA-N 721055 N-{4-[3-(2-chloroanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 13 Casein kinase I isoform delta Homo sapiens 7.06 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721055 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721055&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674269 513841107 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492354 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2Cl)C(=O)NCC3)ccn1 InChI=1S/C26H21ClFN5O2/c27-18-3-1-2-4-19(18)31-25-23-20(10-12-30-26(23)35)32-24(25)16-9-11-29-21(14-16)33-22(34)13-15-5-7-17(28)8-6-15/h1-9,11,14,31-32H,10,12-13H2,(H,30,35)(H,29,33,34) CNNUFNBSGQUOFZ-UHFFFAOYSA-N 721055 N-{4-[3-(2-chloroanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 13 Casein kinase I isoform alpha Homo sapiens 37.0 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721055 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721055&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674269 513841107 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492355 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2Cl)C(=O)NCC3)ccn1)c1ccc(F)cc1 InChI=1S/C27H23ClFN5O2/c1-15(16-6-8-18(29)9-7-16)26(35)34-22-14-17(10-12-30-22)24-25(32-20-5-3-2-4-19(20)28)23-21(33-24)11-13-31-27(23)36/h2-10,12,14-15,32-33H,11,13H2,1H3,(H,31,36)(H,30,34,35) CDPQTBTYURAFME-UHFFFAOYSA-N 721056 N-{4-[3-(2-chloroanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide::US12227501, Example 14 Casein kinase I isoform alpha Homo sapiens 4.96 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721056 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721056&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674290 513841108 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492356 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2Cl)C(=O)NCC3)ccn1)c1ccc(F)cc1 InChI=1S/C27H23ClFN5O2/c1-15(16-6-8-18(29)9-7-16)26(35)34-22-14-17(10-12-30-22)24-25(32-20-5-3-2-4-19(20)28)23-21(33-24)11-13-31-27(23)36/h2-10,12,14-15,32-33H,11,13H2,1H3,(H,31,36)(H,30,34,35) CDPQTBTYURAFME-UHFFFAOYSA-N 721056 N-{4-[3-(2-chloroanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide::US12227501, Example 14 Casein kinase I isoform delta Homo sapiens 14.0 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721056 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721056&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674290 513841108 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492357 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2Cl)C(=O)NCC3)ccn1)c1ccc(F)cc1 InChI=1S/C27H23ClFN5O2/c1-15(16-6-8-18(29)9-7-16)26(35)34-22-14-17(10-12-30-22)24-25(32-20-5-3-2-4-19(20)28)23-21(33-24)11-13-31-27(23)36/h2-10,12,14-15,32-33H,11,13H2,1H3,(H,31,36)(H,30,34,35) CDPQTBTYURAFME-UHFFFAOYSA-N 721056 N-{4-[3-(2-chloroanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide::US12227501, Example 14 Casein kinase I isoform alpha Homo sapiens 73.9 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721056 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721056&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674290 513841108 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492358 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2Cl)C(=O)NCC3)ccn1)c1ccc(F)cc1 InChI=1S/C27H23ClFN5O2/c1-15(16-6-8-18(29)9-7-16)26(35)34-22-14-17(10-12-30-22)24-25(32-20-5-3-2-4-19(20)28)23-21(33-24)11-13-31-27(23)36/h2-10,12,14-15,32-33H,11,13H2,1H3,(H,31,36)(H,30,34,35) CDPQTBTYURAFME-UHFFFAOYSA-N 721057 N-{4-[3-(2-chloroanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Stereoisomer 1)::US12227501, Example 15 Casein kinase I isoform alpha Homo sapiens 42.5 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721057 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721057&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674290 513841109 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492359 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2Cl)C(=O)NCC3)ccn1)c1ccc(F)cc1 InChI=1S/C27H23ClFN5O2/c1-15(16-6-8-18(29)9-7-16)26(35)34-22-14-17(10-12-30-22)24-25(32-20-5-3-2-4-19(20)28)23-21(33-24)11-13-31-27(23)36/h2-10,12,14-15,32-33H,11,13H2,1H3,(H,31,36)(H,30,34,35) CDPQTBTYURAFME-UHFFFAOYSA-N 721057 N-{4-[3-(2-chloroanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Stereoisomer 1)::US12227501, Example 15 Casein kinase I isoform delta Homo sapiens 38.6 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721057 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721057&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674290 513841109 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492360 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2Cl)C(=O)NCC3)ccn1)c1ccc(F)cc1 InChI=1S/C27H23ClFN5O2/c1-15(16-6-8-18(29)9-7-16)26(35)34-22-14-17(10-12-30-22)24-25(32-20-5-3-2-4-19(20)28)23-21(33-24)11-13-31-27(23)36/h2-10,12,14-15,32-33H,11,13H2,1H3,(H,31,36)(H,30,34,35) CDPQTBTYURAFME-UHFFFAOYSA-N 721057 N-{4-[3-(2-chloroanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Stereoisomer 1)::US12227501, Example 15 Casein kinase I isoform alpha Homo sapiens 10700 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721057 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721057&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674290 513841109 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492361 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2Cl)C(=O)NCC3)ccn1)c1ccc(F)cc1 InChI=1S/C27H23ClFN5O2/c1-15(16-6-8-18(29)9-7-16)26(35)34-22-14-17(10-12-30-22)24-25(32-20-5-3-2-4-19(20)28)23-21(33-24)11-13-31-27(23)36/h2-10,12,14-15,32-33H,11,13H2,1H3,(H,31,36)(H,30,34,35) CDPQTBTYURAFME-UHFFFAOYSA-N 721058 N-{4-[3-(2-chloroanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Stereoisomer 2)::US12227501, Example 16 Casein kinase I isoform alpha Homo sapiens 2.57 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721058 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721058&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674290 513841110 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492362 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2Cl)C(=O)NCC3)ccn1)c1ccc(F)cc1 InChI=1S/C27H23ClFN5O2/c1-15(16-6-8-18(29)9-7-16)26(35)34-22-14-17(10-12-30-22)24-25(32-20-5-3-2-4-19(20)28)23-21(33-24)11-13-31-27(23)36/h2-10,12,14-15,32-33H,11,13H2,1H3,(H,31,36)(H,30,34,35) CDPQTBTYURAFME-UHFFFAOYSA-N 721058 N-{4-[3-(2-chloroanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Stereoisomer 2)::US12227501, Example 16 Casein kinase I isoform delta Homo sapiens 8.00 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721058 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721058&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674290 513841110 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492363 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2Cl)C(=O)NCC3)ccn1)c1ccc(F)cc1 InChI=1S/C27H23ClFN5O2/c1-15(16-6-8-18(29)9-7-16)26(35)34-22-14-17(10-12-30-22)24-25(32-20-5-3-2-4-19(20)28)23-21(33-24)11-13-31-27(23)36/h2-10,12,14-15,32-33H,11,13H2,1H3,(H,31,36)(H,30,34,35) CDPQTBTYURAFME-UHFFFAOYSA-N 721058 N-{4-[3-(2-chloroanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Stereoisomer 2)::US12227501, Example 16 Casein kinase I isoform alpha Homo sapiens 102 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721058 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721058&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674290 513841110 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492364 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CO)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H26FN5O3/c1-34-14-12-22-24(28(34)37)26(31-20-5-3-2-4-6-20)25(32-22)18-11-13-30-23(15-18)33-27(36)21(16-35)17-7-9-19(29)10-8-17/h2-11,13,15,21,31-32,35H,12,14,16H2,1H3,(H,30,33,36) DUYUPVFZOHBSBS-UHFFFAOYSA-N 721059 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)-3-hydroxypropanamide::US12227501, Example 17 Casein kinase I isoform alpha Homo sapiens 10.9 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721059 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721059&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674501 513841111 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492365 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CO)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H26FN5O3/c1-34-14-12-22-24(28(34)37)26(31-20-5-3-2-4-6-20)25(32-22)18-11-13-30-23(15-18)33-27(36)21(16-35)17-7-9-19(29)10-8-17/h2-11,13,15,21,31-32,35H,12,14,16H2,1H3,(H,30,33,36) DUYUPVFZOHBSBS-UHFFFAOYSA-N 721059 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)-3-hydroxypropanamide::US12227501, Example 17 Casein kinase I isoform delta Homo sapiens 39.3 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721059 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721059&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674501 513841111 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492366 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CO)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H26FN5O3/c1-34-14-12-22-24(28(34)37)26(31-20-5-3-2-4-6-20)25(32-22)18-11-13-30-23(15-18)33-27(36)21(16-35)17-7-9-19(29)10-8-17/h2-11,13,15,21,31-32,35H,12,14,16H2,1H3,(H,30,33,36) DUYUPVFZOHBSBS-UHFFFAOYSA-N 721059 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)-3-hydroxypropanamide::US12227501, Example 17 Casein kinase I isoform alpha Homo sapiens 66.5 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721059 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721059&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674501 513841111 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492367 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CO)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H26FN5O3/c1-34-14-12-22-24(28(34)37)26(31-20-5-3-2-4-6-20)25(32-22)18-11-13-30-23(15-18)33-27(36)21(16-35)17-7-9-19(29)10-8-17/h2-11,13,15,21,31-32,35H,12,14,16H2,1H3,(H,30,33,36) DUYUPVFZOHBSBS-UHFFFAOYSA-N 721060 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)-3-hydroxypropanamide (Stereoisomer 1)::US12227501, Example 18 Casein kinase I isoform alpha Homo sapiens 20.4 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721060 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721060&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674501 513841112 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492368 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CO)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H26FN5O3/c1-34-14-12-22-24(28(34)37)26(31-20-5-3-2-4-6-20)25(32-22)18-11-13-30-23(15-18)33-27(36)21(16-35)17-7-9-19(29)10-8-17/h2-11,13,15,21,31-32,35H,12,14,16H2,1H3,(H,30,33,36) DUYUPVFZOHBSBS-UHFFFAOYSA-N 721060 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)-3-hydroxypropanamide (Stereoisomer 1)::US12227501, Example 18 Casein kinase I isoform delta Homo sapiens 44.7 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721060 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721060&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674501 513841112 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492369 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CO)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H26FN5O3/c1-34-14-12-22-24(28(34)37)26(31-20-5-3-2-4-6-20)25(32-22)18-11-13-30-23(15-18)33-27(36)21(16-35)17-7-9-19(29)10-8-17/h2-11,13,15,21,31-32,35H,12,14,16H2,1H3,(H,30,33,36) DUYUPVFZOHBSBS-UHFFFAOYSA-N 721060 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)-3-hydroxypropanamide (Stereoisomer 1)::US12227501, Example 18 Casein kinase I isoform alpha Homo sapiens 1790 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721060 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721060&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674501 513841112 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492370 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CO)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H26FN5O3/c1-34-14-12-22-24(28(34)37)26(31-20-5-3-2-4-6-20)25(32-22)18-11-13-30-23(15-18)33-27(36)21(16-35)17-7-9-19(29)10-8-17/h2-11,13,15,21,31-32,35H,12,14,16H2,1H3,(H,30,33,36) DUYUPVFZOHBSBS-UHFFFAOYSA-N 721061 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)-3-hydroxypropanamide (Stereoisomer 2)::US12227501, Example 19 Casein kinase I isoform alpha Homo sapiens 1.70 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721061 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721061&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674501 513841113 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492371 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CO)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H26FN5O3/c1-34-14-12-22-24(28(34)37)26(31-20-5-3-2-4-6-20)25(32-22)18-11-13-30-23(15-18)33-27(36)21(16-35)17-7-9-19(29)10-8-17/h2-11,13,15,21,31-32,35H,12,14,16H2,1H3,(H,30,33,36) DUYUPVFZOHBSBS-UHFFFAOYSA-N 721061 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)-3-hydroxypropanamide (Stereoisomer 2)::US12227501, Example 19 Casein kinase I isoform delta Homo sapiens 6.55 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721061 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721061&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674501 513841113 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492372 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CO)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H26FN5O3/c1-34-14-12-22-24(28(34)37)26(31-20-5-3-2-4-6-20)25(32-22)18-11-13-30-23(15-18)33-27(36)21(16-35)17-7-9-19(29)10-8-17/h2-11,13,15,21,31-32,35H,12,14,16H2,1H3,(H,30,33,36) DUYUPVFZOHBSBS-UHFFFAOYSA-N 721061 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)-3-hydroxypropanamide (Stereoisomer 2)::US12227501, Example 19 Casein kinase I isoform alpha Homo sapiens 10.6 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721061 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721061&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674501 513841113 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492373 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(CC2CC2)CC3)ccn1 InChI=1S/C30H28FN5O2/c31-22-10-8-19(9-11-22)16-26(37)35-25-17-21(12-14-32-25)28-29(33-23-4-2-1-3-5-23)27-24(34-28)13-15-36(30(27)38)18-20-6-7-20/h1-5,8-12,14,17,20,33-34H,6-7,13,15-16,18H2,(H,32,35,37) BYINJOSWODJSOV-UHFFFAOYSA-N 721062 N-{4-[3-anilino-5-(cyclopropylmethyl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 20 Casein kinase I isoform alpha Homo sapiens 9.72 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721062 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721062&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674372 513841114 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492374 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(CC2CC2)CC3)ccn1 InChI=1S/C30H28FN5O2/c31-22-10-8-19(9-11-22)16-26(37)35-25-17-21(12-14-32-25)28-29(33-23-4-2-1-3-5-23)27-24(34-28)13-15-36(30(27)38)18-20-6-7-20/h1-5,8-12,14,17,20,33-34H,6-7,13,15-16,18H2,(H,32,35,37) BYINJOSWODJSOV-UHFFFAOYSA-N 721062 N-{4-[3-anilino-5-(cyclopropylmethyl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 20 Casein kinase I isoform delta Homo sapiens 24.2 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721062 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721062&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674372 513841114 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492375 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(CC2CC2)CC3)ccn1 InChI=1S/C30H28FN5O2/c31-22-10-8-19(9-11-22)16-26(37)35-25-17-21(12-14-32-25)28-29(33-23-4-2-1-3-5-23)27-24(34-28)13-15-36(30(27)38)18-20-6-7-20/h1-5,8-12,14,17,20,33-34H,6-7,13,15-16,18H2,(H,32,35,37) BYINJOSWODJSOV-UHFFFAOYSA-N 721062 N-{4-[3-anilino-5-(cyclopropylmethyl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 20 Casein kinase I isoform alpha Homo sapiens 1660 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721062 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721062&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674372 513841114 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492376 CCN1CCc2[nH]c(-c3ccnc(NC(=O)C(C)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H28FN5O2/c1-3-35-16-14-23-25(29(35)37)27(32-22-7-5-4-6-8-22)26(33-23)20-13-15-31-24(17-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-13,15,17-18,32-33H,3,14,16H2,1-2H3,(H,31,34,36) BZFZAOWFYOKWDA-UHFFFAOYSA-N 721063 N-[4-(3-anilino-5-ethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide::US12227501, Example 21 Casein kinase I isoform alpha Homo sapiens 7.67 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721063 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721063&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674374 513841115 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492377 CCN1CCc2[nH]c(-c3ccnc(NC(=O)C(C)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H28FN5O2/c1-3-35-16-14-23-25(29(35)37)27(32-22-7-5-4-6-8-22)26(33-23)20-13-15-31-24(17-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-13,15,17-18,32-33H,3,14,16H2,1-2H3,(H,31,34,36) BZFZAOWFYOKWDA-UHFFFAOYSA-N 721063 N-[4-(3-anilino-5-ethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide::US12227501, Example 21 Casein kinase I isoform delta Homo sapiens 21.5 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721063 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721063&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674374 513841115 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492378 CCN1CCc2[nH]c(-c3ccnc(NC(=O)C(C)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H28FN5O2/c1-3-35-16-14-23-25(29(35)37)27(32-22-7-5-4-6-8-22)26(33-23)20-13-15-31-24(17-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-13,15,17-18,32-33H,3,14,16H2,1-2H3,(H,31,34,36) BZFZAOWFYOKWDA-UHFFFAOYSA-N 721063 N-[4-(3-anilino-5-ethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide::US12227501, Example 21 Casein kinase I isoform alpha Homo sapiens 344 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721063 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721063&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674374 513841115 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492379 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C28H26FN5O2/c1-28(2)16-21-24(27(36)34-28)26(31-20-6-4-3-5-7-20)25(32-21)18-12-13-30-22(15-18)33-23(35)14-17-8-10-19(29)11-9-17/h3-13,15,31-32H,14,16H2,1-2H3,(H,34,36)(H,30,33,35) DIBZPOAEDBOEEZ-UHFFFAOYSA-N 721064 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 22 Casein kinase I isoform alpha Homo sapiens 4.23 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721064 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721064&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674495 513841116 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492380 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C28H26FN5O2/c1-28(2)16-21-24(27(36)34-28)26(31-20-6-4-3-5-7-20)25(32-21)18-12-13-30-22(15-18)33-23(35)14-17-8-10-19(29)11-9-17/h3-13,15,31-32H,14,16H2,1-2H3,(H,34,36)(H,30,33,35) DIBZPOAEDBOEEZ-UHFFFAOYSA-N 721064 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 22 Casein kinase I isoform delta Homo sapiens 11.9 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721064 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721064&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674495 513841116 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492381 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C28H26FN5O2/c1-28(2)16-21-24(27(36)34-28)26(31-20-6-4-3-5-7-20)25(32-21)18-12-13-30-22(15-18)33-23(35)14-17-8-10-19(29)11-9-17/h3-13,15,31-32H,14,16H2,1-2H3,(H,34,36)(H,30,33,35) DIBZPOAEDBOEEZ-UHFFFAOYSA-N 721064 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 22 Casein kinase I isoform alpha Homo sapiens 54.7 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721064 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721064&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674495 513841116 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492382 CC(C)(O)CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C30H30FN5O3/c1-30(2,39)18-36-15-13-23-26(29(36)38)28(33-22-6-4-3-5-7-22)27(34-23)20-12-14-32-24(17-20)35-25(37)16-19-8-10-21(31)11-9-19/h3-12,14,17,33-34,39H,13,15-16,18H2,1-2H3,(H,32,35,37) HRJDYJVDFILFKO-UHFFFAOYSA-N 721065 N-{4-[3-anilino-5-(2-hydroxy-2-methylpropyl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 23 Casein kinase I isoform alpha Homo sapiens 26.7 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721065 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721065&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674305 513841117 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492383 CC(C)(O)CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C30H30FN5O3/c1-30(2,39)18-36-15-13-23-26(29(36)38)28(33-22-6-4-3-5-7-22)27(34-23)20-12-14-32-24(17-20)35-25(37)16-19-8-10-21(31)11-9-19/h3-12,14,17,33-34,39H,13,15-16,18H2,1-2H3,(H,32,35,37) HRJDYJVDFILFKO-UHFFFAOYSA-N 721065 N-{4-[3-anilino-5-(2-hydroxy-2-methylpropyl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 23 Casein kinase I isoform delta Homo sapiens 36.8 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721065 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721065&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674305 513841117 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492384 CC(C)(O)CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C30H30FN5O3/c1-30(2,39)18-36-15-13-23-26(29(36)38)28(33-22-6-4-3-5-7-22)27(34-23)20-12-14-32-24(17-20)35-25(37)16-19-8-10-21(31)11-9-19/h3-12,14,17,33-34,39H,13,15-16,18H2,1-2H3,(H,32,35,37) HRJDYJVDFILFKO-UHFFFAOYSA-N 721065 N-{4-[3-anilino-5-(2-hydroxy-2-methylpropyl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 23 Casein kinase I isoform alpha Homo sapiens 2620 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721065 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721065&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674305 513841117 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492385 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(CC(C)(C)O)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C31H32FN5O3/c1-19(20-9-11-22(32)12-10-20)29(38)36-25-17-21(13-15-33-25)27-28(34-23-7-5-4-6-8-23)26-24(35-27)14-16-37(30(26)39)18-31(2,3)40/h4-13,15,17,19,34-35,40H,14,16,18H2,1-3H3,(H,33,36,38) GQYLIQAEIRWFEC-UHFFFAOYSA-N 721066 N-{4-[3-anilino-5-(2-hydroxy-2-methylpropyl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide::US12227501, Example 24 Casein kinase I isoform alpha Homo sapiens 39.2 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721066 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721066&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674478 513841118 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492386 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(CC(C)(C)O)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C31H32FN5O3/c1-19(20-9-11-22(32)12-10-20)29(38)36-25-17-21(13-15-33-25)27-28(34-23-7-5-4-6-8-23)26-24(35-27)14-16-37(30(26)39)18-31(2,3)40/h4-13,15,17,19,34-35,40H,14,16,18H2,1-3H3,(H,33,36,38) GQYLIQAEIRWFEC-UHFFFAOYSA-N 721066 N-{4-[3-anilino-5-(2-hydroxy-2-methylpropyl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide::US12227501, Example 24 Casein kinase I isoform delta Homo sapiens 64.0 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721066 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721066&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674478 513841118 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492387 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(CC(C)(C)O)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C31H32FN5O3/c1-19(20-9-11-22(32)12-10-20)29(38)36-25-17-21(13-15-33-25)27-28(34-23-7-5-4-6-8-23)26-24(35-27)14-16-37(30(26)39)18-31(2,3)40/h4-13,15,17,19,34-35,40H,14,16,18H2,1-3H3,(H,33,36,38) GQYLIQAEIRWFEC-UHFFFAOYSA-N 721066 N-{4-[3-anilino-5-(2-hydroxy-2-methylpropyl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide::US12227501, Example 24 Casein kinase I isoform alpha Homo sapiens >5710 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721066 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721066&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674478 513841118 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492388 CCN1CCc2[nH]c(-c3ccnc(NC(=O)C(C)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H28FN5O2/c1-3-35-16-14-23-25(29(35)37)27(32-22-7-5-4-6-8-22)26(33-23)20-13-15-31-24(17-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-13,15,17-18,32-33H,3,14,16H2,1-2H3,(H,31,34,36) BZFZAOWFYOKWDA-UHFFFAOYSA-N 721067 N-[4-(3-anilino-5-ethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 1)::US12227501, Example 25 Casein kinase I isoform alpha Homo sapiens 55.4 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721067 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721067&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674374 513841119 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492389 CCN1CCc2[nH]c(-c3ccnc(NC(=O)C(C)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H28FN5O2/c1-3-35-16-14-23-25(29(35)37)27(32-22-7-5-4-6-8-22)26(33-23)20-13-15-31-24(17-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-13,15,17-18,32-33H,3,14,16H2,1-2H3,(H,31,34,36) BZFZAOWFYOKWDA-UHFFFAOYSA-N 721067 N-[4-(3-anilino-5-ethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 1)::US12227501, Example 25 Casein kinase I isoform delta Homo sapiens 88.6 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721067 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721067&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674374 513841119 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492390 CCN1CCc2[nH]c(-c3ccnc(NC(=O)C(C)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H28FN5O2/c1-3-35-16-14-23-25(29(35)37)27(32-22-7-5-4-6-8-22)26(33-23)20-13-15-31-24(17-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-13,15,17-18,32-33H,3,14,16H2,1-2H3,(H,31,34,36) BZFZAOWFYOKWDA-UHFFFAOYSA-N 721067 N-[4-(3-anilino-5-ethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 1)::US12227501, Example 25 Casein kinase I isoform alpha Homo sapiens 12700 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721067 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721067&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674374 513841119 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492391 CCN1CCc2[nH]c(-c3ccnc(NC(=O)C(C)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H28FN5O2/c1-3-35-16-14-23-25(29(35)37)27(32-22-7-5-4-6-8-22)26(33-23)20-13-15-31-24(17-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-13,15,17-18,32-33H,3,14,16H2,1-2H3,(H,31,34,36) BZFZAOWFYOKWDA-UHFFFAOYSA-N 721068 N-[4-(3-anilino-5-ethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 2)::US12227501, Example 26 Casein kinase I isoform alpha Homo sapiens 4.05 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721068 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721068&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674374 513841120 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492392 CCN1CCc2[nH]c(-c3ccnc(NC(=O)C(C)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H28FN5O2/c1-3-35-16-14-23-25(29(35)37)27(32-22-7-5-4-6-8-22)26(33-23)20-13-15-31-24(17-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-13,15,17-18,32-33H,3,14,16H2,1-2H3,(H,31,34,36) BZFZAOWFYOKWDA-UHFFFAOYSA-N 721068 N-[4-(3-anilino-5-ethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 2)::US12227501, Example 26 Casein kinase I isoform delta Homo sapiens 23.1 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721068 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721068&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674374 513841120 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492393 CCN1CCc2[nH]c(-c3ccnc(NC(=O)C(C)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H28FN5O2/c1-3-35-16-14-23-25(29(35)37)27(32-22-7-5-4-6-8-22)26(33-23)20-13-15-31-24(17-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-13,15,17-18,32-33H,3,14,16H2,1-2H3,(H,31,34,36) BZFZAOWFYOKWDA-UHFFFAOYSA-N 721068 N-[4-(3-anilino-5-ethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 2)::US12227501, Example 26 Casein kinase I isoform alpha Homo sapiens 288 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721068 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721068&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674374 513841120 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492394 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NC(C)(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17(18-9-11-20(30)12-10-18)27(36)34-23-15-19(13-14-31-23)25-26(32-21-7-5-4-6-8-21)24-22(33-25)16-29(2,3)35-28(24)37/h4-15,17,32-33H,16H2,1-3H3,(H,35,37)(H,31,34,36) KOFPMBNUPXOKAY-UHFFFAOYSA-N 721069 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide::US12227501, Example 27 Casein kinase I isoform alpha Homo sapiens 7.70 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721069 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721069&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674352 513841121 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492395 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NC(C)(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17(18-9-11-20(30)12-10-18)27(36)34-23-15-19(13-14-31-23)25-26(32-21-7-5-4-6-8-21)24-22(33-25)16-29(2,3)35-28(24)37/h4-15,17,32-33H,16H2,1-3H3,(H,35,37)(H,31,34,36) KOFPMBNUPXOKAY-UHFFFAOYSA-N 721069 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide::US12227501, Example 27 Casein kinase I isoform delta Homo sapiens 36.2 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721069 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721069&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674352 513841121 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492396 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NC(C)(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17(18-9-11-20(30)12-10-18)27(36)34-23-15-19(13-14-31-23)25-26(32-21-7-5-4-6-8-21)24-22(33-25)16-29(2,3)35-28(24)37/h4-15,17,32-33H,16H2,1-3H3,(H,35,37)(H,31,34,36) KOFPMBNUPXOKAY-UHFFFAOYSA-N 721069 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide::US12227501, Example 27 Casein kinase I isoform alpha Homo sapiens 157 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721069 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721069&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674352 513841121 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492397 CCN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H26FN5O2/c1-2-34-15-13-22-25(28(34)36)27(31-21-6-4-3-5-7-21)26(32-22)19-12-14-30-23(17-19)33-24(35)16-18-8-10-20(29)11-9-18/h3-12,14,17,31-32H,2,13,15-16H2,1H3,(H,30,33,35) ZSGYTKAQRWJXFD-UHFFFAOYSA-N 721070 N-[4-(3-anilino-5-ethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 28 Casein kinase I isoform alpha Homo sapiens 11.4 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721070 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721070&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674303 513841122 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492398 CCN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H26FN5O2/c1-2-34-15-13-22-25(28(34)36)27(31-21-6-4-3-5-7-21)26(32-22)19-12-14-30-23(17-19)33-24(35)16-18-8-10-20(29)11-9-18/h3-12,14,17,31-32H,2,13,15-16H2,1H3,(H,30,33,35) ZSGYTKAQRWJXFD-UHFFFAOYSA-N 721070 N-[4-(3-anilino-5-ethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 28 Casein kinase I isoform delta Homo sapiens 71.2 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721070 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721070&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674303 513841122 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492399 CCN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H26FN5O2/c1-2-34-15-13-22-25(28(34)36)27(31-21-6-4-3-5-7-21)26(32-22)19-12-14-30-23(17-19)33-24(35)16-18-8-10-20(29)11-9-18/h3-12,14,17,31-32H,2,13,15-16H2,1H3,(H,30,33,35) ZSGYTKAQRWJXFD-UHFFFAOYSA-N 721070 N-[4-(3-anilino-5-ethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 28 Casein kinase I isoform alpha Homo sapiens 1980 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721070 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721070&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674303 513841122 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492400 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2F)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C28H25F2N5O2/c1-16(17-7-9-19(29)10-8-17)27(36)34-23-15-18(11-13-31-23)25-26(32-21-6-4-3-5-20(21)30)24-22(33-25)12-14-35(2)28(24)37/h3-11,13,15-16,32-33H,12,14H2,1-2H3,(H,31,34,36) LWQRCWSAGSPNNW-UHFFFAOYSA-N 721071 N-{4-[3-(2-fluoroanilino)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide::US12227501, Example 29 Casein kinase I isoform alpha Homo sapiens 3.19 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721071 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721071&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674480 513841123 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492401 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2F)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C28H25F2N5O2/c1-16(17-7-9-19(29)10-8-17)27(36)34-23-15-18(11-13-31-23)25-26(32-21-6-4-3-5-20(21)30)24-22(33-25)12-14-35(2)28(24)37/h3-11,13,15-16,32-33H,12,14H2,1-2H3,(H,31,34,36) LWQRCWSAGSPNNW-UHFFFAOYSA-N 721071 N-{4-[3-(2-fluoroanilino)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide::US12227501, Example 29 Casein kinase I isoform alpha Homo sapiens 138 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721071 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721071&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674480 513841123 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492402 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CCN4CCOCC4)c4ccccc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C33H36N6O3/c1-38-16-14-27-29(33(38)41)31(35-25-10-6-3-7-11-25)30(36-27)24-12-15-34-28(22-24)37-32(40)26(23-8-4-2-5-9-23)13-17-39-18-20-42-21-19-39/h2-12,15,22,26,35-36H,13-14,16-21H2,1H3,(H,34,37,40) XGFIIXQAEJTAHR-UHFFFAOYSA-N 721072 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4-(morpholin-4-yl)-2-phenylbutanamide::US12227501, Example 30 Casein kinase I isoform alpha Homo sapiens 8.01 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721072 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721072&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674440 513841124 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492403 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CCN4CCOCC4)c4ccccc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C33H36N6O3/c1-38-16-14-27-29(33(38)41)31(35-25-10-6-3-7-11-25)30(36-27)24-12-15-34-28(22-24)37-32(40)26(23-8-4-2-5-9-23)13-17-39-18-20-42-21-19-39/h2-12,15,22,26,35-36H,13-14,16-21H2,1H3,(H,34,37,40) XGFIIXQAEJTAHR-UHFFFAOYSA-N 721072 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4-(morpholin-4-yl)-2-phenylbutanamide::US12227501, Example 30 Casein kinase I isoform delta Homo sapiens 25.9 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721072 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721072&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674440 513841124 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492404 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CCN4CCOCC4)c4ccccc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C33H36N6O3/c1-38-16-14-27-29(33(38)41)31(35-25-10-6-3-7-11-25)30(36-27)24-12-15-34-28(22-24)37-32(40)26(23-8-4-2-5-9-23)13-17-39-18-20-42-21-19-39/h2-12,15,22,26,35-36H,13-14,16-21H2,1H3,(H,34,37,40) XGFIIXQAEJTAHR-UHFFFAOYSA-N 721072 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4-(morpholin-4-yl)-2-phenylbutanamide::US12227501, Example 30 Casein kinase I isoform alpha Homo sapiens 485 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721072 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721072&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674440 513841124 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492405 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CCN4CCOCC4)c4ccccc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C33H36N6O3/c1-38-16-14-27-29(33(38)41)31(35-25-10-6-3-7-11-25)30(36-27)24-12-15-34-28(22-24)37-32(40)26(23-8-4-2-5-9-23)13-17-39-18-20-42-21-19-39/h2-12,15,22,26,35-36H,13-14,16-21H2,1H3,(H,34,37,40) XGFIIXQAEJTAHR-UHFFFAOYSA-N 721073 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4-(morpholin-4-yl)-2-phenylbutanamide, (Stereoisomer 1)::US12227501, Example 31 Casein kinase I isoform alpha Homo sapiens 3.85 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721073 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721073&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674440 513841125 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492406 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CCN4CCOCC4)c4ccccc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C33H36N6O3/c1-38-16-14-27-29(33(38)41)31(35-25-10-6-3-7-11-25)30(36-27)24-12-15-34-28(22-24)37-32(40)26(23-8-4-2-5-9-23)13-17-39-18-20-42-21-19-39/h2-12,15,22,26,35-36H,13-14,16-21H2,1H3,(H,34,37,40) XGFIIXQAEJTAHR-UHFFFAOYSA-N 721073 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4-(morpholin-4-yl)-2-phenylbutanamide, (Stereoisomer 1)::US12227501, Example 31 Casein kinase I isoform alpha Homo sapiens 249 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721073 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721073&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674440 513841125 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492407 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CCN4CCOCC4)c4ccccc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C33H36N6O3/c1-38-16-14-27-29(33(38)41)31(35-25-10-6-3-7-11-25)30(36-27)24-12-15-34-28(22-24)37-32(40)26(23-8-4-2-5-9-23)13-17-39-18-20-42-21-19-39/h2-12,15,22,26,35-36H,13-14,16-21H2,1H3,(H,34,37,40) XGFIIXQAEJTAHR-UHFFFAOYSA-N 721074 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4-(morpholin-4-yl)-2-phenylbutanamide, (Stereoisomer 2)::US12227501, Example 32 Casein kinase I isoform alpha Homo sapiens 72.2 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721074 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721074&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674440 513841126 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492408 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CCN4CCOCC4)c4ccccc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C33H36N6O3/c1-38-16-14-27-29(33(38)41)31(35-25-10-6-3-7-11-25)30(36-27)24-12-15-34-28(22-24)37-32(40)26(23-8-4-2-5-9-23)13-17-39-18-20-42-21-19-39/h2-12,15,22,26,35-36H,13-14,16-21H2,1H3,(H,34,37,40) XGFIIXQAEJTAHR-UHFFFAOYSA-N 721074 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4-(morpholin-4-yl)-2-phenylbutanamide, (Stereoisomer 2)::US12227501, Example 32 Casein kinase I isoform alpha Homo sapiens 4560 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721074 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721074&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674440 513841126 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492409 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccccc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H27F2N5O2/c1-36-15-13-22-25(29(36)38)27(33-20-10-6-3-7-11-20)26(34-22)19-12-14-32-24(16-19)35-28(37)21(17-23(30)31)18-8-4-2-5-9-18/h2-12,14,16,21,23,33-34H,13,15,17H2,1H3,(H,32,35,37) AKGWIZHTFUPWKX-UHFFFAOYSA-N 721075 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-phenylbutanamide::US12227501, Example 33 Casein kinase I isoform alpha Homo sapiens 6.15 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721075 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721075&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674389 513841127 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492410 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccccc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H27F2N5O2/c1-36-15-13-22-25(29(36)38)27(33-20-10-6-3-7-11-20)26(34-22)19-12-14-32-24(16-19)35-28(37)21(17-23(30)31)18-8-4-2-5-9-18/h2-12,14,16,21,23,33-34H,13,15,17H2,1H3,(H,32,35,37) AKGWIZHTFUPWKX-UHFFFAOYSA-N 721075 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-phenylbutanamide::US12227501, Example 33 Casein kinase I isoform delta Homo sapiens 18.1 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721075 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721075&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674389 513841127 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492411 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccccc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H27F2N5O2/c1-36-15-13-22-25(29(36)38)27(33-20-10-6-3-7-11-20)26(34-22)19-12-14-32-24(16-19)35-28(37)21(17-23(30)31)18-8-4-2-5-9-18/h2-12,14,16,21,23,33-34H,13,15,17H2,1H3,(H,32,35,37) AKGWIZHTFUPWKX-UHFFFAOYSA-N 721075 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-phenylbutanamide::US12227501, Example 33 Casein kinase I isoform alpha Homo sapiens 72.2 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721075 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721075&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674389 513841127 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492412 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccccc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H27F2N5O2/c1-36-15-13-22-25(29(36)38)27(33-20-10-6-3-7-11-20)26(34-22)19-12-14-32-24(16-19)35-28(37)21(17-23(30)31)18-8-4-2-5-9-18/h2-12,14,16,21,23,33-34H,13,15,17H2,1H3,(H,32,35,37) AKGWIZHTFUPWKX-UHFFFAOYSA-N 721076 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-phenylbutanamide, (Stereoisomer 1)::US12227501, Example 34 Casein kinase I isoform alpha Homo sapiens 2.68 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721076 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721076&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674389 513841128 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492413 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccccc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H27F2N5O2/c1-36-15-13-22-25(29(36)38)27(33-20-10-6-3-7-11-20)26(34-22)19-12-14-32-24(16-19)35-28(37)21(17-23(30)31)18-8-4-2-5-9-18/h2-12,14,16,21,23,33-34H,13,15,17H2,1H3,(H,32,35,37) AKGWIZHTFUPWKX-UHFFFAOYSA-N 721076 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-phenylbutanamide, (Stereoisomer 1)::US12227501, Example 34 Casein kinase I isoform alpha Homo sapiens 16.5 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721076 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721076&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674389 513841128 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492414 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccccc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H27F2N5O2/c1-36-15-13-22-25(29(36)38)27(33-20-10-6-3-7-11-20)26(34-22)19-12-14-32-24(16-19)35-28(37)21(17-23(30)31)18-8-4-2-5-9-18/h2-12,14,16,21,23,33-34H,13,15,17H2,1H3,(H,32,35,37) AKGWIZHTFUPWKX-UHFFFAOYSA-N 721077 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-phenylbutanamide, (Stereoisomer 2)::US12227501, Example 35 Casein kinase I isoform alpha Homo sapiens 20.5 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721077 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721077&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674389 513841129 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492415 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccccc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H27F2N5O2/c1-36-15-13-22-25(29(36)38)27(33-20-10-6-3-7-11-20)26(34-22)19-12-14-32-24(16-19)35-28(37)21(17-23(30)31)18-8-4-2-5-9-18/h2-12,14,16,21,23,33-34H,13,15,17H2,1H3,(H,32,35,37) AKGWIZHTFUPWKX-UHFFFAOYSA-N 721077 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-phenylbutanamide, (Stereoisomer 2)::US12227501, Example 35 Casein kinase I isoform alpha Homo sapiens 705 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721077 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721077&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674389 513841129 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492416 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(CC(F)(F)F)CC3)ccn1 InChI=1S/C28H23F4N5O2/c29-19-8-6-17(7-9-19)14-23(38)36-22-15-18(10-12-33-22)25-26(34-20-4-2-1-3-5-20)24-21(35-25)11-13-37(27(24)39)16-28(30,31)32/h1-10,12,15,34-35H,11,13-14,16H2,(H,33,36,38) LLNDXKIYUWEGML-UHFFFAOYSA-N 721078 N-{4-[3-anilino-4-oxo-5-(2,2,2-trifluoroethyl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 36 Casein kinase I isoform alpha Homo sapiens 11.3 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721078 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721078&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674274 513841130 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492417 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(CC(F)(F)F)CC3)ccn1 InChI=1S/C28H23F4N5O2/c29-19-8-6-17(7-9-19)14-23(38)36-22-15-18(10-12-33-22)25-26(34-20-4-2-1-3-5-20)24-21(35-25)11-13-37(27(24)39)16-28(30,31)32/h1-10,12,15,34-35H,11,13-14,16H2,(H,33,36,38) LLNDXKIYUWEGML-UHFFFAOYSA-N 721078 N-{4-[3-anilino-4-oxo-5-(2,2,2-trifluoroethyl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 36 Casein kinase I isoform alpha Homo sapiens 1080 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721078 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721078&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674274 513841130 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492418 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(CC(F)(F)F)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C29H25F4N5O2/c1-17(18-7-9-20(30)10-8-18)27(39)37-23-15-19(11-13-34-23)25-26(35-21-5-3-2-4-6-21)24-22(36-25)12-14-38(28(24)40)16-29(31,32)33/h2-11,13,15,17,35-36H,12,14,16H2,1H3,(H,34,37,39) YBEISSBKQZYBNE-UHFFFAOYSA-N 721079 N-{4-[3-anilino-4-oxo-5-(2,2,2-trifluoroethyl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide::US12227501, Example 37 Casein kinase I isoform alpha Homo sapiens 22.6 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721079 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721079&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674402 513841131 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492419 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(CC(F)(F)F)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C29H25F4N5O2/c1-17(18-7-9-20(30)10-8-18)27(39)37-23-15-19(11-13-34-23)25-26(35-21-5-3-2-4-6-21)24-22(36-25)12-14-38(28(24)40)16-29(31,32)33/h2-11,13,15,17,35-36H,12,14,16H2,1H3,(H,34,37,39) YBEISSBKQZYBNE-UHFFFAOYSA-N 721079 N-{4-[3-anilino-4-oxo-5-(2,2,2-trifluoroethyl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide::US12227501, Example 37 Casein kinase I isoform alpha Homo sapiens >1630 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721079 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721079&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674402 513841131 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492420 CN(C)CCC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccccc1 InChI=1S/C31H34N6O2/c1-36(2)18-15-24(21-10-6-4-7-11-21)30(38)35-26-20-22(14-17-32-26)28-29(33-23-12-8-5-9-13-23)27-25(34-28)16-19-37(3)31(27)39/h4-14,17,20,24,33-34H,15-16,18-19H2,1-3H3,(H,32,35,38) PWVRJUMBGYGGEW-UHFFFAOYSA-N 721080 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4-(dimethylamino)-2-phenylbutanamide::US12227501, Example 38 Casein kinase I isoform alpha Homo sapiens 14.6 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721080 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721080&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674499 513841132 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492421 CN(C)CCC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccccc1 InChI=1S/C31H34N6O2/c1-36(2)18-15-24(21-10-6-4-7-11-21)30(38)35-26-20-22(14-17-32-26)28-29(33-23-12-8-5-9-13-23)27-25(34-28)16-19-37(3)31(27)39/h4-14,17,20,24,33-34H,15-16,18-19H2,1-3H3,(H,32,35,38) PWVRJUMBGYGGEW-UHFFFAOYSA-N 721080 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4-(dimethylamino)-2-phenylbutanamide::US12227501, Example 38 Casein kinase I isoform alpha Homo sapiens 1290 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721080 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721080&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674499 513841132 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492422 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NC(C)(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17(18-9-11-20(30)12-10-18)27(36)34-23-15-19(13-14-31-23)25-26(32-21-7-5-4-6-8-21)24-22(33-25)16-29(2,3)35-28(24)37/h4-15,17,32-33H,16H2,1-3H3,(H,35,37)(H,31,34,36) KOFPMBNUPXOKAY-UHFFFAOYSA-N 721081 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 1)::US12227501, Example 39 Casein kinase I isoform alpha Homo sapiens 179 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721081 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721081&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674352 513841133 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492423 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NC(C)(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17(18-9-11-20(30)12-10-18)27(36)34-23-15-19(13-14-31-23)25-26(32-21-7-5-4-6-8-21)24-22(33-25)16-29(2,3)35-28(24)37/h4-15,17,32-33H,16H2,1-3H3,(H,35,37)(H,31,34,36) KOFPMBNUPXOKAY-UHFFFAOYSA-N 721081 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 1)::US12227501, Example 39 Casein kinase I isoform delta Homo sapiens 214 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721081 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721081&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674352 513841133 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492424 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NC(C)(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17(18-9-11-20(30)12-10-18)27(36)34-23-15-19(13-14-31-23)25-26(32-21-7-5-4-6-8-21)24-22(33-25)16-29(2,3)35-28(24)37/h4-15,17,32-33H,16H2,1-3H3,(H,35,37)(H,31,34,36) KOFPMBNUPXOKAY-UHFFFAOYSA-N 721081 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 1)::US12227501, Example 39 Casein kinase I isoform alpha Homo sapiens 2840 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721081 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721081&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674352 513841133 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492425 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NC(C)(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17(18-9-11-20(30)12-10-18)27(36)34-23-15-19(13-14-31-23)25-26(32-21-7-5-4-6-8-21)24-22(33-25)16-29(2,3)35-28(24)37/h4-15,17,32-33H,16H2,1-3H3,(H,35,37)(H,31,34,36) KOFPMBNUPXOKAY-UHFFFAOYSA-N 721082 (+)-N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 2)::US12227501, Example 40 Casein kinase I isoform alpha Homo sapiens 4.59 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721082 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721082&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674352 513841134 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492426 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NC(C)(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17(18-9-11-20(30)12-10-18)27(36)34-23-15-19(13-14-31-23)25-26(32-21-7-5-4-6-8-21)24-22(33-25)16-29(2,3)35-28(24)37/h4-15,17,32-33H,16H2,1-3H3,(H,35,37)(H,31,34,36) KOFPMBNUPXOKAY-UHFFFAOYSA-N 721082 (+)-N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 2)::US12227501, Example 40 Casein kinase I isoform delta Homo sapiens 10.5 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721082 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721082&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674352 513841134 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492427 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NC(C)(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17(18-9-11-20(30)12-10-18)27(36)34-23-15-19(13-14-31-23)25-26(32-21-7-5-4-6-8-21)24-22(33-25)16-29(2,3)35-28(24)37/h4-15,17,32-33H,16H2,1-3H3,(H,35,37)(H,31,34,36) KOFPMBNUPXOKAY-UHFFFAOYSA-N 721082 (+)-N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 2)::US12227501, Example 40 Casein kinase I isoform alpha Homo sapiens 51.7 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721082 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721082&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674352 513841134 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492428 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2F)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C28H25F2N5O2/c1-16(17-7-9-19(29)10-8-17)27(36)34-23-15-18(11-13-31-23)25-26(32-21-6-4-3-5-20(21)30)24-22(33-25)12-14-35(2)28(24)37/h3-11,13,15-16,32-33H,12,14H2,1-2H3,(H,31,34,36) LWQRCWSAGSPNNW-UHFFFAOYSA-N 721083 (−)-N-{4-[3-(2-fluoroanilino)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Enantiomer 1)::US12227501, Example 41 Casein kinase I isoform alpha Homo sapiens 22.6 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721083 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721083&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674480 513841135 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492429 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2F)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C28H25F2N5O2/c1-16(17-7-9-19(29)10-8-17)27(36)34-23-15-18(11-13-31-23)25-26(32-21-6-4-3-5-20(21)30)24-22(33-25)12-14-35(2)28(24)37/h3-11,13,15-16,32-33H,12,14H2,1-2H3,(H,31,34,36) LWQRCWSAGSPNNW-UHFFFAOYSA-N 721083 (−)-N-{4-[3-(2-fluoroanilino)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Enantiomer 1)::US12227501, Example 41 Casein kinase I isoform delta Homo sapiens 31.2 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721083 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721083&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674480 513841135 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492430 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2F)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C28H25F2N5O2/c1-16(17-7-9-19(29)10-8-17)27(36)34-23-15-18(11-13-31-23)25-26(32-21-6-4-3-5-20(21)30)24-22(33-25)12-14-35(2)28(24)37/h3-11,13,15-16,32-33H,12,14H2,1-2H3,(H,31,34,36) LWQRCWSAGSPNNW-UHFFFAOYSA-N 721083 (−)-N-{4-[3-(2-fluoroanilino)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Enantiomer 1)::US12227501, Example 41 Casein kinase I isoform alpha Homo sapiens 3530 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721083 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721083&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674480 513841135 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492431 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2F)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C28H25F2N5O2/c1-16(17-7-9-19(29)10-8-17)27(36)34-23-15-18(11-13-31-23)25-26(32-21-6-4-3-5-20(21)30)24-22(33-25)12-14-35(2)28(24)37/h3-11,13,15-16,32-33H,12,14H2,1-2H3,(H,31,34,36) LWQRCWSAGSPNNW-UHFFFAOYSA-N 721084 N-{4-[3-(2-fluoroanilino)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Enantiomer 2)::US12227501, Example 42 Casein kinase I isoform alpha Homo sapiens 2.40 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721084 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721084&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674480 513841136 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492432 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2F)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C28H25F2N5O2/c1-16(17-7-9-19(29)10-8-17)27(36)34-23-15-18(11-13-31-23)25-26(32-21-6-4-3-5-20(21)30)24-22(33-25)12-14-35(2)28(24)37/h3-11,13,15-16,32-33H,12,14H2,1-2H3,(H,31,34,36) LWQRCWSAGSPNNW-UHFFFAOYSA-N 721084 N-{4-[3-(2-fluoroanilino)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Enantiomer 2)::US12227501, Example 42 Casein kinase I isoform delta Homo sapiens 4.92 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721084 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721084&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674480 513841136 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492433 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2F)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C28H25F2N5O2/c1-16(17-7-9-19(29)10-8-17)27(36)34-23-15-18(11-13-31-23)25-26(32-21-6-4-3-5-20(21)30)24-22(33-25)12-14-35(2)28(24)37/h3-11,13,15-16,32-33H,12,14H2,1-2H3,(H,31,34,36) LWQRCWSAGSPNNW-UHFFFAOYSA-N 721084 N-{4-[3-(2-fluoroanilino)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Enantiomer 2)::US12227501, Example 42 Casein kinase I isoform alpha Homo sapiens 57.2 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721084 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721084&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674480 513841136 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492434 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NC(C(F)(F)F)C3)ccn1 InChI=1S/C27H21F4N5O2/c28-17-8-6-15(7-9-17)12-22(37)36-21-13-16(10-11-32-21)24-25(33-18-4-2-1-3-5-18)23-19(34-24)14-20(27(29,30)31)35-26(23)38/h1-11,13,20,33-34H,12,14H2,(H,35,38)(H,32,36,37) ATSAULVLXRFCAQ-UHFFFAOYSA-N 721085 N-{4-[3-anilino-4-oxo-6-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Racemate)::US12227501, Example 43 Casein kinase I isoform alpha Homo sapiens 3.52 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721085 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721085&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674255 513841137 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492435 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NC(C(F)(F)F)C3)ccn1 InChI=1S/C27H21F4N5O2/c28-17-8-6-15(7-9-17)12-22(37)36-21-13-16(10-11-32-21)24-25(33-18-4-2-1-3-5-18)23-19(34-24)14-20(27(29,30)31)35-26(23)38/h1-11,13,20,33-34H,12,14H2,(H,35,38)(H,32,36,37) ATSAULVLXRFCAQ-UHFFFAOYSA-N 721085 N-{4-[3-anilino-4-oxo-6-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Racemate)::US12227501, Example 43 Casein kinase I isoform delta Homo sapiens 7.12 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721085 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721085&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674255 513841137 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492436 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NC(C(F)(F)F)C3)ccn1 InChI=1S/C27H21F4N5O2/c28-17-8-6-15(7-9-17)12-22(37)36-21-13-16(10-11-32-21)24-25(33-18-4-2-1-3-5-18)23-19(34-24)14-20(27(29,30)31)35-26(23)38/h1-11,13,20,33-34H,12,14H2,(H,35,38)(H,32,36,37) ATSAULVLXRFCAQ-UHFFFAOYSA-N 721085 N-{4-[3-anilino-4-oxo-6-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Racemate)::US12227501, Example 43 Casein kinase I isoform alpha Homo sapiens 67.5 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721085 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721085&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674255 513841137 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492437 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c2Nc2ccccc2)CC1(C)C InChI=1S/C29H28FN5O2/c1-29(2)17-22-25(28(37)35(29)3)27(32-21-7-5-4-6-8-21)26(33-22)19-13-14-31-23(16-19)34-24(36)15-18-9-11-20(30)12-10-18/h4-14,16,32-33H,15,17H2,1-3H3,(H,31,34,36) DSVNYHIVOUUYFJ-UHFFFAOYSA-N 721086 N-[4-(3-anilino-5,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 44 Casein kinase I isoform alpha Homo sapiens 4.82 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721086 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721086&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674448 513841138 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492438 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c2Nc2ccccc2)CC1(C)C InChI=1S/C29H28FN5O2/c1-29(2)17-22-25(28(37)35(29)3)27(32-21-7-5-4-6-8-21)26(33-22)19-13-14-31-23(16-19)34-24(36)15-18-9-11-20(30)12-10-18/h4-14,16,32-33H,15,17H2,1-3H3,(H,31,34,36) DSVNYHIVOUUYFJ-UHFFFAOYSA-N 721086 N-[4-(3-anilino-5,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 44 Casein kinase I isoform delta Homo sapiens 10.7 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721086 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721086&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674448 513841138 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492439 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c2Nc2ccccc2)CC1(C)C InChI=1S/C29H28FN5O2/c1-29(2)17-22-25(28(37)35(29)3)27(32-21-7-5-4-6-8-21)26(33-22)19-13-14-31-23(16-19)34-24(36)15-18-9-11-20(30)12-10-18/h4-14,16,32-33H,15,17H2,1-3H3,(H,31,34,36) DSVNYHIVOUUYFJ-UHFFFAOYSA-N 721086 N-[4-(3-anilino-5,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 44 Casein kinase I isoform alpha Homo sapiens 671 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721086 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721086&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674448 513841138 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492440 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c2Nc2ccccc2F)CC1(C)C InChI=1S/C31H29F4N5O2/c1-31(2)16-23-26(30(42)40(31)3)28(37-22-7-5-4-6-21(22)33)27(38-23)18-12-13-36-25(14-18)39-29(41)20(15-24(34)35)17-8-10-19(32)11-9-17/h4-14,20,24,37-38H,15-16H2,1-3H3,(H,36,39,41) YUGAWPXFORPIGO-UHFFFAOYSA-N 721087 4,4-difluoro-N-{4-[3-(2-fluoroanilino)-5,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 45 Casein kinase I isoform alpha Homo sapiens 16.3 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721087 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721087&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674505 513841139 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492441 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c2Nc2ccccc2F)CC1(C)C InChI=1S/C31H29F4N5O2/c1-31(2)16-23-26(30(42)40(31)3)28(37-22-7-5-4-6-21(22)33)27(38-23)18-12-13-36-25(14-18)39-29(41)20(15-24(34)35)17-8-10-19(32)11-9-17/h4-14,20,24,37-38H,15-16H2,1-3H3,(H,36,39,41) YUGAWPXFORPIGO-UHFFFAOYSA-N 721087 4,4-difluoro-N-{4-[3-(2-fluoroanilino)-5,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 45 Casein kinase I isoform delta Homo sapiens 13.2 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721087 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721087&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674505 513841139 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492442 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c2Nc2ccccc2F)CC1(C)C InChI=1S/C31H29F4N5O2/c1-31(2)16-23-26(30(42)40(31)3)28(37-22-7-5-4-6-21(22)33)27(38-23)18-12-13-36-25(14-18)39-29(41)20(15-24(34)35)17-8-10-19(32)11-9-17/h4-14,20,24,37-38H,15-16H2,1-3H3,(H,36,39,41) YUGAWPXFORPIGO-UHFFFAOYSA-N 721087 4,4-difluoro-N-{4-[3-(2-fluoroanilino)-5,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 45 Casein kinase I isoform alpha Homo sapiens 273 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721087 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721087&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674505 513841139 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492443 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c2Nc2ccccc2F)CC1(C)C InChI=1S/C31H29F4N5O2/c1-31(2)16-23-26(30(42)40(31)3)28(37-22-7-5-4-6-21(22)33)27(38-23)18-12-13-36-25(14-18)39-29(41)20(15-24(34)35)17-8-10-19(32)11-9-17/h4-14,20,24,37-38H,15-16H2,1-3H3,(H,36,39,41) YUGAWPXFORPIGO-UHFFFAOYSA-N 721088 4,4-difluoro-N-{4-[3-(2-fluoroanilino)-5,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 46 Casein kinase I isoform alpha Homo sapiens 6.64 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721088 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721088&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674505 513841140 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492444 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c2Nc2ccccc2F)CC1(C)C InChI=1S/C31H29F4N5O2/c1-31(2)16-23-26(30(42)40(31)3)28(37-22-7-5-4-6-21(22)33)27(38-23)18-12-13-36-25(14-18)39-29(41)20(15-24(34)35)17-8-10-19(32)11-9-17/h4-14,20,24,37-38H,15-16H2,1-3H3,(H,36,39,41) YUGAWPXFORPIGO-UHFFFAOYSA-N 721088 4,4-difluoro-N-{4-[3-(2-fluoroanilino)-5,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 46 Casein kinase I isoform delta Homo sapiens 8.33 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721088 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721088&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674505 513841140 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492445 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c2Nc2ccccc2F)CC1(C)C InChI=1S/C31H29F4N5O2/c1-31(2)16-23-26(30(42)40(31)3)28(37-22-7-5-4-6-21(22)33)27(38-23)18-12-13-36-25(14-18)39-29(41)20(15-24(34)35)17-8-10-19(32)11-9-17/h4-14,20,24,37-38H,15-16H2,1-3H3,(H,36,39,41) YUGAWPXFORPIGO-UHFFFAOYSA-N 721088 4,4-difluoro-N-{4-[3-(2-fluoroanilino)-5,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 46 Casein kinase I isoform alpha Homo sapiens 119 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721088 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721088&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674505 513841140 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492446 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c2Nc2ccccc2F)CC1(C)C InChI=1S/C31H29F4N5O2/c1-31(2)16-23-26(30(42)40(31)3)28(37-22-7-5-4-6-21(22)33)27(38-23)18-12-13-36-25(14-18)39-29(41)20(15-24(34)35)17-8-10-19(32)11-9-17/h4-14,20,24,37-38H,15-16H2,1-3H3,(H,36,39,41) YUGAWPXFORPIGO-UHFFFAOYSA-N 721089 4,4-difluoro-N-{4-[3-(2-fluoroanilino)-5,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 47 Casein kinase I isoform alpha Homo sapiens 163 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721089 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721089&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674505 513841141 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492447 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c2Nc2ccccc2F)CC1(C)C InChI=1S/C31H29F4N5O2/c1-31(2)16-23-26(30(42)40(31)3)28(37-22-7-5-4-6-21(22)33)27(38-23)18-12-13-36-25(14-18)39-29(41)20(15-24(34)35)17-8-10-19(32)11-9-17/h4-14,20,24,37-38H,15-16H2,1-3H3,(H,36,39,41) YUGAWPXFORPIGO-UHFFFAOYSA-N 721089 4,4-difluoro-N-{4-[3-(2-fluoroanilino)-5,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 47 Casein kinase I isoform delta Homo sapiens 151 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721089 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721089&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674505 513841141 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492448 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c2Nc2ccccc2F)CC1(C)C InChI=1S/C31H29F4N5O2/c1-31(2)16-23-26(30(42)40(31)3)28(37-22-7-5-4-6-21(22)33)27(38-23)18-12-13-36-25(14-18)39-29(41)20(15-24(34)35)17-8-10-19(32)11-9-17/h4-14,20,24,37-38H,15-16H2,1-3H3,(H,36,39,41) YUGAWPXFORPIGO-UHFFFAOYSA-N 721089 4,4-difluoro-N-{4-[3-(2-fluoroanilino)-5,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 47 Casein kinase I isoform alpha Homo sapiens >20000 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721089 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721089&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674505 513841141 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492449 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C30H28F3N5O2/c1-30(2)16-22-25(29(40)38-30)27(35-20-6-4-3-5-7-20)26(36-22)18-12-13-34-24(14-18)37-28(39)21(15-23(32)33)17-8-10-19(31)11-9-17/h3-14,21,23,35-36H,15-16H2,1-2H3,(H,38,40)(H,34,37,39) KKRDXOPMQOYAGZ-UHFFFAOYSA-N 721090 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 48 Casein kinase I isoform alpha Homo sapiens 7.69 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721090 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721090&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674360 513841142 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492450 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C30H28F3N5O2/c1-30(2)16-22-25(29(40)38-30)27(35-20-6-4-3-5-7-20)26(36-22)18-12-13-34-24(14-18)37-28(39)21(15-23(32)33)17-8-10-19(31)11-9-17/h3-14,21,23,35-36H,15-16H2,1-2H3,(H,38,40)(H,34,37,39) KKRDXOPMQOYAGZ-UHFFFAOYSA-N 721090 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 48 Casein kinase I isoform delta Homo sapiens 13.4 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721090 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721090&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674360 513841142 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492451 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C30H28F3N5O2/c1-30(2)16-22-25(29(40)38-30)27(35-20-6-4-3-5-7-20)26(36-22)18-12-13-34-24(14-18)37-28(39)21(15-23(32)33)17-8-10-19(31)11-9-17/h3-14,21,23,35-36H,15-16H2,1-2H3,(H,38,40)(H,34,37,39) KKRDXOPMQOYAGZ-UHFFFAOYSA-N 721090 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 48 Casein kinase I isoform alpha Homo sapiens 37.0 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721090 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721090&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674360 513841142 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492452 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C30H28F3N5O2/c1-30(2)16-22-25(29(40)38-30)27(35-20-6-4-3-5-7-20)26(36-22)18-12-13-34-24(14-18)37-28(39)21(15-23(32)33)17-8-10-19(31)11-9-17/h3-14,21,23,35-36H,15-16H2,1-2H3,(H,38,40)(H,34,37,39) KKRDXOPMQOYAGZ-UHFFFAOYSA-N 721091 (+)-N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 49 Casein kinase I isoform alpha Homo sapiens 4.57 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721091 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721091&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674360 513841143 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492453 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C30H28F3N5O2/c1-30(2)16-22-25(29(40)38-30)27(35-20-6-4-3-5-7-20)26(36-22)18-12-13-34-24(14-18)37-28(39)21(15-23(32)33)17-8-10-19(31)11-9-17/h3-14,21,23,35-36H,15-16H2,1-2H3,(H,38,40)(H,34,37,39) KKRDXOPMQOYAGZ-UHFFFAOYSA-N 721091 (+)-N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 49 Casein kinase I isoform delta Homo sapiens 7.30 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721091 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721091&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674360 513841143 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492454 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C30H28F3N5O2/c1-30(2)16-22-25(29(40)38-30)27(35-20-6-4-3-5-7-20)26(36-22)18-12-13-34-24(14-18)37-28(39)21(15-23(32)33)17-8-10-19(31)11-9-17/h3-14,21,23,35-36H,15-16H2,1-2H3,(H,38,40)(H,34,37,39) KKRDXOPMQOYAGZ-UHFFFAOYSA-N 721091 (+)-N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 49 Casein kinase I isoform alpha Homo sapiens 19.6 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721091 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721091&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674360 513841143 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492455 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C30H28F3N5O2/c1-30(2)16-22-25(29(40)38-30)27(35-20-6-4-3-5-7-20)26(36-22)18-12-13-34-24(14-18)37-28(39)21(15-23(32)33)17-8-10-19(31)11-9-17/h3-14,21,23,35-36H,15-16H2,1-2H3,(H,38,40)(H,34,37,39) KKRDXOPMQOYAGZ-UHFFFAOYSA-N 721092 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 50 Casein kinase I isoform alpha Homo sapiens 51.0 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721092 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721092&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674360 513841144 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492456 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C30H28F3N5O2/c1-30(2)16-22-25(29(40)38-30)27(35-20-6-4-3-5-7-20)26(36-22)18-12-13-34-24(14-18)37-28(39)21(15-23(32)33)17-8-10-19(31)11-9-17/h3-14,21,23,35-36H,15-16H2,1-2H3,(H,38,40)(H,34,37,39) KKRDXOPMQOYAGZ-UHFFFAOYSA-N 721092 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 50 Casein kinase I isoform delta Homo sapiens 68.2 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721092 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721092&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674360 513841144 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492457 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C30H28F3N5O2/c1-30(2)16-22-25(29(40)38-30)27(35-20-6-4-3-5-7-20)26(36-22)18-12-13-34-24(14-18)37-28(39)21(15-23(32)33)17-8-10-19(31)11-9-17/h3-14,21,23,35-36H,15-16H2,1-2H3,(H,38,40)(H,34,37,39) KKRDXOPMQOYAGZ-UHFFFAOYSA-N 721092 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 50 Casein kinase I isoform alpha Homo sapiens 2460 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721092 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721092&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674360 513841144 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492458 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccncc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C27H26N6O2/c1-27(2)16-20-23(26(35)33-27)25(30-19-6-4-3-5-7-19)24(31-20)18-10-13-29-21(15-18)32-22(34)14-17-8-11-28-12-9-17/h3-13,15,30-31H,14,16H2,1-2H3,(H,33,35)(H,29,32,34) IJUJMMPOXXBQCM-UHFFFAOYSA-N 721093 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-4-yl)acetamide::US12227501, Example 51 Casein kinase I isoform alpha Homo sapiens 4.87 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721093 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721093&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674359 513841145 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492459 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccncc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C27H26N6O2/c1-27(2)16-20-23(26(35)33-27)25(30-19-6-4-3-5-7-19)24(31-20)18-10-13-29-21(15-18)32-22(34)14-17-8-11-28-12-9-17/h3-13,15,30-31H,14,16H2,1-2H3,(H,33,35)(H,29,32,34) IJUJMMPOXXBQCM-UHFFFAOYSA-N 721093 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-4-yl)acetamide::US12227501, Example 51 Casein kinase I isoform delta Homo sapiens 6.67 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721093 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721093&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674359 513841145 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492460 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccncc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C27H26N6O2/c1-27(2)16-20-23(26(35)33-27)25(30-19-6-4-3-5-7-19)24(31-20)18-10-13-29-21(15-18)32-22(34)14-17-8-11-28-12-9-17/h3-13,15,30-31H,14,16H2,1-2H3,(H,33,35)(H,29,32,34) IJUJMMPOXXBQCM-UHFFFAOYSA-N 721093 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-4-yl)acetamide::US12227501, Example 51 Casein kinase I isoform alpha Homo sapiens 25.8 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721093 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721093&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674359 513841145 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492461 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4cccnc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C27H26N6O2/c1-27(2)15-20-23(26(35)33-27)25(30-19-8-4-3-5-9-19)24(31-20)18-10-12-29-21(14-18)32-22(34)13-17-7-6-11-28-16-17/h3-12,14,16,30-31H,13,15H2,1-2H3,(H,33,35)(H,29,32,34) WJNUSNNYLBLXMQ-UHFFFAOYSA-N 721094 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-3-yl)acetamide::US12227501, Example 52 Casein kinase I isoform alpha Homo sapiens 4.91 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721094 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721094&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674479 513841146 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492462 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4cccnc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C27H26N6O2/c1-27(2)15-20-23(26(35)33-27)25(30-19-8-4-3-5-9-19)24(31-20)18-10-12-29-21(14-18)32-22(34)13-17-7-6-11-28-16-17/h3-12,14,16,30-31H,13,15H2,1-2H3,(H,33,35)(H,29,32,34) WJNUSNNYLBLXMQ-UHFFFAOYSA-N 721094 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-3-yl)acetamide::US12227501, Example 52 Casein kinase I isoform delta Homo sapiens 6.78 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721094 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721094&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674479 513841146 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492463 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4cccnc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C27H26N6O2/c1-27(2)15-20-23(26(35)33-27)25(30-19-8-4-3-5-9-19)24(31-20)18-10-12-29-21(14-18)32-22(34)13-17-7-6-11-28-16-17/h3-12,14,16,30-31H,13,15H2,1-2H3,(H,33,35)(H,29,32,34) WJNUSNNYLBLXMQ-UHFFFAOYSA-N 721094 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-3-yl)acetamide::US12227501, Example 52 Casein kinase I isoform alpha Homo sapiens 25.4 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721094 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721094&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674479 513841146 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492464 COCCN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H28FN5O3/c1-38-16-15-35-14-12-23-26(29(35)37)28(32-22-5-3-2-4-6-22)27(33-23)20-11-13-31-24(18-20)34-25(36)17-19-7-9-21(30)10-8-19/h2-11,13,18,32-33H,12,14-17H2,1H3,(H,31,34,36) IJAGJGCELDNCJJ-UHFFFAOYSA-N 721095 N-{4-[3-anilino-5-(2-methoxyethyl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 53 Casein kinase I isoform alpha Homo sapiens 9.68 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721095 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721095&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674256 513841147 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492465 COCCN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H28FN5O3/c1-38-16-15-35-14-12-23-26(29(35)37)28(32-22-5-3-2-4-6-22)27(33-23)20-11-13-31-24(18-20)34-25(36)17-19-7-9-21(30)10-8-19/h2-11,13,18,32-33H,12,14-17H2,1H3,(H,31,34,36) IJAGJGCELDNCJJ-UHFFFAOYSA-N 721095 N-{4-[3-anilino-5-(2-methoxyethyl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 53 Casein kinase I isoform delta Homo sapiens 15.0 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721095 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721095&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674256 513841147 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492466 COCCN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H28FN5O3/c1-38-16-15-35-14-12-23-26(29(35)37)28(32-22-5-3-2-4-6-22)27(33-23)20-11-13-31-24(18-20)34-25(36)17-19-7-9-21(30)10-8-19/h2-11,13,18,32-33H,12,14-17H2,1H3,(H,31,34,36) IJAGJGCELDNCJJ-UHFFFAOYSA-N 721095 N-{4-[3-anilino-5-(2-methoxyethyl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 53 Casein kinase I isoform alpha Homo sapiens 907 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721095 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721095&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674256 513841147 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492467 O=C1NC2(CCC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c21 InChI=1S/C31H28F3N5O2/c32-20-9-7-18(8-10-20)22(16-24(33)34)29(40)38-25-15-19(11-14-35-25)27-28(36-21-5-2-1-3-6-21)26-23(37-27)17-31(12-4-13-31)39-30(26)41/h1-3,5-11,14-15,22,24,36-37H,4,12-13,16-17H2,(H,39,41)(H,35,38,40) KIAWAHJOKQOSAO-UHFFFAOYSA-N 721096 N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 54 Casein kinase I isoform alpha Homo sapiens 4.62 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721096 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721096&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674435 513841148 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492468 O=C1NC2(CCC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c21 InChI=1S/C31H28F3N5O2/c32-20-9-7-18(8-10-20)22(16-24(33)34)29(40)38-25-15-19(11-14-35-25)27-28(36-21-5-2-1-3-6-21)26-23(37-27)17-31(12-4-13-31)39-30(26)41/h1-3,5-11,14-15,22,24,36-37H,4,12-13,16-17H2,(H,39,41)(H,35,38,40) KIAWAHJOKQOSAO-UHFFFAOYSA-N 721096 N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 54 Casein kinase I isoform delta Homo sapiens 5.50 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721096 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721096&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674435 513841148 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492469 O=C1NC2(CCC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c21 InChI=1S/C31H28F3N5O2/c32-20-9-7-18(8-10-20)22(16-24(33)34)29(40)38-25-15-19(11-14-35-25)27-28(36-21-5-2-1-3-6-21)26-23(37-27)17-31(12-4-13-31)39-30(26)41/h1-3,5-11,14-15,22,24,36-37H,4,12-13,16-17H2,(H,39,41)(H,35,38,40) KIAWAHJOKQOSAO-UHFFFAOYSA-N 721096 N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 54 Casein kinase I isoform alpha Homo sapiens 14.6 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721096 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721096&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674435 513841148 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492470 O=C1NC2(CCC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c21 InChI=1S/C31H28F3N5O2/c32-20-9-7-18(8-10-20)22(16-24(33)34)29(40)38-25-15-19(11-14-35-25)27-28(36-21-5-2-1-3-6-21)26-23(37-27)17-31(12-4-13-31)39-30(26)41/h1-3,5-11,14-15,22,24,36-37H,4,12-13,16-17H2,(H,39,41)(H,35,38,40) KIAWAHJOKQOSAO-UHFFFAOYSA-N 721097 (+)-N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 55 Casein kinase I isoform alpha Homo sapiens 4.25 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721097 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721097&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674435 513841149 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492471 O=C1NC2(CCC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c21 InChI=1S/C31H28F3N5O2/c32-20-9-7-18(8-10-20)22(16-24(33)34)29(40)38-25-15-19(11-14-35-25)27-28(36-21-5-2-1-3-6-21)26-23(37-27)17-31(12-4-13-31)39-30(26)41/h1-3,5-11,14-15,22,24,36-37H,4,12-13,16-17H2,(H,39,41)(H,35,38,40) KIAWAHJOKQOSAO-UHFFFAOYSA-N 721097 (+)-N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 55 Casein kinase I isoform delta Homo sapiens 4.38 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721097 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721097&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674435 513841149 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492472 O=C1NC2(CCC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c21 InChI=1S/C31H28F3N5O2/c32-20-9-7-18(8-10-20)22(16-24(33)34)29(40)38-25-15-19(11-14-35-25)27-28(36-21-5-2-1-3-6-21)26-23(37-27)17-31(12-4-13-31)39-30(26)41/h1-3,5-11,14-15,22,24,36-37H,4,12-13,16-17H2,(H,39,41)(H,35,38,40) KIAWAHJOKQOSAO-UHFFFAOYSA-N 721097 (+)-N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 55 Casein kinase I isoform alpha Homo sapiens 9.10 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721097 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721097&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674435 513841149 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492473 O=C1NC2(CCC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c21 InChI=1S/C31H28F3N5O2/c32-20-9-7-18(8-10-20)22(16-24(33)34)29(40)38-25-15-19(11-14-35-25)27-28(36-21-5-2-1-3-6-21)26-23(37-27)17-31(12-4-13-31)39-30(26)41/h1-3,5-11,14-15,22,24,36-37H,4,12-13,16-17H2,(H,39,41)(H,35,38,40) KIAWAHJOKQOSAO-UHFFFAOYSA-N 721098 (−)-N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 56 Casein kinase I isoform alpha Homo sapiens 19.2 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721098 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721098&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674435 513841150 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492474 O=C1NC2(CCC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c21 InChI=1S/C31H28F3N5O2/c32-20-9-7-18(8-10-20)22(16-24(33)34)29(40)38-25-15-19(11-14-35-25)27-28(36-21-5-2-1-3-6-21)26-23(37-27)17-31(12-4-13-31)39-30(26)41/h1-3,5-11,14-15,22,24,36-37H,4,12-13,16-17H2,(H,39,41)(H,35,38,40) KIAWAHJOKQOSAO-UHFFFAOYSA-N 721098 (−)-N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 56 Casein kinase I isoform delta Homo sapiens 27.9 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721098 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721098&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674435 513841150 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492475 O=C1NC2(CCC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c21 InChI=1S/C31H28F3N5O2/c32-20-9-7-18(8-10-20)22(16-24(33)34)29(40)38-25-15-19(11-14-35-25)27-28(36-21-5-2-1-3-6-21)26-23(37-27)17-31(12-4-13-31)39-30(26)41/h1-3,5-11,14-15,22,24,36-37H,4,12-13,16-17H2,(H,39,41)(H,35,38,40) KIAWAHJOKQOSAO-UHFFFAOYSA-N 721098 (−)-N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 56 Casein kinase I isoform alpha Homo sapiens 1080 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721098 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721098&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674435 513841150 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492476 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NC2(CCC2)C3)ccn1 InChI=1S/C29H26FN5O2/c30-20-9-7-18(8-10-20)15-24(36)34-23-16-19(11-14-31-23)26-27(32-21-5-2-1-3-6-21)25-22(33-26)17-29(12-4-13-29)35-28(25)37/h1-3,5-11,14,16,32-33H,4,12-13,15,17H2,(H,35,37)(H,31,34,36) BALRJMDHDGPHTH-UHFFFAOYSA-N 721099 N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 57 Casein kinase I isoform alpha Homo sapiens 2.01 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721099 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721099&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674497 513841151 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492477 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NC2(CCC2)C3)ccn1 InChI=1S/C29H26FN5O2/c30-20-9-7-18(8-10-20)15-24(36)34-23-16-19(11-14-31-23)26-27(32-21-5-2-1-3-6-21)25-22(33-26)17-29(12-4-13-29)35-28(25)37/h1-3,5-11,14,16,32-33H,4,12-13,15,17H2,(H,35,37)(H,31,34,36) BALRJMDHDGPHTH-UHFFFAOYSA-N 721099 N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 57 Casein kinase I isoform delta Homo sapiens 3.10 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721099 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721099&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674497 513841151 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492478 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NC2(CCC2)C3)ccn1 InChI=1S/C29H26FN5O2/c30-20-9-7-18(8-10-20)15-24(36)34-23-16-19(11-14-31-23)26-27(32-21-5-2-1-3-6-21)25-22(33-26)17-29(12-4-13-29)35-28(25)37/h1-3,5-11,14,16,32-33H,4,12-13,15,17H2,(H,35,37)(H,31,34,36) BALRJMDHDGPHTH-UHFFFAOYSA-N 721099 N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 57 Casein kinase I isoform alpha Homo sapiens 10.3 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721099 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721099&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674497 513841151 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492479 CN(C)CCCC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccccc1 InChI=1S/C32H36N6O2/c1-37(2)19-10-15-25(22-11-6-4-7-12-22)31(39)36-27-21-23(16-18-33-27)29-30(34-24-13-8-5-9-14-24)28-26(35-29)17-20-38(3)32(28)40/h4-9,11-14,16,18,21,25,34-35H,10,15,17,19-20H2,1-3H3,(H,33,36,39) YCWSXEOEVCQKSE-UHFFFAOYSA-N 721100 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-5-(dimethylamino)-2-phenylpentanamide (Racemate)::US12227501, Example 58 Casein kinase I isoform alpha Homo sapiens 12.4 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721100 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721100&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674447 513841152 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492480 CN(C)CCCC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccccc1 InChI=1S/C32H36N6O2/c1-37(2)19-10-15-25(22-11-6-4-7-12-22)31(39)36-27-21-23(16-18-33-27)29-30(34-24-13-8-5-9-14-24)28-26(35-29)17-20-38(3)32(28)40/h4-9,11-14,16,18,21,25,34-35H,10,15,17,19-20H2,1-3H3,(H,33,36,39) YCWSXEOEVCQKSE-UHFFFAOYSA-N 721100 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-5-(dimethylamino)-2-phenylpentanamide (Racemate)::US12227501, Example 58 Casein kinase I isoform delta Homo sapiens 40.6 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721100 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721100&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674447 513841152 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492481 CN(C)CCCC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccccc1 InChI=1S/C32H36N6O2/c1-37(2)19-10-15-25(22-11-6-4-7-12-22)31(39)36-27-21-23(16-18-33-27)29-30(34-24-13-8-5-9-14-24)28-26(35-29)17-20-38(3)32(28)40/h4-9,11-14,16,18,21,25,34-35H,10,15,17,19-20H2,1-3H3,(H,33,36,39) YCWSXEOEVCQKSE-UHFFFAOYSA-N 721100 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-5-(dimethylamino)-2-phenylpentanamide (Racemate)::US12227501, Example 58 Casein kinase I isoform alpha Homo sapiens 1200 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721100 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721100&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674447 513841152 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492482 CN(C)CCCC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccccc1 InChI=1S/C32H36N6O2/c1-37(2)19-10-15-25(22-11-6-4-7-12-22)31(39)36-27-21-23(16-18-33-27)29-30(34-24-13-8-5-9-14-24)28-26(35-29)17-20-38(3)32(28)40/h4-9,11-14,16,18,21,25,34-35H,10,15,17,19-20H2,1-3H3,(H,33,36,39) YCWSXEOEVCQKSE-UHFFFAOYSA-N 721101 (−)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-5-(dimethylamino)-2-phenylpentanamide (Enantiomer 1)::US12227501, Example 59 Casein kinase I isoform alpha Homo sapiens 94.3 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721101 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721101&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674447 513841153 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492483 CN(C)CCCC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccccc1 InChI=1S/C32H36N6O2/c1-37(2)19-10-15-25(22-11-6-4-7-12-22)31(39)36-27-21-23(16-18-33-27)29-30(34-24-13-8-5-9-14-24)28-26(35-29)17-20-38(3)32(28)40/h4-9,11-14,16,18,21,25,34-35H,10,15,17,19-20H2,1-3H3,(H,33,36,39) YCWSXEOEVCQKSE-UHFFFAOYSA-N 721101 (−)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-5-(dimethylamino)-2-phenylpentanamide (Enantiomer 1)::US12227501, Example 59 Casein kinase I isoform delta Homo sapiens 86.2 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721101 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721101&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674447 513841153 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492484 CN(C)CCCC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccccc1 InChI=1S/C32H36N6O2/c1-37(2)19-10-15-25(22-11-6-4-7-12-22)31(39)36-27-21-23(16-18-33-27)29-30(34-24-13-8-5-9-14-24)28-26(35-29)17-20-38(3)32(28)40/h4-9,11-14,16,18,21,25,34-35H,10,15,17,19-20H2,1-3H3,(H,33,36,39) YCWSXEOEVCQKSE-UHFFFAOYSA-N 721101 (−)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-5-(dimethylamino)-2-phenylpentanamide (Enantiomer 1)::US12227501, Example 59 Casein kinase I isoform alpha Homo sapiens 7300 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721101 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721101&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674447 513841153 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492485 CN(C)CCCC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccccc1 InChI=1S/C32H36N6O2/c1-37(2)19-10-15-25(22-11-6-4-7-12-22)31(39)36-27-21-23(16-18-33-27)29-30(34-24-13-8-5-9-14-24)28-26(35-29)17-20-38(3)32(28)40/h4-9,11-14,16,18,21,25,34-35H,10,15,17,19-20H2,1-3H3,(H,33,36,39) YCWSXEOEVCQKSE-UHFFFAOYSA-N 721102 (+)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-5-(dimethylamino)-2-phenylpentanamide (Enantiomer 2)::US12227501, Example 60 Casein kinase I isoform alpha Homo sapiens 7.34 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721102 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721102&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674447 513841154 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492486 CN(C)CCCC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccccc1 InChI=1S/C32H36N6O2/c1-37(2)19-10-15-25(22-11-6-4-7-12-22)31(39)36-27-21-23(16-18-33-27)29-30(34-24-13-8-5-9-14-24)28-26(35-29)17-20-38(3)32(28)40/h4-9,11-14,16,18,21,25,34-35H,10,15,17,19-20H2,1-3H3,(H,33,36,39) YCWSXEOEVCQKSE-UHFFFAOYSA-N 721102 (+)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-5-(dimethylamino)-2-phenylpentanamide (Enantiomer 2)::US12227501, Example 60 Casein kinase I isoform delta Homo sapiens 11.8 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721102 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721102&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674447 513841154 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492487 CN(C)CCCC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccccc1 InChI=1S/C32H36N6O2/c1-37(2)19-10-15-25(22-11-6-4-7-12-22)31(39)36-27-21-23(16-18-33-27)29-30(34-24-13-8-5-9-14-24)28-26(35-29)17-20-38(3)32(28)40/h4-9,11-14,16,18,21,25,34-35H,10,15,17,19-20H2,1-3H3,(H,33,36,39) YCWSXEOEVCQKSE-UHFFFAOYSA-N 721102 (+)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-5-(dimethylamino)-2-phenylpentanamide (Enantiomer 2)::US12227501, Example 60 Casein kinase I isoform alpha Homo sapiens 437 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721102 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721102&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674447 513841154 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492488 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H26F3N5O2/c1-37-14-12-22-25(29(37)39)27(34-20-5-3-2-4-6-20)26(35-22)18-11-13-33-24(15-18)36-28(38)21(16-23(31)32)17-7-9-19(30)10-8-17/h2-11,13,15,21,23,34-35H,12,14,16H2,1H3,(H,33,36,38) IKATWWUGCJFQJV-UHFFFAOYSA-N 721103 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 61 Casein kinase I isoform alpha Homo sapiens 5.11 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721103 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721103&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674383 513841155 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492489 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H26F3N5O2/c1-37-14-12-22-25(29(37)39)27(34-20-5-3-2-4-6-20)26(35-22)18-11-13-33-24(15-18)36-28(38)21(16-23(31)32)17-7-9-19(30)10-8-17/h2-11,13,15,21,23,34-35H,12,14,16H2,1H3,(H,33,36,38) IKATWWUGCJFQJV-UHFFFAOYSA-N 721103 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 61 Casein kinase I isoform delta Homo sapiens 7.68 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721103 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721103&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674383 513841155 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492490 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H26F3N5O2/c1-37-14-12-22-25(29(37)39)27(34-20-5-3-2-4-6-20)26(35-22)18-11-13-33-24(15-18)36-28(38)21(16-23(31)32)17-7-9-19(30)10-8-17/h2-11,13,15,21,23,34-35H,12,14,16H2,1H3,(H,33,36,38) IKATWWUGCJFQJV-UHFFFAOYSA-N 721103 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 61 Casein kinase I isoform alpha Homo sapiens 21.9 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721103 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721103&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674383 513841155 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492491 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H26F3N5O2/c1-37-14-12-22-25(29(37)39)27(34-20-5-3-2-4-6-20)26(35-22)18-11-13-33-24(15-18)36-28(38)21(16-23(31)32)17-7-9-19(30)10-8-17/h2-11,13,15,21,23,34-35H,12,14,16H2,1H3,(H,33,36,38) IKATWWUGCJFQJV-UHFFFAOYSA-N 721104 (−)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 62 Casein kinase I isoform alpha Homo sapiens 21.0 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721104 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721104&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674383 513841156 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492492 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H26F3N5O2/c1-37-14-12-22-25(29(37)39)27(34-20-5-3-2-4-6-20)26(35-22)18-11-13-33-24(15-18)36-28(38)21(16-23(31)32)17-7-9-19(30)10-8-17/h2-11,13,15,21,23,34-35H,12,14,16H2,1H3,(H,33,36,38) IKATWWUGCJFQJV-UHFFFAOYSA-N 721104 (−)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 62 Casein kinase I isoform delta Homo sapiens 29.7 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721104 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721104&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674383 513841156 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492493 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H26F3N5O2/c1-37-14-12-22-25(29(37)39)27(34-20-5-3-2-4-6-20)26(35-22)18-11-13-33-24(15-18)36-28(38)21(16-23(31)32)17-7-9-19(30)10-8-17/h2-11,13,15,21,23,34-35H,12,14,16H2,1H3,(H,33,36,38) IKATWWUGCJFQJV-UHFFFAOYSA-N 721104 (−)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 62 Casein kinase I isoform alpha Homo sapiens 1500 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721104 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721104&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674383 513841156 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492494 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H26F3N5O2/c1-37-14-12-22-25(29(37)39)27(34-20-5-3-2-4-6-20)26(35-22)18-11-13-33-24(15-18)36-28(38)21(16-23(31)32)17-7-9-19(30)10-8-17/h2-11,13,15,21,23,34-35H,12,14,16H2,1H3,(H,33,36,38) IKATWWUGCJFQJV-UHFFFAOYSA-N 721105 (+)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 63 Casein kinase I isoform alpha Homo sapiens 2.12 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721105 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721105&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674383 513841157 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492495 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H26F3N5O2/c1-37-14-12-22-25(29(37)39)27(34-20-5-3-2-4-6-20)26(35-22)18-11-13-33-24(15-18)36-28(38)21(16-23(31)32)17-7-9-19(30)10-8-17/h2-11,13,15,21,23,34-35H,12,14,16H2,1H3,(H,33,36,38) IKATWWUGCJFQJV-UHFFFAOYSA-N 721105 (+)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 63 Casein kinase I isoform delta Homo sapiens 4.00 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721105 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721105&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674383 513841157 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492496 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H26F3N5O2/c1-37-14-12-22-25(29(37)39)27(34-20-5-3-2-4-6-20)26(35-22)18-11-13-33-24(15-18)36-28(38)21(16-23(31)32)17-7-9-19(30)10-8-17/h2-11,13,15,21,23,34-35H,12,14,16H2,1H3,(H,33,36,38) IKATWWUGCJFQJV-UHFFFAOYSA-N 721105 (+)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 63 Casein kinase I isoform alpha Homo sapiens 12.1 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721105 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721105&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674383 513841157 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492497 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccncc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C26H24N6O2/c1-32-14-10-20-23(26(32)34)25(29-19-5-3-2-4-6-19)24(30-20)18-9-13-28-21(16-18)31-22(33)15-17-7-11-27-12-8-17/h2-9,11-13,16,29-30H,10,14-15H2,1H3,(H,28,31,33) OCJNACKDBJHBPG-UHFFFAOYSA-N 721106 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-4-yl)acetamide::US12227501, Example 64 Casein kinase I isoform alpha Homo sapiens 2.65 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721106 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721106&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674306 513841158 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492498 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccncc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C26H24N6O2/c1-32-14-10-20-23(26(32)34)25(29-19-5-3-2-4-6-19)24(30-20)18-9-13-28-21(16-18)31-22(33)15-17-7-11-27-12-8-17/h2-9,11-13,16,29-30H,10,14-15H2,1H3,(H,28,31,33) OCJNACKDBJHBPG-UHFFFAOYSA-N 721106 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-4-yl)acetamide::US12227501, Example 64 Casein kinase I isoform delta Homo sapiens 5.51 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721106 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721106&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674306 513841158 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492499 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccncc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C26H24N6O2/c1-32-14-10-20-23(26(32)34)25(29-19-5-3-2-4-6-19)24(30-20)18-9-13-28-21(16-18)31-22(33)15-17-7-11-27-12-8-17/h2-9,11-13,16,29-30H,10,14-15H2,1H3,(H,28,31,33) OCJNACKDBJHBPG-UHFFFAOYSA-N 721106 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-4-yl)acetamide::US12227501, Example 64 Casein kinase I isoform alpha Homo sapiens 31.0 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721106 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721106&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674306 513841158 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492500 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(S(C)(=O)=O)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H27N5O4S/c1-33-15-13-22-25(28(33)35)27(30-20-6-4-3-5-7-20)26(31-22)19-12-14-29-23(17-19)32-24(34)16-18-8-10-21(11-9-18)38(2,36)37/h3-12,14,17,30-31H,13,15-16H2,1-2H3,(H,29,32,34) GKHICIJKBRWUCL-UHFFFAOYSA-N 721107 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-[4-(methanesulfonyl)phenyl]acetamide::US12227501, Example 65 Casein kinase I isoform alpha Homo sapiens 1.51 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721107 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721107&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674277 513841159 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492501 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(S(C)(=O)=O)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H27N5O4S/c1-33-15-13-22-25(28(33)35)27(30-20-6-4-3-5-7-20)26(31-22)19-12-14-29-23(17-19)32-24(34)16-18-8-10-21(11-9-18)38(2,36)37/h3-12,14,17,30-31H,13,15-16H2,1-2H3,(H,29,32,34) GKHICIJKBRWUCL-UHFFFAOYSA-N 721107 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-[4-(methanesulfonyl)phenyl]acetamide::US12227501, Example 65 Casein kinase I isoform delta Homo sapiens 5.46 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721107 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721107&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674277 513841159 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492502 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(S(C)(=O)=O)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H27N5O4S/c1-33-15-13-22-25(28(33)35)27(30-20-6-4-3-5-7-20)26(31-22)19-12-14-29-23(17-19)32-24(34)16-18-8-10-21(11-9-18)38(2,36)37/h3-12,14,17,30-31H,13,15-16H2,1-2H3,(H,29,32,34) GKHICIJKBRWUCL-UHFFFAOYSA-N 721107 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-[4-(methanesulfonyl)phenyl]acetamide::US12227501, Example 65 Casein kinase I isoform alpha Homo sapiens 17.5 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721107 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721107&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674277 513841159 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492503 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(C(F)(F)F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H24F3N5O2/c1-36-14-12-21-24(27(36)38)26(33-20-5-3-2-4-6-20)25(34-21)18-11-13-32-22(16-18)35-23(37)15-17-7-9-19(10-8-17)28(29,30)31/h2-11,13,16,33-34H,12,14-15H2,1H3,(H,32,35,37) XQNREAZQMGMBMX-UHFFFAOYSA-N 721108 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-[4-(trifluoromethyl)phenyl]acetamide::US12227501, Example 66 Casein kinase I isoform alpha Homo sapiens 2.75 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721108 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721108&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674427 513841160 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492504 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(C(F)(F)F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H24F3N5O2/c1-36-14-12-21-24(27(36)38)26(33-20-5-3-2-4-6-20)25(34-21)18-11-13-32-22(16-18)35-23(37)15-17-7-9-19(10-8-17)28(29,30)31/h2-11,13,16,33-34H,12,14-15H2,1H3,(H,32,35,37) XQNREAZQMGMBMX-UHFFFAOYSA-N 721108 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-[4-(trifluoromethyl)phenyl]acetamide::US12227501, Example 66 Casein kinase I isoform delta Homo sapiens 5.57 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721108 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721108&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674427 513841160 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492505 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(C(F)(F)F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H24F3N5O2/c1-36-14-12-21-24(27(36)38)26(33-20-5-3-2-4-6-20)25(34-21)18-11-13-32-22(16-18)35-23(37)15-17-7-9-19(10-8-17)28(29,30)31/h2-11,13,16,33-34H,12,14-15H2,1H3,(H,32,35,37) XQNREAZQMGMBMX-UHFFFAOYSA-N 721108 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-[4-(trifluoromethyl)phenyl]acetamide::US12227501, Example 66 Casein kinase I isoform alpha Homo sapiens 33.5 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721108 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721108&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674427 513841160 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492506 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4cccnc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C26H24N6O2/c1-32-13-10-20-23(26(32)34)25(29-19-7-3-2-4-8-19)24(30-20)18-9-12-28-21(15-18)31-22(33)14-17-6-5-11-27-16-17/h2-9,11-12,15-16,29-30H,10,13-14H2,1H3,(H,28,31,33) MRRGNSSCHWNURS-UHFFFAOYSA-N 721109 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-3-yl)acetamide::US12227501, Example 67 Casein kinase I isoform alpha Homo sapiens 2.41 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721109 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721109&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674323 513841161 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492507 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4cccnc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C26H24N6O2/c1-32-13-10-20-23(26(32)34)25(29-19-7-3-2-4-8-19)24(30-20)18-9-12-28-21(15-18)31-22(33)14-17-6-5-11-27-16-17/h2-9,11-12,15-16,29-30H,10,13-14H2,1H3,(H,28,31,33) MRRGNSSCHWNURS-UHFFFAOYSA-N 721109 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-3-yl)acetamide::US12227501, Example 67 Casein kinase I isoform delta Homo sapiens 3.79 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721109 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721109&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674323 513841161 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492508 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4cccnc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C26H24N6O2/c1-32-13-10-20-23(26(32)34)25(29-19-7-3-2-4-8-19)24(30-20)18-9-12-28-21(15-18)31-22(33)14-17-6-5-11-27-16-17/h2-9,11-12,15-16,29-30H,10,13-14H2,1H3,(H,28,31,33) MRRGNSSCHWNURS-UHFFFAOYSA-N 721109 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-3-yl)acetamide::US12227501, Example 67 Casein kinase I isoform alpha Homo sapiens 44.6 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721109 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721109&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674323 513841161 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492509 Cc1ccc(CC(=O)Nc2cc(-c3[nH]c4c(c3Nc3ccccc3)C(=O)N(C)CC4)ccn2)cc1 InChI=1S/C28H27N5O2/c1-18-8-10-19(11-9-18)16-24(34)32-23-17-20(12-14-29-23)26-27(30-21-6-4-3-5-7-21)25-22(31-26)13-15-33(2)28(25)35/h3-12,14,17,30-31H,13,15-16H2,1-2H3,(H,29,32,34) ILZYLHZIAQJQGN-UHFFFAOYSA-N 721110 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-methylphenyl)acetamide::US12227501, Example 68 Casein kinase I isoform alpha Homo sapiens 3.20 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721110 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721110&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674412 513841162 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492510 Cc1ccc(CC(=O)Nc2cc(-c3[nH]c4c(c3Nc3ccccc3)C(=O)N(C)CC4)ccn2)cc1 InChI=1S/C28H27N5O2/c1-18-8-10-19(11-9-18)16-24(34)32-23-17-20(12-14-29-23)26-27(30-21-6-4-3-5-7-21)25-22(31-26)13-15-33(2)28(25)35/h3-12,14,17,30-31H,13,15-16H2,1-2H3,(H,29,32,34) ILZYLHZIAQJQGN-UHFFFAOYSA-N 721110 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-methylphenyl)acetamide::US12227501, Example 68 Casein kinase I isoform delta Homo sapiens 3.63 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721110 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721110&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674412 513841162 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492511 Cc1ccc(CC(=O)Nc2cc(-c3[nH]c4c(c3Nc3ccccc3)C(=O)N(C)CC4)ccn2)cc1 InChI=1S/C28H27N5O2/c1-18-8-10-19(11-9-18)16-24(34)32-23-17-20(12-14-29-23)26-27(30-21-6-4-3-5-7-21)25-22(31-26)13-15-33(2)28(25)35/h3-12,14,17,30-31H,13,15-16H2,1-2H3,(H,29,32,34) ILZYLHZIAQJQGN-UHFFFAOYSA-N 721110 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-methylphenyl)acetamide::US12227501, Example 68 Casein kinase I isoform alpha Homo sapiens 74.2 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721110 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721110&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674412 513841162 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492512 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4cccc(S(C)(=O)=O)c4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H27N5O4S/c1-33-14-12-22-25(28(33)35)27(30-20-8-4-3-5-9-20)26(31-22)19-11-13-29-23(17-19)32-24(34)16-18-7-6-10-21(15-18)38(2,36)37/h3-11,13,15,17,30-31H,12,14,16H2,1-2H3,(H,29,32,34) JQPFYUYZGQPQOZ-UHFFFAOYSA-N 721111 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-[3-(methanesulfonyl)phenyl]acetamide::US12227501, Example 69 Casein kinase I isoform alpha Homo sapiens 3.13 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721111 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721111&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674297 513841163 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492513 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4cccc(S(C)(=O)=O)c4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H27N5O4S/c1-33-14-12-22-25(28(33)35)27(30-20-8-4-3-5-9-20)26(31-22)19-11-13-29-23(17-19)32-24(34)16-18-7-6-10-21(15-18)38(2,36)37/h3-11,13,15,17,30-31H,12,14,16H2,1-2H3,(H,29,32,34) JQPFYUYZGQPQOZ-UHFFFAOYSA-N 721111 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-[3-(methanesulfonyl)phenyl]acetamide::US12227501, Example 69 Casein kinase I isoform delta Homo sapiens 4.68 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721111 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721111&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674297 513841163 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492514 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4cccc(S(C)(=O)=O)c4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H27N5O4S/c1-33-14-12-22-25(28(33)35)27(30-20-8-4-3-5-9-20)26(31-22)19-11-13-29-23(17-19)32-24(34)16-18-7-6-10-21(15-18)38(2,36)37/h3-11,13,15,17,30-31H,12,14,16H2,1-2H3,(H,29,32,34) JQPFYUYZGQPQOZ-UHFFFAOYSA-N 721111 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-[3-(methanesulfonyl)phenyl]acetamide::US12227501, Example 69 Casein kinase I isoform alpha Homo sapiens 81.7 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721111 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721111&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674297 513841163 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492515 Cc1cccc(CC(=O)Nc2cc(-c3[nH]c4c(c3Nc3ccccc3)C(=O)N(C)CC4)ccn2)c1 InChI=1S/C28H27N5O2/c1-18-7-6-8-19(15-18)16-24(34)32-23-17-20(11-13-29-23)26-27(30-21-9-4-3-5-10-21)25-22(31-26)12-14-33(2)28(25)35/h3-11,13,15,17,30-31H,12,14,16H2,1-2H3,(H,29,32,34) UUSCGSSISCGHIZ-UHFFFAOYSA-N 721112 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(3-methylphenyl)acetamide::US12227501, Example 70 Casein kinase I isoform alpha Homo sapiens 3.20 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721112 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721112&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674369 513841164 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492516 Cc1cccc(CC(=O)Nc2cc(-c3[nH]c4c(c3Nc3ccccc3)C(=O)N(C)CC4)ccn2)c1 InChI=1S/C28H27N5O2/c1-18-7-6-8-19(15-18)16-24(34)32-23-17-20(11-13-29-23)26-27(30-21-9-4-3-5-10-21)25-22(31-26)12-14-33(2)28(25)35/h3-11,13,15,17,30-31H,12,14,16H2,1-2H3,(H,29,32,34) UUSCGSSISCGHIZ-UHFFFAOYSA-N 721112 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(3-methylphenyl)acetamide::US12227501, Example 70 Casein kinase I isoform delta Homo sapiens 3.66 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721112 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721112&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674369 513841164 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492517 Cc1cccc(CC(=O)Nc2cc(-c3[nH]c4c(c3Nc3ccccc3)C(=O)N(C)CC4)ccn2)c1 InChI=1S/C28H27N5O2/c1-18-7-6-8-19(15-18)16-24(34)32-23-17-20(11-13-29-23)26-27(30-21-9-4-3-5-10-21)25-22(31-26)12-14-33(2)28(25)35/h3-11,13,15,17,30-31H,12,14,16H2,1-2H3,(H,29,32,34) UUSCGSSISCGHIZ-UHFFFAOYSA-N 721112 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(3-methylphenyl)acetamide::US12227501, Example 70 Casein kinase I isoform alpha Homo sapiens 140 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721112 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721112&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674369 513841164 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492518 Cc1ccccc1CC(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1 InChI=1S/C28H27N5O2/c1-18-8-6-7-9-19(18)17-24(34)32-23-16-20(12-14-29-23)26-27(30-21-10-4-3-5-11-21)25-22(31-26)13-15-33(2)28(25)35/h3-12,14,16,30-31H,13,15,17H2,1-2H3,(H,29,32,34) MHLPTBJWCVRRPC-UHFFFAOYSA-N 721113 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(2-methylphenyl)acetamide::US12227501, Example 71 Casein kinase I isoform alpha Homo sapiens 4.79 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721113 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721113&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674251 513841165 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492519 Cc1ccccc1CC(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1 InChI=1S/C28H27N5O2/c1-18-8-6-7-9-19(18)17-24(34)32-23-16-20(12-14-29-23)26-27(30-21-10-4-3-5-11-21)25-22(31-26)13-15-33(2)28(25)35/h3-12,14,16,30-31H,13,15,17H2,1-2H3,(H,29,32,34) MHLPTBJWCVRRPC-UHFFFAOYSA-N 721113 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(2-methylphenyl)acetamide::US12227501, Example 71 Casein kinase I isoform delta Homo sapiens 6.47 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721113 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721113&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674251 513841165 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492520 Cc1ccccc1CC(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1 InChI=1S/C28H27N5O2/c1-18-8-6-7-9-19(18)17-24(34)32-23-16-20(12-14-29-23)26-27(30-21-10-4-3-5-11-21)25-22(31-26)13-15-33(2)28(25)35/h3-12,14,16,30-31H,13,15,17H2,1-2H3,(H,29,32,34) MHLPTBJWCVRRPC-UHFFFAOYSA-N 721113 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(2-methylphenyl)acetamide::US12227501, Example 71 Casein kinase I isoform alpha Homo sapiens 241 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721113 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721113&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674251 513841165 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492521 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccncc1 InChI=1S/C27H26N6O2/c1-17(18-8-12-28-13-9-18)26(34)32-22-16-19(10-14-29-22)24-25(30-20-6-4-3-5-7-20)23-21(31-24)11-15-33(2)27(23)35/h3-10,12-14,16-17,30-31H,11,15H2,1-2H3,(H,29,32,34) VZLYECDBMSJTQG-UHFFFAOYSA-N 721114 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-4-yl)propanamide (Racemate)::US12227501, Example 72 Casein kinase I isoform alpha Homo sapiens 3.97 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721114 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721114&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674234 513841166 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492522 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccncc1 InChI=1S/C27H26N6O2/c1-17(18-8-12-28-13-9-18)26(34)32-22-16-19(10-14-29-22)24-25(30-20-6-4-3-5-7-20)23-21(31-24)11-15-33(2)27(23)35/h3-10,12-14,16-17,30-31H,11,15H2,1-2H3,(H,29,32,34) VZLYECDBMSJTQG-UHFFFAOYSA-N 721114 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-4-yl)propanamide (Racemate)::US12227501, Example 72 Casein kinase I isoform delta Homo sapiens 6.09 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721114 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721114&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674234 513841166 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492523 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccncc1 InChI=1S/C27H26N6O2/c1-17(18-8-12-28-13-9-18)26(34)32-22-16-19(10-14-29-22)24-25(30-20-6-4-3-5-7-20)23-21(31-24)11-15-33(2)27(23)35/h3-10,12-14,16-17,30-31H,11,15H2,1-2H3,(H,29,32,34) VZLYECDBMSJTQG-UHFFFAOYSA-N 721114 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-4-yl)propanamide (Racemate)::US12227501, Example 72 Casein kinase I isoform alpha Homo sapiens 66.4 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721114 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721114&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674234 513841166 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492524 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccncc1 InChI=1S/C27H26N6O2/c1-17(18-8-12-28-13-9-18)26(34)32-22-16-19(10-14-29-22)24-25(30-20-6-4-3-5-7-20)23-21(31-24)11-15-33(2)27(23)35/h3-10,12-14,16-17,30-31H,11,15H2,1-2H3,(H,29,32,34) VZLYECDBMSJTQG-UHFFFAOYSA-N 721115 (+)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-4-yl)propanamide (Enantiomer 1)::US12227501, Example 73 Casein kinase I isoform alpha Homo sapiens 2.38 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721115 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721115&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674234 513841167 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492525 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccncc1 InChI=1S/C27H26N6O2/c1-17(18-8-12-28-13-9-18)26(34)32-22-16-19(10-14-29-22)24-25(30-20-6-4-3-5-7-20)23-21(31-24)11-15-33(2)27(23)35/h3-10,12-14,16-17,30-31H,11,15H2,1-2H3,(H,29,32,34) VZLYECDBMSJTQG-UHFFFAOYSA-N 721115 (+)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-4-yl)propanamide (Enantiomer 1)::US12227501, Example 73 Casein kinase I isoform delta Homo sapiens 4.46 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721115 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721115&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674234 513841167 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492526 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccncc1 InChI=1S/C27H26N6O2/c1-17(18-8-12-28-13-9-18)26(34)32-22-16-19(10-14-29-22)24-25(30-20-6-4-3-5-7-20)23-21(31-24)11-15-33(2)27(23)35/h3-10,12-14,16-17,30-31H,11,15H2,1-2H3,(H,29,32,34) VZLYECDBMSJTQG-UHFFFAOYSA-N 721115 (+)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-4-yl)propanamide (Enantiomer 1)::US12227501, Example 73 Casein kinase I isoform alpha Homo sapiens 63.3 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721115 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721115&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674234 513841167 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492527 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccncc1 InChI=1S/C27H26N6O2/c1-17(18-8-12-28-13-9-18)26(34)32-22-16-19(10-14-29-22)24-25(30-20-6-4-3-5-7-20)23-21(31-24)11-15-33(2)27(23)35/h3-10,12-14,16-17,30-31H,11,15H2,1-2H3,(H,29,32,34) VZLYECDBMSJTQG-UHFFFAOYSA-N 721116 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-4-yl)propanamide (Enantiomer 2)::US12227501, Example 74 Casein kinase I isoform alpha Homo sapiens 33.9 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721116 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721116&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674234 513841168 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492528 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccncc1 InChI=1S/C27H26N6O2/c1-17(18-8-12-28-13-9-18)26(34)32-22-16-19(10-14-29-22)24-25(30-20-6-4-3-5-7-20)23-21(31-24)11-15-33(2)27(23)35/h3-10,12-14,16-17,30-31H,11,15H2,1-2H3,(H,29,32,34) VZLYECDBMSJTQG-UHFFFAOYSA-N 721116 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-4-yl)propanamide (Enantiomer 2)::US12227501, Example 74 Casein kinase I isoform delta Homo sapiens 55.1 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721116 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721116&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674234 513841168 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492529 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccncc1 InChI=1S/C27H26N6O2/c1-17(18-8-12-28-13-9-18)26(34)32-22-16-19(10-14-29-22)24-25(30-20-6-4-3-5-7-20)23-21(31-24)11-15-33(2)27(23)35/h3-10,12-14,16-17,30-31H,11,15H2,1-2H3,(H,29,32,34) VZLYECDBMSJTQG-UHFFFAOYSA-N 721116 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-4-yl)propanamide (Enantiomer 2)::US12227501, Example 74 Casein kinase I isoform alpha Homo sapiens 599 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721116 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721116&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674234 513841168 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492530 CCC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-3-22(18-9-11-20(30)12-10-18)28(36)34-24-17-19(13-15-31-24)26-27(32-21-7-5-4-6-8-21)25-23(33-26)14-16-35(2)29(25)37/h4-13,15,17,22,32-33H,3,14,16H2,1-2H3,(H,31,34,36) GGXUUYZKIPHVAW-UHFFFAOYSA-N 721117 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 75 Casein kinase I isoform alpha Homo sapiens 5.49 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721117 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721117&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674401 513841169 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492531 CCC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-3-22(18-9-11-20(30)12-10-18)28(36)34-24-17-19(13-15-31-24)26-27(32-21-7-5-4-6-8-21)25-23(33-26)14-16-35(2)29(25)37/h4-13,15,17,22,32-33H,3,14,16H2,1-2H3,(H,31,34,36) GGXUUYZKIPHVAW-UHFFFAOYSA-N 721117 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 75 Casein kinase I isoform delta Homo sapiens 8.28 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721117 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721117&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674401 513841169 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492532 CCC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-3-22(18-9-11-20(30)12-10-18)28(36)34-24-17-19(13-15-31-24)26-27(32-21-7-5-4-6-8-21)25-23(33-26)14-16-35(2)29(25)37/h4-13,15,17,22,32-33H,3,14,16H2,1-2H3,(H,31,34,36) GGXUUYZKIPHVAW-UHFFFAOYSA-N 721117 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 75 Casein kinase I isoform alpha Homo sapiens 164 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721117 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721117&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674401 513841169 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492533 CCC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-3-22(18-9-11-20(30)12-10-18)28(36)34-24-17-19(13-15-31-24)26-27(32-21-7-5-4-6-8-21)25-23(33-26)14-16-35(2)29(25)37/h4-13,15,17,22,32-33H,3,14,16H2,1-2H3,(H,31,34,36) GGXUUYZKIPHVAW-UHFFFAOYSA-N 721118 (−)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 76 Casein kinase I isoform alpha Homo sapiens 14.4 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721118 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721118&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674401 513841170 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492534 CCC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-3-22(18-9-11-20(30)12-10-18)28(36)34-24-17-19(13-15-31-24)26-27(32-21-7-5-4-6-8-21)25-23(33-26)14-16-35(2)29(25)37/h4-13,15,17,22,32-33H,3,14,16H2,1-2H3,(H,31,34,36) GGXUUYZKIPHVAW-UHFFFAOYSA-N 721118 (−)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 76 Casein kinase I isoform delta Homo sapiens 17.5 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721118 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721118&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674401 513841170 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492535 CCC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-3-22(18-9-11-20(30)12-10-18)28(36)34-24-17-19(13-15-31-24)26-27(32-21-7-5-4-6-8-21)25-23(33-26)14-16-35(2)29(25)37/h4-13,15,17,22,32-33H,3,14,16H2,1-2H3,(H,31,34,36) GGXUUYZKIPHVAW-UHFFFAOYSA-N 721118 (−)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 76 Casein kinase I isoform alpha Homo sapiens 506 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721118 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721118&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674401 513841170 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492536 CCC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-3-22(18-9-11-20(30)12-10-18)28(36)34-24-17-19(13-15-31-24)26-27(32-21-7-5-4-6-8-21)25-23(33-26)14-16-35(2)29(25)37/h4-13,15,17,22,32-33H,3,14,16H2,1-2H3,(H,31,34,36) GGXUUYZKIPHVAW-UHFFFAOYSA-N 721119 (+)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 77 Casein kinase I isoform alpha Homo sapiens 2.12 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721119 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721119&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674401 513841171 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492537 CCC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-3-22(18-9-11-20(30)12-10-18)28(36)34-24-17-19(13-15-31-24)26-27(32-21-7-5-4-6-8-21)25-23(33-26)14-16-35(2)29(25)37/h4-13,15,17,22,32-33H,3,14,16H2,1-2H3,(H,31,34,36) GGXUUYZKIPHVAW-UHFFFAOYSA-N 721119 (+)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 77 Casein kinase I isoform delta Homo sapiens 4.43 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721119 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721119&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674401 513841171 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492538 CCC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-3-22(18-9-11-20(30)12-10-18)28(36)34-24-17-19(13-15-31-24)26-27(32-21-7-5-4-6-8-21)25-23(33-26)14-16-35(2)29(25)37/h4-13,15,17,22,32-33H,3,14,16H2,1-2H3,(H,31,34,36) GGXUUYZKIPHVAW-UHFFFAOYSA-N 721119 (+)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 77 Casein kinase I isoform alpha Homo sapiens 86.7 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721119 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721119&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674401 513841171 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492539 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(C(F)F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H25F2N5O2/c1-35-14-12-21-24(28(35)37)26(32-20-5-3-2-4-6-20)25(33-21)19-11-13-31-22(16-19)34-23(36)15-17-7-9-18(10-8-17)27(29)30/h2-11,13,16,27,32-33H,12,14-15H2,1H3,(H,31,34,36) QHLWRPSEJQXVCM-UHFFFAOYSA-N 721120 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-[4-(difluoromethyl)phenyl]acetamide::US12227501, Example 78 Casein kinase I isoform alpha Homo sapiens 2.95 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721120 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721120&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674321 513841172 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492540 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(C(F)F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H25F2N5O2/c1-35-14-12-21-24(28(35)37)26(32-20-5-3-2-4-6-20)25(33-21)19-11-13-31-22(16-19)34-23(36)15-17-7-9-18(10-8-17)27(29)30/h2-11,13,16,27,32-33H,12,14-15H2,1H3,(H,31,34,36) QHLWRPSEJQXVCM-UHFFFAOYSA-N 721120 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-[4-(difluoromethyl)phenyl]acetamide::US12227501, Example 78 Casein kinase I isoform delta Homo sapiens 7.93 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721120 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721120&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674321 513841172 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492541 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(C(F)F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H25F2N5O2/c1-35-14-12-21-24(28(35)37)26(32-20-5-3-2-4-6-20)25(33-21)19-11-13-31-22(16-19)34-23(36)15-17-7-9-18(10-8-17)27(29)30/h2-11,13,16,27,32-33H,12,14-15H2,1H3,(H,31,34,36) QHLWRPSEJQXVCM-UHFFFAOYSA-N 721120 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-[4-(difluoromethyl)phenyl]acetamide::US12227501, Example 78 Casein kinase I isoform alpha Homo sapiens 95.5 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721120 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721120&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674321 513841172 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492542 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(Cl)cc1 InChI=1S/C28H26ClN5O2/c1-17(18-8-10-20(29)11-9-18)27(35)33-23-16-19(12-14-30-23)25-26(31-21-6-4-3-5-7-21)24-22(32-25)13-15-34(2)28(24)36/h3-12,14,16-17,31-32H,13,15H2,1-2H3,(H,30,33,35) AWQFFDDPKOKUOH-UHFFFAOYSA-N 721121 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-chlorophenyl)propanamide (Racemate)::US12227501, Example 79 Casein kinase I isoform alpha Homo sapiens 8.93 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721121 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721121&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674313 513841173 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492543 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(Cl)cc1 InChI=1S/C28H26ClN5O2/c1-17(18-8-10-20(29)11-9-18)27(35)33-23-16-19(12-14-30-23)25-26(31-21-6-4-3-5-7-21)24-22(32-25)13-15-34(2)28(24)36/h3-12,14,16-17,31-32H,13,15H2,1-2H3,(H,30,33,35) AWQFFDDPKOKUOH-UHFFFAOYSA-N 721121 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-chlorophenyl)propanamide (Racemate)::US12227501, Example 79 Casein kinase I isoform delta Homo sapiens 19.5 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721121 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721121&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674313 513841173 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492544 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(Cl)cc1 InChI=1S/C28H26ClN5O2/c1-17(18-8-10-20(29)11-9-18)27(35)33-23-16-19(12-14-30-23)25-26(31-21-6-4-3-5-7-21)24-22(32-25)13-15-34(2)28(24)36/h3-12,14,16-17,31-32H,13,15H2,1-2H3,(H,30,33,35) AWQFFDDPKOKUOH-UHFFFAOYSA-N 721121 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-chlorophenyl)propanamide (Racemate)::US12227501, Example 79 Casein kinase I isoform alpha Homo sapiens 337 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721121 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721121&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674313 513841173 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492545 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(Cl)cc1 InChI=1S/C28H26ClN5O2/c1-17(18-8-10-20(29)11-9-18)27(35)33-23-16-19(12-14-30-23)25-26(31-21-6-4-3-5-7-21)24-22(32-25)13-15-34(2)28(24)36/h3-12,14,16-17,31-32H,13,15H2,1-2H3,(H,30,33,35) AWQFFDDPKOKUOH-UHFFFAOYSA-N 721122 (−)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-chlorophenyl)propanamide (Enantiomer 1)::US12227501, Example 80 Casein kinase I isoform alpha Homo sapiens 24.1 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721122 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721122&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674313 513841174 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492546 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(Cl)cc1 InChI=1S/C28H26ClN5O2/c1-17(18-8-10-20(29)11-9-18)27(35)33-23-16-19(12-14-30-23)25-26(31-21-6-4-3-5-7-21)24-22(32-25)13-15-34(2)28(24)36/h3-12,14,16-17,31-32H,13,15H2,1-2H3,(H,30,33,35) AWQFFDDPKOKUOH-UHFFFAOYSA-N 721122 (−)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-chlorophenyl)propanamide (Enantiomer 1)::US12227501, Example 80 Casein kinase I isoform delta Homo sapiens 30.3 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721122 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721122&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674313 513841174 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492547 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(Cl)cc1 InChI=1S/C28H26ClN5O2/c1-17(18-8-10-20(29)11-9-18)27(35)33-23-16-19(12-14-30-23)25-26(31-21-6-4-3-5-7-21)24-22(32-25)13-15-34(2)28(24)36/h3-12,14,16-17,31-32H,13,15H2,1-2H3,(H,30,33,35) AWQFFDDPKOKUOH-UHFFFAOYSA-N 721122 (−)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-chlorophenyl)propanamide (Enantiomer 1)::US12227501, Example 80 Casein kinase I isoform alpha Homo sapiens 2840 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721122 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721122&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674313 513841174 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492548 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(Cl)cc1 InChI=1S/C28H26ClN5O2/c1-17(18-8-10-20(29)11-9-18)27(35)33-23-16-19(12-14-30-23)25-26(31-21-6-4-3-5-7-21)24-22(32-25)13-15-34(2)28(24)36/h3-12,14,16-17,31-32H,13,15H2,1-2H3,(H,30,33,35) AWQFFDDPKOKUOH-UHFFFAOYSA-N 721123 (+)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-chlorophenyl)propanamide (Enantiomer 2)::US12227501, Example 81 Casein kinase I isoform alpha Homo sapiens 4.33 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721123 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721123&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674313 513841175 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492549 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(Cl)cc1 InChI=1S/C28H26ClN5O2/c1-17(18-8-10-20(29)11-9-18)27(35)33-23-16-19(12-14-30-23)25-26(31-21-6-4-3-5-7-21)24-22(32-25)13-15-34(2)28(24)36/h3-12,14,16-17,31-32H,13,15H2,1-2H3,(H,30,33,35) AWQFFDDPKOKUOH-UHFFFAOYSA-N 721123 (+)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-chlorophenyl)propanamide (Enantiomer 2)::US12227501, Example 81 Casein kinase I isoform delta Homo sapiens 8.47 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721123 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721123&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674313 513841175 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492550 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(Cl)cc1 InChI=1S/C28H26ClN5O2/c1-17(18-8-10-20(29)11-9-18)27(35)33-23-16-19(12-14-30-23)25-26(31-21-6-4-3-5-7-21)24-22(32-25)13-15-34(2)28(24)36/h3-12,14,16-17,31-32H,13,15H2,1-2H3,(H,30,33,35) AWQFFDDPKOKUOH-UHFFFAOYSA-N 721123 (+)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-chlorophenyl)propanamide (Enantiomer 2)::US12227501, Example 81 Casein kinase I isoform alpha Homo sapiens 71.4 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721123 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721123&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674313 513841175 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492551 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4F)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C27H23F2N5O2/c1-34-12-10-21-24(27(34)36)26(31-19-5-3-2-4-6-19)25(32-21)17-9-11-30-22(13-17)33-23(35)14-16-7-8-18(28)15-20(16)29/h2-9,11,13,15,31-32H,10,12,14H2,1H3,(H,30,33,35) NWLSEQZPIYEHII-UHFFFAOYSA-N 721124 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(2,4-difluorophenyl)acetamide::US12227501, Example 82 Casein kinase I isoform alpha Homo sapiens 2.26 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721124 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721124&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674327 513841176 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492552 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4F)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C27H23F2N5O2/c1-34-12-10-21-24(27(34)36)26(31-19-5-3-2-4-6-19)25(32-21)17-9-11-30-22(13-17)33-23(35)14-16-7-8-18(28)15-20(16)29/h2-9,11,13,15,31-32H,10,12,14H2,1H3,(H,30,33,35) NWLSEQZPIYEHII-UHFFFAOYSA-N 721124 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(2,4-difluorophenyl)acetamide::US12227501, Example 82 Casein kinase I isoform delta Homo sapiens 5.52 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721124 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721124&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674327 513841176 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492553 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4F)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C27H23F2N5O2/c1-34-12-10-21-24(27(34)36)26(31-19-5-3-2-4-6-19)25(32-21)17-9-11-30-22(13-17)33-23(35)14-16-7-8-18(28)15-20(16)29/h2-9,11,13,15,31-32H,10,12,14H2,1H3,(H,30,33,35) NWLSEQZPIYEHII-UHFFFAOYSA-N 721124 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(2,4-difluorophenyl)acetamide::US12227501, Example 82 Casein kinase I isoform alpha Homo sapiens 162 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721124 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721124&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674327 513841176 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492554 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)c(F)c4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C27H23F2N5O2/c1-34-12-10-21-24(27(34)36)26(31-18-5-3-2-4-6-18)25(32-21)17-9-11-30-22(15-17)33-23(35)14-16-7-8-19(28)20(29)13-16/h2-9,11,13,15,31-32H,10,12,14H2,1H3,(H,30,33,35) FHYLCIXGVBYKBV-UHFFFAOYSA-N 721125 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(3,4-difluorophenyl)acetamide::US12227501, Example 83 Casein kinase I isoform alpha Homo sapiens 3.03 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721125 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721125&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674376 513841177 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492555 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)c(F)c4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C27H23F2N5O2/c1-34-12-10-21-24(27(34)36)26(31-18-5-3-2-4-6-18)25(32-21)17-9-11-30-22(15-17)33-23(35)14-16-7-8-19(28)20(29)13-16/h2-9,11,13,15,31-32H,10,12,14H2,1H3,(H,30,33,35) FHYLCIXGVBYKBV-UHFFFAOYSA-N 721125 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(3,4-difluorophenyl)acetamide::US12227501, Example 83 Casein kinase I isoform delta Homo sapiens 7.30 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721125 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721125&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674376 513841177 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492556 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)c(F)c4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C27H23F2N5O2/c1-34-12-10-21-24(27(34)36)26(31-18-5-3-2-4-6-18)25(32-21)17-9-11-30-22(15-17)33-23(35)14-16-7-8-19(28)20(29)13-16/h2-9,11,13,15,31-32H,10,12,14H2,1H3,(H,30,33,35) FHYLCIXGVBYKBV-UHFFFAOYSA-N 721125 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(3,4-difluorophenyl)acetamide::US12227501, Example 83 Casein kinase I isoform alpha Homo sapiens 61.4 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721125 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721125&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674376 513841177 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492557 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(N(C)C)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H30N6O2/c1-34(2)22-11-9-19(10-12-22)17-25(36)33-24-18-20(13-15-30-24)27-28(31-21-7-5-4-6-8-21)26-23(32-27)14-16-35(3)29(26)37/h4-13,15,18,31-32H,14,16-17H2,1-3H3,(H,30,33,36) ZMLOZXFOYBKPSP-UHFFFAOYSA-N 721126 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-[4-(dimethylamino)phenyl]acetamide::US12227501, Example 84 Casein kinase I isoform alpha Homo sapiens 2.64 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721126 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721126&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674325 513841178 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492558 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(N(C)C)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H30N6O2/c1-34(2)22-11-9-19(10-12-22)17-25(36)33-24-18-20(13-15-30-24)27-28(31-21-7-5-4-6-8-21)26-23(32-27)14-16-35(3)29(26)37/h4-13,15,18,31-32H,14,16-17H2,1-3H3,(H,30,33,36) ZMLOZXFOYBKPSP-UHFFFAOYSA-N 721126 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-[4-(dimethylamino)phenyl]acetamide::US12227501, Example 84 Casein kinase I isoform delta Homo sapiens 8.50 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721126 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721126&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674325 513841178 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492559 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(N(C)C)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H30N6O2/c1-34(2)22-11-9-19(10-12-22)17-25(36)33-24-18-20(13-15-30-24)27-28(31-21-7-5-4-6-8-21)26-23(32-27)14-16-35(3)29(26)37/h4-13,15,18,31-32H,14,16-17H2,1-3H3,(H,30,33,36) ZMLOZXFOYBKPSP-UHFFFAOYSA-N 721126 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-[4-(dimethylamino)phenyl]acetamide::US12227501, Example 84 Casein kinase I isoform alpha Homo sapiens 217 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721126 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721126&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674325 513841178 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492560 Cc1cc(CC(=O)Nc2cc(-c3[nH]c4c(c3Nc3ccccc3)C(=O)N(C)CC4)ccn2)ccn1 InChI=1S/C27H26N6O2/c1-17-14-18(8-11-28-17)15-23(34)32-22-16-19(9-12-29-22)25-26(30-20-6-4-3-5-7-20)24-21(31-25)10-13-33(2)27(24)35/h3-9,11-12,14,16,30-31H,10,13,15H2,1-2H3,(H,29,32,34) LHIQTHDBSXSQTG-UHFFFAOYSA-N 721127 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(2-methylpyridin-4-yl)acetamide::US12227501, Example 85 Casein kinase I isoform alpha Homo sapiens 1.78 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721127 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721127&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674424 513841179 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492561 Cc1cc(CC(=O)Nc2cc(-c3[nH]c4c(c3Nc3ccccc3)C(=O)N(C)CC4)ccn2)ccn1 InChI=1S/C27H26N6O2/c1-17-14-18(8-11-28-17)15-23(34)32-22-16-19(9-12-29-22)25-26(30-20-6-4-3-5-7-20)24-21(31-25)10-13-33(2)27(24)35/h3-9,11-12,14,16,30-31H,10,13,15H2,1-2H3,(H,29,32,34) LHIQTHDBSXSQTG-UHFFFAOYSA-N 721127 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(2-methylpyridin-4-yl)acetamide::US12227501, Example 85 Casein kinase I isoform delta Homo sapiens 3.36 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721127 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721127&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674424 513841179 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492562 Cc1cc(CC(=O)Nc2cc(-c3[nH]c4c(c3Nc3ccccc3)C(=O)N(C)CC4)ccn2)ccn1 InChI=1S/C27H26N6O2/c1-17-14-18(8-11-28-17)15-23(34)32-22-16-19(9-12-29-22)25-26(30-20-6-4-3-5-7-20)24-21(31-25)10-13-33(2)27(24)35/h3-9,11-12,14,16,30-31H,10,13,15H2,1-2H3,(H,29,32,34) LHIQTHDBSXSQTG-UHFFFAOYSA-N 721127 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(2-methylpyridin-4-yl)acetamide::US12227501, Example 85 Casein kinase I isoform alpha Homo sapiens 26.5 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721127 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721127&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674424 513841179 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492563 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1 InChI=1S/C28H25F2N5O2/c1-28(2)15-21-24(27(37)35-28)26(32-20-6-4-3-5-19(20)30)25(33-21)17-11-12-31-22(14-17)34-23(36)13-16-7-9-18(29)10-8-16/h3-12,14,32-33H,13,15H2,1-2H3,(H,35,37)(H,31,34,36) NEOVWVIFEVIRBF-UHFFFAOYSA-N 721128 N-{4-[3-(2-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 86 Casein kinase I isoform alpha Homo sapiens 4.44 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721128 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721128&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674489 513841180 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492564 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1 InChI=1S/C28H25F2N5O2/c1-28(2)15-21-24(27(37)35-28)26(32-20-6-4-3-5-19(20)30)25(33-21)17-11-12-31-22(14-17)34-23(36)13-16-7-9-18(29)10-8-16/h3-12,14,32-33H,13,15H2,1-2H3,(H,35,37)(H,31,34,36) NEOVWVIFEVIRBF-UHFFFAOYSA-N 721128 N-{4-[3-(2-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 86 Casein kinase I isoform delta Homo sapiens 9.48 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721128 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721128&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674489 513841180 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492565 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1 InChI=1S/C28H25F2N5O2/c1-28(2)15-21-24(27(37)35-28)26(32-20-6-4-3-5-19(20)30)25(33-21)17-11-12-31-22(14-17)34-23(36)13-16-7-9-18(29)10-8-16/h3-12,14,32-33H,13,15H2,1-2H3,(H,35,37)(H,31,34,36) NEOVWVIFEVIRBF-UHFFFAOYSA-N 721128 N-{4-[3-(2-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 86 Casein kinase I isoform alpha Homo sapiens 110 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721128 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721128&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674489 513841180 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492566 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2cccc(F)c2Cl)C(=O)NCC3)ccn1 InChI=1S/C26H20ClF2N5O2/c27-23-17(29)2-1-3-19(23)33-25-22-18(9-11-31-26(22)36)32-24(25)15-8-10-30-20(13-15)34-21(35)12-14-4-6-16(28)7-5-14/h1-8,10,13,32-33H,9,11-12H2,(H,31,36)(H,30,34,35) UJJMQXWMFBWWJA-UHFFFAOYSA-N 721129 N-{4-[3-(2-chloro-3-fluoroanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 87 Casein kinase I isoform alpha Homo sapiens 2.57 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721129 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721129&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674502 513841181 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492567 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2cccc(F)c2Cl)C(=O)NCC3)ccn1 InChI=1S/C26H20ClF2N5O2/c27-23-17(29)2-1-3-19(23)33-25-22-18(9-11-31-26(22)36)32-24(25)15-8-10-30-20(13-15)34-21(35)12-14-4-6-16(28)7-5-14/h1-8,10,13,32-33H,9,11-12H2,(H,31,36)(H,30,34,35) UJJMQXWMFBWWJA-UHFFFAOYSA-N 721129 N-{4-[3-(2-chloro-3-fluoroanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 87 Casein kinase I isoform delta Homo sapiens 6.02 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721129 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721129&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674502 513841181 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492568 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2cccc(F)c2Cl)C(=O)NCC3)ccn1 InChI=1S/C26H20ClF2N5O2/c27-23-17(29)2-1-3-19(23)33-25-22-18(9-11-31-26(22)36)32-24(25)15-8-10-30-20(13-15)34-21(35)12-14-4-6-16(28)7-5-14/h1-8,10,13,32-33H,9,11-12H2,(H,31,36)(H,30,34,35) UJJMQXWMFBWWJA-UHFFFAOYSA-N 721129 N-{4-[3-(2-chloro-3-fluoroanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 87 Casein kinase I isoform alpha Homo sapiens 64.7 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721129 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721129&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674502 513841181 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492569 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1C InChI=1S/C28H26FN5O2/c1-17-14-22-25(28(36)34(17)2)27(31-21-6-4-3-5-7-21)26(32-22)19-12-13-30-23(16-19)33-24(35)15-18-8-10-20(29)11-9-18/h3-13,16-17,31-32H,14-15H2,1-2H3,(H,30,33,35) CEDLEAIGKVAXEE-UHFFFAOYSA-N 721130 N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Racemate)::US12227501, Example 88 Casein kinase I isoform alpha Homo sapiens 2.33 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721130 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721130&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674361 513841182 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492570 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1C InChI=1S/C28H26FN5O2/c1-17-14-22-25(28(36)34(17)2)27(31-21-6-4-3-5-7-21)26(32-22)19-12-13-30-23(16-19)33-24(35)15-18-8-10-20(29)11-9-18/h3-13,16-17,31-32H,14-15H2,1-2H3,(H,30,33,35) CEDLEAIGKVAXEE-UHFFFAOYSA-N 721130 N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Racemate)::US12227501, Example 88 Casein kinase I isoform delta Homo sapiens 5.18 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721130 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721130&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674361 513841182 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492571 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1C InChI=1S/C28H26FN5O2/c1-17-14-22-25(28(36)34(17)2)27(31-21-6-4-3-5-7-21)26(32-22)19-12-13-30-23(16-19)33-24(35)15-18-8-10-20(29)11-9-18/h3-13,16-17,31-32H,14-15H2,1-2H3,(H,30,33,35) CEDLEAIGKVAXEE-UHFFFAOYSA-N 721130 N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Racemate)::US12227501, Example 88 Casein kinase I isoform alpha Homo sapiens 65.1 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721130 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721130&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674361 513841182 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492572 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1C InChI=1S/C28H26FN5O2/c1-17-14-22-25(28(36)34(17)2)27(31-21-6-4-3-5-7-21)26(32-22)19-12-13-30-23(16-19)33-24(35)15-18-8-10-20(29)11-9-18/h3-13,16-17,31-32H,14-15H2,1-2H3,(H,30,33,35) CEDLEAIGKVAXEE-UHFFFAOYSA-N 721131 (+)-N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Enantiomer 1)::US12227501, Example 89 Casein kinase I isoform alpha Homo sapiens 1.88 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721131 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721131&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674361 513841183 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492573 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1C InChI=1S/C28H26FN5O2/c1-17-14-22-25(28(36)34(17)2)27(31-21-6-4-3-5-7-21)26(32-22)19-12-13-30-23(16-19)33-24(35)15-18-8-10-20(29)11-9-18/h3-13,16-17,31-32H,14-15H2,1-2H3,(H,30,33,35) CEDLEAIGKVAXEE-UHFFFAOYSA-N 721131 (+)-N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Enantiomer 1)::US12227501, Example 89 Casein kinase I isoform delta Homo sapiens 5.72 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721131 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721131&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674361 513841183 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492574 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1C InChI=1S/C28H26FN5O2/c1-17-14-22-25(28(36)34(17)2)27(31-21-6-4-3-5-7-21)26(32-22)19-12-13-30-23(16-19)33-24(35)15-18-8-10-20(29)11-9-18/h3-13,16-17,31-32H,14-15H2,1-2H3,(H,30,33,35) CEDLEAIGKVAXEE-UHFFFAOYSA-N 721131 (+)-N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Enantiomer 1)::US12227501, Example 89 Casein kinase I isoform alpha Homo sapiens 364 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721131 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721131&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674361 513841183 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492575 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1C InChI=1S/C28H26FN5O2/c1-17-14-22-25(28(36)34(17)2)27(31-21-6-4-3-5-7-21)26(32-22)19-12-13-30-23(16-19)33-24(35)15-18-8-10-20(29)11-9-18/h3-13,16-17,31-32H,14-15H2,1-2H3,(H,30,33,35) CEDLEAIGKVAXEE-UHFFFAOYSA-N 721132 (−)-N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Enantiomer 2)::US12227501, Example 90 Casein kinase I isoform alpha Homo sapiens 1.43 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721132 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721132&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674361 513841184 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492576 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1C InChI=1S/C28H26FN5O2/c1-17-14-22-25(28(36)34(17)2)27(31-21-6-4-3-5-7-21)26(32-22)19-12-13-30-23(16-19)33-24(35)15-18-8-10-20(29)11-9-18/h3-13,16-17,31-32H,14-15H2,1-2H3,(H,30,33,35) CEDLEAIGKVAXEE-UHFFFAOYSA-N 721132 (−)-N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Enantiomer 2)::US12227501, Example 90 Casein kinase I isoform delta Homo sapiens 3.79 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721132 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721132&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674361 513841184 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492577 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1C InChI=1S/C28H26FN5O2/c1-17-14-22-25(28(36)34(17)2)27(31-21-6-4-3-5-7-21)26(32-22)19-12-13-30-23(16-19)33-24(35)15-18-8-10-20(29)11-9-18/h3-13,16-17,31-32H,14-15H2,1-2H3,(H,30,33,35) CEDLEAIGKVAXEE-UHFFFAOYSA-N 721132 (−)-N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Enantiomer 2)::US12227501, Example 90 Casein kinase I isoform alpha Homo sapiens 62.4 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721132 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721132&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674361 513841184 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492578 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17-15-23-25(29(37)35(17)3)27(32-22-7-5-4-6-8-22)26(33-23)20-13-14-31-24(16-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-14,16-18,32-33H,15H2,1-3H3,(H,31,34,36) KBQAVBKOEJZTFM-UHFFFAOYSA-N 721133 (+)-(2RS)—N-{4-[(6R*)-3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (2 Stereoisomers #1)::US12227501, Example 91 Casein kinase I isoform alpha Homo sapiens 4.73 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721133 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721133&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674434 513841185 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492579 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17-15-23-25(29(37)35(17)3)27(32-22-7-5-4-6-8-22)26(33-23)20-13-14-31-24(16-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-14,16-18,32-33H,15H2,1-3H3,(H,31,34,36) KBQAVBKOEJZTFM-UHFFFAOYSA-N 721133 (+)-(2RS)—N-{4-[(6R*)-3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (2 Stereoisomers #1)::US12227501, Example 91 Casein kinase I isoform delta Homo sapiens 8.83 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721133 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721133&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674434 513841185 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492580 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17-15-23-25(29(37)35(17)3)27(32-22-7-5-4-6-8-22)26(33-23)20-13-14-31-24(16-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-14,16-18,32-33H,15H2,1-3H3,(H,31,34,36) KBQAVBKOEJZTFM-UHFFFAOYSA-N 721133 (+)-(2RS)—N-{4-[(6R*)-3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (2 Stereoisomers #1)::US12227501, Example 91 Casein kinase I isoform alpha Homo sapiens 693 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721133 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721133&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674434 513841185 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492581 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17-15-23-25(29(37)35(17)3)27(32-22-7-5-4-6-8-22)26(33-23)20-13-14-31-24(16-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-14,16-18,32-33H,15H2,1-3H3,(H,31,34,36) KBQAVBKOEJZTFM-UHFFFAOYSA-N 721134 (+)-N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Single Stereoisomer 1)::US12227501, Example 92 Casein kinase I isoform alpha Homo sapiens 4.66 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721134 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721134&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674434 513841186 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492582 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17-15-23-25(29(37)35(17)3)27(32-22-7-5-4-6-8-22)26(33-23)20-13-14-31-24(16-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-14,16-18,32-33H,15H2,1-3H3,(H,31,34,36) KBQAVBKOEJZTFM-UHFFFAOYSA-N 721134 (+)-N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Single Stereoisomer 1)::US12227501, Example 92 Casein kinase I isoform delta Homo sapiens 10.7 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721134 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721134&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674434 513841186 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492583 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17-15-23-25(29(37)35(17)3)27(32-22-7-5-4-6-8-22)26(33-23)20-13-14-31-24(16-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-14,16-18,32-33H,15H2,1-3H3,(H,31,34,36) KBQAVBKOEJZTFM-UHFFFAOYSA-N 721134 (+)-N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Single Stereoisomer 1)::US12227501, Example 92 Casein kinase I isoform alpha Homo sapiens 230 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721134 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721134&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674434 513841186 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492584 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17-15-23-25(29(37)35(17)3)27(32-22-7-5-4-6-8-22)26(33-23)20-13-14-31-24(16-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-14,16-18,32-33H,15H2,1-3H3,(H,31,34,36) KBQAVBKOEJZTFM-UHFFFAOYSA-N 721135 (−)-N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Single Stereoisomer 2)::US12227501, Example 93 Casein kinase I isoform alpha Homo sapiens 47.2 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721135 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721135&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674434 513841187 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492585 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17-15-23-25(29(37)35(17)3)27(32-22-7-5-4-6-8-22)26(33-23)20-13-14-31-24(16-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-14,16-18,32-33H,15H2,1-3H3,(H,31,34,36) KBQAVBKOEJZTFM-UHFFFAOYSA-N 721135 (−)-N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Single Stereoisomer 2)::US12227501, Example 93 Casein kinase I isoform delta Homo sapiens 47.3 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721135 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721135&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674434 513841187 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492586 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17-15-23-25(29(37)35(17)3)27(32-22-7-5-4-6-8-22)26(33-23)20-13-14-31-24(16-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-14,16-18,32-33H,15H2,1-3H3,(H,31,34,36) KBQAVBKOEJZTFM-UHFFFAOYSA-N 721135 (−)-N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Single Stereoisomer 2)::US12227501, Example 93 Casein kinase I isoform alpha Homo sapiens 3180 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721135 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721135&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674434 513841187 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492587 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17-15-23-25(29(37)35(17)3)27(32-22-7-5-4-6-8-22)26(33-23)20-13-14-31-24(16-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-14,16-18,32-33H,15H2,1-3H3,(H,31,34,36) KBQAVBKOEJZTFM-UHFFFAOYSA-N 721136 (−)-(2RS)—N-{4-[(6R*)-3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (2 Stereoisomers #2)::US12227501, Example 94 Casein kinase I isoform alpha Homo sapiens 4.33 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721136 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721136&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674434 513841188 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492588 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17-15-23-25(29(37)35(17)3)27(32-22-7-5-4-6-8-22)26(33-23)20-13-14-31-24(16-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-14,16-18,32-33H,15H2,1-3H3,(H,31,34,36) KBQAVBKOEJZTFM-UHFFFAOYSA-N 721136 (−)-(2RS)—N-{4-[(6R*)-3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (2 Stereoisomers #2)::US12227501, Example 94 Casein kinase I isoform delta Homo sapiens 7.02 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721136 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721136&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674434 513841188 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492589 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17-15-23-25(29(37)35(17)3)27(32-22-7-5-4-6-8-22)26(33-23)20-13-14-31-24(16-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-14,16-18,32-33H,15H2,1-3H3,(H,31,34,36) KBQAVBKOEJZTFM-UHFFFAOYSA-N 721136 (−)-(2RS)—N-{4-[(6R*)-3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (2 Stereoisomers #2)::US12227501, Example 94 Casein kinase I isoform alpha Homo sapiens 154 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721136 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721136&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674434 513841188 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492590 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17-15-23-25(29(37)35(17)3)27(32-22-7-5-4-6-8-22)26(33-23)20-13-14-31-24(16-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-14,16-18,32-33H,15H2,1-3H3,(H,31,34,36) KBQAVBKOEJZTFM-UHFFFAOYSA-N 721137 (−)-N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Single Stereoisomer 3)::US12227501, Example 95 Casein kinase I isoform alpha Homo sapiens 46.2 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721137 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721137&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674434 513841189 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492591 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17-15-23-25(29(37)35(17)3)27(32-22-7-5-4-6-8-22)26(33-23)20-13-14-31-24(16-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-14,16-18,32-33H,15H2,1-3H3,(H,31,34,36) KBQAVBKOEJZTFM-UHFFFAOYSA-N 721137 (−)-N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Single Stereoisomer 3)::US12227501, Example 95 Casein kinase I isoform delta Homo sapiens 45.3 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721137 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721137&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674434 513841189 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492592 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17-15-23-25(29(37)35(17)3)27(32-22-7-5-4-6-8-22)26(33-23)20-13-14-31-24(16-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-14,16-18,32-33H,15H2,1-3H3,(H,31,34,36) KBQAVBKOEJZTFM-UHFFFAOYSA-N 721137 (−)-N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Single Stereoisomer 3)::US12227501, Example 95 Casein kinase I isoform alpha Homo sapiens 2460 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721137 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721137&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674434 513841189 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492593 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17-15-23-25(29(37)35(17)3)27(32-22-7-5-4-6-8-22)26(33-23)20-13-14-31-24(16-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-14,16-18,32-33H,15H2,1-3H3,(H,31,34,36) KBQAVBKOEJZTFM-UHFFFAOYSA-N 721138 (+)-N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Single Stereoisomer 4)::US12227501, Example 96 Casein kinase I isoform alpha Homo sapiens 5.37 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721138 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721138&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674434 513841190 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492594 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17-15-23-25(29(37)35(17)3)27(32-22-7-5-4-6-8-22)26(33-23)20-13-14-31-24(16-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-14,16-18,32-33H,15H2,1-3H3,(H,31,34,36) KBQAVBKOEJZTFM-UHFFFAOYSA-N 721138 (+)-N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Single Stereoisomer 4)::US12227501, Example 96 Casein kinase I isoform delta Homo sapiens 4.36 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721138 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721138&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674434 513841190 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492595 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17-15-23-25(29(37)35(17)3)27(32-22-7-5-4-6-8-22)26(33-23)20-13-14-31-24(16-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-14,16-18,32-33H,15H2,1-3H3,(H,31,34,36) KBQAVBKOEJZTFM-UHFFFAOYSA-N 721138 (+)-N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Single Stereoisomer 4)::US12227501, Example 96 Casein kinase I isoform alpha Homo sapiens 35.8 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721138 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721138&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674434 513841190 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492596 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccncc4)c3)c(Nc3ccccc3)c2C(=O)N1C InChI=1S/C27H26N6O2/c1-17-14-21-24(27(35)33(17)2)26(30-20-6-4-3-5-7-20)25(31-21)19-10-13-29-22(16-19)32-23(34)15-18-8-11-28-12-9-18/h3-13,16-17,30-31H,14-15H2,1-2H3,(H,29,32,34) OVWHGYZCHAOSFL-UHFFFAOYSA-N 721139 N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(pyridin-4-yl)acetamide (Racemate)::US12227501, Example 97 Casein kinase I isoform alpha Homo sapiens 4.40 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721139 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721139&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674358 513841191 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492597 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccncc4)c3)c(Nc3ccccc3)c2C(=O)N1C InChI=1S/C27H26N6O2/c1-17-14-21-24(27(35)33(17)2)26(30-20-6-4-3-5-7-20)25(31-21)19-10-13-29-22(16-19)32-23(34)15-18-8-11-28-12-9-18/h3-13,16-17,30-31H,14-15H2,1-2H3,(H,29,32,34) OVWHGYZCHAOSFL-UHFFFAOYSA-N 721139 N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(pyridin-4-yl)acetamide (Racemate)::US12227501, Example 97 Casein kinase I isoform delta Homo sapiens 5.73 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721139 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721139&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674358 513841191 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492598 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccncc4)c3)c(Nc3ccccc3)c2C(=O)N1C InChI=1S/C27H26N6O2/c1-17-14-21-24(27(35)33(17)2)26(30-20-6-4-3-5-7-20)25(31-21)19-10-13-29-22(16-19)32-23(34)15-18-8-11-28-12-9-18/h3-13,16-17,30-31H,14-15H2,1-2H3,(H,29,32,34) OVWHGYZCHAOSFL-UHFFFAOYSA-N 721139 N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(pyridin-4-yl)acetamide (Racemate)::US12227501, Example 97 Casein kinase I isoform alpha Homo sapiens 47.0 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721139 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721139&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674358 513841191 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492599 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccncc4)c3)c(Nc3ccccc3)c2C(=O)N1C InChI=1S/C27H26N6O2/c1-17-14-21-24(27(35)33(17)2)26(30-20-6-4-3-5-7-20)25(31-21)19-10-13-29-22(16-19)32-23(34)15-18-8-11-28-12-9-18/h3-13,16-17,30-31H,14-15H2,1-2H3,(H,29,32,34) OVWHGYZCHAOSFL-UHFFFAOYSA-N 721140 (+)-N-{4-[(6R*)-3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(pyridin-4-yl)acetamide (Enantiomer 1)::US12227501, Example 98 Casein kinase I isoform alpha Homo sapiens 4.16 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721140 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721140&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674358 513841192 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492600 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccncc4)c3)c(Nc3ccccc3)c2C(=O)N1C InChI=1S/C27H26N6O2/c1-17-14-21-24(27(35)33(17)2)26(30-20-6-4-3-5-7-20)25(31-21)19-10-13-29-22(16-19)32-23(34)15-18-8-11-28-12-9-18/h3-13,16-17,30-31H,14-15H2,1-2H3,(H,29,32,34) OVWHGYZCHAOSFL-UHFFFAOYSA-N 721140 (+)-N-{4-[(6R*)-3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(pyridin-4-yl)acetamide (Enantiomer 1)::US12227501, Example 98 Casein kinase I isoform delta Homo sapiens 6.13 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721140 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721140&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674358 513841192 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492601 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccncc4)c3)c(Nc3ccccc3)c2C(=O)N1C InChI=1S/C27H26N6O2/c1-17-14-21-24(27(35)33(17)2)26(30-20-6-4-3-5-7-20)25(31-21)19-10-13-29-22(16-19)32-23(34)15-18-8-11-28-12-9-18/h3-13,16-17,30-31H,14-15H2,1-2H3,(H,29,32,34) OVWHGYZCHAOSFL-UHFFFAOYSA-N 721140 (+)-N-{4-[(6R*)-3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(pyridin-4-yl)acetamide (Enantiomer 1)::US12227501, Example 98 Casein kinase I isoform alpha Homo sapiens 149 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721140 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721140&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674358 513841192 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492602 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccncc4)c3)c(Nc3ccccc3)c2C(=O)N1C InChI=1S/C27H26N6O2/c1-17-14-21-24(27(35)33(17)2)26(30-20-6-4-3-5-7-20)25(31-21)19-10-13-29-22(16-19)32-23(34)15-18-8-11-28-12-9-18/h3-13,16-17,30-31H,14-15H2,1-2H3,(H,29,32,34) OVWHGYZCHAOSFL-UHFFFAOYSA-N 721141 (−)-N-{4-[(6S*)-3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(pyridin-4-yl)acetamide (Enantiomer 2)::US12227501, Example 99 Casein kinase I isoform alpha Homo sapiens 3.78 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721141 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721141&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674358 513841193 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492603 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccncc4)c3)c(Nc3ccccc3)c2C(=O)N1C InChI=1S/C27H26N6O2/c1-17-14-21-24(27(35)33(17)2)26(30-20-6-4-3-5-7-20)25(31-21)19-10-13-29-22(16-19)32-23(34)15-18-8-11-28-12-9-18/h3-13,16-17,30-31H,14-15H2,1-2H3,(H,29,32,34) OVWHGYZCHAOSFL-UHFFFAOYSA-N 721141 (−)-N-{4-[(6S*)-3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(pyridin-4-yl)acetamide (Enantiomer 2)::US12227501, Example 99 Casein kinase I isoform delta Homo sapiens 5.10 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721141 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721141&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674358 513841193 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492604 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccncc4)c3)c(Nc3ccccc3)c2C(=O)N1C InChI=1S/C27H26N6O2/c1-17-14-21-24(27(35)33(17)2)26(30-20-6-4-3-5-7-20)25(31-21)19-10-13-29-22(16-19)32-23(34)15-18-8-11-28-12-9-18/h3-13,16-17,30-31H,14-15H2,1-2H3,(H,29,32,34) OVWHGYZCHAOSFL-UHFFFAOYSA-N 721141 (−)-N-{4-[(6S*)-3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(pyridin-4-yl)acetamide (Enantiomer 2)::US12227501, Example 99 Casein kinase I isoform alpha Homo sapiens 25.9 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721141 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721141&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674358 513841193 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492605 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C28H25F2N5O2/c1-16-13-22-25(28(37)35(16)2)27(32-21-6-4-3-5-20(21)30)26(33-22)18-11-12-31-23(15-18)34-24(36)14-17-7-9-19(29)10-8-17/h3-12,15-16,32-33H,13-14H2,1-2H3,(H,31,34,36) DQGYZGUWRZBVCE-UHFFFAOYSA-N 721142 N-{4-[3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Racemate)::US12227501, Example 100 Casein kinase I isoform alpha Homo sapiens 3.97 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721142 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721142&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674239 513841194 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492606 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C28H25F2N5O2/c1-16-13-22-25(28(37)35(16)2)27(32-21-6-4-3-5-20(21)30)26(33-22)18-11-12-31-23(15-18)34-24(36)14-17-7-9-19(29)10-8-17/h3-12,15-16,32-33H,13-14H2,1-2H3,(H,31,34,36) DQGYZGUWRZBVCE-UHFFFAOYSA-N 721142 N-{4-[3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Racemate)::US12227501, Example 100 Casein kinase I isoform delta Homo sapiens 15.6 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721142 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721142&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674239 513841194 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492607 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C28H25F2N5O2/c1-16-13-22-25(28(37)35(16)2)27(32-21-6-4-3-5-20(21)30)26(33-22)18-11-12-31-23(15-18)34-24(36)14-17-7-9-19(29)10-8-17/h3-12,15-16,32-33H,13-14H2,1-2H3,(H,31,34,36) DQGYZGUWRZBVCE-UHFFFAOYSA-N 721142 N-{4-[3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Racemate)::US12227501, Example 100 Casein kinase I isoform alpha Homo sapiens 254 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721142 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721142&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674239 513841194 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492608 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C28H25F2N5O2/c1-16-13-22-25(28(37)35(16)2)27(32-21-6-4-3-5-20(21)30)26(33-22)18-11-12-31-23(15-18)34-24(36)14-17-7-9-19(29)10-8-17/h3-12,15-16,32-33H,13-14H2,1-2H3,(H,31,34,36) DQGYZGUWRZBVCE-UHFFFAOYSA-N 721143 (+)-N-{4-[3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Enantiomer 1)::US12227501, Example 101 Casein kinase I isoform alpha Homo sapiens 3.74 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721143 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721143&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674239 513841195 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492609 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C28H25F2N5O2/c1-16-13-22-25(28(37)35(16)2)27(32-21-6-4-3-5-20(21)30)26(33-22)18-11-12-31-23(15-18)34-24(36)14-17-7-9-19(29)10-8-17/h3-12,15-16,32-33H,13-14H2,1-2H3,(H,31,34,36) DQGYZGUWRZBVCE-UHFFFAOYSA-N 721143 (+)-N-{4-[3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Enantiomer 1)::US12227501, Example 101 Casein kinase I isoform delta Homo sapiens 7.42 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721143 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721143&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674239 513841195 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492610 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C28H25F2N5O2/c1-16-13-22-25(28(37)35(16)2)27(32-21-6-4-3-5-20(21)30)26(33-22)18-11-12-31-23(15-18)34-24(36)14-17-7-9-19(29)10-8-17/h3-12,15-16,32-33H,13-14H2,1-2H3,(H,31,34,36) DQGYZGUWRZBVCE-UHFFFAOYSA-N 721143 (+)-N-{4-[3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Enantiomer 1)::US12227501, Example 101 Casein kinase I isoform alpha Homo sapiens 258 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721143 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721143&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674239 513841195 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492611 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C28H25F2N5O2/c1-16-13-22-25(28(37)35(16)2)27(32-21-6-4-3-5-20(21)30)26(33-22)18-11-12-31-23(15-18)34-24(36)14-17-7-9-19(29)10-8-17/h3-12,15-16,32-33H,13-14H2,1-2H3,(H,31,34,36) DQGYZGUWRZBVCE-UHFFFAOYSA-N 721144 (−)-N-{4-[3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Enantiomer 2)::US12227501, Example 102 Casein kinase I isoform alpha Homo sapiens 3.60 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721144 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721144&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674239 513841196 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492612 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C28H25F2N5O2/c1-16-13-22-25(28(37)35(16)2)27(32-21-6-4-3-5-20(21)30)26(33-22)18-11-12-31-23(15-18)34-24(36)14-17-7-9-19(29)10-8-17/h3-12,15-16,32-33H,13-14H2,1-2H3,(H,31,34,36) DQGYZGUWRZBVCE-UHFFFAOYSA-N 721144 (−)-N-{4-[3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Enantiomer 2)::US12227501, Example 102 Casein kinase I isoform delta Homo sapiens 7.21 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721144 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721144&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674239 513841196 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492613 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C28H25F2N5O2/c1-16-13-22-25(28(37)35(16)2)27(32-21-6-4-3-5-20(21)30)26(33-22)18-11-12-31-23(15-18)34-24(36)14-17-7-9-19(29)10-8-17/h3-12,15-16,32-33H,13-14H2,1-2H3,(H,31,34,36) DQGYZGUWRZBVCE-UHFFFAOYSA-N 721144 (−)-N-{4-[3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Enantiomer 2)::US12227501, Example 102 Casein kinase I isoform alpha Homo sapiens 51.0 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721144 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721144&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674239 513841196 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492614 CC1Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C30H27F4N5O2/c1-16-13-23-26(30(41)39(16)2)28(36-22-6-4-3-5-21(22)32)27(37-23)18-11-12-35-25(14-18)38-29(40)20(15-24(33)34)17-7-9-19(31)10-8-17/h3-12,14,16,20,24,36-37H,13,15H2,1-2H3,(H,35,38,40) FSUKRPNMEJYOMM-UHFFFAOYSA-N 721145 (+)-(2RS)-4,4-difluoro-N-{4-[(6R*)-3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (2 Stereoisomers #1)::US12227501, Example 103 Casein kinase I isoform alpha Homo sapiens 12.8 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721145 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721145&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674276 513841197 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492615 CC1Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C30H27F4N5O2/c1-16-13-23-26(30(41)39(16)2)28(36-22-6-4-3-5-21(22)32)27(37-23)18-11-12-35-25(14-18)38-29(40)20(15-24(33)34)17-7-9-19(31)10-8-17/h3-12,14,16,20,24,36-37H,13,15H2,1-2H3,(H,35,38,40) FSUKRPNMEJYOMM-UHFFFAOYSA-N 721145 (+)-(2RS)-4,4-difluoro-N-{4-[(6R*)-3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (2 Stereoisomers #1)::US12227501, Example 103 Casein kinase I isoform delta Homo sapiens 17.3 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721145 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721145&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674276 513841197 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492616 CC1Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C30H27F4N5O2/c1-16-13-23-26(30(41)39(16)2)28(36-22-6-4-3-5-21(22)32)27(37-23)18-11-12-35-25(14-18)38-29(40)20(15-24(33)34)17-7-9-19(31)10-8-17/h3-12,14,16,20,24,36-37H,13,15H2,1-2H3,(H,35,38,40) FSUKRPNMEJYOMM-UHFFFAOYSA-N 721145 (+)-(2RS)-4,4-difluoro-N-{4-[(6R*)-3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (2 Stereoisomers #1)::US12227501, Example 103 Casein kinase I isoform alpha Homo sapiens 268 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721145 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721145&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674276 513841197 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492617 CC1Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C30H27F4N5O2/c1-16-13-23-26(30(41)39(16)2)28(36-22-6-4-3-5-21(22)32)27(37-23)18-11-12-35-25(14-18)38-29(40)20(15-24(33)34)17-7-9-19(31)10-8-17/h3-12,14,16,20,24,36-37H,13,15H2,1-2H3,(H,35,38,40) FSUKRPNMEJYOMM-UHFFFAOYSA-N 721146 (−)-4,4-difluoro-N-{4-[3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 104 Casein kinase I isoform alpha Homo sapiens 67.9 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721146 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721146&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674276 513841198 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492618 CC1Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C30H27F4N5O2/c1-16-13-23-26(30(41)39(16)2)28(36-22-6-4-3-5-21(22)32)27(37-23)18-11-12-35-25(14-18)38-29(40)20(15-24(33)34)17-7-9-19(31)10-8-17/h3-12,14,16,20,24,36-37H,13,15H2,1-2H3,(H,35,38,40) FSUKRPNMEJYOMM-UHFFFAOYSA-N 721146 (−)-4,4-difluoro-N-{4-[3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 104 Casein kinase I isoform delta Homo sapiens 60.5 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721146 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721146&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674276 513841198 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492619 CC1Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C30H27F4N5O2/c1-16-13-23-26(30(41)39(16)2)28(36-22-6-4-3-5-21(22)32)27(37-23)18-11-12-35-25(14-18)38-29(40)20(15-24(33)34)17-7-9-19(31)10-8-17/h3-12,14,16,20,24,36-37H,13,15H2,1-2H3,(H,35,38,40) FSUKRPNMEJYOMM-UHFFFAOYSA-N 721146 (−)-4,4-difluoro-N-{4-[3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 104 Casein kinase I isoform alpha Homo sapiens 4490 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721146 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721146&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674276 513841198 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492620 CC1Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C30H27F4N5O2/c1-16-13-23-26(30(41)39(16)2)28(36-22-6-4-3-5-21(22)32)27(37-23)18-11-12-35-25(14-18)38-29(40)20(15-24(33)34)17-7-9-19(31)10-8-17/h3-12,14,16,20,24,36-37H,13,15H2,1-2H3,(H,35,38,40) FSUKRPNMEJYOMM-UHFFFAOYSA-N 721147 (+)-4,4-difluoro-N-{4-[3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 105 Casein kinase I isoform alpha Homo sapiens 4.06 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721147 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721147&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674276 513841199 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492621 CC1Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C30H27F4N5O2/c1-16-13-23-26(30(41)39(16)2)28(36-22-6-4-3-5-21(22)32)27(37-23)18-11-12-35-25(14-18)38-29(40)20(15-24(33)34)17-7-9-19(31)10-8-17/h3-12,14,16,20,24,36-37H,13,15H2,1-2H3,(H,35,38,40) FSUKRPNMEJYOMM-UHFFFAOYSA-N 721147 (+)-4,4-difluoro-N-{4-[3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 105 Casein kinase I isoform delta Homo sapiens 5.45 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721147 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721147&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674276 513841199 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492622 CC1Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C30H27F4N5O2/c1-16-13-23-26(30(41)39(16)2)28(36-22-6-4-3-5-21(22)32)27(37-23)18-11-12-35-25(14-18)38-29(40)20(15-24(33)34)17-7-9-19(31)10-8-17/h3-12,14,16,20,24,36-37H,13,15H2,1-2H3,(H,35,38,40) FSUKRPNMEJYOMM-UHFFFAOYSA-N 721147 (+)-4,4-difluoro-N-{4-[3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 105 Casein kinase I isoform alpha Homo sapiens 94.5 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721147 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721147&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674276 513841199 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492623 CC1Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C30H27F4N5O2/c1-16-13-23-26(30(41)39(16)2)28(36-22-6-4-3-5-21(22)32)27(37-23)18-11-12-35-25(14-18)38-29(40)20(15-24(33)34)17-7-9-19(31)10-8-17/h3-12,14,16,20,24,36-37H,13,15H2,1-2H3,(H,35,38,40) FSUKRPNMEJYOMM-UHFFFAOYSA-N 721148 (−)-(2RS)-4,4-difluoro-N-{4-[(6R*)-3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (2 Stereoisomers #2)::US12227501, Example 106 Casein kinase I isoform alpha Homo sapiens 17.8 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721148 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721148&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674276 513841200 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492624 CC1Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C30H27F4N5O2/c1-16-13-23-26(30(41)39(16)2)28(36-22-6-4-3-5-21(22)32)27(37-23)18-11-12-35-25(14-18)38-29(40)20(15-24(33)34)17-7-9-19(31)10-8-17/h3-12,14,16,20,24,36-37H,13,15H2,1-2H3,(H,35,38,40) FSUKRPNMEJYOMM-UHFFFAOYSA-N 721148 (−)-(2RS)-4,4-difluoro-N-{4-[(6R*)-3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (2 Stereoisomers #2)::US12227501, Example 106 Casein kinase I isoform delta Homo sapiens 22.3 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721148 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721148&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674276 513841200 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492625 CC1Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C30H27F4N5O2/c1-16-13-23-26(30(41)39(16)2)28(36-22-6-4-3-5-21(22)32)27(37-23)18-11-12-35-25(14-18)38-29(40)20(15-24(33)34)17-7-9-19(31)10-8-17/h3-12,14,16,20,24,36-37H,13,15H2,1-2H3,(H,35,38,40) FSUKRPNMEJYOMM-UHFFFAOYSA-N 721148 (−)-(2RS)-4,4-difluoro-N-{4-[(6R*)-3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (2 Stereoisomers #2)::US12227501, Example 106 Casein kinase I isoform alpha Homo sapiens 56.2 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721148 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721148&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674276 513841200 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492626 CC1Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C30H27F4N5O2/c1-16-13-23-26(30(41)39(16)2)28(36-22-6-4-3-5-21(22)32)27(37-23)18-11-12-35-25(14-18)38-29(40)20(15-24(33)34)17-7-9-19(31)10-8-17/h3-12,14,16,20,24,36-37H,13,15H2,1-2H3,(H,35,38,40) FSUKRPNMEJYOMM-UHFFFAOYSA-N 721149 (−)-4,4-difluoro-N-{4-[3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Enantiomer 3)::US12227501, Example 107 Casein kinase I isoform alpha Homo sapiens 45.7 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721149 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721149&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674276 513841201 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492627 CC1Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C30H27F4N5O2/c1-16-13-23-26(30(41)39(16)2)28(36-22-6-4-3-5-21(22)32)27(37-23)18-11-12-35-25(14-18)38-29(40)20(15-24(33)34)17-7-9-19(31)10-8-17/h3-12,14,16,20,24,36-37H,13,15H2,1-2H3,(H,35,38,40) FSUKRPNMEJYOMM-UHFFFAOYSA-N 721149 (−)-4,4-difluoro-N-{4-[3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Enantiomer 3)::US12227501, Example 107 Casein kinase I isoform delta Homo sapiens 59.2 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721149 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721149&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674276 513841201 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492628 CC1Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C30H27F4N5O2/c1-16-13-23-26(30(41)39(16)2)28(36-22-6-4-3-5-21(22)32)27(37-23)18-11-12-35-25(14-18)38-29(40)20(15-24(33)34)17-7-9-19(31)10-8-17/h3-12,14,16,20,24,36-37H,13,15H2,1-2H3,(H,35,38,40) FSUKRPNMEJYOMM-UHFFFAOYSA-N 721149 (−)-4,4-difluoro-N-{4-[3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Enantiomer 3)::US12227501, Example 107 Casein kinase I isoform alpha Homo sapiens 3160 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721149 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721149&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674276 513841201 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492629 CC1Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C30H27F4N5O2/c1-16-13-23-26(30(41)39(16)2)28(36-22-6-4-3-5-21(22)32)27(37-23)18-11-12-35-25(14-18)38-29(40)20(15-24(33)34)17-7-9-19(31)10-8-17/h3-12,14,16,20,24,36-37H,13,15H2,1-2H3,(H,35,38,40) FSUKRPNMEJYOMM-UHFFFAOYSA-N 721150 (+)-4,4-difluoro-N-{4-[3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Enantiomer 4)::US12227501, Example 108 Casein kinase I isoform alpha Homo sapiens 3.27 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721150 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721150&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674276 513841202 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492630 CC1Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C30H27F4N5O2/c1-16-13-23-26(30(41)39(16)2)28(36-22-6-4-3-5-21(22)32)27(37-23)18-11-12-35-25(14-18)38-29(40)20(15-24(33)34)17-7-9-19(31)10-8-17/h3-12,14,16,20,24,36-37H,13,15H2,1-2H3,(H,35,38,40) FSUKRPNMEJYOMM-UHFFFAOYSA-N 721150 (+)-4,4-difluoro-N-{4-[3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Enantiomer 4)::US12227501, Example 108 Casein kinase I isoform delta Homo sapiens 4.62 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721150 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721150&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674276 513841202 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492631 CC1Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C30H27F4N5O2/c1-16-13-23-26(30(41)39(16)2)28(36-22-6-4-3-5-21(22)32)27(37-23)18-11-12-35-25(14-18)38-29(40)20(15-24(33)34)17-7-9-19(31)10-8-17/h3-12,14,16,20,24,36-37H,13,15H2,1-2H3,(H,35,38,40) FSUKRPNMEJYOMM-UHFFFAOYSA-N 721150 (+)-4,4-difluoro-N-{4-[3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Enantiomer 4)::US12227501, Example 108 Casein kinase I isoform alpha Homo sapiens 8.33 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721150 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721150&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674276 513841202 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492632 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3Cl)c2C(=O)N1 InChI=1S/C30H26ClF4N5O2/c1-30(2)14-21-24(29(42)40-30)27(37-20-5-3-4-19(33)25(20)31)26(38-21)16-10-11-36-23(12-16)39-28(41)18(13-22(34)35)15-6-8-17(32)9-7-15/h3-12,18,22,37-38H,13-14H2,1-2H3,(H,40,42)(H,36,39,41) BMIMXMZRHINYQM-UHFFFAOYSA-N 721151 N-{4-[3-(2-chloro-3-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 109 Casein kinase I isoform alpha Homo sapiens 16.4 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721151 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721151&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674308 513841203 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492633 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3Cl)c2C(=O)N1 InChI=1S/C30H26ClF4N5O2/c1-30(2)14-21-24(29(42)40-30)27(37-20-5-3-4-19(33)25(20)31)26(38-21)16-10-11-36-23(12-16)39-28(41)18(13-22(34)35)15-6-8-17(32)9-7-15/h3-12,18,22,37-38H,13-14H2,1-2H3,(H,40,42)(H,36,39,41) BMIMXMZRHINYQM-UHFFFAOYSA-N 721151 N-{4-[3-(2-chloro-3-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 109 Casein kinase I isoform delta Homo sapiens 14.1 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721151 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721151&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674308 513841203 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492634 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3Cl)c2C(=O)N1 InChI=1S/C30H26ClF4N5O2/c1-30(2)14-21-24(29(42)40-30)27(37-20-5-3-4-19(33)25(20)31)26(38-21)16-10-11-36-23(12-16)39-28(41)18(13-22(34)35)15-6-8-17(32)9-7-15/h3-12,18,22,37-38H,13-14H2,1-2H3,(H,40,42)(H,36,39,41) BMIMXMZRHINYQM-UHFFFAOYSA-N 721151 N-{4-[3-(2-chloro-3-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 109 Casein kinase I isoform alpha Homo sapiens 136 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721151 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721151&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674308 513841203 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492635 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3Cl)c2C(=O)N1 InChI=1S/C30H26ClF4N5O2/c1-30(2)14-21-24(29(42)40-30)27(37-20-5-3-4-19(33)25(20)31)26(38-21)16-10-11-36-23(12-16)39-28(41)18(13-22(34)35)15-6-8-17(32)9-7-15/h3-12,18,22,37-38H,13-14H2,1-2H3,(H,40,42)(H,36,39,41) BMIMXMZRHINYQM-UHFFFAOYSA-N 721152 (−)-N-{4-[3-(2-chloro-3-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 110 Casein kinase I isoform alpha Homo sapiens 262 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721152 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721152&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674308 513841204 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492636 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3Cl)c2C(=O)N1 InChI=1S/C30H26ClF4N5O2/c1-30(2)14-21-24(29(42)40-30)27(37-20-5-3-4-19(33)25(20)31)26(38-21)16-10-11-36-23(12-16)39-28(41)18(13-22(34)35)15-6-8-17(32)9-7-15/h3-12,18,22,37-38H,13-14H2,1-2H3,(H,40,42)(H,36,39,41) BMIMXMZRHINYQM-UHFFFAOYSA-N 721152 (−)-N-{4-[3-(2-chloro-3-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 110 Casein kinase I isoform delta Homo sapiens 249 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721152 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721152&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674308 513841204 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492637 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3Cl)c2C(=O)N1 InChI=1S/C30H26ClF4N5O2/c1-30(2)14-21-24(29(42)40-30)27(37-20-5-3-4-19(33)25(20)31)26(38-21)16-10-11-36-23(12-16)39-28(41)18(13-22(34)35)15-6-8-17(32)9-7-15/h3-12,18,22,37-38H,13-14H2,1-2H3,(H,40,42)(H,36,39,41) BMIMXMZRHINYQM-UHFFFAOYSA-N 721152 (−)-N-{4-[3-(2-chloro-3-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 110 Casein kinase I isoform alpha Homo sapiens >20000 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721152 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721152&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674308 513841204 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492638 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3Cl)c2C(=O)N1 InChI=1S/C30H26ClF4N5O2/c1-30(2)14-21-24(29(42)40-30)27(37-20-5-3-4-19(33)25(20)31)26(38-21)16-10-11-36-23(12-16)39-28(41)18(13-22(34)35)15-6-8-17(32)9-7-15/h3-12,18,22,37-38H,13-14H2,1-2H3,(H,40,42)(H,36,39,41) BMIMXMZRHINYQM-UHFFFAOYSA-N 721153 (+)-N-{4-[3-(2-chloro-3-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 111 Casein kinase I isoform alpha Homo sapiens 10.9 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721153 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721153&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674308 513841205 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492639 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3Cl)c2C(=O)N1 InChI=1S/C30H26ClF4N5O2/c1-30(2)14-21-24(29(42)40-30)27(37-20-5-3-4-19(33)25(20)31)26(38-21)16-10-11-36-23(12-16)39-28(41)18(13-22(34)35)15-6-8-17(32)9-7-15/h3-12,18,22,37-38H,13-14H2,1-2H3,(H,40,42)(H,36,39,41) BMIMXMZRHINYQM-UHFFFAOYSA-N 721153 (+)-N-{4-[3-(2-chloro-3-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 111 Casein kinase I isoform delta Homo sapiens 10.2 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721153 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721153&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674308 513841205 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492640 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3Cl)c2C(=O)N1 InChI=1S/C30H26ClF4N5O2/c1-30(2)14-21-24(29(42)40-30)27(37-20-5-3-4-19(33)25(20)31)26(38-21)16-10-11-36-23(12-16)39-28(41)18(13-22(34)35)15-6-8-17(32)9-7-15/h3-12,18,22,37-38H,13-14H2,1-2H3,(H,40,42)(H,36,39,41) BMIMXMZRHINYQM-UHFFFAOYSA-N 721153 (+)-N-{4-[3-(2-chloro-3-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 111 Casein kinase I isoform alpha Homo sapiens 135 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721153 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721153&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674308 513841205 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492641 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3cccc(F)c3Cl)c2C(=O)N1 InChI=1S/C28H24ClF2N5O2/c1-28(2)14-20-23(27(38)36-28)26(33-19-5-3-4-18(31)24(19)29)25(34-20)16-10-11-32-21(13-16)35-22(37)12-15-6-8-17(30)9-7-15/h3-11,13,33-34H,12,14H2,1-2H3,(H,36,38)(H,32,35,37) XBJAOZKEXGWEPB-UHFFFAOYSA-N 721154 N-{4-[3-(2-chloro-3-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 112 Casein kinase I isoform alpha Homo sapiens 6.69 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721154 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721154&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674316 513841206 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492642 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3cccc(F)c3Cl)c2C(=O)N1 InChI=1S/C28H24ClF2N5O2/c1-28(2)14-20-23(27(38)36-28)26(33-19-5-3-4-18(31)24(19)29)25(34-20)16-10-11-32-21(13-16)35-22(37)12-15-6-8-17(30)9-7-15/h3-11,13,33-34H,12,14H2,1-2H3,(H,36,38)(H,32,35,37) XBJAOZKEXGWEPB-UHFFFAOYSA-N 721154 N-{4-[3-(2-chloro-3-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 112 Casein kinase I isoform delta Homo sapiens 8.41 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721154 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721154&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674316 513841206 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492643 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3cccc(F)c3Cl)c2C(=O)N1 InChI=1S/C28H24ClF2N5O2/c1-28(2)14-20-23(27(38)36-28)26(33-19-5-3-4-18(31)24(19)29)25(34-20)16-10-11-32-21(13-16)35-22(37)12-15-6-8-17(30)9-7-15/h3-11,13,33-34H,12,14H2,1-2H3,(H,36,38)(H,32,35,37) XBJAOZKEXGWEPB-UHFFFAOYSA-N 721154 N-{4-[3-(2-chloro-3-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 112 Casein kinase I isoform alpha Homo sapiens 167 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721154 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721154&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674316 513841206 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492644 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C29H28FN5O2/c1-17-6-4-5-7-21(17)32-27-25-22(16-29(2,3)35-28(25)37)33-26(27)19-12-13-31-23(15-19)34-24(36)14-18-8-10-20(30)11-9-18/h4-13,15,32-33H,14,16H2,1-3H3,(H,35,37)(H,31,34,36) HOMKDCYPLCAGBD-UHFFFAOYSA-N 721155 N-{4-[6,6-dimethyl-3-(2-methylanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 113 Casein kinase I isoform alpha Homo sapiens 13.7 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721155 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721155&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674468 513841207 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492645 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C29H28FN5O2/c1-17-6-4-5-7-21(17)32-27-25-22(16-29(2,3)35-28(25)37)33-26(27)19-12-13-31-23(15-19)34-24(36)14-18-8-10-20(30)11-9-18/h4-13,15,32-33H,14,16H2,1-3H3,(H,35,37)(H,31,34,36) HOMKDCYPLCAGBD-UHFFFAOYSA-N 721155 N-{4-[6,6-dimethyl-3-(2-methylanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 113 Casein kinase I isoform delta Homo sapiens 16.1 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721155 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721155&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674468 513841207 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492646 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C29H28FN5O2/c1-17-6-4-5-7-21(17)32-27-25-22(16-29(2,3)35-28(25)37)33-26(27)19-12-13-31-23(15-19)34-24(36)14-18-8-10-20(30)11-9-18/h4-13,15,32-33H,14,16H2,1-3H3,(H,35,37)(H,31,34,36) HOMKDCYPLCAGBD-UHFFFAOYSA-N 721155 N-{4-[6,6-dimethyl-3-(2-methylanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 113 Casein kinase I isoform alpha Homo sapiens 166 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721155 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721155&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674468 513841207 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492647 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4cnccn4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C25H23N7O2/c1-32-12-8-19-22(25(32)34)24(29-17-5-3-2-4-6-17)23(30-19)16-7-9-28-20(13-16)31-21(33)14-18-15-26-10-11-27-18/h2-7,9-11,13,15,29-30H,8,12,14H2,1H3,(H,28,31,33) KVIQZRSTAIWWJF-UHFFFAOYSA-N 721156 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyrazin-2-yl)acetamide::US12227501, Example 114 Casein kinase I isoform alpha Homo sapiens 2.43 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721156 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721156&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674232 513841208 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492648 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4cnccn4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C25H23N7O2/c1-32-12-8-19-22(25(32)34)24(29-17-5-3-2-4-6-17)23(30-19)16-7-9-28-20(13-16)31-21(33)14-18-15-26-10-11-27-18/h2-7,9-11,13,15,29-30H,8,12,14H2,1H3,(H,28,31,33) KVIQZRSTAIWWJF-UHFFFAOYSA-N 721156 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyrazin-2-yl)acetamide::US12227501, Example 114 Casein kinase I isoform delta Homo sapiens 4.70 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721156 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721156&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674232 513841208 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492649 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4cnccn4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C25H23N7O2/c1-32-12-8-19-22(25(32)34)24(29-17-5-3-2-4-6-17)23(30-19)16-7-9-28-20(13-16)31-21(33)14-18-15-26-10-11-27-18/h2-7,9-11,13,15,29-30H,8,12,14H2,1H3,(H,28,31,33) KVIQZRSTAIWWJF-UHFFFAOYSA-N 721156 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyrazin-2-yl)acetamide::US12227501, Example 114 Casein kinase I isoform alpha Homo sapiens 227 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721156 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721156&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674232 513841208 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492650 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccccn4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C26H24N6O2/c1-32-14-11-20-23(26(32)34)25(29-18-7-3-2-4-8-18)24(30-20)17-10-13-28-21(15-17)31-22(33)16-19-9-5-6-12-27-19/h2-10,12-13,15,29-30H,11,14,16H2,1H3,(H,28,31,33) WYFBDHPKVNKMTH-UHFFFAOYSA-N 721157 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-2-yl)acetamide::US12227501, Example 115 Casein kinase I isoform alpha Homo sapiens 2.41 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721157 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721157&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674442 513841209 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492651 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccccn4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C26H24N6O2/c1-32-14-11-20-23(26(32)34)25(29-18-7-3-2-4-8-18)24(30-20)17-10-13-28-21(15-17)31-22(33)16-19-9-5-6-12-27-19/h2-10,12-13,15,29-30H,11,14,16H2,1H3,(H,28,31,33) WYFBDHPKVNKMTH-UHFFFAOYSA-N 721157 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-2-yl)acetamide::US12227501, Example 115 Casein kinase I isoform delta Homo sapiens 5.09 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721157 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721157&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674442 513841209 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492652 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccccn4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C26H24N6O2/c1-32-14-11-20-23(26(32)34)25(29-18-7-3-2-4-8-18)24(30-20)17-10-13-28-21(15-17)31-22(33)16-19-9-5-6-12-27-19/h2-10,12-13,15,29-30H,11,14,16H2,1H3,(H,28,31,33) WYFBDHPKVNKMTH-UHFFFAOYSA-N 721157 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-2-yl)acetamide::US12227501, Example 115 Casein kinase I isoform alpha Homo sapiens 248 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721157 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721157&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674442 513841209 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492653 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4cccc(C(F)(F)F)c4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H24F3N5O2/c1-36-13-11-21-24(27(36)38)26(33-20-8-3-2-4-9-20)25(34-21)18-10-12-32-22(16-18)35-23(37)15-17-6-5-7-19(14-17)28(29,30)31/h2-10,12,14,16,33-34H,11,13,15H2,1H3,(H,32,35,37) IVISHGNTPOVTQM-UHFFFAOYSA-N 721158 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-[3-(trifluoromethyl)phenyl]acetamide::US12227501, Example 116 Casein kinase I isoform alpha Homo sapiens 18.6 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721158 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721158&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674419 513841210 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492654 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4cccc(C(F)(F)F)c4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H24F3N5O2/c1-36-13-11-21-24(27(36)38)26(33-20-8-3-2-4-9-20)25(34-21)18-10-12-32-22(16-18)35-23(37)15-17-6-5-7-19(14-17)28(29,30)31/h2-10,12,14,16,33-34H,11,13,15H2,1H3,(H,32,35,37) IVISHGNTPOVTQM-UHFFFAOYSA-N 721158 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-[3-(trifluoromethyl)phenyl]acetamide::US12227501, Example 116 Casein kinase I isoform delta Homo sapiens 54.4 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721158 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721158&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674419 513841210 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492655 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4cccc(C(F)(F)F)c4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H24F3N5O2/c1-36-13-11-21-24(27(36)38)26(33-20-8-3-2-4-9-20)25(34-21)18-10-12-32-22(16-18)35-23(37)15-17-6-5-7-19(14-17)28(29,30)31/h2-10,12,14,16,33-34H,11,13,15H2,1H3,(H,32,35,37) IVISHGNTPOVTQM-UHFFFAOYSA-N 721158 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-[3-(trifluoromethyl)phenyl]acetamide::US12227501, Example 116 Casein kinase I isoform alpha Homo sapiens 453 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721158 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721158&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674419 513841210 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492656 COC(=O)c1ccc(CC(=O)Nc2cc(-c3[nH]c4c(c3Nc3ccccc3)C(=O)N(C)CC4)ccn2)cc1 InChI=1S/C29H27N5O4/c1-34-15-13-22-25(28(34)36)27(31-21-6-4-3-5-7-21)26(32-22)20-12-14-30-23(17-20)33-24(35)16-18-8-10-19(11-9-18)29(37)38-2/h3-12,14,17,31-32H,13,15-16H2,1-2H3,(H,30,33,35) QCSBVNWGWVHGRR-UHFFFAOYSA-N 721159 methyl 4-(2-{[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]amino}-2-oxoethyl)benzoate::US12227501, Example 117 Casein kinase I isoform alpha Homo sapiens 1.46 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721159 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721159&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674454 513841211 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492657 COC(=O)c1ccc(CC(=O)Nc2cc(-c3[nH]c4c(c3Nc3ccccc3)C(=O)N(C)CC4)ccn2)cc1 InChI=1S/C29H27N5O4/c1-34-15-13-22-25(28(34)36)27(31-21-6-4-3-5-7-21)26(32-22)20-12-14-30-23(17-20)33-24(35)16-18-8-10-19(11-9-18)29(37)38-2/h3-12,14,17,31-32H,13,15-16H2,1-2H3,(H,30,33,35) QCSBVNWGWVHGRR-UHFFFAOYSA-N 721159 methyl 4-(2-{[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]amino}-2-oxoethyl)benzoate::US12227501, Example 117 Casein kinase I isoform delta Homo sapiens 2.99 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721159 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721159&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674454 513841211 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492658 COC(=O)c1ccc(CC(=O)Nc2cc(-c3[nH]c4c(c3Nc3ccccc3)C(=O)N(C)CC4)ccn2)cc1 InChI=1S/C29H27N5O4/c1-34-15-13-22-25(28(34)36)27(31-21-6-4-3-5-7-21)26(32-22)20-12-14-30-23(17-20)33-24(35)16-18-8-10-19(11-9-18)29(37)38-2/h3-12,14,17,31-32H,13,15-16H2,1-2H3,(H,30,33,35) QCSBVNWGWVHGRR-UHFFFAOYSA-N 721159 methyl 4-(2-{[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]amino}-2-oxoethyl)benzoate::US12227501, Example 117 Casein kinase I isoform alpha Homo sapiens 96.2 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721159 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721159&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674454 513841211 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492659 CC(F)CC(C(=O)N(F)c1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NC(C)(C)C3)ccn1)c1ccc(S(C)(=O)=O)cc1 InChI=1S/C32H33F2N5O4S/c1-19(33)16-24(20-10-12-23(13-11-20)44(4,42)43)31(41)39(34)26-17-21(14-15-35-26)28-29(36-22-8-6-5-7-9-22)27-25(37-28)18-32(2,3)38-30(27)40/h5-15,17,19,24,36-37H,16,18H2,1-4H3,(H,38,40) RCHPQGHUPYFPMV-UHFFFAOYSA-N 721160 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-[4-(methanesulfonyl)phenyl]butanamide (Racemate)::US12227501, Example 118 Casein kinase I isoform alpha Homo sapiens 5.16 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721160 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721160&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 175682201 513841212 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492660 CC(F)CC(C(=O)N(F)c1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NC(C)(C)C3)ccn1)c1ccc(S(C)(=O)=O)cc1 InChI=1S/C32H33F2N5O4S/c1-19(33)16-24(20-10-12-23(13-11-20)44(4,42)43)31(41)39(34)26-17-21(14-15-35-26)28-29(36-22-8-6-5-7-9-22)27-25(37-28)18-32(2,3)38-30(27)40/h5-15,17,19,24,36-37H,16,18H2,1-4H3,(H,38,40) RCHPQGHUPYFPMV-UHFFFAOYSA-N 721160 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-[4-(methanesulfonyl)phenyl]butanamide (Racemate)::US12227501, Example 118 Casein kinase I isoform delta Homo sapiens 12.9 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721160 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721160&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 175682201 513841212 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492661 CC(F)CC(C(=O)N(F)c1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NC(C)(C)C3)ccn1)c1ccc(S(C)(=O)=O)cc1 InChI=1S/C32H33F2N5O4S/c1-19(33)16-24(20-10-12-23(13-11-20)44(4,42)43)31(41)39(34)26-17-21(14-15-35-26)28-29(36-22-8-6-5-7-9-22)27-25(37-28)18-32(2,3)38-30(27)40/h5-15,17,19,24,36-37H,16,18H2,1-4H3,(H,38,40) RCHPQGHUPYFPMV-UHFFFAOYSA-N 721160 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-[4-(methanesulfonyl)phenyl]butanamide (Racemate)::US12227501, Example 118 Casein kinase I isoform alpha Homo sapiens 107 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721160 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721160&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 175682201 513841212 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492662 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3cccc(F)c3)c2C(=O)N1 InChI=1S/C28H25F2N5O2/c1-28(2)15-21-24(27(37)35-28)26(32-20-5-3-4-19(30)14-20)25(33-21)17-10-11-31-22(13-17)34-23(36)12-16-6-8-18(29)9-7-16/h3-11,13-14,32-33H,12,15H2,1-2H3,(H,35,37)(H,31,34,36) RDIZWXHOXKMYHK-UHFFFAOYSA-N 721161 N-{4-[3-(3-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 119 Casein kinase I isoform alpha Homo sapiens 5.65 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721161 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721161&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674288 513841213 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492663 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3cccc(F)c3)c2C(=O)N1 InChI=1S/C28H25F2N5O2/c1-28(2)15-21-24(27(37)35-28)26(32-20-5-3-4-19(30)14-20)25(33-21)17-10-11-31-22(13-17)34-23(36)12-16-6-8-18(29)9-7-16/h3-11,13-14,32-33H,12,15H2,1-2H3,(H,35,37)(H,31,34,36) RDIZWXHOXKMYHK-UHFFFAOYSA-N 721161 N-{4-[3-(3-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 119 Casein kinase I isoform delta Homo sapiens 10.8 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721161 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721161&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674288 513841213 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492664 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3cccc(F)c3)c2C(=O)N1 InChI=1S/C28H25F2N5O2/c1-28(2)15-21-24(27(37)35-28)26(32-20-5-3-4-19(30)14-20)25(33-21)17-10-11-31-22(13-17)34-23(36)12-16-6-8-18(29)9-7-16/h3-11,13-14,32-33H,12,15H2,1-2H3,(H,35,37)(H,31,34,36) RDIZWXHOXKMYHK-UHFFFAOYSA-N 721161 N-{4-[3-(3-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 119 Casein kinase I isoform alpha Homo sapiens 354 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721161 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721161&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674288 513841213 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492665 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3)c2C(=O)N1 InChI=1S/C30H27F4N5O2/c1-30(2)15-22-25(29(41)39-30)27(36-20-5-3-4-19(32)13-20)26(37-22)17-10-11-35-24(12-17)38-28(40)21(14-23(33)34)16-6-8-18(31)9-7-16/h3-13,21,23,36-37H,14-15H2,1-2H3,(H,39,41)(H,35,38,40) HMUYZTPOWOYZKW-UHFFFAOYSA-N 721162 4,4-difluoro-N-{4-[3-(3-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide::US12227501, Example 120 Casein kinase I isoform alpha Homo sapiens 9.64 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721162 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721162&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674328 513841214 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492666 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3)c2C(=O)N1 InChI=1S/C30H27F4N5O2/c1-30(2)15-22-25(29(41)39-30)27(36-20-5-3-4-19(32)13-20)26(37-22)17-10-11-35-24(12-17)38-28(40)21(14-23(33)34)16-6-8-18(31)9-7-16/h3-13,21,23,36-37H,14-15H2,1-2H3,(H,39,41)(H,35,38,40) HMUYZTPOWOYZKW-UHFFFAOYSA-N 721162 4,4-difluoro-N-{4-[3-(3-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide::US12227501, Example 120 Casein kinase I isoform delta Homo sapiens 11.0 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721162 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721162&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674328 513841214 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492667 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3)c2C(=O)N1 InChI=1S/C30H27F4N5O2/c1-30(2)15-22-25(29(41)39-30)27(36-20-5-3-4-19(32)13-20)26(37-22)17-10-11-35-24(12-17)38-28(40)21(14-23(33)34)16-6-8-18(31)9-7-16/h3-13,21,23,36-37H,14-15H2,1-2H3,(H,39,41)(H,35,38,40) HMUYZTPOWOYZKW-UHFFFAOYSA-N 721162 4,4-difluoro-N-{4-[3-(3-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide::US12227501, Example 120 Casein kinase I isoform alpha Homo sapiens 477 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721162 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721162&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674328 513841214 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492668 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3)c2C(=O)N1 InChI=1S/C30H27F4N5O2/c1-30(2)15-22-25(29(41)39-30)27(36-20-5-3-4-19(32)13-20)26(37-22)17-10-11-35-24(12-17)38-28(40)21(14-23(33)34)16-6-8-18(31)9-7-16/h3-13,21,23,36-37H,14-15H2,1-2H3,(H,39,41)(H,35,38,40) HMUYZTPOWOYZKW-UHFFFAOYSA-N 721163 4,4-difluoro-N-{4-[3-(3-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 121 Casein kinase I isoform alpha Homo sapiens 70.1 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721163 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721163&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674328 513841215 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492669 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3)c2C(=O)N1 InChI=1S/C30H27F4N5O2/c1-30(2)15-22-25(29(41)39-30)27(36-20-5-3-4-19(32)13-20)26(37-22)17-10-11-35-24(12-17)38-28(40)21(14-23(33)34)16-6-8-18(31)9-7-16/h3-13,21,23,36-37H,14-15H2,1-2H3,(H,39,41)(H,35,38,40) HMUYZTPOWOYZKW-UHFFFAOYSA-N 721163 4,4-difluoro-N-{4-[3-(3-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 121 Casein kinase I isoform delta Homo sapiens 63.5 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721163 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721163&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674328 513841215 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492670 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3)c2C(=O)N1 InChI=1S/C30H27F4N5O2/c1-30(2)15-22-25(29(41)39-30)27(36-20-5-3-4-19(32)13-20)26(37-22)17-10-11-35-24(12-17)38-28(40)21(14-23(33)34)16-6-8-18(31)9-7-16/h3-13,21,23,36-37H,14-15H2,1-2H3,(H,39,41)(H,35,38,40) HMUYZTPOWOYZKW-UHFFFAOYSA-N 721163 4,4-difluoro-N-{4-[3-(3-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 121 Casein kinase I isoform alpha Homo sapiens 10200 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721163 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721163&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674328 513841215 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492671 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2cccc(F)c2Cl)C(=O)NC2(CCC2)C3)ccn1 InChI=1S/C29H24ClF2N5O2/c30-25-19(32)3-1-4-20(25)34-27-24-21(15-29(10-2-11-29)37-28(24)39)35-26(27)17-9-12-33-22(14-17)36-23(38)13-16-5-7-18(31)8-6-16/h1,3-9,12,14,34-35H,2,10-11,13,15H2,(H,37,39)(H,33,36,38) RUBGULKMMNPVRT-UHFFFAOYSA-N 721164 N-{4-[3'-(2-chloro-3-fluoroanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 122 Casein kinase I isoform alpha Homo sapiens 4.12 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721164 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721164&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 155055649 513841216 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492672 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2cccc(F)c2Cl)C(=O)NC2(CCC2)C3)ccn1 InChI=1S/C29H24ClF2N5O2/c30-25-19(32)3-1-4-20(25)34-27-24-21(15-29(10-2-11-29)37-28(24)39)35-26(27)17-9-12-33-22(14-17)36-23(38)13-16-5-7-18(31)8-6-16/h1,3-9,12,14,34-35H,2,10-11,13,15H2,(H,37,39)(H,33,36,38) RUBGULKMMNPVRT-UHFFFAOYSA-N 721164 N-{4-[3'-(2-chloro-3-fluoroanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 122 Casein kinase I isoform delta Homo sapiens 4.71 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721164 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721164&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 155055649 513841216 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492673 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2cccc(F)c2Cl)C(=O)NC2(CCC2)C3)ccn1 InChI=1S/C29H24ClF2N5O2/c30-25-19(32)3-1-4-20(25)34-27-24-21(15-29(10-2-11-29)37-28(24)39)35-26(27)17-9-12-33-22(14-17)36-23(38)13-16-5-7-18(31)8-6-16/h1,3-9,12,14,34-35H,2,10-11,13,15H2,(H,37,39)(H,33,36,38) RUBGULKMMNPVRT-UHFFFAOYSA-N 721164 N-{4-[3'-(2-chloro-3-fluoroanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 122 Casein kinase I isoform alpha Homo sapiens 26.8 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721164 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721164&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 155055649 513841216 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492674 O=C1NC2(CCC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3Cl)c21 InChI=1S/C31H26ClF4N5O2/c32-26-20(34)3-1-4-21(26)38-28-25-22(15-31(10-2-11-31)41-30(25)43)39-27(28)17-9-12-37-24(13-17)40-29(42)19(14-23(35)36)16-5-7-18(33)8-6-16/h1,3-9,12-13,19,23,38-39H,2,10-11,14-15H2,(H,41,43)(H,37,40,42) RFSUZJIQGIZAAA-UHFFFAOYSA-N 721165 N-{4-[3'-(2-chloro-3-fluoroanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 123 Casein kinase I isoform alpha Homo sapiens 13.5 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721165 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721165&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674387 513841217 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492675 O=C1NC2(CCC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3Cl)c21 InChI=1S/C31H26ClF4N5O2/c32-26-20(34)3-1-4-21(26)38-28-25-22(15-31(10-2-11-31)41-30(25)43)39-27(28)17-9-12-37-24(13-17)40-29(42)19(14-23(35)36)16-5-7-18(33)8-6-16/h1,3-9,12-13,19,23,38-39H,2,10-11,14-15H2,(H,41,43)(H,37,40,42) RFSUZJIQGIZAAA-UHFFFAOYSA-N 721165 N-{4-[3'-(2-chloro-3-fluoroanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 123 Casein kinase I isoform delta Homo sapiens 9.91 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721165 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721165&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674387 513841217 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492676 O=C1NC2(CCC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3Cl)c21 InChI=1S/C31H26ClF4N5O2/c32-26-20(34)3-1-4-21(26)38-28-25-22(15-31(10-2-11-31)41-30(25)43)39-27(28)17-9-12-37-24(13-17)40-29(42)19(14-23(35)36)16-5-7-18(33)8-6-16/h1,3-9,12-13,19,23,38-39H,2,10-11,14-15H2,(H,41,43)(H,37,40,42) RFSUZJIQGIZAAA-UHFFFAOYSA-N 721165 N-{4-[3'-(2-chloro-3-fluoroanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 123 Casein kinase I isoform alpha Homo sapiens 29.1 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721165 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721165&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674387 513841217 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492677 O=C1NC2(CCC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3Cl)c21 InChI=1S/C31H26ClF4N5O2/c32-26-20(34)3-1-4-21(26)38-28-25-22(15-31(10-2-11-31)41-30(25)43)39-27(28)17-9-12-37-24(13-17)40-29(42)19(14-23(35)36)16-5-7-18(33)8-6-16/h1,3-9,12-13,19,23,38-39H,2,10-11,14-15H2,(H,41,43)(H,37,40,42) RFSUZJIQGIZAAA-UHFFFAOYSA-N 721166 (−)-N-{4-[3'-(2-chloro-3-fluoroanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 124 Casein kinase I isoform alpha Homo sapiens 74.6 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721166 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721166&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674387 513841218 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492678 O=C1NC2(CCC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3Cl)c21 InChI=1S/C31H26ClF4N5O2/c32-26-20(34)3-1-4-21(26)38-28-25-22(15-31(10-2-11-31)41-30(25)43)39-27(28)17-9-12-37-24(13-17)40-29(42)19(14-23(35)36)16-5-7-18(33)8-6-16/h1,3-9,12-13,19,23,38-39H,2,10-11,14-15H2,(H,41,43)(H,37,40,42) RFSUZJIQGIZAAA-UHFFFAOYSA-N 721166 (−)-N-{4-[3'-(2-chloro-3-fluoroanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 124 Casein kinase I isoform delta Homo sapiens 58.7 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721166 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721166&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674387 513841218 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492679 O=C1NC2(CCC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3Cl)c21 InChI=1S/C31H26ClF4N5O2/c32-26-20(34)3-1-4-21(26)38-28-25-22(15-31(10-2-11-31)41-30(25)43)39-27(28)17-9-12-37-24(13-17)40-29(42)19(14-23(35)36)16-5-7-18(33)8-6-16/h1,3-9,12-13,19,23,38-39H,2,10-11,14-15H2,(H,41,43)(H,37,40,42) RFSUZJIQGIZAAA-UHFFFAOYSA-N 721166 (−)-N-{4-[3'-(2-chloro-3-fluoroanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 124 Casein kinase I isoform alpha Homo sapiens >5710 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721166 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721166&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674387 513841218 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492680 O=C1NC2(CCC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3Cl)c21 InChI=1S/C31H26ClF4N5O2/c32-26-20(34)3-1-4-21(26)38-28-25-22(15-31(10-2-11-31)41-30(25)43)39-27(28)17-9-12-37-24(13-17)40-29(42)19(14-23(35)36)16-5-7-18(33)8-6-16/h1,3-9,12-13,19,23,38-39H,2,10-11,14-15H2,(H,41,43)(H,37,40,42) RFSUZJIQGIZAAA-UHFFFAOYSA-N 721167 (+)-N-{4-[3'-(2-chloro-3-fluoroanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 125 Casein kinase I isoform alpha Homo sapiens 10.5 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721167 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721167&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674387 513841219 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492681 O=C1NC2(CCC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3Cl)c21 InChI=1S/C31H26ClF4N5O2/c32-26-20(34)3-1-4-21(26)38-28-25-22(15-31(10-2-11-31)41-30(25)43)39-27(28)17-9-12-37-24(13-17)40-29(42)19(14-23(35)36)16-5-7-18(33)8-6-16/h1,3-9,12-13,19,23,38-39H,2,10-11,14-15H2,(H,41,43)(H,37,40,42) RFSUZJIQGIZAAA-UHFFFAOYSA-N 721167 (+)-N-{4-[3'-(2-chloro-3-fluoroanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 125 Casein kinase I isoform delta Homo sapiens 9.39 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721167 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721167&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674387 513841219 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492682 O=C1NC2(CCC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3Cl)c21 InChI=1S/C31H26ClF4N5O2/c32-26-20(34)3-1-4-21(26)38-28-25-22(15-31(10-2-11-31)41-30(25)43)39-27(28)17-9-12-37-24(13-17)40-29(42)19(14-23(35)36)16-5-7-18(33)8-6-16/h1,3-9,12-13,19,23,38-39H,2,10-11,14-15H2,(H,41,43)(H,37,40,42) RFSUZJIQGIZAAA-UHFFFAOYSA-N 721167 (+)-N-{4-[3'-(2-chloro-3-fluoroanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 125 Casein kinase I isoform alpha Homo sapiens 12.1 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721167 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721167&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674387 513841219 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492683 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3cccc(F)n3)c2C(=O)N1 InChI=1S/C27H24F2N6O2/c1-27(2)14-18-23(26(37)35-27)25(34-20-5-3-4-19(29)32-20)24(31-18)16-10-11-30-21(13-16)33-22(36)12-15-6-8-17(28)9-7-15/h3-11,13,31H,12,14H2,1-2H3,(H,32,34)(H,35,37)(H,30,33,36) XJDSDBTWZHZYJT-UHFFFAOYSA-N 721168 2-(4-fluorophenyl)-N-(4-{3-[(6-fluoropyridin-2-yl)amino]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl}pyridin-2-yl)acetamide::US12227501, Example 126 Casein kinase I isoform alpha Homo sapiens 4.44 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721168 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721168&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674266 513841220 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492684 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3cccc(F)n3)c2C(=O)N1 InChI=1S/C27H24F2N6O2/c1-27(2)14-18-23(26(37)35-27)25(34-20-5-3-4-19(29)32-20)24(31-18)16-10-11-30-21(13-16)33-22(36)12-15-6-8-17(28)9-7-15/h3-11,13,31H,12,14H2,1-2H3,(H,32,34)(H,35,37)(H,30,33,36) XJDSDBTWZHZYJT-UHFFFAOYSA-N 721168 2-(4-fluorophenyl)-N-(4-{3-[(6-fluoropyridin-2-yl)amino]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl}pyridin-2-yl)acetamide::US12227501, Example 126 Casein kinase I isoform delta Homo sapiens 14.4 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721168 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721168&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674266 513841220 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492685 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3cccc(F)n3)c2C(=O)N1 InChI=1S/C27H24F2N6O2/c1-27(2)14-18-23(26(37)35-27)25(34-20-5-3-4-19(29)32-20)24(31-18)16-10-11-30-21(13-16)33-22(36)12-15-6-8-17(28)9-7-15/h3-11,13,31H,12,14H2,1-2H3,(H,32,34)(H,35,37)(H,30,33,36) XJDSDBTWZHZYJT-UHFFFAOYSA-N 721168 2-(4-fluorophenyl)-N-(4-{3-[(6-fluoropyridin-2-yl)amino]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl}pyridin-2-yl)acetamide::US12227501, Example 126 Casein kinase I isoform alpha Homo sapiens 47.8 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721168 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721168&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674266 513841220 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492686 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3cccc(F)n3)c2C(=O)N1 InChI=1S/C27H24F2N6O2/c1-27(2)14-18-23(26(37)35-27)25(34-20-5-3-4-19(29)32-20)24(31-18)16-10-11-30-21(13-16)33-22(36)12-15-6-8-17(28)9-7-15/h3-11,13,31H,12,14H2,1-2H3,(H,32,34)(H,35,37)(H,30,33,36) XJDSDBTWZHZYJT-UHFFFAOYSA-N 721169 2-(4-fluorophenyl)-N-(4-{3-[(6-fluoropyridin-2-yl)amino]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl}pyridin-2-yl)acetamide-1,1',1″-phosphoryltripyrrolidine salt::US12227501, Example 127 Casein kinase I isoform alpha Homo sapiens 4.74 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721169 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721169&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674266 513841221 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492687 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3cccc(F)n3)c2C(=O)N1 InChI=1S/C27H24F2N6O2/c1-27(2)14-18-23(26(37)35-27)25(34-20-5-3-4-19(29)32-20)24(31-18)16-10-11-30-21(13-16)33-22(36)12-15-6-8-17(28)9-7-15/h3-11,13,31H,12,14H2,1-2H3,(H,32,34)(H,35,37)(H,30,33,36) XJDSDBTWZHZYJT-UHFFFAOYSA-N 721169 2-(4-fluorophenyl)-N-(4-{3-[(6-fluoropyridin-2-yl)amino]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl}pyridin-2-yl)acetamide-1,1',1″-phosphoryltripyrrolidine salt::US12227501, Example 127 Casein kinase I isoform delta Homo sapiens 14.6 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721169 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721169&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674266 513841221 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492688 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3cccc(F)n3)c2C(=O)N1 InChI=1S/C27H24F2N6O2/c1-27(2)14-18-23(26(37)35-27)25(34-20-5-3-4-19(29)32-20)24(31-18)16-10-11-30-21(13-16)33-22(36)12-15-6-8-17(28)9-7-15/h3-11,13,31H,12,14H2,1-2H3,(H,32,34)(H,35,37)(H,30,33,36) XJDSDBTWZHZYJT-UHFFFAOYSA-N 721169 2-(4-fluorophenyl)-N-(4-{3-[(6-fluoropyridin-2-yl)amino]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl}pyridin-2-yl)acetamide-1,1',1″-phosphoryltripyrrolidine salt::US12227501, Example 127 Casein kinase I isoform alpha Homo sapiens 23.1 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721169 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721169&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674266 513841221 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492689 CC(F)CC(C(=O)N(F)c1cc(-c2[nH]c3c(c2Nc2cccc(F)n2)C(=O)NC(C)(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C30H28F4N6O2/c1-16(31)13-20(17-7-9-19(32)10-8-17)29(42)40(34)24-14-18(11-12-35-24)26-27(38-23-6-4-5-22(33)37-23)25-21(36-26)15-30(2,3)39-28(25)41/h4-12,14,16,20,36H,13,15H2,1-3H3,(H,37,38)(H,39,41) YDOZYQCKMQHHAB-UHFFFAOYSA-N 721170 4,4-difluoro-2-(4-fluorophenyl)-N-(4-{3-[(6-fluoropyridin-2-yl)amino]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl}pyridin-2-yl)butanamide (Racemate)::US12227501, Example 128 Casein kinase I isoform alpha Homo sapiens 7.16 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721170 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721170&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 175682202 513841222 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492690 CC(F)CC(C(=O)N(F)c1cc(-c2[nH]c3c(c2Nc2cccc(F)n2)C(=O)NC(C)(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C30H28F4N6O2/c1-16(31)13-20(17-7-9-19(32)10-8-17)29(42)40(34)24-14-18(11-12-35-24)26-27(38-23-6-4-5-22(33)37-23)25-21(36-26)15-30(2,3)39-28(25)41/h4-12,14,16,20,36H,13,15H2,1-3H3,(H,37,38)(H,39,41) YDOZYQCKMQHHAB-UHFFFAOYSA-N 721170 4,4-difluoro-2-(4-fluorophenyl)-N-(4-{3-[(6-fluoropyridin-2-yl)amino]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl}pyridin-2-yl)butanamide (Racemate)::US12227501, Example 128 Casein kinase I isoform delta Homo sapiens 11.4 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721170 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721170&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 175682202 513841222 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492691 CC(F)CC(C(=O)N(F)c1cc(-c2[nH]c3c(c2Nc2cccc(F)n2)C(=O)NC(C)(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C30H28F4N6O2/c1-16(31)13-20(17-7-9-19(32)10-8-17)29(42)40(34)24-14-18(11-12-35-24)26-27(38-23-6-4-5-22(33)37-23)25-21(36-26)15-30(2,3)39-28(25)41/h4-12,14,16,20,36H,13,15H2,1-3H3,(H,37,38)(H,39,41) YDOZYQCKMQHHAB-UHFFFAOYSA-N 721170 4,4-difluoro-2-(4-fluorophenyl)-N-(4-{3-[(6-fluoropyridin-2-yl)amino]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl}pyridin-2-yl)butanamide (Racemate)::US12227501, Example 128 Casein kinase I isoform alpha Homo sapiens 31.4 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721170 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721170&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 175682202 513841222 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492692 CC(F)CC(C(=O)N(F)c1cc(-c2[nH]c3c(c2Nc2cccc(F)n2)C(=O)NC(C)(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C30H28F4N6O2/c1-16(31)13-20(17-7-9-19(32)10-8-17)29(42)40(34)24-14-18(11-12-35-24)26-27(38-23-6-4-5-22(33)37-23)25-21(36-26)15-30(2,3)39-28(25)41/h4-12,14,16,20,36H,13,15H2,1-3H3,(H,37,38)(H,39,41) YDOZYQCKMQHHAB-UHFFFAOYSA-N 721171 4,4-difluoro-2-(4-fluorophenyl)-N-(4-{3-[(6-fluoropyridin-2-yl)amino]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl}pyridin-2-yl)butanamide (Enantiomer 1)::US12227501, Example 129 Casein kinase I isoform alpha Homo sapiens 3.39 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721171 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721171&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 175682202 513841223 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492693 CC(F)CC(C(=O)N(F)c1cc(-c2[nH]c3c(c2Nc2cccc(F)n2)C(=O)NC(C)(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C30H28F4N6O2/c1-16(31)13-20(17-7-9-19(32)10-8-17)29(42)40(34)24-14-18(11-12-35-24)26-27(38-23-6-4-5-22(33)37-23)25-21(36-26)15-30(2,3)39-28(25)41/h4-12,14,16,20,36H,13,15H2,1-3H3,(H,37,38)(H,39,41) YDOZYQCKMQHHAB-UHFFFAOYSA-N 721171 4,4-difluoro-2-(4-fluorophenyl)-N-(4-{3-[(6-fluoropyridin-2-yl)amino]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl}pyridin-2-yl)butanamide (Enantiomer 1)::US12227501, Example 129 Casein kinase I isoform delta Homo sapiens 5.40 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721171 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721171&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 175682202 513841223 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492694 CC(F)CC(C(=O)N(F)c1cc(-c2[nH]c3c(c2Nc2cccc(F)n2)C(=O)NC(C)(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C30H28F4N6O2/c1-16(31)13-20(17-7-9-19(32)10-8-17)29(42)40(34)24-14-18(11-12-35-24)26-27(38-23-6-4-5-22(33)37-23)25-21(36-26)15-30(2,3)39-28(25)41/h4-12,14,16,20,36H,13,15H2,1-3H3,(H,37,38)(H,39,41) YDOZYQCKMQHHAB-UHFFFAOYSA-N 721171 4,4-difluoro-2-(4-fluorophenyl)-N-(4-{3-[(6-fluoropyridin-2-yl)amino]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl}pyridin-2-yl)butanamide (Enantiomer 1)::US12227501, Example 129 Casein kinase I isoform alpha Homo sapiens 6.37 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721171 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721171&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 175682202 513841223 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492695 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)n3)c2C(=O)N1 InChI=1S/C29H26F4N6O2/c1-29(2)14-19-24(28(41)39-29)26(37-22-5-3-4-21(33)36-22)25(35-19)16-10-11-34-23(12-16)38-27(40)18(13-20(31)32)15-6-8-17(30)9-7-15/h3-12,18,20,35H,13-14H2,1-2H3,(H,36,37)(H,39,41)(H,34,38,40) JOJTYLQIUBKNMM-UHFFFAOYSA-N 721172 4,4-difluoro-2-(4-fluorophenyl)-N-(4-{3-[(6-fluoropyridin-2-yl)amino]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl}pyridin-2-yl)butanamide (Enantiomer 2)::US12227501, Example 130 Casein kinase I isoform alpha Homo sapiens 26.7 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721172 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721172&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674289 513841224 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492696 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)n3)c2C(=O)N1 InChI=1S/C29H26F4N6O2/c1-29(2)14-19-24(28(41)39-29)26(37-22-5-3-4-21(33)36-22)25(35-19)16-10-11-34-23(12-16)38-27(40)18(13-20(31)32)15-6-8-17(30)9-7-15/h3-12,18,20,35H,13-14H2,1-2H3,(H,36,37)(H,39,41)(H,34,38,40) JOJTYLQIUBKNMM-UHFFFAOYSA-N 721172 4,4-difluoro-2-(4-fluorophenyl)-N-(4-{3-[(6-fluoropyridin-2-yl)amino]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl}pyridin-2-yl)butanamide (Enantiomer 2)::US12227501, Example 130 Casein kinase I isoform delta Homo sapiens 71.6 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721172 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721172&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674289 513841224 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492697 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)n3)c2C(=O)N1 InChI=1S/C29H26F4N6O2/c1-29(2)14-19-24(28(41)39-29)26(37-22-5-3-4-21(33)36-22)25(35-19)16-10-11-34-23(12-16)38-27(40)18(13-20(31)32)15-6-8-17(30)9-7-15/h3-12,18,20,35H,13-14H2,1-2H3,(H,36,37)(H,39,41)(H,34,38,40) JOJTYLQIUBKNMM-UHFFFAOYSA-N 721172 4,4-difluoro-2-(4-fluorophenyl)-N-(4-{3-[(6-fluoropyridin-2-yl)amino]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl}pyridin-2-yl)butanamide (Enantiomer 2)::US12227501, Example 130 Casein kinase I isoform alpha Homo sapiens 1340 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721172 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721172&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674289 513841224 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492698 Cc1c(F)cccc1Nc1c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C29H27F2N5O2/c1-16-20(31)5-4-6-21(16)33-27-25-22(15-29(2,3)36-28(25)38)34-26(27)18-11-12-32-23(14-18)35-24(37)13-17-7-9-19(30)10-8-17/h4-12,14,33-34H,13,15H2,1-3H3,(H,36,38)(H,32,35,37) UVTIDTZUUMJEGM-UHFFFAOYSA-N 721173 N-{4-[3-(3-fluoro-2-methylanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 131 Casein kinase I isoform alpha Homo sapiens 9.38 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721173 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721173&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674243 513841225 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492699 Cc1c(F)cccc1Nc1c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C29H27F2N5O2/c1-16-20(31)5-4-6-21(16)33-27-25-22(15-29(2,3)36-28(25)38)34-26(27)18-11-12-32-23(14-18)35-24(37)13-17-7-9-19(30)10-8-17/h4-12,14,33-34H,13,15H2,1-3H3,(H,36,38)(H,32,35,37) UVTIDTZUUMJEGM-UHFFFAOYSA-N 721173 N-{4-[3-(3-fluoro-2-methylanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 131 Casein kinase I isoform delta Homo sapiens 11.6 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721173 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721173&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674243 513841225 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492700 Cc1c(F)cccc1Nc1c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C29H27F2N5O2/c1-16-20(31)5-4-6-21(16)33-27-25-22(15-29(2,3)36-28(25)38)34-26(27)18-11-12-32-23(14-18)35-24(37)13-17-7-9-19(30)10-8-17/h4-12,14,33-34H,13,15H2,1-3H3,(H,36,38)(H,32,35,37) UVTIDTZUUMJEGM-UHFFFAOYSA-N 721173 N-{4-[3-(3-fluoro-2-methylanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 131 Casein kinase I isoform alpha Homo sapiens 464 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721173 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721173&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674243 513841225 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492701 Cc1c(F)cccc1Nc1c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C29H27F2N5O2/c1-16-20(31)5-4-6-21(16)33-27-25-22(15-29(2,3)36-28(25)38)34-26(27)18-11-12-32-23(14-18)35-24(37)13-17-7-9-19(30)10-8-17/h4-12,14,33-34H,13,15H2,1-3H3,(H,36,38)(H,32,35,37) UVTIDTZUUMJEGM-UHFFFAOYSA-N 721174 N-{4-[6,6-dimethyl-3-(2-methylanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate)::US12227501, Example 132 Casein kinase I isoform alpha Homo sapiens 24.3 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721174 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721174&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674243 513841226 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492702 Cc1c(F)cccc1Nc1c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C29H27F2N5O2/c1-16-20(31)5-4-6-21(16)33-27-25-22(15-29(2,3)36-28(25)38)34-26(27)18-11-12-32-23(14-18)35-24(37)13-17-7-9-19(30)10-8-17/h4-12,14,33-34H,13,15H2,1-3H3,(H,36,38)(H,32,35,37) UVTIDTZUUMJEGM-UHFFFAOYSA-N 721174 N-{4-[6,6-dimethyl-3-(2-methylanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate)::US12227501, Example 132 Casein kinase I isoform delta Homo sapiens 32.9 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721174 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721174&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674243 513841226 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492703 Cc1c(F)cccc1Nc1c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C29H27F2N5O2/c1-16-20(31)5-4-6-21(16)33-27-25-22(15-29(2,3)36-28(25)38)34-26(27)18-11-12-32-23(14-18)35-24(37)13-17-7-9-19(30)10-8-17/h4-12,14,33-34H,13,15H2,1-3H3,(H,36,38)(H,32,35,37) UVTIDTZUUMJEGM-UHFFFAOYSA-N 721174 N-{4-[6,6-dimethyl-3-(2-methylanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate)::US12227501, Example 132 Casein kinase I isoform alpha Homo sapiens 915 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721174 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721174&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674243 513841226 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492704 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(C)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C30H30FN5O2/c1-17-7-5-6-8-22(17)33-27-25-23(16-30(3,4)36-29(25)38)34-26(27)20-13-14-32-24(15-20)35-28(37)18(2)19-9-11-21(31)12-10-19/h5-15,18,33-34H,16H2,1-4H3,(H,36,38)(H,32,35,37) NVZGKHUBLBRWMH-UHFFFAOYSA-N 721175 (−)-N-{4-[6,6-dimethyl-3-(2-methylanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Enantiomer 1)::US12227501, Example 133 Casein kinase I isoform alpha Homo sapiens 197 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721175 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721175&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674258 513841227 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492705 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(C)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C30H30FN5O2/c1-17-7-5-6-8-22(17)33-27-25-23(16-30(3,4)36-29(25)38)34-26(27)20-13-14-32-24(15-20)35-28(37)18(2)19-9-11-21(31)12-10-19/h5-15,18,33-34H,16H2,1-4H3,(H,36,38)(H,32,35,37) NVZGKHUBLBRWMH-UHFFFAOYSA-N 721175 (−)-N-{4-[6,6-dimethyl-3-(2-methylanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Enantiomer 1)::US12227501, Example 133 Casein kinase I isoform delta Homo sapiens 280 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721175 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721175&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674258 513841227 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492706 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(C)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C30H30FN5O2/c1-17-7-5-6-8-22(17)33-27-25-23(16-30(3,4)36-29(25)38)34-26(27)20-13-14-32-24(15-20)35-28(37)18(2)19-9-11-21(31)12-10-19/h5-15,18,33-34H,16H2,1-4H3,(H,36,38)(H,32,35,37) NVZGKHUBLBRWMH-UHFFFAOYSA-N 721175 (−)-N-{4-[6,6-dimethyl-3-(2-methylanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Enantiomer 1)::US12227501, Example 133 Casein kinase I isoform alpha Homo sapiens >5710 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721175 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721175&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674258 513841227 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492707 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(C)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C30H30FN5O2/c1-17-7-5-6-8-22(17)33-27-25-23(16-30(3,4)36-29(25)38)34-26(27)20-13-14-32-24(15-20)35-28(37)18(2)19-9-11-21(31)12-10-19/h5-15,18,33-34H,16H2,1-4H3,(H,36,38)(H,32,35,37) NVZGKHUBLBRWMH-UHFFFAOYSA-N 721176 N-{4-[6,6-dimethyl-3-(2-methylanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Enantiomer 2)::US12227501, Example 134 Casein kinase I isoform alpha Homo sapiens 19.1 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721176 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721176&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674258 513841228 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492708 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(C)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C30H30FN5O2/c1-17-7-5-6-8-22(17)33-27-25-23(16-30(3,4)36-29(25)38)34-26(27)20-13-14-32-24(15-20)35-28(37)18(2)19-9-11-21(31)12-10-19/h5-15,18,33-34H,16H2,1-4H3,(H,36,38)(H,32,35,37) NVZGKHUBLBRWMH-UHFFFAOYSA-N 721176 N-{4-[6,6-dimethyl-3-(2-methylanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Enantiomer 2)::US12227501, Example 134 Casein kinase I isoform delta Homo sapiens 45.9 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721176 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721176&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674258 513841228 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492709 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(C)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C30H30FN5O2/c1-17-7-5-6-8-22(17)33-27-25-23(16-30(3,4)36-29(25)38)34-26(27)20-13-14-32-24(15-20)35-28(37)18(2)19-9-11-21(31)12-10-19/h5-15,18,33-34H,16H2,1-4H3,(H,36,38)(H,32,35,37) NVZGKHUBLBRWMH-UHFFFAOYSA-N 721176 N-{4-[6,6-dimethyl-3-(2-methylanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Enantiomer 2)::US12227501, Example 134 Casein kinase I isoform alpha Homo sapiens 304 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721176 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721176&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674258 513841228 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492710 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(CC(F)F)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C31H30F3N5O2/c1-17-6-4-5-7-22(17)36-28-26-23(16-31(2,3)39-30(26)41)37-27(28)19-12-13-35-25(14-19)38-29(40)21(15-24(33)34)18-8-10-20(32)11-9-18/h4-14,21,24,36-37H,15-16H2,1-3H3,(H,39,41)(H,35,38,40) BOQMJAHNAMIBMJ-UHFFFAOYSA-N 721177 N-{4-[6,6-dimethyl-3-(2-methylanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 135 Casein kinase I isoform alpha Homo sapiens 25.8 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721177 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721177&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674340 513841229 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492711 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(CC(F)F)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C31H30F3N5O2/c1-17-6-4-5-7-22(17)36-28-26-23(16-31(2,3)39-30(26)41)37-27(28)19-12-13-35-25(14-19)38-29(40)21(15-24(33)34)18-8-10-20(32)11-9-18/h4-14,21,24,36-37H,15-16H2,1-3H3,(H,39,41)(H,35,38,40) BOQMJAHNAMIBMJ-UHFFFAOYSA-N 721177 N-{4-[6,6-dimethyl-3-(2-methylanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 135 Casein kinase I isoform delta Homo sapiens 19.9 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721177 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721177&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674340 513841229 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492712 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(CC(F)F)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C31H30F3N5O2/c1-17-6-4-5-7-22(17)36-28-26-23(16-31(2,3)39-30(26)41)37-27(28)19-12-13-35-25(14-19)38-29(40)21(15-24(33)34)18-8-10-20(32)11-9-18/h4-14,21,24,36-37H,15-16H2,1-3H3,(H,39,41)(H,35,38,40) BOQMJAHNAMIBMJ-UHFFFAOYSA-N 721177 N-{4-[6,6-dimethyl-3-(2-methylanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 135 Casein kinase I isoform alpha Homo sapiens 365 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721177 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721177&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674340 513841229 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492713 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(CC(F)F)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C31H30F3N5O2/c1-17-6-4-5-7-22(17)36-28-26-23(16-31(2,3)39-30(26)41)37-27(28)19-12-13-35-25(14-19)38-29(40)21(15-24(33)34)18-8-10-20(32)11-9-18/h4-14,21,24,36-37H,15-16H2,1-3H3,(H,39,41)(H,35,38,40) BOQMJAHNAMIBMJ-UHFFFAOYSA-N 721178 N-{4-[6,6-dimethyl-3-(2-methylanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 136 Casein kinase I isoform alpha Homo sapiens 13.7 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721178 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721178&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674340 513841230 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492714 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(CC(F)F)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C31H30F3N5O2/c1-17-6-4-5-7-22(17)36-28-26-23(16-31(2,3)39-30(26)41)37-27(28)19-12-13-35-25(14-19)38-29(40)21(15-24(33)34)18-8-10-20(32)11-9-18/h4-14,21,24,36-37H,15-16H2,1-3H3,(H,39,41)(H,35,38,40) BOQMJAHNAMIBMJ-UHFFFAOYSA-N 721178 N-{4-[6,6-dimethyl-3-(2-methylanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 136 Casein kinase I isoform delta Homo sapiens 45.3 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721178 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721178&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674340 513841230 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492715 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(CC(F)F)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C31H30F3N5O2/c1-17-6-4-5-7-22(17)36-28-26-23(16-31(2,3)39-30(26)41)37-27(28)19-12-13-35-25(14-19)38-29(40)21(15-24(33)34)18-8-10-20(32)11-9-18/h4-14,21,24,36-37H,15-16H2,1-3H3,(H,39,41)(H,35,38,40) BOQMJAHNAMIBMJ-UHFFFAOYSA-N 721178 N-{4-[6,6-dimethyl-3-(2-methylanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 136 Casein kinase I isoform alpha Homo sapiens 45.6 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721178 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721178&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674340 513841230 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492716 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(CC(F)F)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C31H30F3N5O2/c1-17-6-4-5-7-22(17)36-28-26-23(16-31(2,3)39-30(26)41)37-27(28)19-12-13-35-25(14-19)38-29(40)21(15-24(33)34)18-8-10-20(32)11-9-18/h4-14,21,24,36-37H,15-16H2,1-3H3,(H,39,41)(H,35,38,40) BOQMJAHNAMIBMJ-UHFFFAOYSA-N 721179 N-{4-[6,6-dimethyl-3-(2-methylanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 137 Casein kinase I isoform alpha Homo sapiens 42.2 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721179 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721179&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674340 513841231 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492717 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(CC(F)F)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C31H30F3N5O2/c1-17-6-4-5-7-22(17)36-28-26-23(16-31(2,3)39-30(26)41)37-27(28)19-12-13-35-25(14-19)38-29(40)21(15-24(33)34)18-8-10-20(32)11-9-18/h4-14,21,24,36-37H,15-16H2,1-3H3,(H,39,41)(H,35,38,40) BOQMJAHNAMIBMJ-UHFFFAOYSA-N 721179 N-{4-[6,6-dimethyl-3-(2-methylanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 137 Casein kinase I isoform delta Homo sapiens 82.7 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721179 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721179&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674340 513841231 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492718 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(CC(F)F)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C31H30F3N5O2/c1-17-6-4-5-7-22(17)36-28-26-23(16-31(2,3)39-30(26)41)37-27(28)19-12-13-35-25(14-19)38-29(40)21(15-24(33)34)18-8-10-20(32)11-9-18/h4-14,21,24,36-37H,15-16H2,1-3H3,(H,39,41)(H,35,38,40) BOQMJAHNAMIBMJ-UHFFFAOYSA-N 721179 N-{4-[6,6-dimethyl-3-(2-methylanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 137 Casein kinase I isoform alpha Homo sapiens 451 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721179 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721179&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674340 513841231 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492719 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CNC(=O)OC(C)(C)C)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C34H37FN6O4/c1-33(2,3)45-32(44)37-19-24(20-11-13-22(35)14-12-20)30(42)40-26-17-21(15-16-36-26)28-29(38-23-9-7-6-8-10-23)27-25(39-28)18-34(4,5)41-31(27)43/h6-17,24,38-39H,18-19H2,1-5H3,(H,37,44)(H,41,43)(H,36,40,42) ATXRBBLJRPAIHG-UHFFFAOYSA-N 721180 tert-butyl [3-{[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]amino}-2-(4-fluorophenyl)-3-oxopropyl]carbamate (Racemate)::US12227501, Example 138 Casein kinase I isoform alpha Homo sapiens 16.6 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721180 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721180&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674287 513841232 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492720 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CNC(=O)OC(C)(C)C)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C34H37FN6O4/c1-33(2,3)45-32(44)37-19-24(20-11-13-22(35)14-12-20)30(42)40-26-17-21(15-16-36-26)28-29(38-23-9-7-6-8-10-23)27-25(39-28)18-34(4,5)41-31(27)43/h6-17,24,38-39H,18-19H2,1-5H3,(H,37,44)(H,41,43)(H,36,40,42) ATXRBBLJRPAIHG-UHFFFAOYSA-N 721180 tert-butyl [3-{[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]amino}-2-(4-fluorophenyl)-3-oxopropyl]carbamate (Racemate)::US12227501, Example 138 Casein kinase I isoform delta Homo sapiens 22.4 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721180 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721180&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674287 513841232 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492721 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CNC(=O)OC(C)(C)C)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C34H37FN6O4/c1-33(2,3)45-32(44)37-19-24(20-11-13-22(35)14-12-20)30(42)40-26-17-21(15-16-36-26)28-29(38-23-9-7-6-8-10-23)27-25(39-28)18-34(4,5)41-31(27)43/h6-17,24,38-39H,18-19H2,1-5H3,(H,37,44)(H,41,43)(H,36,40,42) ATXRBBLJRPAIHG-UHFFFAOYSA-N 721180 tert-butyl [3-{[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]amino}-2-(4-fluorophenyl)-3-oxopropyl]carbamate (Racemate)::US12227501, Example 138 Casein kinase I isoform alpha Homo sapiens 430 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721180 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721180&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674287 513841232 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492722 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CN)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C29H29FN6O2/c1-29(2)15-22-24(28(38)36-29)26(33-20-6-4-3-5-7-20)25(34-22)18-12-13-32-23(14-18)35-27(37)21(16-31)17-8-10-19(30)11-9-17/h3-14,21,33-34H,15-16,31H2,1-2H3,(H,36,38)(H,32,35,37) GWTJDEOZCYRULI-UHFFFAOYSA-N 721181 3-amino-N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide-hydrogen chloride salt (Racemate)::US12227501, Example 139 Casein kinase I isoform alpha Homo sapiens 3.21 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721181 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721181&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674378 513841233 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492723 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CN)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C29H29FN6O2/c1-29(2)15-22-24(28(38)36-29)26(33-20-6-4-3-5-7-20)25(34-22)18-12-13-32-23(14-18)35-27(37)21(16-31)17-8-10-19(30)11-9-17/h3-14,21,33-34H,15-16,31H2,1-2H3,(H,36,38)(H,32,35,37) GWTJDEOZCYRULI-UHFFFAOYSA-N 721181 3-amino-N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide-hydrogen chloride salt (Racemate)::US12227501, Example 139 Casein kinase I isoform delta Homo sapiens 7.73 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721181 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721181&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674378 513841233 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492724 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CN)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C29H29FN6O2/c1-29(2)15-22-24(28(38)36-29)26(33-20-6-4-3-5-7-20)25(34-22)18-12-13-32-23(14-18)35-27(37)21(16-31)17-8-10-19(30)11-9-17/h3-14,21,33-34H,15-16,31H2,1-2H3,(H,36,38)(H,32,35,37) GWTJDEOZCYRULI-UHFFFAOYSA-N 721181 3-amino-N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide-hydrogen chloride salt (Racemate)::US12227501, Example 139 Casein kinase I isoform alpha Homo sapiens 41.4 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721181 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721181&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674378 513841233 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492725 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CN)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C29H29FN6O2/c1-29(2)15-22-24(28(38)36-29)26(33-20-6-4-3-5-7-20)25(34-22)18-12-13-32-23(14-18)35-27(37)21(16-31)17-8-10-19(30)11-9-17/h3-14,21,33-34H,15-16,31H2,1-2H3,(H,36,38)(H,32,35,37) GWTJDEOZCYRULI-UHFFFAOYSA-N 721182 3-amino-N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 1)::US12227501, Example 140 Casein kinase I isoform alpha Homo sapiens 4.10 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721182 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721182&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674378 513841234 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492726 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CN)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C29H29FN6O2/c1-29(2)15-22-24(28(38)36-29)26(33-20-6-4-3-5-7-20)25(34-22)18-12-13-32-23(14-18)35-27(37)21(16-31)17-8-10-19(30)11-9-17/h3-14,21,33-34H,15-16,31H2,1-2H3,(H,36,38)(H,32,35,37) GWTJDEOZCYRULI-UHFFFAOYSA-N 721182 3-amino-N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 1)::US12227501, Example 140 Casein kinase I isoform delta Homo sapiens 9.95 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721182 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721182&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674378 513841234 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492727 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CN)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C29H29FN6O2/c1-29(2)15-22-24(28(38)36-29)26(33-20-6-4-3-5-7-20)25(34-22)18-12-13-32-23(14-18)35-27(37)21(16-31)17-8-10-19(30)11-9-17/h3-14,21,33-34H,15-16,31H2,1-2H3,(H,36,38)(H,32,35,37) GWTJDEOZCYRULI-UHFFFAOYSA-N 721182 3-amino-N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 1)::US12227501, Example 140 Casein kinase I isoform alpha Homo sapiens 56.9 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721182 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721182&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674378 513841234 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492728 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CN)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C29H29FN6O2/c1-29(2)15-22-24(28(38)36-29)26(33-20-6-4-3-5-7-20)25(34-22)18-12-13-32-23(14-18)35-27(37)21(16-31)17-8-10-19(30)11-9-17/h3-14,21,33-34H,15-16,31H2,1-2H3,(H,36,38)(H,32,35,37) GWTJDEOZCYRULI-UHFFFAOYSA-N 721183 3-amino-N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 2)::US12227501, Example 141 Casein kinase I isoform alpha Homo sapiens 57.8 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721183 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721183&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674378 513841235 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492729 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CN)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C29H29FN6O2/c1-29(2)15-22-24(28(38)36-29)26(33-20-6-4-3-5-7-20)25(34-22)18-12-13-32-23(14-18)35-27(37)21(16-31)17-8-10-19(30)11-9-17/h3-14,21,33-34H,15-16,31H2,1-2H3,(H,36,38)(H,32,35,37) GWTJDEOZCYRULI-UHFFFAOYSA-N 721183 3-amino-N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 2)::US12227501, Example 141 Casein kinase I isoform delta Homo sapiens 127 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721183 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721183&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674378 513841235 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492730 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CN)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C29H29FN6O2/c1-29(2)15-22-24(28(38)36-29)26(33-20-6-4-3-5-7-20)25(34-22)18-12-13-32-23(14-18)35-27(37)21(16-31)17-8-10-19(30)11-9-17/h3-14,21,33-34H,15-16,31H2,1-2H3,(H,36,38)(H,32,35,37) GWTJDEOZCYRULI-UHFFFAOYSA-N 721183 3-amino-N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 2)::US12227501, Example 141 Casein kinase I isoform alpha Homo sapiens 599 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721183 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721183&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674378 513841235 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492731 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]c2c1C(=O)NC1(CCC1)C2 InChI=1S/C30H28FN5O2/c1-18-5-2-3-6-22(18)33-28-26-23(17-30(12-4-13-30)36-29(26)38)34-27(28)20-11-14-32-24(16-20)35-25(37)15-19-7-9-21(31)10-8-19/h2-3,5-11,14,16,33-34H,4,12-13,15,17H2,1H3,(H,36,38)(H,32,35,37) MXKWSWPSGNBXIT-UHFFFAOYSA-N 721184 2-(4-fluorophenyl)-N-{4-[3'-(2-methylanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}acetamide::US12227501, Example 142 Casein kinase I isoform alpha Homo sapiens 5.10 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721184 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721184&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674444 513841236 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492732 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]c2c1C(=O)NC1(CCC1)C2 InChI=1S/C30H28FN5O2/c1-18-5-2-3-6-22(18)33-28-26-23(17-30(12-4-13-30)36-29(26)38)34-27(28)20-11-14-32-24(16-20)35-25(37)15-19-7-9-21(31)10-8-19/h2-3,5-11,14,16,33-34H,4,12-13,15,17H2,1H3,(H,36,38)(H,32,35,37) MXKWSWPSGNBXIT-UHFFFAOYSA-N 721184 2-(4-fluorophenyl)-N-{4-[3'-(2-methylanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}acetamide::US12227501, Example 142 Casein kinase I isoform delta Homo sapiens 9.35 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721184 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721184&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674444 513841236 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492733 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]c2c1C(=O)NC1(CCC1)C2 InChI=1S/C30H28FN5O2/c1-18-5-2-3-6-22(18)33-28-26-23(17-30(12-4-13-30)36-29(26)38)34-27(28)20-11-14-32-24(16-20)35-25(37)15-19-7-9-21(31)10-8-19/h2-3,5-11,14,16,33-34H,4,12-13,15,17H2,1H3,(H,36,38)(H,32,35,37) MXKWSWPSGNBXIT-UHFFFAOYSA-N 721184 2-(4-fluorophenyl)-N-{4-[3'-(2-methylanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}acetamide::US12227501, Example 142 Casein kinase I isoform alpha Homo sapiens 12.3 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721184 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721184&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674444 513841236 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492734 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(CC(F)F)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC1(CCC1)C2 InChI=1S/C32H30F3N5O2/c1-18-5-2-3-6-23(18)37-29-27-24(17-32(12-4-13-32)40-31(27)42)38-28(29)20-11-14-36-26(15-20)39-30(41)22(16-25(34)35)19-7-9-21(33)10-8-19/h2-3,5-11,14-15,22,25,37-38H,4,12-13,16-17H2,1H3,(H,40,42)(H,36,39,41) HVAVBAIPXDAXHC-UHFFFAOYSA-N 721185 4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3'-(2-methylanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}butanamide (Racemate)::US12227501, Example 143 Casein kinase I isoform alpha Homo sapiens 16.7 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721185 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721185&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674252 513841237 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492735 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(CC(F)F)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC1(CCC1)C2 InChI=1S/C32H30F3N5O2/c1-18-5-2-3-6-23(18)37-29-27-24(17-32(12-4-13-32)40-31(27)42)38-28(29)20-11-14-36-26(15-20)39-30(41)22(16-25(34)35)19-7-9-21(33)10-8-19/h2-3,5-11,14-15,22,25,37-38H,4,12-13,16-17H2,1H3,(H,40,42)(H,36,39,41) HVAVBAIPXDAXHC-UHFFFAOYSA-N 721185 4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3'-(2-methylanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}butanamide (Racemate)::US12227501, Example 143 Casein kinase I isoform delta Homo sapiens 18.4 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721185 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721185&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674252 513841237 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492736 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(CC(F)F)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC1(CCC1)C2 InChI=1S/C32H30F3N5O2/c1-18-5-2-3-6-23(18)37-29-27-24(17-32(12-4-13-32)40-31(27)42)38-28(29)20-11-14-36-26(15-20)39-30(41)22(16-25(34)35)19-7-9-21(33)10-8-19/h2-3,5-11,14-15,22,25,37-38H,4,12-13,16-17H2,1H3,(H,40,42)(H,36,39,41) HVAVBAIPXDAXHC-UHFFFAOYSA-N 721185 4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3'-(2-methylanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}butanamide (Racemate)::US12227501, Example 143 Casein kinase I isoform alpha Homo sapiens 32.0 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721185 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721185&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674252 513841237 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492737 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(CC(F)F)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC1(CCC1)C2 InChI=1S/C32H30F3N5O2/c1-18-5-2-3-6-23(18)37-29-27-24(17-32(12-4-13-32)40-31(27)42)38-28(29)20-11-14-36-26(15-20)39-30(41)22(16-25(34)35)19-7-9-21(33)10-8-19/h2-3,5-11,14-15,22,25,37-38H,4,12-13,16-17H2,1H3,(H,40,42)(H,36,39,41) HVAVBAIPXDAXHC-UHFFFAOYSA-N 721186 (−)-4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3'-(2-methylanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}butanamide-(Enantiomer 1)::US12227501, Example 144 Casein kinase I isoform alpha Homo sapiens 80.7 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721186 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721186&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674252 513841238 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492738 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(CC(F)F)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC1(CCC1)C2 InChI=1S/C32H30F3N5O2/c1-18-5-2-3-6-23(18)37-29-27-24(17-32(12-4-13-32)40-31(27)42)38-28(29)20-11-14-36-26(15-20)39-30(41)22(16-25(34)35)19-7-9-21(33)10-8-19/h2-3,5-11,14-15,22,25,37-38H,4,12-13,16-17H2,1H3,(H,40,42)(H,36,39,41) HVAVBAIPXDAXHC-UHFFFAOYSA-N 721186 (−)-4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3'-(2-methylanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}butanamide-(Enantiomer 1)::US12227501, Example 144 Casein kinase I isoform delta Homo sapiens 82.0 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721186 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721186&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674252 513841238 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492739 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(CC(F)F)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC1(CCC1)C2 InChI=1S/C32H30F3N5O2/c1-18-5-2-3-6-23(18)37-29-27-24(17-32(12-4-13-32)40-31(27)42)38-28(29)20-11-14-36-26(15-20)39-30(41)22(16-25(34)35)19-7-9-21(33)10-8-19/h2-3,5-11,14-15,22,25,37-38H,4,12-13,16-17H2,1H3,(H,40,42)(H,36,39,41) HVAVBAIPXDAXHC-UHFFFAOYSA-N 721186 (−)-4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3'-(2-methylanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}butanamide-(Enantiomer 1)::US12227501, Example 144 Casein kinase I isoform alpha Homo sapiens 5060 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721186 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721186&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674252 513841238 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492740 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(CC(F)F)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC1(CCC1)C2 InChI=1S/C32H30F3N5O2/c1-18-5-2-3-6-23(18)37-29-27-24(17-32(12-4-13-32)40-31(27)42)38-28(29)20-11-14-36-26(15-20)39-30(41)22(16-25(34)35)19-7-9-21(33)10-8-19/h2-3,5-11,14-15,22,25,37-38H,4,12-13,16-17H2,1H3,(H,40,42)(H,36,39,41) HVAVBAIPXDAXHC-UHFFFAOYSA-N 721187 (+)-4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3'-(2-methylanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}butanamide-(Enantiomer 2)::US12227501, Example 145 Casein kinase I isoform alpha Homo sapiens 10.7 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721187 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721187&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674252 513841239 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492741 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(CC(F)F)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC1(CCC1)C2 InChI=1S/C32H30F3N5O2/c1-18-5-2-3-6-23(18)37-29-27-24(17-32(12-4-13-32)40-31(27)42)38-28(29)20-11-14-36-26(15-20)39-30(41)22(16-25(34)35)19-7-9-21(33)10-8-19/h2-3,5-11,14-15,22,25,37-38H,4,12-13,16-17H2,1H3,(H,40,42)(H,36,39,41) HVAVBAIPXDAXHC-UHFFFAOYSA-N 721187 (+)-4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3'-(2-methylanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}butanamide-(Enantiomer 2)::US12227501, Example 145 Casein kinase I isoform delta Homo sapiens 8.21 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721187 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721187&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674252 513841239 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492742 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(CC(F)F)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC1(CCC1)C2 InChI=1S/C32H30F3N5O2/c1-18-5-2-3-6-23(18)37-29-27-24(17-32(12-4-13-32)40-31(27)42)38-28(29)20-11-14-36-26(15-20)39-30(41)22(16-25(34)35)19-7-9-21(33)10-8-19/h2-3,5-11,14-15,22,25,37-38H,4,12-13,16-17H2,1H3,(H,40,42)(H,36,39,41) HVAVBAIPXDAXHC-UHFFFAOYSA-N 721187 (+)-4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3'-(2-methylanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}butanamide-(Enantiomer 2)::US12227501, Example 145 Casein kinase I isoform alpha Homo sapiens 14.8 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721187 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721187&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674252 513841239 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492743 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NC2(CC2)C3)ccn1 InChI=1S/C28H24FN5O2/c29-19-8-6-17(7-9-19)14-23(35)33-22-15-18(10-13-30-22)25-26(31-20-4-2-1-3-5-20)24-21(32-25)16-28(11-12-28)34-27(24)36/h1-10,13,15,31-32H,11-12,14,16H2,(H,34,36)(H,30,33,35) ZGFMJKVWQXPLNE-UHFFFAOYSA-N 721188 N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclopropane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 146 Casein kinase I isoform alpha Homo sapiens 1.38 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721188 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721188&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674355 513841240 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492744 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NC2(CC2)C3)ccn1 InChI=1S/C28H24FN5O2/c29-19-8-6-17(7-9-19)14-23(35)33-22-15-18(10-13-30-22)25-26(31-20-4-2-1-3-5-20)24-21(32-25)16-28(11-12-28)34-27(24)36/h1-10,13,15,31-32H,11-12,14,16H2,(H,34,36)(H,30,33,35) ZGFMJKVWQXPLNE-UHFFFAOYSA-N 721188 N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclopropane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 146 Casein kinase I isoform delta Homo sapiens 6.28 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721188 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721188&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674355 513841240 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492745 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NC2(CC2)C3)ccn1 InChI=1S/C28H24FN5O2/c29-19-8-6-17(7-9-19)14-23(35)33-22-15-18(10-13-30-22)25-26(31-20-4-2-1-3-5-20)24-21(32-25)16-28(11-12-28)34-27(24)36/h1-10,13,15,31-32H,11-12,14,16H2,(H,34,36)(H,30,33,35) ZGFMJKVWQXPLNE-UHFFFAOYSA-N 721188 N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclopropane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 146 Casein kinase I isoform alpha Homo sapiens 5.04 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721188 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721188&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674355 513841240 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492746 O=C1NC2(CC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c21 InChI=1S/C30H26F3N5O2/c31-19-8-6-17(7-9-19)21(15-23(32)33)28(39)37-24-14-18(10-13-34-24)26-27(35-20-4-2-1-3-5-20)25-22(36-26)16-30(11-12-30)38-29(25)40/h1-10,13-14,21,23,35-36H,11-12,15-16H2,(H,38,40)(H,34,37,39) MQRBKUYTZJQBKW-UHFFFAOYSA-N 721189 N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclopropane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 147 Casein kinase I isoform alpha Homo sapiens 6.20 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721189 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721189&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674439 513841241 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492747 O=C1NC2(CC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c21 InChI=1S/C30H26F3N5O2/c31-19-8-6-17(7-9-19)21(15-23(32)33)28(39)37-24-14-18(10-13-34-24)26-27(35-20-4-2-1-3-5-20)25-22(36-26)16-30(11-12-30)38-29(25)40/h1-10,13-14,21,23,35-36H,11-12,15-16H2,(H,38,40)(H,34,37,39) MQRBKUYTZJQBKW-UHFFFAOYSA-N 721189 N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclopropane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 147 Casein kinase I isoform delta Homo sapiens 11.6 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721189 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721189&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674439 513841241 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492748 O=C1NC2(CC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c21 InChI=1S/C30H26F3N5O2/c31-19-8-6-17(7-9-19)21(15-23(32)33)28(39)37-24-14-18(10-13-34-24)26-27(35-20-4-2-1-3-5-20)25-22(36-26)16-30(11-12-30)38-29(25)40/h1-10,13-14,21,23,35-36H,11-12,15-16H2,(H,38,40)(H,34,37,39) MQRBKUYTZJQBKW-UHFFFAOYSA-N 721189 N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclopropane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 147 Casein kinase I isoform alpha Homo sapiens 19.2 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721189 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721189&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674439 513841241 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492749 O=C1NC2(CC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c21 InChI=1S/C30H26F3N5O2/c31-19-8-6-17(7-9-19)21(15-23(32)33)28(39)37-24-14-18(10-13-34-24)26-27(35-20-4-2-1-3-5-20)25-22(36-26)16-30(11-12-30)38-29(25)40/h1-10,13-14,21,23,35-36H,11-12,15-16H2,(H,38,40)(H,34,37,39) MQRBKUYTZJQBKW-UHFFFAOYSA-N 721190 N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclopropane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 148 Casein kinase I isoform alpha Homo sapiens 8.82 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721190 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721190&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674439 513841242 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492750 O=C1NC2(CC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c21 InChI=1S/C30H26F3N5O2/c31-19-8-6-17(7-9-19)21(15-23(32)33)28(39)37-24-14-18(10-13-34-24)26-27(35-20-4-2-1-3-5-20)25-22(36-26)16-30(11-12-30)38-29(25)40/h1-10,13-14,21,23,35-36H,11-12,15-16H2,(H,38,40)(H,34,37,39) MQRBKUYTZJQBKW-UHFFFAOYSA-N 721190 N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclopropane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 148 Casein kinase I isoform delta Homo sapiens 8.31 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721190 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721190&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674439 513841242 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492751 O=C1NC2(CC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c21 InChI=1S/C30H26F3N5O2/c31-19-8-6-17(7-9-19)21(15-23(32)33)28(39)37-24-14-18(10-13-34-24)26-27(35-20-4-2-1-3-5-20)25-22(36-26)16-30(11-12-30)38-29(25)40/h1-10,13-14,21,23,35-36H,11-12,15-16H2,(H,38,40)(H,34,37,39) MQRBKUYTZJQBKW-UHFFFAOYSA-N 721190 N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclopropane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 148 Casein kinase I isoform alpha Homo sapiens 12.8 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721190 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721190&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674439 513841242 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492752 O=C1NC2(CC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c21 InChI=1S/C30H26F3N5O2/c31-19-8-6-17(7-9-19)21(15-23(32)33)28(39)37-24-14-18(10-13-34-24)26-27(35-20-4-2-1-3-5-20)25-22(36-26)16-30(11-12-30)38-29(25)40/h1-10,13-14,21,23,35-36H,11-12,15-16H2,(H,38,40)(H,34,37,39) MQRBKUYTZJQBKW-UHFFFAOYSA-N 721191 N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclopropane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 149 Casein kinase I isoform alpha Homo sapiens 40.4 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721191 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721191&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674439 513841243 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492753 O=C1NC2(CC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c21 InChI=1S/C30H26F3N5O2/c31-19-8-6-17(7-9-19)21(15-23(32)33)28(39)37-24-14-18(10-13-34-24)26-27(35-20-4-2-1-3-5-20)25-22(36-26)16-30(11-12-30)38-29(25)40/h1-10,13-14,21,23,35-36H,11-12,15-16H2,(H,38,40)(H,34,37,39) MQRBKUYTZJQBKW-UHFFFAOYSA-N 721191 N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclopropane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 149 Casein kinase I isoform delta Homo sapiens 39.4 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721191 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721191&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674439 513841243 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492754 O=C1NC2(CC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c21 InChI=1S/C30H26F3N5O2/c31-19-8-6-17(7-9-19)21(15-23(32)33)28(39)37-24-14-18(10-13-34-24)26-27(35-20-4-2-1-3-5-20)25-22(36-26)16-30(11-12-30)38-29(25)40/h1-10,13-14,21,23,35-36H,11-12,15-16H2,(H,38,40)(H,34,37,39) MQRBKUYTZJQBKW-UHFFFAOYSA-N 721191 N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclopropane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 149 Casein kinase I isoform alpha Homo sapiens 473 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721191 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721191&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674439 513841243 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492755 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3cc(F)ccc3F)c2C1=O InChI=1S/C27H22F3N5O2/c1-35-11-9-20-24(27(35)37)26(33-21-14-18(29)6-7-19(21)30)25(32-20)16-8-10-31-22(13-16)34-23(36)12-15-2-4-17(28)5-3-15/h2-8,10,13-14,32-33H,9,11-12H2,1H3,(H,31,34,36) LXTFCMYUAINYQN-UHFFFAOYSA-N 721192 N-{4-[3-(2,5-difluoroanilino)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 150 Casein kinase I isoform alpha Homo sapiens 17.9 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721192 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721192&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674460 513841244 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492756 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3cc(F)ccc3F)c2C1=O InChI=1S/C27H22F3N5O2/c1-35-11-9-20-24(27(35)37)26(33-21-14-18(29)6-7-19(21)30)25(32-20)16-8-10-31-22(13-16)34-23(36)12-15-2-4-17(28)5-3-15/h2-8,10,13-14,32-33H,9,11-12H2,1H3,(H,31,34,36) LXTFCMYUAINYQN-UHFFFAOYSA-N 721192 N-{4-[3-(2,5-difluoroanilino)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 150 Casein kinase I isoform delta Homo sapiens 26.6 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721192 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721192&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674460 513841244 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492757 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3cc(F)ccc3F)c2C1=O InChI=1S/C27H22F3N5O2/c1-35-11-9-20-24(27(35)37)26(33-21-14-18(29)6-7-19(21)30)25(32-20)16-8-10-31-22(13-16)34-23(36)12-15-2-4-17(28)5-3-15/h2-8,10,13-14,32-33H,9,11-12H2,1H3,(H,31,34,36) LXTFCMYUAINYQN-UHFFFAOYSA-N 721192 N-{4-[3-(2,5-difluoroanilino)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 150 Casein kinase I isoform alpha Homo sapiens 1270 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721192 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721192&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674460 513841244 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492758 COCCNC(=O)c1ccc(CC(=O)Nc2cc(-c3[nH]c4c(c3Nc3ccccc3)C(=O)N(C)CC4)ccn2)cc1 InChI=1S/C31H32N6O4/c1-37-16-13-24-27(31(37)40)29(34-23-6-4-3-5-7-23)28(35-24)22-12-14-32-25(19-22)36-26(38)18-20-8-10-21(11-9-20)30(39)33-15-17-41-2/h3-12,14,19,34-35H,13,15-18H2,1-2H3,(H,33,39)(H,32,36,38) SWZLQQMKDWLWKC-UHFFFAOYSA-N 721193 4-(2-{[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]amino}-2-oxoethyl)-N-(2-methoxyethyl)benzamide::US12227501, Example 152 Casein kinase I isoform alpha Homo sapiens 2.45 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721193 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721193&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674324 513841245 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492759 COCCNC(=O)c1ccc(CC(=O)Nc2cc(-c3[nH]c4c(c3Nc3ccccc3)C(=O)N(C)CC4)ccn2)cc1 InChI=1S/C31H32N6O4/c1-37-16-13-24-27(31(37)40)29(34-23-6-4-3-5-7-23)28(35-24)22-12-14-32-25(19-22)36-26(38)18-20-8-10-21(11-9-20)30(39)33-15-17-41-2/h3-12,14,19,34-35H,13,15-18H2,1-2H3,(H,33,39)(H,32,36,38) SWZLQQMKDWLWKC-UHFFFAOYSA-N 721193 4-(2-{[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]amino}-2-oxoethyl)-N-(2-methoxyethyl)benzamide::US12227501, Example 152 Casein kinase I isoform delta Homo sapiens 7.96 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721193 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721193&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674324 513841245 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492760 COCCNC(=O)c1ccc(CC(=O)Nc2cc(-c3[nH]c4c(c3Nc3ccccc3)C(=O)N(C)CC4)ccn2)cc1 InChI=1S/C31H32N6O4/c1-37-16-13-24-27(31(37)40)29(34-23-6-4-3-5-7-23)28(35-24)22-12-14-32-25(19-22)36-26(38)18-20-8-10-21(11-9-20)30(39)33-15-17-41-2/h3-12,14,19,34-35H,13,15-18H2,1-2H3,(H,33,39)(H,32,36,38) SWZLQQMKDWLWKC-UHFFFAOYSA-N 721193 4-(2-{[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]amino}-2-oxoethyl)-N-(2-methoxyethyl)benzamide::US12227501, Example 152 Casein kinase I isoform alpha Homo sapiens 37.0 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721193 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721193&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674324 513841245 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492761 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(C(=O)N5CCNCC5)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C32H33N7O3/c1-38-16-12-25-28(32(38)42)30(35-24-5-3-2-4-6-24)29(36-25)23-11-13-34-26(20-23)37-27(40)19-21-7-9-22(10-8-21)31(41)39-17-14-33-15-18-39/h2-11,13,20,33,35-36H,12,14-19H2,1H3,(H,34,37,40) SXBIWPGTSITBPU-UHFFFAOYSA-N 721194 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-[4-(piperazine-1-carbonyl)phenyl]acetamide::US12227501, Example 153 Casein kinase I isoform alpha Homo sapiens 1.96 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721194 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721194&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674267 513841246 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492762 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(C(=O)N5CCNCC5)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C32H33N7O3/c1-38-16-12-25-28(32(38)42)30(35-24-5-3-2-4-6-24)29(36-25)23-11-13-34-26(20-23)37-27(40)19-21-7-9-22(10-8-21)31(41)39-17-14-33-15-18-39/h2-11,13,20,33,35-36H,12,14-19H2,1H3,(H,34,37,40) SXBIWPGTSITBPU-UHFFFAOYSA-N 721194 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-[4-(piperazine-1-carbonyl)phenyl]acetamide::US12227501, Example 153 Casein kinase I isoform delta Homo sapiens 9.28 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721194 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721194&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674267 513841246 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492763 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(C(=O)N5CCNCC5)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C32H33N7O3/c1-38-16-12-25-28(32(38)42)30(35-24-5-3-2-4-6-24)29(36-25)23-11-13-34-26(20-23)37-27(40)19-21-7-9-22(10-8-21)31(41)39-17-14-33-15-18-39/h2-11,13,20,33,35-36H,12,14-19H2,1H3,(H,34,37,40) SXBIWPGTSITBPU-UHFFFAOYSA-N 721194 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-[4-(piperazine-1-carbonyl)phenyl]acetamide::US12227501, Example 153 Casein kinase I isoform alpha Homo sapiens 73.9 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721194 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721194&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674267 513841246 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492764 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3cccc(F)c3F)c2C1=O InChI=1S/C27H22F3N5O2/c1-35-12-10-19-23(27(35)37)26(33-20-4-2-3-18(29)24(20)30)25(32-19)16-9-11-31-21(14-16)34-22(36)13-15-5-7-17(28)8-6-15/h2-9,11,14,32-33H,10,12-13H2,1H3,(H,31,34,36) VYKBWPLPWBMVTQ-UHFFFAOYSA-N 721195 N-{4-[3-(2,3-difluoroanilino)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide formamide salt::US12227501, Example 154 Casein kinase I isoform alpha Homo sapiens 3.33 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721195 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721195&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674223 513841247 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492765 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3cccc(F)c3F)c2C1=O InChI=1S/C27H22F3N5O2/c1-35-12-10-19-23(27(35)37)26(33-20-4-2-3-18(29)24(20)30)25(32-19)16-9-11-31-21(14-16)34-22(36)13-15-5-7-17(28)8-6-15/h2-9,11,14,32-33H,10,12-13H2,1H3,(H,31,34,36) VYKBWPLPWBMVTQ-UHFFFAOYSA-N 721195 N-{4-[3-(2,3-difluoroanilino)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide formamide salt::US12227501, Example 154 Casein kinase I isoform delta Homo sapiens 4.45 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721195 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721195&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674223 513841247 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492766 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3cccc(F)c3F)c2C1=O InChI=1S/C27H22F3N5O2/c1-35-12-10-19-23(27(35)37)26(33-20-4-2-3-18(29)24(20)30)25(32-19)16-9-11-31-21(14-16)34-22(36)13-15-5-7-17(28)8-6-15/h2-9,11,14,32-33H,10,12-13H2,1H3,(H,31,34,36) VYKBWPLPWBMVTQ-UHFFFAOYSA-N 721195 N-{4-[3-(2,3-difluoroanilino)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide formamide salt::US12227501, Example 154 Casein kinase I isoform alpha Homo sapiens 119 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721195 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721195&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674223 513841247 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492767 CN(C)CCNC(=O)c1ccc(CC(=O)Nc2cc(-c3[nH]c4c(c3Nc3ccccc3)C(=O)N(C)CC4)ccn2)cc1 InChI=1S/C32H35N7O3/c1-38(2)18-16-34-31(41)22-11-9-21(10-12-22)19-27(40)37-26-20-23(13-15-33-26)29-30(35-24-7-5-4-6-8-24)28-25(36-29)14-17-39(3)32(28)42/h4-13,15,20,35-36H,14,16-19H2,1-3H3,(H,34,41)(H,33,37,40) VTHDNDMZUMSBFW-UHFFFAOYSA-N 721196 4-(2-{[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]amino}-2-oxoethyl)-N-[2-(dimethylamino)ethyl]benzamide::US12227501, Example 155 Casein kinase I isoform alpha Homo sapiens 3.12 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721196 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721196&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674237 513841248 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492768 CN(C)CCNC(=O)c1ccc(CC(=O)Nc2cc(-c3[nH]c4c(c3Nc3ccccc3)C(=O)N(C)CC4)ccn2)cc1 InChI=1S/C32H35N7O3/c1-38(2)18-16-34-31(41)22-11-9-21(10-12-22)19-27(40)37-26-20-23(13-15-33-26)29-30(35-24-7-5-4-6-8-24)28-25(36-29)14-17-39(3)32(28)42/h4-13,15,20,35-36H,14,16-19H2,1-3H3,(H,34,41)(H,33,37,40) VTHDNDMZUMSBFW-UHFFFAOYSA-N 721196 4-(2-{[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]amino}-2-oxoethyl)-N-[2-(dimethylamino)ethyl]benzamide::US12227501, Example 155 Casein kinase I isoform delta Homo sapiens 7.01 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721196 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721196&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674237 513841248 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492769 CN(C)CCNC(=O)c1ccc(CC(=O)Nc2cc(-c3[nH]c4c(c3Nc3ccccc3)C(=O)N(C)CC4)ccn2)cc1 InChI=1S/C32H35N7O3/c1-38(2)18-16-34-31(41)22-11-9-21(10-12-22)19-27(40)37-26-20-23(13-15-33-26)29-30(35-24-7-5-4-6-8-24)28-25(36-29)14-17-39(3)32(28)42/h4-13,15,20,35-36H,14,16-19H2,1-3H3,(H,34,41)(H,33,37,40) VTHDNDMZUMSBFW-UHFFFAOYSA-N 721196 4-(2-{[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]amino}-2-oxoethyl)-N-[2-(dimethylamino)ethyl]benzamide::US12227501, Example 155 Casein kinase I isoform alpha Homo sapiens 48.5 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721196 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721196&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674237 513841248 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492770 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c2Nc2ccccc2)CC12CCC2 InChI=1S/C30H28FN5O2/c1-36-29(38)26-23(18-30(36)13-5-14-30)34-27(28(26)33-22-6-3-2-4-7-22)20-12-15-32-24(17-20)35-25(37)16-19-8-10-21(31)11-9-19/h2-4,6-12,15,17,33-34H,5,13-14,16,18H2,1H3,(H,32,35,37) WTEKKYAHRWEYNN-UHFFFAOYSA-N 721197 N-[4-(3'-anilino-5'-methyl-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 156 Casein kinase I isoform alpha Homo sapiens 6.09 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721197 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721197&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674334 513841249 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492771 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c2Nc2ccccc2)CC12CCC2 InChI=1S/C30H28FN5O2/c1-36-29(38)26-23(18-30(36)13-5-14-30)34-27(28(26)33-22-6-3-2-4-7-22)20-12-15-32-24(17-20)35-25(37)16-19-8-10-21(31)11-9-19/h2-4,6-12,15,17,33-34H,5,13-14,16,18H2,1H3,(H,32,35,37) WTEKKYAHRWEYNN-UHFFFAOYSA-N 721197 N-[4-(3'-anilino-5'-methyl-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 156 Casein kinase I isoform delta Homo sapiens 9.38 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721197 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721197&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674334 513841249 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492772 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c2Nc2ccccc2)CC12CCC2 InChI=1S/C30H28FN5O2/c1-36-29(38)26-23(18-30(36)13-5-14-30)34-27(28(26)33-22-6-3-2-4-7-22)20-12-15-32-24(17-20)35-25(37)16-19-8-10-21(31)11-9-19/h2-4,6-12,15,17,33-34H,5,13-14,16,18H2,1H3,(H,32,35,37) WTEKKYAHRWEYNN-UHFFFAOYSA-N 721197 N-[4-(3'-anilino-5'-methyl-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 156 Casein kinase I isoform alpha Homo sapiens 29.7 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721197 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721197&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674334 513841249 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492773 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C2(CCC2)C3)ccn1)c1ccc(F)cc1 InChI=1S/C31H30FN5O2/c1-19(20-9-11-22(32)12-10-20)29(38)36-25-17-21(13-16-33-25)27-28(34-23-7-4-3-5-8-23)26-24(35-27)18-31(14-6-15-31)37(2)30(26)39/h3-5,7-13,16-17,19,34-35H,6,14-15,18H2,1-2H3,(H,33,36,38) HGZBLFDJBJBFKL-UHFFFAOYSA-N 721198 N-[4-(3'-anilino-5'-methyl-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Racemate)::US12227501, Example 157 Casein kinase I isoform alpha Homo sapiens 8.76 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721198 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721198&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674422 513841250 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492774 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C2(CCC2)C3)ccn1)c1ccc(F)cc1 InChI=1S/C31H30FN5O2/c1-19(20-9-11-22(32)12-10-20)29(38)36-25-17-21(13-16-33-25)27-28(34-23-7-4-3-5-8-23)26-24(35-27)18-31(14-6-15-31)37(2)30(26)39/h3-5,7-13,16-17,19,34-35H,6,14-15,18H2,1-2H3,(H,33,36,38) HGZBLFDJBJBFKL-UHFFFAOYSA-N 721198 N-[4-(3'-anilino-5'-methyl-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Racemate)::US12227501, Example 157 Casein kinase I isoform delta Homo sapiens 15.8 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721198 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721198&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674422 513841250 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492775 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C2(CCC2)C3)ccn1)c1ccc(F)cc1 InChI=1S/C31H30FN5O2/c1-19(20-9-11-22(32)12-10-20)29(38)36-25-17-21(13-16-33-25)27-28(34-23-7-4-3-5-8-23)26-24(35-27)18-31(14-6-15-31)37(2)30(26)39/h3-5,7-13,16-17,19,34-35H,6,14-15,18H2,1-2H3,(H,33,36,38) HGZBLFDJBJBFKL-UHFFFAOYSA-N 721198 N-[4-(3'-anilino-5'-methyl-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Racemate)::US12227501, Example 157 Casein kinase I isoform alpha Homo sapiens 50.8 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721198 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721198&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674422 513841250 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492776 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C2(CCC2)C3)ccn1)c1ccc(F)cc1 InChI=1S/C31H30FN5O2/c1-19(20-9-11-22(32)12-10-20)29(38)36-25-17-21(13-16-33-25)27-28(34-23-7-4-3-5-8-23)26-24(35-27)18-31(14-6-15-31)37(2)30(26)39/h3-5,7-13,16-17,19,34-35H,6,14-15,18H2,1-2H3,(H,33,36,38) HGZBLFDJBJBFKL-UHFFFAOYSA-N 721199 (−)-N-[4-(3'-anilino-5'-methyl-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 1)::US12227501, Example 158 Casein kinase I isoform alpha Homo sapiens 239 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721199 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721199&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674422 513841251 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492777 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C2(CCC2)C3)ccn1)c1ccc(F)cc1 InChI=1S/C31H30FN5O2/c1-19(20-9-11-22(32)12-10-20)29(38)36-25-17-21(13-16-33-25)27-28(34-23-7-4-3-5-8-23)26-24(35-27)18-31(14-6-15-31)37(2)30(26)39/h3-5,7-13,16-17,19,34-35H,6,14-15,18H2,1-2H3,(H,33,36,38) HGZBLFDJBJBFKL-UHFFFAOYSA-N 721199 (−)-N-[4-(3'-anilino-5'-methyl-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 1)::US12227501, Example 158 Casein kinase I isoform delta Homo sapiens 188 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721199 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721199&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674422 513841251 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492778 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C2(CCC2)C3)ccn1)c1ccc(F)cc1 InChI=1S/C31H30FN5O2/c1-19(20-9-11-22(32)12-10-20)29(38)36-25-17-21(13-16-33-25)27-28(34-23-7-4-3-5-8-23)26-24(35-27)18-31(14-6-15-31)37(2)30(26)39/h3-5,7-13,16-17,19,34-35H,6,14-15,18H2,1-2H3,(H,33,36,38) HGZBLFDJBJBFKL-UHFFFAOYSA-N 721199 (−)-N-[4-(3'-anilino-5'-methyl-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 1)::US12227501, Example 158 Casein kinase I isoform alpha Homo sapiens >1630 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721199 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721199&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674422 513841251 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492779 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C2(CCC2)C3)ccn1)c1ccc(F)cc1 InChI=1S/C31H30FN5O2/c1-19(20-9-11-22(32)12-10-20)29(38)36-25-17-21(13-16-33-25)27-28(34-23-7-4-3-5-8-23)26-24(35-27)18-31(14-6-15-31)37(2)30(26)39/h3-5,7-13,16-17,19,34-35H,6,14-15,18H2,1-2H3,(H,33,36,38) HGZBLFDJBJBFKL-UHFFFAOYSA-N 721200 (+)-N-[4-(3'-anilino-5'-methyl-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 2)::US12227501, Example 159 Casein kinase I isoform alpha Homo sapiens 90.3 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721200 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721200&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674422 513841252 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492780 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C2(CCC2)C3)ccn1)c1ccc(F)cc1 InChI=1S/C31H30FN5O2/c1-19(20-9-11-22(32)12-10-20)29(38)36-25-17-21(13-16-33-25)27-28(34-23-7-4-3-5-8-23)26-24(35-27)18-31(14-6-15-31)37(2)30(26)39/h3-5,7-13,16-17,19,34-35H,6,14-15,18H2,1-2H3,(H,33,36,38) HGZBLFDJBJBFKL-UHFFFAOYSA-N 721200 (+)-N-[4-(3'-anilino-5'-methyl-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 2)::US12227501, Example 159 Casein kinase I isoform delta Homo sapiens 90.7 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721200 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721200&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674422 513841252 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492781 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C2(CCC2)C3)ccn1)c1ccc(F)cc1 InChI=1S/C31H30FN5O2/c1-19(20-9-11-22(32)12-10-20)29(38)36-25-17-21(13-16-33-25)27-28(34-23-7-4-3-5-8-23)26-24(35-27)18-31(14-6-15-31)37(2)30(26)39/h3-5,7-13,16-17,19,34-35H,6,14-15,18H2,1-2H3,(H,33,36,38) HGZBLFDJBJBFKL-UHFFFAOYSA-N 721200 (+)-N-[4-(3'-anilino-5'-methyl-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 2)::US12227501, Example 159 Casein kinase I isoform alpha Homo sapiens 217 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721200 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721200&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674422 513841252 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492782 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c2Nc2ccccc2)CC12CCC2 InChI=1S/C32H30F3N5O2/c1-40-31(42)27-24(18-32(40)13-5-14-32)38-28(29(27)37-22-6-3-2-4-7-22)20-12-15-36-26(16-20)39-30(41)23(17-25(34)35)19-8-10-21(33)11-9-19/h2-4,6-12,15-16,23,25,37-38H,5,13-14,17-18H2,1H3,(H,36,39,41) CFRUQBGKKYVHHQ-UHFFFAOYSA-N 721201 N-[4-(3'-anilino-5'-methyl-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 160 Casein kinase I isoform alpha Homo sapiens 13.3 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721201 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721201&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674465 513841253 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492783 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c2Nc2ccccc2)CC12CCC2 InChI=1S/C32H30F3N5O2/c1-40-31(42)27-24(18-32(40)13-5-14-32)38-28(29(27)37-22-6-3-2-4-7-22)20-12-15-36-26(16-20)39-30(41)23(17-25(34)35)19-8-10-21(33)11-9-19/h2-4,6-12,15-16,23,25,37-38H,5,13-14,17-18H2,1H3,(H,36,39,41) CFRUQBGKKYVHHQ-UHFFFAOYSA-N 721201 N-[4-(3'-anilino-5'-methyl-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 160 Casein kinase I isoform delta Homo sapiens 15.8 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721201 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721201&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674465 513841253 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492784 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c2Nc2ccccc2)CC12CCC2 InChI=1S/C32H30F3N5O2/c1-40-31(42)27-24(18-32(40)13-5-14-32)38-28(29(27)37-22-6-3-2-4-7-22)20-12-15-36-26(16-20)39-30(41)23(17-25(34)35)19-8-10-21(33)11-9-19/h2-4,6-12,15-16,23,25,37-38H,5,13-14,17-18H2,1H3,(H,36,39,41) CFRUQBGKKYVHHQ-UHFFFAOYSA-N 721201 N-[4-(3'-anilino-5'-methyl-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 160 Casein kinase I isoform alpha Homo sapiens 27.2 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721201 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721201&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674465 513841253 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492785 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c2Nc2ccccc2)CC12CCC2 InChI=1S/C32H30F3N5O2/c1-40-31(42)27-24(18-32(40)13-5-14-32)38-28(29(27)37-22-6-3-2-4-7-22)20-12-15-36-26(16-20)39-30(41)23(17-25(34)35)19-8-10-21(33)11-9-19/h2-4,6-12,15-16,23,25,37-38H,5,13-14,17-18H2,1H3,(H,36,39,41) CFRUQBGKKYVHHQ-UHFFFAOYSA-N 721202 (−)-N-[4-(3'-anilino-5'-methyl-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 161 Casein kinase I isoform alpha Homo sapiens 342 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721202 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721202&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674465 513841254 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492786 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c2Nc2ccccc2)CC12CCC2 InChI=1S/C32H30F3N5O2/c1-40-31(42)27-24(18-32(40)13-5-14-32)38-28(29(27)37-22-6-3-2-4-7-22)20-12-15-36-26(16-20)39-30(41)23(17-25(34)35)19-8-10-21(33)11-9-19/h2-4,6-12,15-16,23,25,37-38H,5,13-14,17-18H2,1H3,(H,36,39,41) CFRUQBGKKYVHHQ-UHFFFAOYSA-N 721202 (−)-N-[4-(3'-anilino-5'-methyl-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 161 Casein kinase I isoform delta Homo sapiens 360 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721202 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721202&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674465 513841254 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492787 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c2Nc2ccccc2)CC12CCC2 InChI=1S/C32H30F3N5O2/c1-40-31(42)27-24(18-32(40)13-5-14-32)38-28(29(27)37-22-6-3-2-4-7-22)20-12-15-36-26(16-20)39-30(41)23(17-25(34)35)19-8-10-21(33)11-9-19/h2-4,6-12,15-16,23,25,37-38H,5,13-14,17-18H2,1H3,(H,36,39,41) CFRUQBGKKYVHHQ-UHFFFAOYSA-N 721202 (−)-N-[4-(3'-anilino-5'-methyl-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 161 Casein kinase I isoform alpha Homo sapiens >20000 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721202 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721202&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674465 513841254 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492788 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c2Nc2ccccc2)CC12CCC2 InChI=1S/C32H30F3N5O2/c1-40-31(42)27-24(18-32(40)13-5-14-32)38-28(29(27)37-22-6-3-2-4-7-22)20-12-15-36-26(16-20)39-30(41)23(17-25(34)35)19-8-10-21(33)11-9-19/h2-4,6-12,15-16,23,25,37-38H,5,13-14,17-18H2,1H3,(H,36,39,41) CFRUQBGKKYVHHQ-UHFFFAOYSA-N 721203 (+)-N-[4-(3'-anilino-5'-methyl-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 162 Casein kinase I isoform alpha Homo sapiens 60.2 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721203 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721203&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674465 513841255 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492789 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c2Nc2ccccc2)CC12CCC2 InChI=1S/C32H30F3N5O2/c1-40-31(42)27-24(18-32(40)13-5-14-32)38-28(29(27)37-22-6-3-2-4-7-22)20-12-15-36-26(16-20)39-30(41)23(17-25(34)35)19-8-10-21(33)11-9-19/h2-4,6-12,15-16,23,25,37-38H,5,13-14,17-18H2,1H3,(H,36,39,41) CFRUQBGKKYVHHQ-UHFFFAOYSA-N 721203 (+)-N-[4-(3'-anilino-5'-methyl-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 162 Casein kinase I isoform delta Homo sapiens 52.9 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721203 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721203&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674465 513841255 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492790 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c2Nc2ccccc2)CC12CCC2 InChI=1S/C32H30F3N5O2/c1-40-31(42)27-24(18-32(40)13-5-14-32)38-28(29(27)37-22-6-3-2-4-7-22)20-12-15-36-26(16-20)39-30(41)23(17-25(34)35)19-8-10-21(33)11-9-19/h2-4,6-12,15-16,23,25,37-38H,5,13-14,17-18H2,1H3,(H,36,39,41) CFRUQBGKKYVHHQ-UHFFFAOYSA-N 721203 (+)-N-[4-(3'-anilino-5'-methyl-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 162 Casein kinase I isoform alpha Homo sapiens 61.4 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721203 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721203&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674465 513841255 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492791 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4c(F)cc(F)cc4F)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C27H22F3N5O2/c1-35-10-8-21-24(27(35)37)26(32-17-5-3-2-4-6-17)25(33-21)15-7-9-31-22(11-15)34-23(36)14-18-19(29)12-16(28)13-20(18)30/h2-7,9,11-13,32-33H,8,10,14H2,1H3,(H,31,34,36) JIEXEDGFFBGAIL-UHFFFAOYSA-N 721204 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(2,4,6-trifluorophenyl)acetamide::US12227501, Example 164 Casein kinase I isoform alpha Homo sapiens 3.83 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721204 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721204&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674285 513841256 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492792 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4c(F)cc(F)cc4F)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C27H22F3N5O2/c1-35-10-8-21-24(27(35)37)26(32-17-5-3-2-4-6-17)25(33-21)15-7-9-31-22(11-15)34-23(36)14-18-19(29)12-16(28)13-20(18)30/h2-7,9,11-13,32-33H,8,10,14H2,1H3,(H,31,34,36) JIEXEDGFFBGAIL-UHFFFAOYSA-N 721204 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(2,4,6-trifluorophenyl)acetamide::US12227501, Example 164 Casein kinase I isoform delta Homo sapiens 3.08 US Patent 10.7270/Q21C22F4 aid2061067 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721204 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721204&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 154674285 513841256 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1492793 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4c(F)cc(F)cc4F)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C27H22F3N5O2/c1-35-10-8-21-24(27(35)37)26(32-17-5-3-2-4-6-17)25(33-21)15-7-9-31-22(11-15)34-23(36)14-18-19(29)12-16(28)13-20(18)30/h2-7,9,11-13,32-33H,8,10,14H2,1H3,(H,31,34,36) JIEXEDGFFBGAIL-UHFFFAOYSA-N 721204 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(2,4,6-trifluorophenyl)acetamide::US12227501, Example 164 Casein kinase I isoform alpha Homo sapiens 149 US Patent 10.7270/Q21C22F4 aid2061068 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721204 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721204&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 154674285 513841256 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492794 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C27H24FN5O2/c1-33-14-12-21-24(27(33)35)26(30-20-5-3-2-4-6-20)25(31-21)18-11-13-29-22(16-18)32-23(34)15-17-7-9-19(28)10-8-17/h2-11,13,16,30-31H,12,14-15H2,1H3,(H,29,32,34) AFSLPDXBYRNVPE-UHFFFAOYSA-N 721030 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 1 Epidermal growth factor receptor [669-1210] 1200 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721030 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721030&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674350 513841082 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492795 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccccc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C27H25N5O2/c1-32-15-13-21-24(27(32)34)26(29-20-10-6-3-7-11-20)25(30-21)19-12-14-28-22(17-19)31-23(33)16-18-8-4-2-5-9-18/h2-12,14,17,29-30H,13,15-16H2,1H3,(H,28,31,33) NCIGMDJBHNIAJD-UHFFFAOYSA-N 721045 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-phenylacetamide::US12227501, Example 2 Epidermal growth factor receptor [669-1210] 1170 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721045 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721045&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674295 513841097 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492796 Cc1cc(CC(=O)Nc2cc(-c3[nH]c4c(c3Nc3ccccc3)C(=O)N(C)CC4)ccn2)ccc1F InChI=1S/C28H26FN5O2/c1-17-14-18(8-9-21(17)29)15-24(35)33-23-16-19(10-12-30-23)26-27(31-20-6-4-3-5-7-20)25-22(32-26)11-13-34(2)28(25)36/h3-10,12,14,16,31-32H,11,13,15H2,1-2H3,(H,30,33,35) PUKUDMLAYTVLDN-UHFFFAOYSA-N 721046 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluoro-3-methylphenyl)acetamide::US12227501, Example 3 Epidermal growth factor receptor [669-1210] 2130 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721046 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721046&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674271 513841098 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492797 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C28H26FN5O2/c1-17(18-8-10-20(29)11-9-18)27(35)33-23-16-19(12-14-30-23)25-26(31-21-6-4-3-5-7-21)24-22(32-25)13-15-34(2)28(24)36/h3-12,14,16-17,31-32H,13,15H2,1-2H3,(H,30,33,35) UYAQWCZWVIFRCN-UHFFFAOYSA-N 721047 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide::US12227501, Example 4 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721047 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721047&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674286 513841099 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492798 C[C@H](C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C28H26FN5O2/c1-17(18-8-10-20(29)11-9-18)27(35)33-23-16-19(12-14-30-23)25-26(31-21-6-4-3-5-7-21)24-22(32-25)13-15-34(2)28(24)36/h3-12,14,16-17,31-32H,13,15H2,1-2H3,(H,30,33,35) UYAQWCZWVIFRCN-UHFFFAOYSA-N 721048 (2S)—N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Stereoisomer 1)::US12227501, Example 5 Epidermal growth factor receptor [669-1210] 14400 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721048 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721048&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674384 513841100 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492799 C[C@@H](C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C28H26FN5O2/c1-17(18-8-10-20(29)11-9-18)27(35)33-23-16-19(12-14-30-23)25-26(31-21-6-4-3-5-7-21)24-22(32-25)13-15-34(2)28(24)36/h3-12,14,16-17,31-32H,13,15H2,1-2H3,(H,30,33,35) UYAQWCZWVIFRCN-UHFFFAOYSA-N 721049 (2R)—N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Stereoisomer 2)::US12227501, Example 6 Epidermal growth factor receptor [669-1210] 16100 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721049 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721049&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674407 513841101 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492800 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C2CC2)CC3)ccn1 InChI=1S/C29H26FN5O2/c30-20-8-6-18(7-9-20)16-25(36)34-24-17-19(12-14-31-24)27-28(32-21-4-2-1-3-5-21)26-23(33-27)13-15-35(29(26)37)22-10-11-22/h1-9,12,14,17,22,32-33H,10-11,13,15-16H2,(H,31,34,36) HUWCGRYLNBSQLN-UHFFFAOYSA-N 721050 N-[4-(3-anilino-5-cyclopropyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 7 Epidermal growth factor receptor [669-1210] 2740 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721050 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721050&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674329 513841102 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492801 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C2CC2)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C30H28FN5O2/c1-18(19-7-9-21(31)10-8-19)29(37)35-25-17-20(13-15-32-25)27-28(33-22-5-3-2-4-6-22)26-24(34-27)14-16-36(30(26)38)23-11-12-23/h2-10,13,15,17-18,23,33-34H,11-12,14,16H2,1H3,(H,32,35,37) KAPROIFCQLMDFT-UHFFFAOYSA-N 721051 N-[4-(3-anilino-5-cyclopropyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide::US12227501, Example 8 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721051 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721051&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674409 513841103 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492802 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NCC3)ccn1)c1ccc(F)cc1 InChI=1S/C27H24FN5O2/c1-16(17-7-9-19(28)10-8-17)26(34)33-22-15-18(11-13-29-22)24-25(31-20-5-3-2-4-6-20)23-21(32-24)12-14-30-27(23)35/h2-11,13,15-16,31-32H,12,14H2,1H3,(H,30,35)(H,29,33,34) UMQXUQDUPKDQIR-UHFFFAOYSA-N 721052 N-[4-(3-anilino-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Stereoisomer 1)::US12227501, Example 10 Epidermal growth factor receptor [669-1210] 12400 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721052 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721052&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674250 513841104 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492803 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NCC3)ccn1)c1ccc(F)cc1 InChI=1S/C27H24FN5O2/c1-16(17-7-9-19(28)10-8-17)26(34)33-22-15-18(11-13-29-22)24-25(31-20-5-3-2-4-6-20)23-21(32-24)12-14-30-27(23)35/h2-11,13,15-16,31-32H,12,14H2,1H3,(H,30,35)(H,29,33,34) UMQXUQDUPKDQIR-UHFFFAOYSA-N 721053 N-[4-(3-anilino-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Stereoisomer 2)::US12227501, Example 11 Epidermal growth factor receptor [669-1210] 2290 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721053&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674250 513841105 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492804 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccn3)c2C1=O InChI=1S/C26H23FN6O2/c1-33-13-10-19-23(26(33)35)25(32-20-4-2-3-11-28-20)24(30-19)17-9-12-29-21(15-17)31-22(34)14-16-5-7-18(27)8-6-16/h2-9,11-12,15,30H,10,13-14H2,1H3,(H,28,32)(H,29,31,34) GUNUORYXEAKXIM-UHFFFAOYSA-N 721054 2-(4-fluorophenyl)-N-(4-{5-methyl-4-oxo-3-[(pyridin-2-yl)amino]-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl}pyridin-2-yl)acetamide::US12227501, Example 12 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721054 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721054&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674326 513841106 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492805 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2Cl)C(=O)NCC3)ccn1 InChI=1S/C26H21ClFN5O2/c27-18-3-1-2-4-19(18)31-25-23-20(10-12-30-26(23)35)32-24(25)16-9-11-29-21(14-16)33-22(34)13-15-5-7-17(28)8-6-15/h1-9,11,14,31-32H,10,12-13H2,(H,30,35)(H,29,33,34) CNNUFNBSGQUOFZ-UHFFFAOYSA-N 721055 N-{4-[3-(2-chloroanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 13 Epidermal growth factor receptor [669-1210] 1050 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721055 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721055&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674269 513841107 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492806 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2Cl)C(=O)NCC3)ccn1)c1ccc(F)cc1 InChI=1S/C27H23ClFN5O2/c1-15(16-6-8-18(29)9-7-16)26(35)34-22-14-17(10-12-30-22)24-25(32-20-5-3-2-4-19(20)28)23-21(33-24)11-13-31-27(23)36/h2-10,12,14-15,32-33H,11,13H2,1H3,(H,31,36)(H,30,34,35) CDPQTBTYURAFME-UHFFFAOYSA-N 721056 N-{4-[3-(2-chloroanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide::US12227501, Example 14 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721056 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721056&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674290 513841108 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492807 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2Cl)C(=O)NCC3)ccn1)c1ccc(F)cc1 InChI=1S/C27H23ClFN5O2/c1-15(16-6-8-18(29)9-7-16)26(35)34-22-14-17(10-12-30-22)24-25(32-20-5-3-2-4-19(20)28)23-21(33-24)11-13-31-27(23)36/h2-10,12,14-15,32-33H,11,13H2,1H3,(H,31,36)(H,30,34,35) CDPQTBTYURAFME-UHFFFAOYSA-N 721057 N-{4-[3-(2-chloroanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Stereoisomer 1)::US12227501, Example 15 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721057 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721057&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674290 513841109 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492808 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2Cl)C(=O)NCC3)ccn1)c1ccc(F)cc1 InChI=1S/C27H23ClFN5O2/c1-15(16-6-8-18(29)9-7-16)26(35)34-22-14-17(10-12-30-22)24-25(32-20-5-3-2-4-19(20)28)23-21(33-24)11-13-31-27(23)36/h2-10,12,14-15,32-33H,11,13H2,1H3,(H,31,36)(H,30,34,35) CDPQTBTYURAFME-UHFFFAOYSA-N 721058 N-{4-[3-(2-chloroanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Stereoisomer 2)::US12227501, Example 16 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721058 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721058&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674290 513841110 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492809 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CO)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H26FN5O3/c1-34-14-12-22-24(28(34)37)26(31-20-5-3-2-4-6-20)25(32-22)18-11-13-30-23(15-18)33-27(36)21(16-35)17-7-9-19(29)10-8-17/h2-11,13,15,21,31-32,35H,12,14,16H2,1H3,(H,30,33,36) DUYUPVFZOHBSBS-UHFFFAOYSA-N 721059 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)-3-hydroxypropanamide::US12227501, Example 17 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721059 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721059&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674501 513841111 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492810 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CO)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H26FN5O3/c1-34-14-12-22-24(28(34)37)26(31-20-5-3-2-4-6-20)25(32-22)18-11-13-30-23(15-18)33-27(36)21(16-35)17-7-9-19(29)10-8-17/h2-11,13,15,21,31-32,35H,12,14,16H2,1H3,(H,30,33,36) DUYUPVFZOHBSBS-UHFFFAOYSA-N 721060 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)-3-hydroxypropanamide (Stereoisomer 1)::US12227501, Example 18 Epidermal growth factor receptor [669-1210] 14900 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721060 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721060&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674501 513841112 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492811 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CO)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H26FN5O3/c1-34-14-12-22-24(28(34)37)26(31-20-5-3-2-4-6-20)25(32-22)18-11-13-30-23(15-18)33-27(36)21(16-35)17-7-9-19(29)10-8-17/h2-11,13,15,21,31-32,35H,12,14,16H2,1H3,(H,30,33,36) DUYUPVFZOHBSBS-UHFFFAOYSA-N 721061 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)-3-hydroxypropanamide (Stereoisomer 2)::US12227501, Example 19 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721061 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721061&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674501 513841113 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492812 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(CC2CC2)CC3)ccn1 InChI=1S/C30H28FN5O2/c31-22-10-8-19(9-11-22)16-26(37)35-25-17-21(12-14-32-25)28-29(33-23-4-2-1-3-5-23)27-24(34-28)13-15-36(30(27)38)18-20-6-7-20/h1-5,8-12,14,17,20,33-34H,6-7,13,15-16,18H2,(H,32,35,37) BYINJOSWODJSOV-UHFFFAOYSA-N 721062 N-{4-[3-anilino-5-(cyclopropylmethyl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 20 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721062 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721062&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674372 513841114 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492813 CCN1CCc2[nH]c(-c3ccnc(NC(=O)C(C)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H28FN5O2/c1-3-35-16-14-23-25(29(35)37)27(32-22-7-5-4-6-8-22)26(33-23)20-13-15-31-24(17-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-13,15,17-18,32-33H,3,14,16H2,1-2H3,(H,31,34,36) BZFZAOWFYOKWDA-UHFFFAOYSA-N 721063 N-[4-(3-anilino-5-ethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide::US12227501, Example 21 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721063 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721063&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674374 513841115 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492814 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C28H26FN5O2/c1-28(2)16-21-24(27(36)34-28)26(31-20-6-4-3-5-7-20)25(32-21)18-12-13-30-22(15-18)33-23(35)14-17-8-10-19(29)11-9-17/h3-13,15,31-32H,14,16H2,1-2H3,(H,34,36)(H,30,33,35) DIBZPOAEDBOEEZ-UHFFFAOYSA-N 721064 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 22 Epidermal growth factor receptor [669-1210] 815 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721064 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721064&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674495 513841116 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492815 CC(C)(O)CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C30H30FN5O3/c1-30(2,39)18-36-15-13-23-26(29(36)38)28(33-22-6-4-3-5-7-22)27(34-23)20-12-14-32-24(17-20)35-25(37)16-19-8-10-21(31)11-9-19/h3-12,14,17,33-34,39H,13,15-16,18H2,1-2H3,(H,32,35,37) HRJDYJVDFILFKO-UHFFFAOYSA-N 721065 N-{4-[3-anilino-5-(2-hydroxy-2-methylpropyl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 23 Epidermal growth factor receptor [669-1210] 7280 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721065 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721065&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674305 513841117 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492816 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(CC(C)(C)O)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C31H32FN5O3/c1-19(20-9-11-22(32)12-10-20)29(38)36-25-17-21(13-15-33-25)27-28(34-23-7-5-4-6-8-23)26-24(35-27)14-16-37(30(26)39)18-31(2,3)40/h4-13,15,17,19,34-35,40H,14,16,18H2,1-3H3,(H,33,36,38) GQYLIQAEIRWFEC-UHFFFAOYSA-N 721066 N-{4-[3-anilino-5-(2-hydroxy-2-methylpropyl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide::US12227501, Example 24 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721066 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721066&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674478 513841118 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492817 CCN1CCc2[nH]c(-c3ccnc(NC(=O)C(C)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H28FN5O2/c1-3-35-16-14-23-25(29(35)37)27(32-22-7-5-4-6-8-22)26(33-23)20-13-15-31-24(17-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-13,15,17-18,32-33H,3,14,16H2,1-2H3,(H,31,34,36) BZFZAOWFYOKWDA-UHFFFAOYSA-N 721067 N-[4-(3-anilino-5-ethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 1)::US12227501, Example 25 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721067 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721067&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674374 513841119 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492818 CCN1CCc2[nH]c(-c3ccnc(NC(=O)C(C)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H28FN5O2/c1-3-35-16-14-23-25(29(35)37)27(32-22-7-5-4-6-8-22)26(33-23)20-13-15-31-24(17-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-13,15,17-18,32-33H,3,14,16H2,1-2H3,(H,31,34,36) BZFZAOWFYOKWDA-UHFFFAOYSA-N 721068 N-[4-(3-anilino-5-ethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 2)::US12227501, Example 26 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721068 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721068&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674374 513841120 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492819 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NC(C)(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17(18-9-11-20(30)12-10-18)27(36)34-23-15-19(13-14-31-23)25-26(32-21-7-5-4-6-8-21)24-22(33-25)16-29(2,3)35-28(24)37/h4-15,17,32-33H,16H2,1-3H3,(H,35,37)(H,31,34,36) KOFPMBNUPXOKAY-UHFFFAOYSA-N 721069 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide::US12227501, Example 27 Epidermal growth factor receptor [669-1210] 18000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721069 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721069&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674352 513841121 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492820 CCN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H26FN5O2/c1-2-34-15-13-22-25(28(34)36)27(31-21-6-4-3-5-7-21)26(32-22)19-12-14-30-23(17-19)33-24(35)16-18-8-10-20(29)11-9-18/h3-12,14,17,31-32H,2,13,15-16H2,1H3,(H,30,33,35) ZSGYTKAQRWJXFD-UHFFFAOYSA-N 721070 N-[4-(3-anilino-5-ethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 28 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721070 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721070&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674303 513841122 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492821 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2F)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C28H25F2N5O2/c1-16(17-7-9-19(29)10-8-17)27(36)34-23-15-18(11-13-31-23)25-26(32-21-6-4-3-5-20(21)30)24-22(33-25)12-14-35(2)28(24)37/h3-11,13,15-16,32-33H,12,14H2,1-2H3,(H,31,34,36) LWQRCWSAGSPNNW-UHFFFAOYSA-N 721071 N-{4-[3-(2-fluoroanilino)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide::US12227501, Example 29 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721071 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721071&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674480 513841123 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492822 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CCN4CCOCC4)c4ccccc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C33H36N6O3/c1-38-16-14-27-29(33(38)41)31(35-25-10-6-3-7-11-25)30(36-27)24-12-15-34-28(22-24)37-32(40)26(23-8-4-2-5-9-23)13-17-39-18-20-42-21-19-39/h2-12,15,22,26,35-36H,13-14,16-21H2,1H3,(H,34,37,40) XGFIIXQAEJTAHR-UHFFFAOYSA-N 721072 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4-(morpholin-4-yl)-2-phenylbutanamide::US12227501, Example 30 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721072 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721072&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674440 513841124 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492823 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CCN4CCOCC4)c4ccccc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C33H36N6O3/c1-38-16-14-27-29(33(38)41)31(35-25-10-6-3-7-11-25)30(36-27)24-12-15-34-28(22-24)37-32(40)26(23-8-4-2-5-9-23)13-17-39-18-20-42-21-19-39/h2-12,15,22,26,35-36H,13-14,16-21H2,1H3,(H,34,37,40) XGFIIXQAEJTAHR-UHFFFAOYSA-N 721073 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4-(morpholin-4-yl)-2-phenylbutanamide, (Stereoisomer 1)::US12227501, Example 31 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721073 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721073&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674440 513841125 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492824 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CCN4CCOCC4)c4ccccc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C33H36N6O3/c1-38-16-14-27-29(33(38)41)31(35-25-10-6-3-7-11-25)30(36-27)24-12-15-34-28(22-24)37-32(40)26(23-8-4-2-5-9-23)13-17-39-18-20-42-21-19-39/h2-12,15,22,26,35-36H,13-14,16-21H2,1H3,(H,34,37,40) XGFIIXQAEJTAHR-UHFFFAOYSA-N 721074 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4-(morpholin-4-yl)-2-phenylbutanamide, (Stereoisomer 2)::US12227501, Example 32 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721074 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721074&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674440 513841126 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492825 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccccc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H27F2N5O2/c1-36-15-13-22-25(29(36)38)27(33-20-10-6-3-7-11-20)26(34-22)19-12-14-32-24(16-19)35-28(37)21(17-23(30)31)18-8-4-2-5-9-18/h2-12,14,16,21,23,33-34H,13,15,17H2,1H3,(H,32,35,37) AKGWIZHTFUPWKX-UHFFFAOYSA-N 721075 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-phenylbutanamide::US12227501, Example 33 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721075 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721075&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674389 513841127 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492826 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccccc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H27F2N5O2/c1-36-15-13-22-25(29(36)38)27(33-20-10-6-3-7-11-20)26(34-22)19-12-14-32-24(16-19)35-28(37)21(17-23(30)31)18-8-4-2-5-9-18/h2-12,14,16,21,23,33-34H,13,15,17H2,1H3,(H,32,35,37) AKGWIZHTFUPWKX-UHFFFAOYSA-N 721076 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-phenylbutanamide, (Stereoisomer 1)::US12227501, Example 34 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721076 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721076&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674389 513841128 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492827 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccccc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H27F2N5O2/c1-36-15-13-22-25(29(36)38)27(33-20-10-6-3-7-11-20)26(34-22)19-12-14-32-24(16-19)35-28(37)21(17-23(30)31)18-8-4-2-5-9-18/h2-12,14,16,21,23,33-34H,13,15,17H2,1H3,(H,32,35,37) AKGWIZHTFUPWKX-UHFFFAOYSA-N 721077 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-phenylbutanamide, (Stereoisomer 2)::US12227501, Example 35 Epidermal growth factor receptor [669-1210] 14800 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721077 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721077&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674389 513841129 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492828 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(CC(F)(F)F)CC3)ccn1 InChI=1S/C28H23F4N5O2/c29-19-8-6-17(7-9-19)14-23(38)36-22-15-18(10-12-33-22)25-26(34-20-4-2-1-3-5-20)24-21(35-25)11-13-37(27(24)39)16-28(30,31)32/h1-10,12,15,34-35H,11,13-14,16H2,(H,33,36,38) LLNDXKIYUWEGML-UHFFFAOYSA-N 721078 N-{4-[3-anilino-4-oxo-5-(2,2,2-trifluoroethyl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 36 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721078 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721078&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674274 513841130 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492829 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(CC(F)(F)F)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C29H25F4N5O2/c1-17(18-7-9-20(30)10-8-18)27(39)37-23-15-19(11-13-34-23)25-26(35-21-5-3-2-4-6-21)24-22(36-25)12-14-38(28(24)40)16-29(31,32)33/h2-11,13,15,17,35-36H,12,14,16H2,1H3,(H,34,37,39) YBEISSBKQZYBNE-UHFFFAOYSA-N 721079 N-{4-[3-anilino-4-oxo-5-(2,2,2-trifluoroethyl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide::US12227501, Example 37 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721079 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721079&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674402 513841131 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492830 CN(C)CCC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccccc1 InChI=1S/C31H34N6O2/c1-36(2)18-15-24(21-10-6-4-7-11-21)30(38)35-26-20-22(14-17-32-26)28-29(33-23-12-8-5-9-13-23)27-25(34-28)16-19-37(3)31(27)39/h4-14,17,20,24,33-34H,15-16,18-19H2,1-3H3,(H,32,35,38) PWVRJUMBGYGGEW-UHFFFAOYSA-N 721080 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4-(dimethylamino)-2-phenylbutanamide::US12227501, Example 38 Epidermal growth factor receptor [669-1210] 6690 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721080 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721080&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674499 513841132 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492831 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NC(C)(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17(18-9-11-20(30)12-10-18)27(36)34-23-15-19(13-14-31-23)25-26(32-21-7-5-4-6-8-21)24-22(33-25)16-29(2,3)35-28(24)37/h4-15,17,32-33H,16H2,1-3H3,(H,35,37)(H,31,34,36) KOFPMBNUPXOKAY-UHFFFAOYSA-N 721081 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 1)::US12227501, Example 39 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721081 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721081&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674352 513841133 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492832 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NC(C)(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17(18-9-11-20(30)12-10-18)27(36)34-23-15-19(13-14-31-23)25-26(32-21-7-5-4-6-8-21)24-22(33-25)16-29(2,3)35-28(24)37/h4-15,17,32-33H,16H2,1-3H3,(H,35,37)(H,31,34,36) KOFPMBNUPXOKAY-UHFFFAOYSA-N 721082 (+)-N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 2)::US12227501, Example 40 Epidermal growth factor receptor [669-1210] 141 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721082 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721082&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674352 513841134 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492833 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2F)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C28H25F2N5O2/c1-16(17-7-9-19(29)10-8-17)27(36)34-23-15-18(11-13-31-23)25-26(32-21-6-4-3-5-20(21)30)24-22(33-25)12-14-35(2)28(24)37/h3-11,13,15-16,32-33H,12,14H2,1-2H3,(H,31,34,36) LWQRCWSAGSPNNW-UHFFFAOYSA-N 721083 (−)-N-{4-[3-(2-fluoroanilino)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Enantiomer 1)::US12227501, Example 41 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721083 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721083&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674480 513841135 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492834 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2F)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C28H25F2N5O2/c1-16(17-7-9-19(29)10-8-17)27(36)34-23-15-18(11-13-31-23)25-26(32-21-6-4-3-5-20(21)30)24-22(33-25)12-14-35(2)28(24)37/h3-11,13,15-16,32-33H,12,14H2,1-2H3,(H,31,34,36) LWQRCWSAGSPNNW-UHFFFAOYSA-N 721084 N-{4-[3-(2-fluoroanilino)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Enantiomer 2)::US12227501, Example 42 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721084 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721084&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674480 513841136 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492835 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NC(C(F)(F)F)C3)ccn1 InChI=1S/C27H21F4N5O2/c28-17-8-6-15(7-9-17)12-22(37)36-21-13-16(10-11-32-21)24-25(33-18-4-2-1-3-5-18)23-19(34-24)14-20(27(29,30)31)35-26(23)38/h1-11,13,20,33-34H,12,14H2,(H,35,38)(H,32,36,37) ATSAULVLXRFCAQ-UHFFFAOYSA-N 721085 N-{4-[3-anilino-4-oxo-6-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Racemate)::US12227501, Example 43 Epidermal growth factor receptor [669-1210] 2000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721085 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721085&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674255 513841137 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492836 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c2Nc2ccccc2)CC1(C)C InChI=1S/C29H28FN5O2/c1-29(2)17-22-25(28(37)35(29)3)27(32-21-7-5-4-6-8-21)26(33-22)19-13-14-31-23(16-19)34-24(36)15-18-9-11-20(30)12-10-18/h4-14,16,32-33H,15,17H2,1-3H3,(H,31,34,36) DSVNYHIVOUUYFJ-UHFFFAOYSA-N 721086 N-[4-(3-anilino-5,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 44 Epidermal growth factor receptor [669-1210] 4140 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721086 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721086&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674448 513841138 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492837 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c2Nc2ccccc2F)CC1(C)C InChI=1S/C31H29F4N5O2/c1-31(2)16-23-26(30(42)40(31)3)28(37-22-7-5-4-6-21(22)33)27(38-23)18-12-13-36-25(14-18)39-29(41)20(15-24(34)35)17-8-10-19(32)11-9-17/h4-14,20,24,37-38H,15-16H2,1-3H3,(H,36,39,41) YUGAWPXFORPIGO-UHFFFAOYSA-N 721087 4,4-difluoro-N-{4-[3-(2-fluoroanilino)-5,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 45 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721087 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721087&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674505 513841139 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492838 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c2Nc2ccccc2F)CC1(C)C InChI=1S/C31H29F4N5O2/c1-31(2)16-23-26(30(42)40(31)3)28(37-22-7-5-4-6-21(22)33)27(38-23)18-12-13-36-25(14-18)39-29(41)20(15-24(34)35)17-8-10-19(32)11-9-17/h4-14,20,24,37-38H,15-16H2,1-3H3,(H,36,39,41) YUGAWPXFORPIGO-UHFFFAOYSA-N 721088 4,4-difluoro-N-{4-[3-(2-fluoroanilino)-5,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 46 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721088 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721088&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674505 513841140 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492839 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c2Nc2ccccc2F)CC1(C)C InChI=1S/C31H29F4N5O2/c1-31(2)16-23-26(30(42)40(31)3)28(37-22-7-5-4-6-21(22)33)27(38-23)18-12-13-36-25(14-18)39-29(41)20(15-24(34)35)17-8-10-19(32)11-9-17/h4-14,20,24,37-38H,15-16H2,1-3H3,(H,36,39,41) YUGAWPXFORPIGO-UHFFFAOYSA-N 721089 4,4-difluoro-N-{4-[3-(2-fluoroanilino)-5,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 47 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721089 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721089&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674505 513841141 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492840 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C30H28F3N5O2/c1-30(2)16-22-25(29(40)38-30)27(35-20-6-4-3-5-7-20)26(36-22)18-12-13-34-24(14-18)37-28(39)21(15-23(32)33)17-8-10-19(31)11-9-17/h3-14,21,23,35-36H,15-16H2,1-2H3,(H,38,40)(H,34,37,39) KKRDXOPMQOYAGZ-UHFFFAOYSA-N 721090 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 48 Epidermal growth factor receptor [669-1210] 14500 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721090 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721090&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674360 513841142 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492841 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C30H28F3N5O2/c1-30(2)16-22-25(29(40)38-30)27(35-20-6-4-3-5-7-20)26(36-22)18-12-13-34-24(14-18)37-28(39)21(15-23(32)33)17-8-10-19(31)11-9-17/h3-14,21,23,35-36H,15-16H2,1-2H3,(H,38,40)(H,34,37,39) KKRDXOPMQOYAGZ-UHFFFAOYSA-N 721091 (+)-N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 49 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721091 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721091&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674360 513841143 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492842 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C30H28F3N5O2/c1-30(2)16-22-25(29(40)38-30)27(35-20-6-4-3-5-7-20)26(36-22)18-12-13-34-24(14-18)37-28(39)21(15-23(32)33)17-8-10-19(31)11-9-17/h3-14,21,23,35-36H,15-16H2,1-2H3,(H,38,40)(H,34,37,39) KKRDXOPMQOYAGZ-UHFFFAOYSA-N 721092 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 50 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721092 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721092&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674360 513841144 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492843 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccncc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C27H26N6O2/c1-27(2)16-20-23(26(35)33-27)25(30-19-6-4-3-5-7-19)24(31-20)18-10-13-29-21(15-18)32-22(34)14-17-8-11-28-12-9-17/h3-13,15,30-31H,14,16H2,1-2H3,(H,33,35)(H,29,32,34) IJUJMMPOXXBQCM-UHFFFAOYSA-N 721093 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-4-yl)acetamide::US12227501, Example 51 Epidermal growth factor receptor [669-1210] 563 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721093 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721093&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674359 513841145 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492844 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4cccnc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C27H26N6O2/c1-27(2)15-20-23(26(35)33-27)25(30-19-8-4-3-5-9-19)24(31-20)18-10-12-29-21(14-18)32-22(34)13-17-7-6-11-28-16-17/h3-12,14,16,30-31H,13,15H2,1-2H3,(H,33,35)(H,29,32,34) WJNUSNNYLBLXMQ-UHFFFAOYSA-N 721094 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-3-yl)acetamide::US12227501, Example 52 Epidermal growth factor receptor [669-1210] 526 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721094 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721094&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674479 513841146 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492845 COCCN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H28FN5O3/c1-38-16-15-35-14-12-23-26(29(35)37)28(32-22-5-3-2-4-6-22)27(33-23)20-11-13-31-24(18-20)34-25(36)17-19-7-9-21(30)10-8-19/h2-11,13,18,32-33H,12,14-17H2,1H3,(H,31,34,36) IJAGJGCELDNCJJ-UHFFFAOYSA-N 721095 N-{4-[3-anilino-5-(2-methoxyethyl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 53 Epidermal growth factor receptor [669-1210] 6030 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721095 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721095&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674256 513841147 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492846 O=C1NC2(CCC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c21 InChI=1S/C31H28F3N5O2/c32-20-9-7-18(8-10-20)22(16-24(33)34)29(40)38-25-15-19(11-14-35-25)27-28(36-21-5-2-1-3-6-21)26-23(37-27)17-31(12-4-13-31)39-30(26)41/h1-3,5-11,14-15,22,24,36-37H,4,12-13,16-17H2,(H,39,41)(H,35,38,40) KIAWAHJOKQOSAO-UHFFFAOYSA-N 721096 N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 54 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721096 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721096&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674435 513841148 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492847 O=C1NC2(CCC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c21 InChI=1S/C31H28F3N5O2/c32-20-9-7-18(8-10-20)22(16-24(33)34)29(40)38-25-15-19(11-14-35-25)27-28(36-21-5-2-1-3-6-21)26-23(37-27)17-31(12-4-13-31)39-30(26)41/h1-3,5-11,14-15,22,24,36-37H,4,12-13,16-17H2,(H,39,41)(H,35,38,40) KIAWAHJOKQOSAO-UHFFFAOYSA-N 721097 (+)-N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 55 Epidermal growth factor receptor [669-1210] 1170 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721097 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721097&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674435 513841149 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492848 O=C1NC2(CCC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c21 InChI=1S/C31H28F3N5O2/c32-20-9-7-18(8-10-20)22(16-24(33)34)29(40)38-25-15-19(11-14-35-25)27-28(36-21-5-2-1-3-6-21)26-23(37-27)17-31(12-4-13-31)39-30(26)41/h1-3,5-11,14-15,22,24,36-37H,4,12-13,16-17H2,(H,39,41)(H,35,38,40) KIAWAHJOKQOSAO-UHFFFAOYSA-N 721098 (−)-N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 56 Epidermal growth factor receptor [669-1210] 857 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721098 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721098&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674435 513841150 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492849 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NC2(CCC2)C3)ccn1 InChI=1S/C29H26FN5O2/c30-20-9-7-18(8-10-20)15-24(36)34-23-16-19(11-14-31-23)26-27(32-21-5-2-1-3-6-21)25-22(33-26)17-29(12-4-13-29)35-28(25)37/h1-3,5-11,14,16,32-33H,4,12-13,15,17H2,(H,35,37)(H,31,34,36) BALRJMDHDGPHTH-UHFFFAOYSA-N 721099 N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 57 Epidermal growth factor receptor [669-1210] 870 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721099 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721099&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674497 513841151 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492850 CN(C)CCCC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccccc1 InChI=1S/C32H36N6O2/c1-37(2)19-10-15-25(22-11-6-4-7-12-22)31(39)36-27-21-23(16-18-33-27)29-30(34-24-13-8-5-9-14-24)28-26(35-29)17-20-38(3)32(28)40/h4-9,11-14,16,18,21,25,34-35H,10,15,17,19-20H2,1-3H3,(H,33,36,39) YCWSXEOEVCQKSE-UHFFFAOYSA-N 721100 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-5-(dimethylamino)-2-phenylpentanamide (Racemate)::US12227501, Example 58 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721100 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721100&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674447 513841152 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492851 CN(C)CCCC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccccc1 InChI=1S/C32H36N6O2/c1-37(2)19-10-15-25(22-11-6-4-7-12-22)31(39)36-27-21-23(16-18-33-27)29-30(34-24-13-8-5-9-14-24)28-26(35-29)17-20-38(3)32(28)40/h4-9,11-14,16,18,21,25,34-35H,10,15,17,19-20H2,1-3H3,(H,33,36,39) YCWSXEOEVCQKSE-UHFFFAOYSA-N 721101 (−)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-5-(dimethylamino)-2-phenylpentanamide (Enantiomer 1)::US12227501, Example 59 Epidermal growth factor receptor [669-1210] 16300 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721101 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721101&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674447 513841153 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492852 CN(C)CCCC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccccc1 InChI=1S/C32H36N6O2/c1-37(2)19-10-15-25(22-11-6-4-7-12-22)31(39)36-27-21-23(16-18-33-27)29-30(34-24-13-8-5-9-14-24)28-26(35-29)17-20-38(3)32(28)40/h4-9,11-14,16,18,21,25,34-35H,10,15,17,19-20H2,1-3H3,(H,33,36,39) YCWSXEOEVCQKSE-UHFFFAOYSA-N 721102 (+)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-5-(dimethylamino)-2-phenylpentanamide (Enantiomer 2)::US12227501, Example 60 Epidermal growth factor receptor [669-1210] 7340 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721102 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721102&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674447 513841154 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492853 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H26F3N5O2/c1-37-14-12-22-25(29(37)39)27(34-20-5-3-2-4-6-20)26(35-22)18-11-13-33-24(15-18)36-28(38)21(16-23(31)32)17-7-9-19(30)10-8-17/h2-11,13,15,21,23,34-35H,12,14,16H2,1H3,(H,33,36,38) IKATWWUGCJFQJV-UHFFFAOYSA-N 721103 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 61 Epidermal growth factor receptor [669-1210] 8020 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721103 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721103&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674383 513841155 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492854 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H26F3N5O2/c1-37-14-12-22-25(29(37)39)27(34-20-5-3-2-4-6-20)26(35-22)18-11-13-33-24(15-18)36-28(38)21(16-23(31)32)17-7-9-19(30)10-8-17/h2-11,13,15,21,23,34-35H,12,14,16H2,1H3,(H,33,36,38) IKATWWUGCJFQJV-UHFFFAOYSA-N 721104 (−)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 62 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721104 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721104&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674383 513841156 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492855 CN1CCc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H26F3N5O2/c1-37-14-12-22-25(29(37)39)27(34-20-5-3-2-4-6-20)26(35-22)18-11-13-33-24(15-18)36-28(38)21(16-23(31)32)17-7-9-19(30)10-8-17/h2-11,13,15,21,23,34-35H,12,14,16H2,1H3,(H,33,36,38) IKATWWUGCJFQJV-UHFFFAOYSA-N 721105 (+)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 63 Epidermal growth factor receptor [669-1210] 6680 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721105 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721105&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674383 513841157 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492856 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccncc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C26H24N6O2/c1-32-14-10-20-23(26(32)34)25(29-19-5-3-2-4-6-19)24(30-20)18-9-13-28-21(16-18)31-22(33)15-17-7-11-27-12-8-17/h2-9,11-13,16,29-30H,10,14-15H2,1H3,(H,28,31,33) OCJNACKDBJHBPG-UHFFFAOYSA-N 721106 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-4-yl)acetamide::US12227501, Example 64 Epidermal growth factor receptor [669-1210] 1200 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721106 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721106&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674306 513841158 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492857 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(S(C)(=O)=O)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H27N5O4S/c1-33-15-13-22-25(28(33)35)27(30-20-6-4-3-5-7-20)26(31-22)19-12-14-29-23(17-19)32-24(34)16-18-8-10-21(11-9-18)38(2,36)37/h3-12,14,17,30-31H,13,15-16H2,1-2H3,(H,29,32,34) GKHICIJKBRWUCL-UHFFFAOYSA-N 721107 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-[4-(methanesulfonyl)phenyl]acetamide::US12227501, Example 65 Epidermal growth factor receptor [669-1210] 490 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721107 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721107&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674277 513841159 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492858 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(C(F)(F)F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H24F3N5O2/c1-36-14-12-21-24(27(36)38)26(33-20-5-3-2-4-6-20)25(34-21)18-11-13-32-22(16-18)35-23(37)15-17-7-9-19(10-8-17)28(29,30)31/h2-11,13,16,33-34H,12,14-15H2,1H3,(H,32,35,37) XQNREAZQMGMBMX-UHFFFAOYSA-N 721108 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-[4-(trifluoromethyl)phenyl]acetamide::US12227501, Example 66 Epidermal growth factor receptor [669-1210] 8550 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721108 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721108&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674427 513841160 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492859 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4cccnc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C26H24N6O2/c1-32-13-10-20-23(26(32)34)25(29-19-7-3-2-4-8-19)24(30-20)18-9-12-28-21(15-18)31-22(33)14-17-6-5-11-27-16-17/h2-9,11-12,15-16,29-30H,10,13-14H2,1H3,(H,28,31,33) MRRGNSSCHWNURS-UHFFFAOYSA-N 721109 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-3-yl)acetamide::US12227501, Example 67 Epidermal growth factor receptor [669-1210] 997 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721109 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721109&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674323 513841161 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492860 Cc1ccc(CC(=O)Nc2cc(-c3[nH]c4c(c3Nc3ccccc3)C(=O)N(C)CC4)ccn2)cc1 InChI=1S/C28H27N5O2/c1-18-8-10-19(11-9-18)16-24(34)32-23-17-20(12-14-29-23)26-27(30-21-6-4-3-5-7-21)25-22(31-26)13-15-33(2)28(25)35/h3-12,14,17,30-31H,13,15-16H2,1-2H3,(H,29,32,34) ILZYLHZIAQJQGN-UHFFFAOYSA-N 721110 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-methylphenyl)acetamide::US12227501, Example 68 Epidermal growth factor receptor [669-1210] 2100 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721110 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721110&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674412 513841162 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492861 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4cccc(S(C)(=O)=O)c4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H27N5O4S/c1-33-14-12-22-25(28(33)35)27(30-20-8-4-3-5-9-20)26(31-22)19-11-13-29-23(17-19)32-24(34)16-18-7-6-10-21(15-18)38(2,36)37/h3-11,13,15,17,30-31H,12,14,16H2,1-2H3,(H,29,32,34) JQPFYUYZGQPQOZ-UHFFFAOYSA-N 721111 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-[3-(methanesulfonyl)phenyl]acetamide::US12227501, Example 69 Epidermal growth factor receptor [669-1210] 510 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721111 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721111&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674297 513841163 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492862 Cc1cccc(CC(=O)Nc2cc(-c3[nH]c4c(c3Nc3ccccc3)C(=O)N(C)CC4)ccn2)c1 InChI=1S/C28H27N5O2/c1-18-7-6-8-19(15-18)16-24(34)32-23-17-20(11-13-29-23)26-27(30-21-9-4-3-5-10-21)25-22(31-26)12-14-33(2)28(25)35/h3-11,13,15,17,30-31H,12,14,16H2,1-2H3,(H,29,32,34) UUSCGSSISCGHIZ-UHFFFAOYSA-N 721112 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(3-methylphenyl)acetamide::US12227501, Example 70 Epidermal growth factor receptor [669-1210] 2040 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721112 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721112&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674369 513841164 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492863 Cc1ccccc1CC(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1 InChI=1S/C28H27N5O2/c1-18-8-6-7-9-19(18)17-24(34)32-23-16-20(12-14-29-23)26-27(30-21-10-4-3-5-11-21)25-22(31-26)13-15-33(2)28(25)35/h3-12,14,16,30-31H,13,15,17H2,1-2H3,(H,29,32,34) MHLPTBJWCVRRPC-UHFFFAOYSA-N 721113 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(2-methylphenyl)acetamide::US12227501, Example 71 Epidermal growth factor receptor [669-1210] 7430 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721113 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721113&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674251 513841165 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492864 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccncc1 InChI=1S/C27H26N6O2/c1-17(18-8-12-28-13-9-18)26(34)32-22-16-19(10-14-29-22)24-25(30-20-6-4-3-5-7-20)23-21(31-24)11-15-33(2)27(23)35/h3-10,12-14,16-17,30-31H,11,15H2,1-2H3,(H,29,32,34) VZLYECDBMSJTQG-UHFFFAOYSA-N 721114 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-4-yl)propanamide (Racemate)::US12227501, Example 72 Epidermal growth factor receptor [669-1210] 7590 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721114 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721114&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674234 513841166 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492865 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccncc1 InChI=1S/C27H26N6O2/c1-17(18-8-12-28-13-9-18)26(34)32-22-16-19(10-14-29-22)24-25(30-20-6-4-3-5-7-20)23-21(31-24)11-15-33(2)27(23)35/h3-10,12-14,16-17,30-31H,11,15H2,1-2H3,(H,29,32,34) VZLYECDBMSJTQG-UHFFFAOYSA-N 721115 (+)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-4-yl)propanamide (Enantiomer 1)::US12227501, Example 73 Epidermal growth factor receptor [669-1210] 6780 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721115 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721115&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674234 513841167 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492866 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccncc1 InChI=1S/C27H26N6O2/c1-17(18-8-12-28-13-9-18)26(34)32-22-16-19(10-14-29-22)24-25(30-20-6-4-3-5-7-20)23-21(31-24)11-15-33(2)27(23)35/h3-10,12-14,16-17,30-31H,11,15H2,1-2H3,(H,29,32,34) VZLYECDBMSJTQG-UHFFFAOYSA-N 721116 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-4-yl)propanamide (Enantiomer 2)::US12227501, Example 74 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721116 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721116&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674234 513841168 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492867 CCC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-3-22(18-9-11-20(30)12-10-18)28(36)34-24-17-19(13-15-31-24)26-27(32-21-7-5-4-6-8-21)25-23(33-26)14-16-35(2)29(25)37/h4-13,15,17,22,32-33H,3,14,16H2,1-2H3,(H,31,34,36) GGXUUYZKIPHVAW-UHFFFAOYSA-N 721117 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 75 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721117 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721117&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674401 513841169 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492868 CCC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-3-22(18-9-11-20(30)12-10-18)28(36)34-24-17-19(13-15-31-24)26-27(32-21-7-5-4-6-8-21)25-23(33-26)14-16-35(2)29(25)37/h4-13,15,17,22,32-33H,3,14,16H2,1-2H3,(H,31,34,36) GGXUUYZKIPHVAW-UHFFFAOYSA-N 721118 (−)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 76 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721118 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721118&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674401 513841170 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492869 CCC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-3-22(18-9-11-20(30)12-10-18)28(36)34-24-17-19(13-15-31-24)26-27(32-21-7-5-4-6-8-21)25-23(33-26)14-16-35(2)29(25)37/h4-13,15,17,22,32-33H,3,14,16H2,1-2H3,(H,31,34,36) GGXUUYZKIPHVAW-UHFFFAOYSA-N 721119 (+)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 77 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721119 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721119&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674401 513841171 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492870 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(C(F)F)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H25F2N5O2/c1-35-14-12-21-24(28(35)37)26(32-20-5-3-2-4-6-20)25(33-21)19-11-13-31-22(16-19)34-23(36)15-17-7-9-18(10-8-17)27(29)30/h2-11,13,16,27,32-33H,12,14-15H2,1H3,(H,31,34,36) QHLWRPSEJQXVCM-UHFFFAOYSA-N 721120 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-[4-(difluoromethyl)phenyl]acetamide::US12227501, Example 78 Epidermal growth factor receptor [669-1210] 3090 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721120 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721120&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674321 513841172 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492871 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(Cl)cc1 InChI=1S/C28H26ClN5O2/c1-17(18-8-10-20(29)11-9-18)27(35)33-23-16-19(12-14-30-23)25-26(31-21-6-4-3-5-7-21)24-22(32-25)13-15-34(2)28(24)36/h3-12,14,16-17,31-32H,13,15H2,1-2H3,(H,30,33,35) AWQFFDDPKOKUOH-UHFFFAOYSA-N 721121 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-chlorophenyl)propanamide (Racemate)::US12227501, Example 79 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721121 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721121&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674313 513841173 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492872 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(Cl)cc1 InChI=1S/C28H26ClN5O2/c1-17(18-8-10-20(29)11-9-18)27(35)33-23-16-19(12-14-30-23)25-26(31-21-6-4-3-5-7-21)24-22(32-25)13-15-34(2)28(24)36/h3-12,14,16-17,31-32H,13,15H2,1-2H3,(H,30,33,35) AWQFFDDPKOKUOH-UHFFFAOYSA-N 721122 (−)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-chlorophenyl)propanamide (Enantiomer 1)::US12227501, Example 80 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721122 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721122&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674313 513841174 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492873 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)CC3)ccn1)c1ccc(Cl)cc1 InChI=1S/C28H26ClN5O2/c1-17(18-8-10-20(29)11-9-18)27(35)33-23-16-19(12-14-30-23)25-26(31-21-6-4-3-5-7-21)24-22(32-25)13-15-34(2)28(24)36/h3-12,14,16-17,31-32H,13,15H2,1-2H3,(H,30,33,35) AWQFFDDPKOKUOH-UHFFFAOYSA-N 721123 (+)-N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-chlorophenyl)propanamide (Enantiomer 2)::US12227501, Example 81 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721123 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721123&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674313 513841175 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492874 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4F)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C27H23F2N5O2/c1-34-12-10-21-24(27(34)36)26(31-19-5-3-2-4-6-19)25(32-21)17-9-11-30-22(13-17)33-23(35)14-16-7-8-18(28)15-20(16)29/h2-9,11,13,15,31-32H,10,12,14H2,1H3,(H,30,33,35) NWLSEQZPIYEHII-UHFFFAOYSA-N 721124 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(2,4-difluorophenyl)acetamide::US12227501, Example 82 Epidermal growth factor receptor [669-1210] 1150 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721124 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721124&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674327 513841176 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492875 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)c(F)c4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C27H23F2N5O2/c1-34-12-10-21-24(27(34)36)26(31-18-5-3-2-4-6-18)25(32-21)17-9-11-30-22(15-17)33-23(35)14-16-7-8-19(28)20(29)13-16/h2-9,11,13,15,31-32H,10,12,14H2,1H3,(H,30,33,35) FHYLCIXGVBYKBV-UHFFFAOYSA-N 721125 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(3,4-difluorophenyl)acetamide::US12227501, Example 83 Epidermal growth factor receptor [669-1210] 2920 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721125 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721125&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674376 513841177 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492876 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(N(C)C)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C29H30N6O2/c1-34(2)22-11-9-19(10-12-22)17-25(36)33-24-18-20(13-15-30-24)27-28(31-21-7-5-4-6-8-21)26-23(32-27)14-16-35(3)29(26)37/h4-13,15,18,31-32H,14,16-17H2,1-3H3,(H,30,33,36) ZMLOZXFOYBKPSP-UHFFFAOYSA-N 721126 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-[4-(dimethylamino)phenyl]acetamide::US12227501, Example 84 Epidermal growth factor receptor [669-1210] 1020 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721126 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721126&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674325 513841178 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492877 Cc1cc(CC(=O)Nc2cc(-c3[nH]c4c(c3Nc3ccccc3)C(=O)N(C)CC4)ccn2)ccn1 InChI=1S/C27H26N6O2/c1-17-14-18(8-11-28-17)15-23(34)32-22-16-19(9-12-29-22)25-26(30-20-6-4-3-5-7-20)24-21(31-25)10-13-33(2)27(24)35/h3-9,11-12,14,16,30-31H,10,13,15H2,1-2H3,(H,29,32,34) LHIQTHDBSXSQTG-UHFFFAOYSA-N 721127 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(2-methylpyridin-4-yl)acetamide::US12227501, Example 85 Epidermal growth factor receptor [669-1210] 937 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721127 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721127&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674424 513841179 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492878 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1 InChI=1S/C28H25F2N5O2/c1-28(2)15-21-24(27(37)35-28)26(32-20-6-4-3-5-19(20)30)25(33-21)17-11-12-31-22(14-17)34-23(36)13-16-7-9-18(29)10-8-16/h3-12,14,32-33H,13,15H2,1-2H3,(H,35,37)(H,31,34,36) NEOVWVIFEVIRBF-UHFFFAOYSA-N 721128 N-{4-[3-(2-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 86 Epidermal growth factor receptor [669-1210] 6470 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721128 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721128&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674489 513841180 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492879 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2cccc(F)c2Cl)C(=O)NCC3)ccn1 InChI=1S/C26H20ClF2N5O2/c27-23-17(29)2-1-3-19(23)33-25-22-18(9-11-31-26(22)36)32-24(25)15-8-10-30-20(13-15)34-21(35)12-14-4-6-16(28)7-5-14/h1-8,10,13,32-33H,9,11-12H2,(H,31,36)(H,30,34,35) UJJMQXWMFBWWJA-UHFFFAOYSA-N 721129 N-{4-[3-(2-chloro-3-fluoroanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 87 Epidermal growth factor receptor [669-1210] 158 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721129 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721129&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674502 513841181 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492880 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1C InChI=1S/C28H26FN5O2/c1-17-14-22-25(28(36)34(17)2)27(31-21-6-4-3-5-7-21)26(32-22)19-12-13-30-23(16-19)33-24(35)15-18-8-10-20(29)11-9-18/h3-13,16-17,31-32H,14-15H2,1-2H3,(H,30,33,35) CEDLEAIGKVAXEE-UHFFFAOYSA-N 721130 N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Racemate)::US12227501, Example 88 Epidermal growth factor receptor [669-1210] 727 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721130 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721130&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674361 513841182 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492881 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1C InChI=1S/C28H26FN5O2/c1-17-14-22-25(28(36)34(17)2)27(31-21-6-4-3-5-7-21)26(32-22)19-12-13-30-23(16-19)33-24(35)15-18-8-10-20(29)11-9-18/h3-13,16-17,31-32H,14-15H2,1-2H3,(H,30,33,35) CEDLEAIGKVAXEE-UHFFFAOYSA-N 721131 (+)-N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Enantiomer 1)::US12227501, Example 89 Epidermal growth factor receptor [669-1210] 6050 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721131 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721131&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674361 513841183 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492882 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1C InChI=1S/C28H26FN5O2/c1-17-14-22-25(28(36)34(17)2)27(31-21-6-4-3-5-7-21)26(32-22)19-12-13-30-23(16-19)33-24(35)15-18-8-10-20(29)11-9-18/h3-13,16-17,31-32H,14-15H2,1-2H3,(H,30,33,35) CEDLEAIGKVAXEE-UHFFFAOYSA-N 721132 (−)-N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Enantiomer 2)::US12227501, Example 90 Epidermal growth factor receptor [669-1210] 561 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721132 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721132&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674361 513841184 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492883 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17-15-23-25(29(37)35(17)3)27(32-22-7-5-4-6-8-22)26(33-23)20-13-14-31-24(16-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-14,16-18,32-33H,15H2,1-3H3,(H,31,34,36) KBQAVBKOEJZTFM-UHFFFAOYSA-N 721133 (+)-(2RS)—N-{4-[(6R*)-3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (2 Stereoisomers #1)::US12227501, Example 91 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721133 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721133&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674434 513841185 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492884 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17-15-23-25(29(37)35(17)3)27(32-22-7-5-4-6-8-22)26(33-23)20-13-14-31-24(16-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-14,16-18,32-33H,15H2,1-3H3,(H,31,34,36) KBQAVBKOEJZTFM-UHFFFAOYSA-N 721134 (+)-N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Single Stereoisomer 1)::US12227501, Example 92 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721134 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721134&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674434 513841186 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492885 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17-15-23-25(29(37)35(17)3)27(32-22-7-5-4-6-8-22)26(33-23)20-13-14-31-24(16-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-14,16-18,32-33H,15H2,1-3H3,(H,31,34,36) KBQAVBKOEJZTFM-UHFFFAOYSA-N 721135 (−)-N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Single Stereoisomer 2)::US12227501, Example 93 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721135 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721135&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674434 513841187 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492886 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17-15-23-25(29(37)35(17)3)27(32-22-7-5-4-6-8-22)26(33-23)20-13-14-31-24(16-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-14,16-18,32-33H,15H2,1-3H3,(H,31,34,36) KBQAVBKOEJZTFM-UHFFFAOYSA-N 721136 (−)-(2RS)—N-{4-[(6R*)-3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (2 Stereoisomers #2)::US12227501, Example 94 Epidermal growth factor receptor [669-1210] 4410 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721136 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721136&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674434 513841188 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492887 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17-15-23-25(29(37)35(17)3)27(32-22-7-5-4-6-8-22)26(33-23)20-13-14-31-24(16-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-14,16-18,32-33H,15H2,1-3H3,(H,31,34,36) KBQAVBKOEJZTFM-UHFFFAOYSA-N 721137 (−)-N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Single Stereoisomer 3)::US12227501, Example 95 Epidermal growth factor receptor [669-1210] 6310 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721137 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721137&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674434 513841189 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492888 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C29H28FN5O2/c1-17-15-23-25(29(37)35(17)3)27(32-22-7-5-4-6-8-22)26(33-23)20-13-14-31-24(16-20)34-28(36)18(2)19-9-11-21(30)12-10-19/h4-14,16-18,32-33H,15H2,1-3H3,(H,31,34,36) KBQAVBKOEJZTFM-UHFFFAOYSA-N 721138 (+)-N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Single Stereoisomer 4)::US12227501, Example 96 Epidermal growth factor receptor [669-1210] 7040 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721138 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721138&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674434 513841190 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492889 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccncc4)c3)c(Nc3ccccc3)c2C(=O)N1C InChI=1S/C27H26N6O2/c1-17-14-21-24(27(35)33(17)2)26(30-20-6-4-3-5-7-20)25(31-21)19-10-13-29-22(16-19)32-23(34)15-18-8-11-28-12-9-18/h3-13,16-17,30-31H,14-15H2,1-2H3,(H,29,32,34) OVWHGYZCHAOSFL-UHFFFAOYSA-N 721139 N-{4-[3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(pyridin-4-yl)acetamide (Racemate)::US12227501, Example 97 Epidermal growth factor receptor [669-1210] 529 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721139 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721139&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674358 513841191 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492890 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccncc4)c3)c(Nc3ccccc3)c2C(=O)N1C InChI=1S/C27H26N6O2/c1-17-14-21-24(27(35)33(17)2)26(30-20-6-4-3-5-7-20)25(31-21)19-10-13-29-22(16-19)32-23(34)15-18-8-11-28-12-9-18/h3-13,16-17,30-31H,14-15H2,1-2H3,(H,29,32,34) OVWHGYZCHAOSFL-UHFFFAOYSA-N 721140 (+)-N-{4-[(6R*)-3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(pyridin-4-yl)acetamide (Enantiomer 1)::US12227501, Example 98 Epidermal growth factor receptor [669-1210] 4340 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721140 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721140&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674358 513841192 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492891 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccncc4)c3)c(Nc3ccccc3)c2C(=O)N1C InChI=1S/C27H26N6O2/c1-17-14-21-24(27(35)33(17)2)26(30-20-6-4-3-5-7-20)25(31-21)19-10-13-29-22(16-19)32-23(34)15-18-8-11-28-12-9-18/h3-13,16-17,30-31H,14-15H2,1-2H3,(H,29,32,34) OVWHGYZCHAOSFL-UHFFFAOYSA-N 721141 (−)-N-{4-[(6S*)-3-anilino-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(pyridin-4-yl)acetamide (Enantiomer 2)::US12227501, Example 99 Epidermal growth factor receptor [669-1210] 329 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721141 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721141&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674358 513841193 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492892 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C28H25F2N5O2/c1-16-13-22-25(28(37)35(16)2)27(32-21-6-4-3-5-20(21)30)26(33-22)18-11-12-31-23(15-18)34-24(36)14-17-7-9-19(29)10-8-17/h3-12,15-16,32-33H,13-14H2,1-2H3,(H,31,34,36) DQGYZGUWRZBVCE-UHFFFAOYSA-N 721142 N-{4-[3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Racemate)::US12227501, Example 100 Epidermal growth factor receptor [669-1210] 3830 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721142 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721142&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674239 513841194 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492893 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C28H25F2N5O2/c1-16-13-22-25(28(37)35(16)2)27(32-21-6-4-3-5-20(21)30)26(33-22)18-11-12-31-23(15-18)34-24(36)14-17-7-9-19(29)10-8-17/h3-12,15-16,32-33H,13-14H2,1-2H3,(H,31,34,36) DQGYZGUWRZBVCE-UHFFFAOYSA-N 721143 (+)-N-{4-[3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Enantiomer 1)::US12227501, Example 101 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721143 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721143&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674239 513841195 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492894 CC1Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C28H25F2N5O2/c1-16-13-22-25(28(37)35(16)2)27(32-21-6-4-3-5-20(21)30)26(33-22)18-11-12-31-23(15-18)34-24(36)14-17-7-9-19(29)10-8-17/h3-12,15-16,32-33H,13-14H2,1-2H3,(H,31,34,36) DQGYZGUWRZBVCE-UHFFFAOYSA-N 721144 (−)-N-{4-[3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Enantiomer 2)::US12227501, Example 102 Epidermal growth factor receptor [669-1210] 2330 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721144 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721144&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674239 513841196 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492895 CC1Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C30H27F4N5O2/c1-16-13-23-26(30(41)39(16)2)28(36-22-6-4-3-5-21(22)32)27(37-23)18-11-12-35-25(14-18)38-29(40)20(15-24(33)34)17-7-9-19(31)10-8-17/h3-12,14,16,20,24,36-37H,13,15H2,1-2H3,(H,35,38,40) FSUKRPNMEJYOMM-UHFFFAOYSA-N 721145 (+)-(2RS)-4,4-difluoro-N-{4-[(6R*)-3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (2 Stereoisomers #1)::US12227501, Example 103 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721145 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721145&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674276 513841197 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492896 CC1Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C30H27F4N5O2/c1-16-13-23-26(30(41)39(16)2)28(36-22-6-4-3-5-21(22)32)27(37-23)18-11-12-35-25(14-18)38-29(40)20(15-24(33)34)17-7-9-19(31)10-8-17/h3-12,14,16,20,24,36-37H,13,15H2,1-2H3,(H,35,38,40) FSUKRPNMEJYOMM-UHFFFAOYSA-N 721146 (−)-4,4-difluoro-N-{4-[3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 104 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721146 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721146&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674276 513841198 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492897 CC1Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C30H27F4N5O2/c1-16-13-23-26(30(41)39(16)2)28(36-22-6-4-3-5-21(22)32)27(37-23)18-11-12-35-25(14-18)38-29(40)20(15-24(33)34)17-7-9-19(31)10-8-17/h3-12,14,16,20,24,36-37H,13,15H2,1-2H3,(H,35,38,40) FSUKRPNMEJYOMM-UHFFFAOYSA-N 721147 (+)-4,4-difluoro-N-{4-[3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 105 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721147 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721147&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674276 513841199 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492898 CC1Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C30H27F4N5O2/c1-16-13-23-26(30(41)39(16)2)28(36-22-6-4-3-5-21(22)32)27(37-23)18-11-12-35-25(14-18)38-29(40)20(15-24(33)34)17-7-9-19(31)10-8-17/h3-12,14,16,20,24,36-37H,13,15H2,1-2H3,(H,35,38,40) FSUKRPNMEJYOMM-UHFFFAOYSA-N 721148 (−)-(2RS)-4,4-difluoro-N-{4-[(6R*)-3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (2 Stereoisomers #2)::US12227501, Example 106 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721148 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721148&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674276 513841200 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492899 CC1Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C30H27F4N5O2/c1-16-13-23-26(30(41)39(16)2)28(36-22-6-4-3-5-21(22)32)27(37-23)18-11-12-35-25(14-18)38-29(40)20(15-24(33)34)17-7-9-19(31)10-8-17/h3-12,14,16,20,24,36-37H,13,15H2,1-2H3,(H,35,38,40) FSUKRPNMEJYOMM-UHFFFAOYSA-N 721149 (−)-4,4-difluoro-N-{4-[3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Enantiomer 3)::US12227501, Example 107 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721149 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721149&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674276 513841201 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492900 CC1Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3F)c2C(=O)N1C InChI=1S/C30H27F4N5O2/c1-16-13-23-26(30(41)39(16)2)28(36-22-6-4-3-5-21(22)32)27(37-23)18-11-12-35-25(14-18)38-29(40)20(15-24(33)34)17-7-9-19(31)10-8-17/h3-12,14,16,20,24,36-37H,13,15H2,1-2H3,(H,35,38,40) FSUKRPNMEJYOMM-UHFFFAOYSA-N 721150 (+)-4,4-difluoro-N-{4-[3-(2-fluoroanilino)-5,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Enantiomer 4)::US12227501, Example 108 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721150 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721150&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674276 513841202 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492901 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3Cl)c2C(=O)N1 InChI=1S/C30H26ClF4N5O2/c1-30(2)14-21-24(29(42)40-30)27(37-20-5-3-4-19(33)25(20)31)26(38-21)16-10-11-36-23(12-16)39-28(41)18(13-22(34)35)15-6-8-17(32)9-7-15/h3-12,18,22,37-38H,13-14H2,1-2H3,(H,40,42)(H,36,39,41) BMIMXMZRHINYQM-UHFFFAOYSA-N 721151 N-{4-[3-(2-chloro-3-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 109 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721151 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721151&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674308 513841203 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492902 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3Cl)c2C(=O)N1 InChI=1S/C30H26ClF4N5O2/c1-30(2)14-21-24(29(42)40-30)27(37-20-5-3-4-19(33)25(20)31)26(38-21)16-10-11-36-23(12-16)39-28(41)18(13-22(34)35)15-6-8-17(32)9-7-15/h3-12,18,22,37-38H,13-14H2,1-2H3,(H,40,42)(H,36,39,41) BMIMXMZRHINYQM-UHFFFAOYSA-N 721152 (−)-N-{4-[3-(2-chloro-3-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 110 Epidermal growth factor receptor [669-1210] 4130 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721152 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721152&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674308 513841204 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492903 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3Cl)c2C(=O)N1 InChI=1S/C30H26ClF4N5O2/c1-30(2)14-21-24(29(42)40-30)27(37-20-5-3-4-19(33)25(20)31)26(38-21)16-10-11-36-23(12-16)39-28(41)18(13-22(34)35)15-6-8-17(32)9-7-15/h3-12,18,22,37-38H,13-14H2,1-2H3,(H,40,42)(H,36,39,41) BMIMXMZRHINYQM-UHFFFAOYSA-N 721153 (+)-N-{4-[3-(2-chloro-3-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 111 Epidermal growth factor receptor [669-1210] 1140 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721153 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721153&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674308 513841205 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492904 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3cccc(F)c3Cl)c2C(=O)N1 InChI=1S/C28H24ClF2N5O2/c1-28(2)14-20-23(27(38)36-28)26(33-19-5-3-4-18(31)24(19)29)25(34-20)16-10-11-32-21(13-16)35-22(37)12-15-6-8-17(30)9-7-15/h3-11,13,33-34H,12,14H2,1-2H3,(H,36,38)(H,32,35,37) XBJAOZKEXGWEPB-UHFFFAOYSA-N 721154 N-{4-[3-(2-chloro-3-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 112 Epidermal growth factor receptor [669-1210] 3430 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721154 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721154&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674316 513841206 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492905 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C29H28FN5O2/c1-17-6-4-5-7-21(17)32-27-25-22(16-29(2,3)35-28(25)37)33-26(27)19-12-13-31-23(15-19)34-24(36)14-18-8-10-20(30)11-9-18/h4-13,15,32-33H,14,16H2,1-3H3,(H,35,37)(H,31,34,36) HOMKDCYPLCAGBD-UHFFFAOYSA-N 721155 N-{4-[6,6-dimethyl-3-(2-methylanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 113 Epidermal growth factor receptor [669-1210] 7710 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721155 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721155&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674468 513841207 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492906 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4cnccn4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C25H23N7O2/c1-32-12-8-19-22(25(32)34)24(29-17-5-3-2-4-6-17)23(30-19)16-7-9-28-20(13-16)31-21(33)14-18-15-26-10-11-27-18/h2-7,9-11,13,15,29-30H,8,12,14H2,1H3,(H,28,31,33) KVIQZRSTAIWWJF-UHFFFAOYSA-N 721156 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyrazin-2-yl)acetamide::US12227501, Example 114 Epidermal growth factor receptor [669-1210] 2060 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721156 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721156&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674232 513841208 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492907 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccccn4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C26H24N6O2/c1-32-14-11-20-23(26(32)34)25(29-18-7-3-2-4-8-18)24(30-20)17-10-13-28-21(15-17)31-22(33)16-19-9-5-6-12-27-19/h2-10,12-13,15,29-30H,11,14,16H2,1H3,(H,28,31,33) WYFBDHPKVNKMTH-UHFFFAOYSA-N 721157 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-2-yl)acetamide::US12227501, Example 115 Epidermal growth factor receptor [669-1210] 3670 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721157 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721157&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674442 513841209 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492908 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4cccc(C(F)(F)F)c4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C28H24F3N5O2/c1-36-13-11-21-24(27(36)38)26(33-20-8-3-2-4-9-20)25(34-21)18-10-12-32-22(16-18)35-23(37)15-17-6-5-7-19(14-17)28(29,30)31/h2-10,12,14,16,33-34H,11,13,15H2,1H3,(H,32,35,37) IVISHGNTPOVTQM-UHFFFAOYSA-N 721158 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-[3-(trifluoromethyl)phenyl]acetamide::US12227501, Example 116 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721158 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721158&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674419 513841210 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492909 COC(=O)c1ccc(CC(=O)Nc2cc(-c3[nH]c4c(c3Nc3ccccc3)C(=O)N(C)CC4)ccn2)cc1 InChI=1S/C29H27N5O4/c1-34-15-13-22-25(28(34)36)27(31-21-6-4-3-5-7-21)26(32-22)20-12-14-30-23(17-20)33-24(35)16-18-8-10-19(11-9-18)29(37)38-2/h3-12,14,17,31-32H,13,15-16H2,1-2H3,(H,30,33,35) QCSBVNWGWVHGRR-UHFFFAOYSA-N 721159 methyl 4-(2-{[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]amino}-2-oxoethyl)benzoate::US12227501, Example 117 Epidermal growth factor receptor [669-1210] 1270 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721159 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721159&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674454 513841211 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492910 CC(F)CC(C(=O)N(F)c1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NC(C)(C)C3)ccn1)c1ccc(S(C)(=O)=O)cc1 InChI=1S/C32H33F2N5O4S/c1-19(33)16-24(20-10-12-23(13-11-20)44(4,42)43)31(41)39(34)26-17-21(14-15-35-26)28-29(36-22-8-6-5-7-9-22)27-25(37-28)18-32(2,3)38-30(27)40/h5-15,17,19,24,36-37H,16,18H2,1-4H3,(H,38,40) RCHPQGHUPYFPMV-UHFFFAOYSA-N 721160 N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-[4-(methanesulfonyl)phenyl]butanamide (Racemate)::US12227501, Example 118 Epidermal growth factor receptor [669-1210] 7260 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721160 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721160&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 175682201 513841212 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492911 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3cccc(F)c3)c2C(=O)N1 InChI=1S/C28H25F2N5O2/c1-28(2)15-21-24(27(37)35-28)26(32-20-5-3-4-19(30)14-20)25(33-21)17-10-11-31-22(13-17)34-23(36)12-16-6-8-18(29)9-7-16/h3-11,13-14,32-33H,12,15H2,1-2H3,(H,35,37)(H,31,34,36) RDIZWXHOXKMYHK-UHFFFAOYSA-N 721161 N-{4-[3-(3-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 119 Epidermal growth factor receptor [669-1210] 2540 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721161 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721161&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674288 513841213 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492912 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3)c2C(=O)N1 InChI=1S/C30H27F4N5O2/c1-30(2)15-22-25(29(41)39-30)27(36-20-5-3-4-19(32)13-20)26(37-22)17-10-11-35-24(12-17)38-28(40)21(14-23(33)34)16-6-8-18(31)9-7-16/h3-13,21,23,36-37H,14-15H2,1-2H3,(H,39,41)(H,35,38,40) HMUYZTPOWOYZKW-UHFFFAOYSA-N 721162 4,4-difluoro-N-{4-[3-(3-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide::US12227501, Example 120 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721162 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721162&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674328 513841214 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492913 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3)c2C(=O)N1 InChI=1S/C30H27F4N5O2/c1-30(2)15-22-25(29(41)39-30)27(36-20-5-3-4-19(32)13-20)26(37-22)17-10-11-35-24(12-17)38-28(40)21(14-23(33)34)16-6-8-18(31)9-7-16/h3-13,21,23,36-37H,14-15H2,1-2H3,(H,39,41)(H,35,38,40) HMUYZTPOWOYZKW-UHFFFAOYSA-N 721163 4,4-difluoro-N-{4-[3-(3-fluoroanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 121 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721163 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721163&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674328 513841215 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492914 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2cccc(F)c2Cl)C(=O)NC2(CCC2)C3)ccn1 InChI=1S/C29H24ClF2N5O2/c30-25-19(32)3-1-4-20(25)34-27-24-21(15-29(10-2-11-29)37-28(24)39)35-26(27)17-9-12-33-22(14-17)36-23(38)13-16-5-7-18(31)8-6-16/h1,3-9,12,14,34-35H,2,10-11,13,15H2,(H,37,39)(H,33,36,38) RUBGULKMMNPVRT-UHFFFAOYSA-N 721164 N-{4-[3'-(2-chloro-3-fluoroanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 122 Epidermal growth factor receptor [669-1210] 2150 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721164 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721164&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 155055649 513841216 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492915 O=C1NC2(CCC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3Cl)c21 InChI=1S/C31H26ClF4N5O2/c32-26-20(34)3-1-4-21(26)38-28-25-22(15-31(10-2-11-31)41-30(25)43)39-27(28)17-9-12-37-24(13-17)40-29(42)19(14-23(35)36)16-5-7-18(33)8-6-16/h1,3-9,12-13,19,23,38-39H,2,10-11,14-15H2,(H,41,43)(H,37,40,42) RFSUZJIQGIZAAA-UHFFFAOYSA-N 721165 N-{4-[3'-(2-chloro-3-fluoroanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 123 Epidermal growth factor receptor [669-1210] 56.4 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721165 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721165&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674387 513841217 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492916 O=C1NC2(CCC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3Cl)c21 InChI=1S/C31H26ClF4N5O2/c32-26-20(34)3-1-4-21(26)38-28-25-22(15-31(10-2-11-31)41-30(25)43)39-27(28)17-9-12-37-24(13-17)40-29(42)19(14-23(35)36)16-5-7-18(33)8-6-16/h1,3-9,12-13,19,23,38-39H,2,10-11,14-15H2,(H,41,43)(H,37,40,42) RFSUZJIQGIZAAA-UHFFFAOYSA-N 721166 (−)-N-{4-[3'-(2-chloro-3-fluoroanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 124 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721166 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721166&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674387 513841218 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492917 O=C1NC2(CCC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)c3Cl)c21 InChI=1S/C31H26ClF4N5O2/c32-26-20(34)3-1-4-21(26)38-28-25-22(15-31(10-2-11-31)41-30(25)43)39-27(28)17-9-12-37-24(13-17)40-29(42)19(14-23(35)36)16-5-7-18(33)8-6-16/h1,3-9,12-13,19,23,38-39H,2,10-11,14-15H2,(H,41,43)(H,37,40,42) RFSUZJIQGIZAAA-UHFFFAOYSA-N 721167 (+)-N-{4-[3'-(2-chloro-3-fluoroanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 125 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721167 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721167&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674387 513841219 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492918 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3cccc(F)n3)c2C(=O)N1 InChI=1S/C27H24F2N6O2/c1-27(2)14-18-23(26(37)35-27)25(34-20-5-3-4-19(29)32-20)24(31-18)16-10-11-30-21(13-16)33-22(36)12-15-6-8-17(28)9-7-15/h3-11,13,31H,12,14H2,1-2H3,(H,32,34)(H,35,37)(H,30,33,36) XJDSDBTWZHZYJT-UHFFFAOYSA-N 721169 2-(4-fluorophenyl)-N-(4-{3-[(6-fluoropyridin-2-yl)amino]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl}pyridin-2-yl)acetamide-1,1',1″-phosphoryltripyrrolidine salt::US12227501, Example 127 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721169 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721169&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674266 513841221 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492919 CC(F)CC(C(=O)N(F)c1cc(-c2[nH]c3c(c2Nc2cccc(F)n2)C(=O)NC(C)(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C30H28F4N6O2/c1-16(31)13-20(17-7-9-19(32)10-8-17)29(42)40(34)24-14-18(11-12-35-24)26-27(38-23-6-4-5-22(33)37-23)25-21(36-26)15-30(2,3)39-28(25)41/h4-12,14,16,20,36H,13,15H2,1-3H3,(H,37,38)(H,39,41) YDOZYQCKMQHHAB-UHFFFAOYSA-N 721170 4,4-difluoro-2-(4-fluorophenyl)-N-(4-{3-[(6-fluoropyridin-2-yl)amino]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl}pyridin-2-yl)butanamide (Racemate)::US12227501, Example 128 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721170 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721170&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 175682202 513841222 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492920 CC(F)CC(C(=O)N(F)c1cc(-c2[nH]c3c(c2Nc2cccc(F)n2)C(=O)NC(C)(C)C3)ccn1)c1ccc(F)cc1 InChI=1S/C30H28F4N6O2/c1-16(31)13-20(17-7-9-19(32)10-8-17)29(42)40(34)24-14-18(11-12-35-24)26-27(38-23-6-4-5-22(33)37-23)25-21(36-26)15-30(2,3)39-28(25)41/h4-12,14,16,20,36H,13,15H2,1-3H3,(H,37,38)(H,39,41) YDOZYQCKMQHHAB-UHFFFAOYSA-N 721171 4,4-difluoro-2-(4-fluorophenyl)-N-(4-{3-[(6-fluoropyridin-2-yl)amino]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl}pyridin-2-yl)butanamide (Enantiomer 1)::US12227501, Example 129 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721171 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721171&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 175682202 513841223 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492921 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3cccc(F)n3)c2C(=O)N1 InChI=1S/C29H26F4N6O2/c1-29(2)14-19-24(28(41)39-29)26(37-22-5-3-4-21(33)36-22)25(35-19)16-10-11-34-23(12-16)38-27(40)18(13-20(31)32)15-6-8-17(30)9-7-15/h3-12,18,20,35H,13-14H2,1-2H3,(H,36,37)(H,39,41)(H,34,38,40) JOJTYLQIUBKNMM-UHFFFAOYSA-N 721172 4,4-difluoro-2-(4-fluorophenyl)-N-(4-{3-[(6-fluoropyridin-2-yl)amino]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl}pyridin-2-yl)butanamide (Enantiomer 2)::US12227501, Example 130 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721172 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721172&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674289 513841224 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492922 Cc1c(F)cccc1Nc1c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C29H27F2N5O2/c1-16-20(31)5-4-6-21(16)33-27-25-22(15-29(2,3)36-28(25)38)34-26(27)18-11-12-32-23(14-18)35-24(37)13-17-7-9-19(30)10-8-17/h4-12,14,33-34H,13,15H2,1-3H3,(H,36,38)(H,32,35,37) UVTIDTZUUMJEGM-UHFFFAOYSA-N 721173 N-{4-[3-(3-fluoro-2-methylanilino)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 131 Epidermal growth factor receptor [669-1210] 1090 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721173 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721173&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674243 513841225 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492923 Cc1c(F)cccc1Nc1c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C29H27F2N5O2/c1-16-20(31)5-4-6-21(16)33-27-25-22(15-29(2,3)36-28(25)38)34-26(27)18-11-12-32-23(14-18)35-24(37)13-17-7-9-19(30)10-8-17/h4-12,14,33-34H,13,15H2,1-3H3,(H,36,38)(H,32,35,37) UVTIDTZUUMJEGM-UHFFFAOYSA-N 721174 N-{4-[6,6-dimethyl-3-(2-methylanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate)::US12227501, Example 132 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721174 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721174&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674243 513841226 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492924 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(C)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C30H30FN5O2/c1-17-7-5-6-8-22(17)33-27-25-23(16-30(3,4)36-29(25)38)34-26(27)20-13-14-32-24(15-20)35-28(37)18(2)19-9-11-21(31)12-10-19/h5-15,18,33-34H,16H2,1-4H3,(H,36,38)(H,32,35,37) NVZGKHUBLBRWMH-UHFFFAOYSA-N 721175 (−)-N-{4-[6,6-dimethyl-3-(2-methylanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Enantiomer 1)::US12227501, Example 133 Epidermal growth factor receptor [669-1210] 405 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721175 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721175&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674258 513841227 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492925 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(C)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C30H30FN5O2/c1-17-7-5-6-8-22(17)33-27-25-23(16-30(3,4)36-29(25)38)34-26(27)20-13-14-32-24(15-20)35-28(37)18(2)19-9-11-21(31)12-10-19/h5-15,18,33-34H,16H2,1-4H3,(H,36,38)(H,32,35,37) NVZGKHUBLBRWMH-UHFFFAOYSA-N 721176 N-{4-[6,6-dimethyl-3-(2-methylanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Enantiomer 2)::US12227501, Example 134 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721176 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721176&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674258 513841228 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492926 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(CC(F)F)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C31H30F3N5O2/c1-17-6-4-5-7-22(17)36-28-26-23(16-31(2,3)39-30(26)41)37-27(28)19-12-13-35-25(14-19)38-29(40)21(15-24(33)34)18-8-10-20(32)11-9-18/h4-14,21,24,36-37H,15-16H2,1-3H3,(H,39,41)(H,35,38,40) BOQMJAHNAMIBMJ-UHFFFAOYSA-N 721177 N-{4-[6,6-dimethyl-3-(2-methylanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 135 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721177 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721177&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674340 513841229 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492927 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(CC(F)F)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C31H30F3N5O2/c1-17-6-4-5-7-22(17)36-28-26-23(16-31(2,3)39-30(26)41)37-27(28)19-12-13-35-25(14-19)38-29(40)21(15-24(33)34)18-8-10-20(32)11-9-18/h4-14,21,24,36-37H,15-16H2,1-3H3,(H,39,41)(H,35,38,40) BOQMJAHNAMIBMJ-UHFFFAOYSA-N 721178 N-{4-[6,6-dimethyl-3-(2-methylanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 136 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721178 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721178&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674340 513841230 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492928 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(CC(F)F)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC(C)(C)C2 InChI=1S/C31H30F3N5O2/c1-17-6-4-5-7-22(17)36-28-26-23(16-31(2,3)39-30(26)41)37-27(28)19-12-13-35-25(14-19)38-29(40)21(15-24(33)34)18-8-10-20(32)11-9-18/h4-14,21,24,36-37H,15-16H2,1-3H3,(H,39,41)(H,35,38,40) BOQMJAHNAMIBMJ-UHFFFAOYSA-N 721179 N-{4-[6,6-dimethyl-3-(2-methylanilino)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 137 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721179 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721179&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674340 513841231 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492929 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CNC(=O)OC(C)(C)C)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C34H37FN6O4/c1-33(2,3)45-32(44)37-19-24(20-11-13-22(35)14-12-20)30(42)40-26-17-21(15-16-36-26)28-29(38-23-9-7-6-8-10-23)27-25(39-28)18-34(4,5)41-31(27)43/h6-17,24,38-39H,18-19H2,1-5H3,(H,37,44)(H,41,43)(H,36,40,42) ATXRBBLJRPAIHG-UHFFFAOYSA-N 721180 tert-butyl [3-{[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]amino}-2-(4-fluorophenyl)-3-oxopropyl]carbamate (Racemate)::US12227501, Example 138 Epidermal growth factor receptor [669-1210] 11100 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721180 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721180&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674287 513841232 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492930 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CN)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C29H29FN6O2/c1-29(2)15-22-24(28(38)36-29)26(33-20-6-4-3-5-7-20)25(34-22)18-12-13-32-23(14-18)35-27(37)21(16-31)17-8-10-19(30)11-9-17/h3-14,21,33-34H,15-16,31H2,1-2H3,(H,36,38)(H,32,35,37) GWTJDEOZCYRULI-UHFFFAOYSA-N 721181 3-amino-N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide-hydrogen chloride salt (Racemate)::US12227501, Example 139 Epidermal growth factor receptor [669-1210] 681 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721181 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721181&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674378 513841233 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492931 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CN)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C29H29FN6O2/c1-29(2)15-22-24(28(38)36-29)26(33-20-6-4-3-5-7-20)25(34-22)18-12-13-32-23(14-18)35-27(37)21(16-31)17-8-10-19(30)11-9-17/h3-14,21,33-34H,15-16,31H2,1-2H3,(H,36,38)(H,32,35,37) GWTJDEOZCYRULI-UHFFFAOYSA-N 721182 3-amino-N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 1)::US12227501, Example 140 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721182 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721182&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674378 513841234 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492932 CC1(C)Cc2[nH]c(-c3ccnc(NC(=O)C(CN)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C(=O)N1 InChI=1S/C29H29FN6O2/c1-29(2)15-22-24(28(38)36-29)26(33-20-6-4-3-5-7-20)25(34-22)18-12-13-32-23(14-18)35-27(37)21(16-31)17-8-10-19(30)11-9-17/h3-14,21,33-34H,15-16,31H2,1-2H3,(H,36,38)(H,32,35,37) GWTJDEOZCYRULI-UHFFFAOYSA-N 721183 3-amino-N-[4-(3-anilino-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 2)::US12227501, Example 141 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721183 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721183&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674378 513841235 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492933 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]c2c1C(=O)NC1(CCC1)C2 InChI=1S/C30H28FN5O2/c1-18-5-2-3-6-22(18)33-28-26-23(17-30(12-4-13-30)36-29(26)38)34-27(28)20-11-14-32-24(16-20)35-25(37)15-19-7-9-21(31)10-8-19/h2-3,5-11,14,16,33-34H,4,12-13,15,17H2,1H3,(H,36,38)(H,32,35,37) MXKWSWPSGNBXIT-UHFFFAOYSA-N 721184 2-(4-fluorophenyl)-N-{4-[3'-(2-methylanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}acetamide::US12227501, Example 142 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721184 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721184&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674444 513841236 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492934 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(CC(F)F)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC1(CCC1)C2 InChI=1S/C32H30F3N5O2/c1-18-5-2-3-6-23(18)37-29-27-24(17-32(12-4-13-32)40-31(27)42)38-28(29)20-11-14-36-26(15-20)39-30(41)22(16-25(34)35)19-7-9-21(33)10-8-19/h2-3,5-11,14-15,22,25,37-38H,4,12-13,16-17H2,1H3,(H,40,42)(H,36,39,41) HVAVBAIPXDAXHC-UHFFFAOYSA-N 721185 4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3'-(2-methylanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}butanamide (Racemate)::US12227501, Example 143 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721185 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721185&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674252 513841237 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492935 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(CC(F)F)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC1(CCC1)C2 InChI=1S/C32H30F3N5O2/c1-18-5-2-3-6-23(18)37-29-27-24(17-32(12-4-13-32)40-31(27)42)38-28(29)20-11-14-36-26(15-20)39-30(41)22(16-25(34)35)19-7-9-21(33)10-8-19/h2-3,5-11,14-15,22,25,37-38H,4,12-13,16-17H2,1H3,(H,40,42)(H,36,39,41) HVAVBAIPXDAXHC-UHFFFAOYSA-N 721186 (−)-4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3'-(2-methylanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}butanamide-(Enantiomer 1)::US12227501, Example 144 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721186 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721186&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674252 513841238 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492936 Cc1ccccc1Nc1c(-c2ccnc(NC(=O)C(CC(F)F)c3ccc(F)cc3)c2)[nH]c2c1C(=O)NC1(CCC1)C2 InChI=1S/C32H30F3N5O2/c1-18-5-2-3-6-23(18)37-29-27-24(17-32(12-4-13-32)40-31(27)42)38-28(29)20-11-14-36-26(15-20)39-30(41)22(16-25(34)35)19-7-9-21(33)10-8-19/h2-3,5-11,14-15,22,25,37-38H,4,12-13,16-17H2,1H3,(H,40,42)(H,36,39,41) HVAVBAIPXDAXHC-UHFFFAOYSA-N 721187 (+)-4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3'-(2-methylanilino)-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}butanamide-(Enantiomer 2)::US12227501, Example 145 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721187 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721187&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674252 513841239 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492937 O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)NC2(CC2)C3)ccn1 InChI=1S/C28H24FN5O2/c29-19-8-6-17(7-9-19)14-23(35)33-22-15-18(10-13-30-22)25-26(31-20-4-2-1-3-5-20)24-21(32-25)16-28(11-12-28)34-27(24)36/h1-10,13,15,31-32H,11-12,14,16H2,(H,34,36)(H,30,33,35) ZGFMJKVWQXPLNE-UHFFFAOYSA-N 721188 N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclopropane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 146 Epidermal growth factor receptor [669-1210] 667 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721188 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721188&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674355 513841240 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492938 O=C1NC2(CC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c21 InChI=1S/C30H26F3N5O2/c31-19-8-6-17(7-9-19)21(15-23(32)33)28(39)37-24-14-18(10-13-34-24)26-27(35-20-4-2-1-3-5-20)25-22(36-26)16-30(11-12-30)38-29(25)40/h1-10,13-14,21,23,35-36H,11-12,15-16H2,(H,38,40)(H,34,37,39) MQRBKUYTZJQBKW-UHFFFAOYSA-N 721189 N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclopropane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 147 Epidermal growth factor receptor [669-1210] 268 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721189 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721189&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674439 513841241 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492939 O=C1NC2(CC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c21 InChI=1S/C30H26F3N5O2/c31-19-8-6-17(7-9-19)21(15-23(32)33)28(39)37-24-14-18(10-13-34-24)26-27(35-20-4-2-1-3-5-20)25-22(36-26)16-30(11-12-30)38-29(25)40/h1-10,13-14,21,23,35-36H,11-12,15-16H2,(H,38,40)(H,34,37,39) MQRBKUYTZJQBKW-UHFFFAOYSA-N 721190 N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclopropane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 148 Epidermal growth factor receptor [669-1210] 3400 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721190 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721190&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674439 513841242 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492940 O=C1NC2(CC2)Cc2[nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c21 InChI=1S/C30H26F3N5O2/c31-19-8-6-17(7-9-19)21(15-23(32)33)28(39)37-24-14-18(10-13-34-24)26-27(35-20-4-2-1-3-5-20)25-22(36-26)16-30(11-12-30)38-29(25)40/h1-10,13-14,21,23,35-36H,11-12,15-16H2,(H,38,40)(H,34,37,39) MQRBKUYTZJQBKW-UHFFFAOYSA-N 721191 N-[4-(3'-anilino-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclopropane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 149 Epidermal growth factor receptor [669-1210] 16700 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721191 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721191&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674439 513841243 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492941 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3cc(F)ccc3F)c2C1=O InChI=1S/C27H22F3N5O2/c1-35-11-9-20-24(27(35)37)26(33-21-14-18(29)6-7-19(21)30)25(32-20)16-8-10-31-22(13-16)34-23(36)12-15-2-4-17(28)5-3-15/h2-8,10,13-14,32-33H,9,11-12H2,1H3,(H,31,34,36) LXTFCMYUAINYQN-UHFFFAOYSA-N 721192 N-{4-[3-(2,5-difluoroanilino)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide::US12227501, Example 150 Epidermal growth factor receptor [669-1210] 18300 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721192 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721192&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674460 513841244 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492942 COCCNC(=O)c1ccc(CC(=O)Nc2cc(-c3[nH]c4c(c3Nc3ccccc3)C(=O)N(C)CC4)ccn2)cc1 InChI=1S/C31H32N6O4/c1-37-16-13-24-27(31(37)40)29(34-23-6-4-3-5-7-23)28(35-24)22-12-14-32-25(19-22)36-26(38)18-20-8-10-21(11-9-20)30(39)33-15-17-41-2/h3-12,14,19,34-35H,13,15-18H2,1-2H3,(H,33,39)(H,32,36,38) SWZLQQMKDWLWKC-UHFFFAOYSA-N 721193 4-(2-{[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]amino}-2-oxoethyl)-N-(2-methoxyethyl)benzamide::US12227501, Example 152 Epidermal growth factor receptor [669-1210] 1660 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721193 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721193&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674324 513841245 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492943 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(C(=O)N5CCNCC5)cc4)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C32H33N7O3/c1-38-16-12-25-28(32(38)42)30(35-24-5-3-2-4-6-24)29(36-25)23-11-13-34-26(20-23)37-27(40)19-21-7-9-22(10-8-21)31(41)39-17-14-33-15-18-39/h2-11,13,20,33,35-36H,12,14-19H2,1H3,(H,34,37,40) SXBIWPGTSITBPU-UHFFFAOYSA-N 721194 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-[4-(piperazine-1-carbonyl)phenyl]acetamide::US12227501, Example 153 Epidermal growth factor receptor [669-1210] 287 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721194 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721194&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674267 513841246 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492944 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c(Nc3cccc(F)c3F)c2C1=O InChI=1S/C27H22F3N5O2/c1-35-12-10-19-23(27(35)37)26(33-20-4-2-3-18(29)24(20)30)25(32-19)16-9-11-31-21(14-16)34-22(36)13-15-5-7-17(28)8-6-15/h2-9,11,14,32-33H,10,12-13H2,1H3,(H,31,34,36) VYKBWPLPWBMVTQ-UHFFFAOYSA-N 721195 N-{4-[3-(2,3-difluoroanilino)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide formamide salt::US12227501, Example 154 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721195 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721195&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674223 513841247 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492945 CN(C)CCNC(=O)c1ccc(CC(=O)Nc2cc(-c3[nH]c4c(c3Nc3ccccc3)C(=O)N(C)CC4)ccn2)cc1 InChI=1S/C32H35N7O3/c1-38(2)18-16-34-31(41)22-11-9-21(10-12-22)19-27(40)37-26-20-23(13-15-33-26)29-30(35-24-7-5-4-6-8-24)28-25(36-29)14-17-39(3)32(28)42/h4-13,15,20,35-36H,14,16-19H2,1-3H3,(H,34,41)(H,33,37,40) VTHDNDMZUMSBFW-UHFFFAOYSA-N 721196 4-(2-{[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]amino}-2-oxoethyl)-N-[2-(dimethylamino)ethyl]benzamide::US12227501, Example 155 Epidermal growth factor receptor [669-1210] 476 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721196 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721196&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674237 513841248 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492946 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)Cc4ccc(F)cc4)c3)c2Nc2ccccc2)CC12CCC2 InChI=1S/C30H28FN5O2/c1-36-29(38)26-23(18-30(36)13-5-14-30)34-27(28(26)33-22-6-3-2-4-7-22)20-12-15-32-24(17-20)35-25(37)16-19-8-10-21(31)11-9-19/h2-4,6-12,15,17,33-34H,5,13-14,16,18H2,1H3,(H,32,35,37) WTEKKYAHRWEYNN-UHFFFAOYSA-N 721197 N-[4-(3'-anilino-5'-methyl-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide::US12227501, Example 156 Epidermal growth factor receptor [669-1210] 6660 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721197 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721197&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674334 513841249 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492947 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C2(CCC2)C3)ccn1)c1ccc(F)cc1 InChI=1S/C31H30FN5O2/c1-19(20-9-11-22(32)12-10-20)29(38)36-25-17-21(13-16-33-25)27-28(34-23-7-4-3-5-8-23)26-24(35-27)18-31(14-6-15-31)37(2)30(26)39/h3-5,7-13,16-17,19,34-35H,6,14-15,18H2,1-2H3,(H,33,36,38) HGZBLFDJBJBFKL-UHFFFAOYSA-N 721198 N-[4-(3'-anilino-5'-methyl-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Racemate)::US12227501, Example 157 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721198 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721198&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674422 513841250 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492948 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C2(CCC2)C3)ccn1)c1ccc(F)cc1 InChI=1S/C31H30FN5O2/c1-19(20-9-11-22(32)12-10-20)29(38)36-25-17-21(13-16-33-25)27-28(34-23-7-4-3-5-8-23)26-24(35-27)18-31(14-6-15-31)37(2)30(26)39/h3-5,7-13,16-17,19,34-35H,6,14-15,18H2,1-2H3,(H,33,36,38) HGZBLFDJBJBFKL-UHFFFAOYSA-N 721199 (−)-N-[4-(3'-anilino-5'-methyl-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 1)::US12227501, Example 158 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721199 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721199&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674422 513841251 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492949 CC(C(=O)Nc1cc(-c2[nH]c3c(c2Nc2ccccc2)C(=O)N(C)C2(CCC2)C3)ccn1)c1ccc(F)cc1 InChI=1S/C31H30FN5O2/c1-19(20-9-11-22(32)12-10-20)29(38)36-25-17-21(13-16-33-25)27-28(34-23-7-4-3-5-8-23)26-24(35-27)18-31(14-6-15-31)37(2)30(26)39/h3-5,7-13,16-17,19,34-35H,6,14-15,18H2,1-2H3,(H,33,36,38) HGZBLFDJBJBFKL-UHFFFAOYSA-N 721200 (+)-N-[4-(3'-anilino-5'-methyl-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Enantiomer 2)::US12227501, Example 159 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721200 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721200&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674422 513841252 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492950 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c2Nc2ccccc2)CC12CCC2 InChI=1S/C32H30F3N5O2/c1-40-31(42)27-24(18-32(40)13-5-14-32)38-28(29(27)37-22-6-3-2-4-7-22)20-12-15-36-26(16-20)39-30(41)23(17-25(34)35)19-8-10-21(33)11-9-19/h2-4,6-12,15-16,23,25,37-38H,5,13-14,17-18H2,1H3,(H,36,39,41) CFRUQBGKKYVHHQ-UHFFFAOYSA-N 721201 N-[4-(3'-anilino-5'-methyl-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US12227501, Example 160 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721201 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721201&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674465 513841253 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492951 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c2Nc2ccccc2)CC12CCC2 InChI=1S/C32H30F3N5O2/c1-40-31(42)27-24(18-32(40)13-5-14-32)38-28(29(27)37-22-6-3-2-4-7-22)20-12-15-36-26(16-20)39-30(41)23(17-25(34)35)19-8-10-21(33)11-9-19/h2-4,6-12,15-16,23,25,37-38H,5,13-14,17-18H2,1H3,(H,36,39,41) CFRUQBGKKYVHHQ-UHFFFAOYSA-N 721202 (−)-N-[4-(3'-anilino-5'-methyl-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1)::US12227501, Example 161 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721202 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721202&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674465 513841254 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492952 CN1C(=O)c2c([nH]c(-c3ccnc(NC(=O)C(CC(F)F)c4ccc(F)cc4)c3)c2Nc2ccccc2)CC12CCC2 InChI=1S/C32H30F3N5O2/c1-40-31(42)27-24(18-32(40)13-5-14-32)38-28(29(27)37-22-6-3-2-4-7-22)20-12-15-36-26(16-20)39-30(41)23(17-25(34)35)19-8-10-21(33)11-9-19/h2-4,6-12,15-16,23,25,37-38H,5,13-14,17-18H2,1H3,(H,36,39,41) CFRUQBGKKYVHHQ-UHFFFAOYSA-N 721203 (+)-N-[4-(3'-anilino-5'-methyl-4'-oxo-1',4',5',7'-tetrahydrospiro[cyclobutane-1,6'-pyrrolo[3,2-c]pyridin]-2'-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2)::US12227501, Example 162 Epidermal growth factor receptor [669-1210] >20000 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721203 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721203&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674465 513841255 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492953 CN1CCc2[nH]c(-c3ccnc(NC(=O)Cc4c(F)cc(F)cc4F)c3)c(Nc3ccccc3)c2C1=O InChI=1S/C27H22F3N5O2/c1-35-10-8-21-24(27(35)37)26(32-17-5-3-2-4-6-17)25(33-21)15-7-9-31-22(11-15)34-23(36)14-18-19(29)12-16(28)13-20(18)30/h2-7,9,11-13,32-33H,8,10,14H2,1H3,(H,31,34,36) JIEXEDGFFBGAIL-UHFFFAOYSA-N 721204 N-[4-(3-anilino-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(2,4,6-trifluorophenyl)acetamide::US12227501, Example 164 Epidermal growth factor receptor [669-1210] 419 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=721204 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=721204&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 154674285 513841256 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492954 CC(=O)Nc1cc(ccn1)-c1[nH]c2CCNC(=O)c2c1Nc1ccccc1 InChI=1S/C20H19N5O2/c1-12(26)23-16-11-13(7-9-21-16)18-19(24-14-5-3-2-4-6-14)17-15(25-18)8-10-22-20(17)27/h2-7,9,11,24-25H,8,10H2,1H3,(H,22,27)(H,21,23,26) OEXTZXWPZXNIIH-UHFFFAOYSA-N 415414 US10428063, Example 14::Example 14 (N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}acetamide)::WO 2016/120196, Example 14::US20230322767, Example No. 14 WO 2016/120196::US20230339939, WO 2016/120196, Example 14::WO2016/120196, Example 14 Casein kinase I isoform alpha Homo sapiens 20.3 US Patent 10.7270/Q21C22F4 aid2061065 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415414 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415414&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 122442118 433915451 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492955 CC(=O)Nc1cc(ccn1)-c1[nH]c2CCNC(=O)c2c1Nc1ccccc1 InChI=1S/C20H19N5O2/c1-12(26)23-16-11-13(7-9-21-16)18-19(24-14-5-3-2-4-6-14)17-15(25-18)8-10-22-20(17)27/h2-7,9,11,24-25H,8,10H2,1H3,(H,22,27)(H,21,23,26) OEXTZXWPZXNIIH-UHFFFAOYSA-N 415414 US10428063, Example 14::Example 14 (N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}acetamide)::WO 2016/120196, Example 14::US20230322767, Example No. 14 WO 2016/120196::US20230339939, WO 2016/120196, Example 14::WO2016/120196, Example 14 Epidermal growth factor receptor [669-1210] 104 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415414 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415414&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 122442118 433915451 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492956 CN1CCc2[nH]c(c(Nc3ccccc3)c2C1=O)-c1ccnc(NC(C)=O)c1 InChI=1S/C21H21N5O2/c1-13(27)23-17-12-14(8-10-22-17)19-20(24-15-6-4-3-5-7-15)18-16(25-19)9-11-26(2)21(18)28/h3-8,10,12,24-25H,9,11H2,1-2H3,(H,22,23,27) LPYBJNPKBPALQQ-UHFFFAOYSA-N 415423 US10428063, Example 23::N-{4-[5-methyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}acetamide::WO 2016/120196, Example 23::US20230322767, Example No. 23 WO 2016/120196::US20230339939, WO 2016/120196, Example 23::WO2016/120196, Example 23 Casein kinase I isoform alpha Homo sapiens 11.4 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415423 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415423&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 122452966 433915460 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492957 CN1CCc2[nH]c(c(Nc3ccccc3)c2C1=O)-c1ccnc(NC(C)=O)c1 InChI=1S/C21H21N5O2/c1-13(27)23-17-12-14(8-10-22-17)19-20(24-15-6-4-3-5-7-15)18-16(25-19)9-11-26(2)21(18)28/h3-8,10,12,24-25H,9,11H2,1-2H3,(H,22,23,27) LPYBJNPKBPALQQ-UHFFFAOYSA-N 415423 US10428063, Example 23::N-{4-[5-methyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}acetamide::WO 2016/120196, Example 23::US20230322767, Example No. 23 WO 2016/120196::US20230339939, WO 2016/120196, Example 23::WO2016/120196, Example 23 Epidermal growth factor receptor [669-1210] 150 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415423 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415423&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 122452966 433915460 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492958 CN1CCc2[nH]c(c(Nc3ccccc3)c2C1=O)-c1ccnc(NC(=O)C2CC2)c1 InChI=1S/C23H23N5O2/c1-28-12-10-17-19(23(28)30)21(25-16-5-3-2-4-6-16)20(26-17)15-9-11-24-18(13-15)27-22(29)14-7-8-14/h2-6,9,11,13-14,25-26H,7-8,10,12H2,1H3,(H,24,27,29) CAOVBAQHBWKZJG-UHFFFAOYSA-N 415424 US10428063, Example 24::N-{4-[5-methyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}cyclopropanecarboxamide::WO 2016/120196, Example 24::US20230322767, Example No. 24 WO 2016/120196::US20230339939, WO 2016/120196, Example 24::WO2016/120196, Example 24 Casein kinase I isoform alpha Homo sapiens <3.43 US Patent 10.7270/Q21C22F4 aid2061065 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415424 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415424&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 122442100 433915461 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492959 CN1CCc2[nH]c(c(Nc3ccccc3)c2C1=O)-c1ccnc(NC(=O)C2CC2)c1 InChI=1S/C23H23N5O2/c1-28-12-10-17-19(23(28)30)21(25-16-5-3-2-4-6-16)20(26-17)15-9-11-24-18(13-15)27-22(29)14-7-8-14/h2-6,9,11,13-14,25-26H,7-8,10,12H2,1H3,(H,24,27,29) CAOVBAQHBWKZJG-UHFFFAOYSA-N 415424 US10428063, Example 24::N-{4-[5-methyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}cyclopropanecarboxamide::WO 2016/120196, Example 24::US20230322767, Example No. 24 WO 2016/120196::US20230339939, WO 2016/120196, Example 24::WO2016/120196, Example 24 Casein kinase I isoform alpha Homo sapiens 4.51 US Patent 10.7270/Q21C22F4 aid2061066 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415424 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415424&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 122442100 433915461 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492960 CN1CCc2[nH]c(c(Nc3ccccc3)c2C1=O)-c1ccnc(NC(=O)C2CC2)c1 InChI=1S/C23H23N5O2/c1-28-12-10-17-19(23(28)30)21(25-16-5-3-2-4-6-16)20(26-17)15-9-11-24-18(13-15)27-22(29)14-7-8-14/h2-6,9,11,13-14,25-26H,7-8,10,12H2,1H3,(H,24,27,29) CAOVBAQHBWKZJG-UHFFFAOYSA-N 415424 US10428063, Example 24::N-{4-[5-methyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}cyclopropanecarboxamide::WO 2016/120196, Example 24::US20230322767, Example No. 24 WO 2016/120196::US20230339939, WO 2016/120196, Example 24::WO2016/120196, Example 24 Epidermal growth factor receptor [669-1210] 42.6 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415424 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415424&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 122442100 433915461 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492961 CN1CCc2[nH]c(c(Nc3ccccc3)c2C1=O)-c1ccnc(NC(=O)[C@H]2C[C@H]2F)c1 |r| InChI=1S/C23H22FN5O2/c1-29-10-8-17-19(23(29)31)21(26-14-5-3-2-4-6-14)20(27-17)13-7-9-25-18(11-13)28-22(30)15-12-16(15)24/h2-7,9,11,15-16,26-27H,8,10,12H2,1H3,(H,25,28,30) BSAVGANXIAKUQK-UHFFFAOYSA-N 625339 US20230322767, Example No. 25 WO 2016/120196::US20230339939, WO 2016/120196, Example 25::rel-(1 R,2R)-2-fluoro-N-{4-[5-methyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1 H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}cyclopropanecarboxamide::WO2016/120196, Example 25 Casein kinase I isoform alpha Homo sapiens 62.5 US Patent 10.7270/Q21C22F4 aid2061065 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625339 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625339&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 122442136 485207673 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492962 CN1CCc2[nH]c(c(Nc3ccccc3)c2C1=O)-c1ccnc(NC(=O)[C@H]2C[C@H]2F)c1 |r| InChI=1S/C23H22FN5O2/c1-29-10-8-17-19(23(29)31)21(26-14-5-3-2-4-6-14)20(27-17)13-7-9-25-18(11-13)28-22(30)15-12-16(15)24/h2-7,9,11,15-16,26-27H,8,10,12H2,1H3,(H,25,28,30) BSAVGANXIAKUQK-UHFFFAOYSA-N 625339 US20230322767, Example No. 25 WO 2016/120196::US20230339939, WO 2016/120196, Example 25::rel-(1 R,2R)-2-fluoro-N-{4-[5-methyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1 H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}cyclopropanecarboxamide::WO2016/120196, Example 25 Epidermal growth factor receptor [669-1210] 321 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625339 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625339&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 122442136 485207673 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1492963 CN5CCc4[nH]c(c2ccnc(NC(=O)[C@@H]1C[C@@H]1F)c2)c(Nc3ccccc3)c4C5=O InChI=1S/C23H22FN5O2/c1-29-10-8-17-19(23(29)31)21(26-14-5-3-2-4-6-14)20(27-17)13-7-9-25-18(11-13)28-22(30)15-12-16(15)24/h2-7,9,11,15-16,26-27H,8,10,12H2,1H3,(H,25,28,30) BSAVGANXIAKUQK-UHFFFAOYSA-N 415440 US10428063, Example 40::(1S,2S)-2-fluoro-N-{4-[5-methyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}cyclopropanecarboxamide::WO2016/120196, Example 40 Casein kinase I isoform alpha Homo sapiens 24.1 US Patent 10.7270/Q21C22F4 aid2061065 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415440 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415440&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1492964 CN5CCc4[nH]c(c2ccnc(NC(=O)[C@@H]1C[C@@H]1F)c2)c(Nc3ccccc3)c4C5=O InChI=1S/C23H22FN5O2/c1-29-10-8-17-19(23(29)31)21(26-14-5-3-2-4-6-14)20(27-17)13-7-9-25-18(11-13)28-22(30)15-12-16(15)24/h2-7,9,11,15-16,26-27H,8,10,12H2,1H3,(H,25,28,30) BSAVGANXIAKUQK-UHFFFAOYSA-N 415440 US10428063, Example 40::(1S,2S)-2-fluoro-N-{4-[5-methyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}cyclopropanecarboxamide::WO2016/120196, Example 40 Epidermal growth factor receptor [669-1210] 85.5 US Patent 10.7270/Q21C22F4 aid2061069 US12227501 Schulze, V; Mengel, A; Schroder, J; Faria Alvares De Lemos, AC; Bone, W; Bomer, U; Sulzle, D; Christ, C; Hillig, R; Lechner, C; Corsello, S; Handing, K; Caliman, A; Rauh, U; Kaulfuss, S; Mortier, JX 2/18/2025 6/17/2025 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415440 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1847&target=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415440&enzyme=Epidermal+growth+factor+receptor+%5B669-1210%5D&column=ki&startPg=0&Increment=50&submit=Search 1 RRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 7SZ7,7SZ5,7SYE,7SYD,3GOP,9P9U,7B85,7AEM,4TKS,1M17,1M14,7SI1,5EM8,5CAV,3VJO,8PNZ,7UKV,7AEI,5UGB,4I23,9QXN,1XKK,9KL4,9GL9,9GI9,9FRD,8SC7,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,2RF9,2GS6,2GS2,9H47,9H46,9H42,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9FZS,9FZR,9DM8,8G63,6VHP,6VHN,6VH4,6D8E,3POZ,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C,8HY7,8HV5,8HV3,8HV1,8A2A,8A27,5HIC,5HIB,5HCZ,5HCY,5HCX,5EM7,5EM6,5EM5,5EDR,5EDQ,5EDP,5CAU,5CAS,5CAQ,5CAP,5CAO,5CAN,5CAL,5C8N,5C8M,5C8K,4RJ8,4RJ7,4RJ6,4RJ5,4RJ4,5Y25,7ZYP,7ZYN,7ZYM,7OXB,6S8A,6S89,3W2R,3W2Q,3W2P,3W2O Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5